data_6snj_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6snj _Structure_validation_residue.Date_analyzed 2020-10-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.824 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 C-N-CA 124.009 3.139 . . . . 0.0 111.932 178.005 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.8 m -101.83 147.85 26.01 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.6 pt -128.84 149.22 33.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.006 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -103.68 149.77 24.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.3 147.96 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 123.105 0.562 . . . . 0.0 111.163 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -139.54 149.07 43.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.95 4.81 57.65 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.718 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.18 -54.46 43.09 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.339 0.57 . . . . 0.0 111.159 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.416 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.28 -179.23 48.08 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.12 -9.65 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.596 0.758 . . . . 0.0 112.299 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -81.59 -1.53 46.77 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.446 0.298 . . . . 0.0 111.44 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.34 156.77 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.45 168.18 27.65 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.83 -39.34 14.9 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.313 1.045 . . . . 0.0 111.71 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -73.92 -28.54 61.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.434 -0.166 . . . . 0.0 110.89 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.63 -49.84 20.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.266 0.226 . . . . 0.0 110.539 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.46 ' CG2' HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.53 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.32 79.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.187 0.449 . . . . 0.0 110.583 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -75.23 -15.7 60.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 111.272 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -95.03 -26.58 16.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -97.88 -20.0 17.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -66.22 -19.13 65.74 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -64.05 -21.07 66.37 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.4 mm -87.8 -28.34 5.55 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.444 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 168.49 170.05 32.68 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.8 mm -68.04 134.85 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 122.519 -0.401 . . . . 0.0 111.247 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.2 mm -76.97 137.09 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.436 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.7 ttmm -69.68 139.33 53.45 Favored 'General case' 0 C--O 1.23 0.041 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.106 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.67 153.42 75.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.798 1.665 . . . . 0.0 109.027 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.436 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.5 mtp -78.69 79.35 5.11 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.786 0.434 . . . . 0.0 111.175 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.46 HG21 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.37 159.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.697 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -156.42 130.62 8.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.97 119.61 31.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -82.79 158.36 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.38 0.61 . . . . 0.0 112.085 -170.733 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.22 1.71 58.1 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -94.32 150.9 19.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.331 0.566 . . . . 0.0 110.916 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.27 165.77 32.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.072 0.549 . . . . 0.0 109.59 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 7.1 m -136.47 122.55 20.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 96.2 t -114.99 124.01 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.7 t -96.29 126.6 41.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.253 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -84.09 148.32 26.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.84 -17.65 59.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 92.4 m-20 -128.13 134.08 25.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 110.687 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.432 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.8 Cg_endo -67.2 -32.94 32.45 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.689 2.259 . . . . 0.0 114.659 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.4 Cg_endo -75.13 -18.94 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 121.11 1.432 . . . . 0.0 110.831 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.8 m -77.19 -29.81 54.54 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.01 78.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -66.0 -37.03 84.89 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.397 -0.189 . . . . 0.0 110.629 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.48 -40.31 81.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.459 0.304 . . . . 0.0 110.969 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.17 -25.92 65.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.26 -56.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.13 -21.68 63.97 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -94.04 -58.67 2.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -70.92 -32.34 69.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.07 112.37 1.33 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.02 -16.48 30.33 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.837 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -94.26 -172.29 2.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.788 1.294 . . . . 0.0 110.07 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -101.73 173.7 6.29 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.622 0.369 . . . . 0.0 110.302 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -127.96 -38.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.3 t -141.73 4.8 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.05 -22.58 4.0 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.61 148.45 34.75 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 151.91 78.25 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.291 2.661 . . . . 0.0 110.74 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.34 169.36 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.629 0.371 . . . . 0.0 110.862 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -134.17 155.88 49.31 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.922 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.74 146.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.956 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.3 m -154.92 173.86 15.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 108.881 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -57.98 159.77 5.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 169.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.676 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 123.996 3.131 . . . . 0.0 112.343 177.087 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -98.43 147.16 25.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.44 149.88 34.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.018 0.527 . . . . 0.0 110.139 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -105.12 149.08 26.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.14 148.19 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 123.181 0.592 . . . . 0.0 111.056 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -138.45 149.55 45.57 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.58 57.61 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.848 -0.418 . . . . 0.0 112.599 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.06 -54.53 38.01 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.404 0.682 . . . . 0.0 111.639 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.474 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.68 -176.81 43.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -170.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -85.44 -9.17 57.86 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.773 0.829 . . . . 0.0 112.265 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -78.77 -5.2 52.67 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.184 -0.322 . . . . 0.0 111.209 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.51 158.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.547 0.739 . . . . 0.0 112.678 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.66 167.16 29.07 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.9 mm -49.32 -39.35 13.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.359 1.064 . . . . 0.0 111.731 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.14 -28.41 62.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.35 -0.219 . . . . 0.0 111.15 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.1 t -75.73 -48.73 20.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.303 0.241 . . . . 0.0 110.765 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.466 ' CG2' HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.44 -53.62 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.55 77.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.36 0.527 . . . . 0.0 110.52 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -75.96 -16.02 60.07 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.217 -0.302 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.98 -27.48 16.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -97.02 -19.86 18.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -65.27 -18.95 65.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.6 -21.59 66.75 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.5 mm -87.67 -25.76 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.047 0 CA-C-O 120.818 0.342 . . . . 0.0 110.313 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 165.81 169.81 29.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.52 135.86 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 O-C-N 122.646 -0.326 . . . . 0.0 110.993 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.2 mm -76.54 137.99 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.409 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.2 ttmm -69.97 147.51 50.07 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.821 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 C--O 1.232 0.184 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.82 155.06 56.77 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.316 2.011 . . . . 0.0 109.413 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.409 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 49.3 mtp -76.9 76.99 3.48 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.723 0.409 . . . . 0.0 111.154 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.466 HG21 ' CG2' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -136.03 154.55 33.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.065 0 C-N-CA 123.283 0.633 . . . . 0.0 110.792 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -151.9 131.9 13.43 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.02 118.06 30.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -80.5 158.44 25.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 CA--C 1.513 -0.462 0 CA-C-O 121.413 0.625 . . . . 0.0 112.59 -173.093 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.474 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.27 1.5 72.07 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.415 0.531 . . . . 0.0 111.911 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.17 148.5 24.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 117.808 0.804 . . . . 0.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.2 165.84 33.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.388 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 5.0 m -135.22 121.22 19.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.976 0.51 . . . . 0.0 111.943 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.08 125.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 33.3 t -96.66 129.68 44.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.49 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.48 147.27 26.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -76.72 -17.35 59.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -124.84 131.25 24.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.069 0.948 . . . . 0.0 110.525 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.428 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 29.9 Cg_endo -66.17 -33.3 40.53 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.798 2.332 . . . . 0.0 114.382 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 93.0 Cg_endo -75.53 -20.27 16.0 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 CA-C-N 121.372 1.526 . . . . 0.0 111.016 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -74.72 -29.81 61.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.52 -47.98 76.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.418 ' HA ' HD11 ' A' ' 351' ' ' ILE . 17.3 tptm -64.62 -38.15 90.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.346 0.117 . . . . 0.0 110.71 -177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.59 82.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.471 0.308 . . . . 0.0 110.808 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.91 -25.81 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 348' ' ' LYS . 66.4 mt -72.54 -57.92 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -59.67 -22.32 61.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -92.65 -60.35 1.84 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.72 -32.03 70.36 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.58 112.45 1.28 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.89 -15.81 31.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.149 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.47 -171.91 2.5 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.719 1.26 . . . . 0.0 109.861 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -101.12 174.68 5.89 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.427 0.291 . . . . 0.0 110.455 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -130.66 -37.38 1.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.617 0.367 . . . . 0.0 110.404 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.3 t -144.37 15.59 1.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.86 10.79 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.82 148.0 34.44 Favored Pre-proline 0 CA--C 1.53 0.175 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.26 151.22 76.77 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.485 2.79 . . . . 0.0 110.646 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.07 169.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 122.858 0.463 . . . . 0.0 110.705 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 156.27 49.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.698 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.06 147.87 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.068 0.547 . . . . 0.0 110.307 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 175.88 13.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.126 0.971 . . . . 0.0 108.809 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.23 163.84 3.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.206 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.456 -0.684 0 C-N-CA 123.787 2.991 . . . . 0.0 112.603 177.304 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.4 m -98.49 148.7 23.47 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.3 pt -128.98 149.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.335 0.654 . . . . 0.0 109.854 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -103.0 149.09 24.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.2 t -133.94 148.34 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.319 0.647 . . . . 0.0 110.892 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -139.14 151.09 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.1 5.34 59.56 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 120.013 -0.326 . . . . 0.0 112.797 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.5 mp -55.09 -55.22 33.51 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.428 0.614 . . . . 0.0 111.292 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.48 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.86 -176.99 44.62 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.03 -7.22 58.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.087 0.955 . . . . 0.0 112.368 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.29 -6.7 55.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.677 0.275 . . . . 0.0 110.805 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.73 159.76 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 163.63 39.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 44.3 mm -50.7 -37.1 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.009 0.924 . . . . 0.0 111.805 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -73.86 -28.59 61.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.251 -0.281 . . . . 0.0 110.991 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.6 t -74.0 -48.52 29.73 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 122.258 0.223 . . . . 0.0 110.548 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.3 m -61.71 -53.45 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.45 79.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.182 0.446 . . . . 0.0 110.884 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -75.33 -16.22 60.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 111.088 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -93.94 -27.56 16.29 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -96.85 -20.08 18.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -65.99 -19.09 65.74 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.31 -21.24 66.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.2 mm -87.99 -23.66 6.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 162.2 169.74 25.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.06 138.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 122.535 -0.391 . . . . 0.0 111.178 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.3 mm -78.9 135.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 15.5 ttpp -70.04 139.18 52.64 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -176.442 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.64 152.39 80.62 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.927 1.752 . . . . 0.0 108.913 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.453 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.2 mtp -78.09 79.8 4.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.004 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.436 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.5 OUTLIER -132.67 152.16 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.328 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -146.42 126.44 13.69 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 36.0 mt -96.07 113.46 25.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -79.25 156.09 28.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 CA--C 1.514 -0.415 0 CA-C-O 121.736 0.779 . . . . 0.0 112.855 -170.08 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.48 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.03 -5.69 61.58 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -87.23 144.98 26.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.76 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.83 166.49 33.23 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.7 m -138.64 119.24 13.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.705 0.402 . . . . 0.0 111.353 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.65 125.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.9 t -96.94 132.91 42.26 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.06 -0.4 . . . . 0.0 110.301 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.89 147.28 23.26 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -73.69 -20.49 60.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.402 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.4 m-20 -124.5 133.16 24.51 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 123.671 0.788 . . . . 0.0 110.706 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.434 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 26.2 Cg_endo -66.69 -33.78 34.07 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.724 2.283 . . . . 0.0 114.031 -175.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 85.5 Cg_endo -76.84 -18.93 14.55 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 CA-C-N 121.214 1.469 . . . . 0.0 111.032 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 56.2 m -75.49 -29.72 59.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.38 -48.03 79.58 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -64.64 -39.04 93.01 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-O 120.595 0.236 . . . . 0.0 110.714 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.72 -39.32 84.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.392 0.277 . . . . 0.0 110.642 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.1 -26.15 65.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -72.79 -57.25 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.68 -22.27 61.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -93.13 -60.37 1.81 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.77 -31.55 69.55 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -56.75 113.24 1.56 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.005 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.33 37.68 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.169 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -96.5 -172.48 2.52 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.545 1.173 . . . . 0.0 110.027 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.96 175.6 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.843 0.354 . . . . 0.0 110.559 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -131.45 -39.41 1.14 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 17.0 t -141.53 19.69 2.2 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.798 0.439 . . . . 0.0 110.101 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.79 -8.29 34.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -111.49 146.77 35.32 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 123.881 0.872 . . . . 0.0 109.587 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.49 149.42 68.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.563 2.842 . . . . 0.0 110.846 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.75 169.72 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.924 0.49 . . . . 0.0 110.878 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -135.83 156.5 48.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.127 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.4 t -144.7 147.55 19.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.09 0.556 . . . . 0.0 110.153 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 71.0 m -155.23 175.41 13.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.054 0.941 . . . . 0.0 108.833 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -59.8 163.81 4.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.887 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 C-N-CA 123.81 3.007 . . . . 0.0 112.377 178.23 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 26.7 m -132.71 150.79 52.11 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.662 0.385 . . . . 0.0 111.146 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.1 pt -128.42 148.84 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.876 0.47 . . . . 0.0 110.271 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -101.15 149.82 23.58 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.4 148.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.362 0.665 . . . . 0.0 110.902 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -138.77 149.53 45.11 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.47 5.59 57.83 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.971 -0.349 . . . . 0.0 112.869 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.91 -56.67 17.82 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 117.479 0.639 . . . . 0.0 111.408 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.86 -179.61 44.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.84 -10.0 59.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.626 0.77 . . . . 0.0 112.281 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -82.17 2.48 31.34 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.386 0.274 . . . . 0.0 111.553 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.91 155.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -158.49 168.91 25.65 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.7 mm -49.62 -40.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.391 1.077 . . . . 0.0 111.645 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.59 -28.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.449 -0.157 . . . . 0.0 110.876 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.7 t -75.08 -49.84 18.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.221 0.208 . . . . 0.0 110.611 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.464 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.8 m -61.09 -53.71 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.1 78.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.212 0.46 . . . . 0.0 110.718 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.4 ' OD2' ' HE2' ' A' ' 306' ' ' LYS . 19.8 t0 -76.07 -15.81 60.04 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.803 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -94.14 -27.63 16.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.411 ' CD2' HG23 ' A' ' 339' ' ' VAL . 45.4 m-85 -97.23 -19.99 18.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HE2' ' OD2' ' A' ' 303' ' ' ASP . 53.1 pttt -65.65 -19.05 65.75 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -173.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.27 -21.02 66.45 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -88.34 -26.04 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.732 0.301 . . . . 0.0 110.474 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.34 170.7 31.58 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 52.1 mm -68.4 134.63 29.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 O-C-N 122.662 -0.316 . . . . 0.0 111.348 -172.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.8 mm -76.19 137.34 22.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.44 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.8 ttmm -67.78 147.37 52.68 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.7 153.87 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.173 1.915 . . . . 0.0 109.102 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.44 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.9 mtp -79.65 78.52 6.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 122.476 0.31 . . . . 0.0 111.001 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.464 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.6 156.86 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.36 0.664 . . . . 0.0 110.71 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -152.76 130.57 11.66 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.918 0.887 . . . . 0.0 109.455 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -94.07 119.49 33.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -84.03 160.09 21.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--N 1.339 0.147 0 CA-C-O 121.763 0.792 . . . . 0.0 110.357 -171.198 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.52 0.22 59.46 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.81 149.44 21.98 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.396 0.598 . . . . 0.0 110.927 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.13 165.83 32.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.378 0.671 . . . . 0.0 109.75 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.0 m -136.9 121.74 18.73 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 305' ' ' PHE . 98.2 t -114.16 121.45 66.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.8 t -92.72 126.42 37.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.17 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -84.46 147.39 27.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.05 -14.81 59.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.427 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 94.0 m-20 -127.64 135.75 27.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 111.221 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.423 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 24.1 Cg_endo -65.82 -35.37 36.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.025 2.484 . . . . 0.0 114.422 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 343' ' ' ASP . 87.8 Cg_endo -76.46 -20.34 14.16 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.719 1.613 . . . . 0.0 111.358 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -74.19 -30.67 62.33 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 122.297 -0.252 . . . . 0.0 110.431 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.73 93.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -65.07 -41.15 95.35 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 120.547 0.213 . . . . 0.0 110.834 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.98 86.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.354 0.262 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -25.08 64.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.6 mt -73.4 -56.59 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -60.36 -21.63 62.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -94.06 -59.92 1.86 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -70.78 -32.52 69.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.46 113.74 1.92 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.16 -17.09 32.14 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.949 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -93.76 -172.88 3.0 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.648 1.224 . . . . 0.0 109.808 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -100.33 173.72 6.46 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.34 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -127.31 -38.7 1.94 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.437 0.295 . . . . 0.0 110.277 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.6 t -143.2 6.61 1.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 110.363 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.48 -22.27 4.18 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.41 149.25 35.92 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 109.463 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.65 151.95 74.7 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.538 2.825 . . . . 0.0 110.388 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.62 168.28 21.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.076 0.55 . . . . 0.0 110.851 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 156.17 47.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.917 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 51.4 t -145.2 146.77 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 123.636 0.585 . . . . 0.0 110.224 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.0 m -155.26 171.65 19.48 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -59.01 162.24 4.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.228 177.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 C-N-CA 123.913 3.075 . . . . 0.0 112.003 178.534 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -98.79 148.44 23.89 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 11.1 pt -131.39 146.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.697 0.399 . . . . 0.0 110.575 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -100.78 149.6 23.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.87 147.32 30.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.111 0.564 . . . . 0.0 111.817 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.73 151.03 48.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 109.811 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.28 5.89 59.06 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 120.025 -0.319 . . . . 0.0 112.699 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.61 -57.68 10.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.397 0.679 . . . . 0.0 111.1 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.418 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.28 -178.57 44.71 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -77.89 -10.87 59.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.974 0.909 . . . . 0.0 112.109 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.02 0.2 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.25 0.22 . . . . 0.0 111.484 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.95 155.59 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.41 168.49 26.81 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.52 -39.73 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.897 0.879 . . . . 0.0 111.878 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.61 62.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.526 -0.109 . . . . 0.0 111.158 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.25 -49.52 19.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.729 -0.1 . . . . 0.0 110.729 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.478 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.5 m -61.56 -53.88 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.36 -37.44 77.92 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.249 0.477 . . . . 0.0 110.804 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -76.07 -15.83 60.04 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 111.099 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.56 -26.96 16.18 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 339' ' ' VAL . 46.6 m-85 -97.17 -20.22 18.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -65.68 -18.85 65.63 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.44 -21.16 66.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.6 mm -87.96 -25.47 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 110.161 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.92 170.28 29.67 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.91 135.24 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 O-C-N 122.478 -0.425 . . . . 0.0 111.135 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.9 mm -76.01 138.08 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -69.15 148.97 49.16 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.091 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.706 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.9 151.96 81.57 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.845 1.697 . . . . 0.0 109.005 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.9 mtp -77.91 78.69 4.4 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.77 0.428 . . . . 0.0 111.206 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.478 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.25 155.3 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 0.0 110.527 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -150.24 121.89 8.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.524 0.73 . . . . 0.0 109.326 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.14 121.67 30.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -77.64 162.83 26.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.418 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.61 16.62 36.11 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.37 156.83 31.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.783 0.791 . . . . 0.0 110.23 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.74 171.2 19.96 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.802 0.441 . . . . 0.0 110.262 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 70.8 m -136.33 129.07 30.82 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 305' ' ' PHE . 93.8 t -118.67 127.89 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.5 t -98.98 127.91 45.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.997 0.362 . . . . 0.0 110.513 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.18 147.95 26.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -75.85 -17.26 59.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.419 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 91.2 m-20 -127.54 133.89 25.59 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.979 0.912 . . . . 0.0 110.987 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.43 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -66.64 -33.79 34.54 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.646 2.231 . . . . 0.0 114.463 -175.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 88.7 Cg_endo -74.81 -19.79 18.0 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 CA-C-N 121.052 1.412 . . . . 0.0 110.843 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.9 m -75.89 -29.45 58.47 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.32 -0.237 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.47 73.34 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -65.33 -36.99 85.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.425 0.155 . . . . 0.0 110.593 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.38 82.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.493 0.317 . . . . 0.0 110.943 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.55 65.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.81 -56.09 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.69 -22.08 63.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -93.92 -59.99 1.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.82 -32.76 71.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.03 110.74 0.87 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.41 -16.09 24.57 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.035 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.6 -171.52 2.39 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.824 1.312 . . . . 0.0 109.902 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.53 173.94 6.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.664 0.269 . . . . 0.0 110.322 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -128.44 -37.44 1.81 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.608 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -145.0 11.05 1.35 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.682 0.393 . . . . 0.0 109.988 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.47 -20.3 6.18 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -103.12 148.64 35.94 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 151.97 75.13 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.388 2.725 . . . . 0.0 110.451 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.18 167.74 21.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.873 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.15 156.47 46.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.803 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.68 146.48 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.047 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 47.1 m -155.05 174.23 15.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.19 150.66 29.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.643 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 C-N-CA 123.486 2.791 . . . . 0.0 112.775 177.423 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.6 m -101.74 150.2 23.38 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.89 147.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 122.545 0.338 . . . . 0.0 110.101 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -102.57 147.94 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.28 147.53 31.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.076 0.551 . . . . 0.0 112.079 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -138.71 151.3 47.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.84 59.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.84 -57.08 13.54 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.359 0.664 . . . . 0.0 111.033 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.402 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.43 -178.05 45.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.62 -10.65 59.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.849 0.86 . . . . 0.0 112.178 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -80.54 -0.55 38.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.321 -0.237 . . . . 0.0 111.234 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.29 156.28 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.06 168.39 26.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.3 mm -48.67 -39.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 124.421 1.088 . . . . 0.0 111.861 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.92 -29.75 63.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.345 -0.222 . . . . 0.0 111.217 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.05 -48.61 23.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.154 0.182 . . . . 0.0 110.679 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.477 ' CG2' HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.57 -54.22 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.8 79.04 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.969 -0.457 . . . . 0.0 110.875 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.95 -15.82 60.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.252 -0.28 . . . . 0.0 110.932 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -94.32 -27.54 16.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.43 ' CD2' HG22 ' A' ' 339' ' ' VAL . 44.3 m-85 -96.59 -19.91 18.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -66.35 -18.63 65.47 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.74 -20.82 66.56 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.7 mm -87.93 -26.28 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.14 170.48 31.11 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.05 134.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 122.58 -0.365 . . . . 0.0 111.299 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.7 mm -76.3 138.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.445 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.7 ttmm -69.08 148.58 49.81 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.1 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 155.03 61.98 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.518 2.145 . . . . 0.0 109.935 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.445 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.7 mtp -79.28 77.44 5.81 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 122.791 0.436 . . . . 0.0 110.81 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.477 HG21 ' CG2' ' A' ' 301' ' ' VAL . 0.5 OUTLIER -130.91 159.26 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.428 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -155.93 124.73 6.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.787 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.13 120.96 31.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -73.36 162.68 29.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.518 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.656 0.741 . . . . 0.0 109.33 -178.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.0 18.86 28.12 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.7 156.08 38.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.417 0.609 . . . . 0.0 110.553 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.96 173.48 16.42 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.71 0.404 . . . . 0.0 110.288 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.0 m -139.92 128.14 22.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 122.658 0.383 . . . . 0.0 109.969 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 305' ' ' PHE . 94.6 t -118.11 127.12 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 124.024 0.93 . . . . 0.0 109.064 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.6 t -97.68 128.01 44.05 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.89 -0.506 . . . . 0.0 110.207 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -85.64 147.26 26.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -76.24 -18.2 59.13 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.407 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 96.9 m-20 -124.88 133.36 24.73 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 123.704 0.802 . . . . 0.0 110.72 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.428 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.4 Cg_endo -66.24 -34.31 36.51 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.818 2.346 . . . . 0.0 114.215 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.79 -19.54 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 121.168 1.453 . . . . 0.0 111.104 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 41.9 m -75.55 -30.52 59.75 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.26 78.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.58 -0.075 . . . . 0.0 110.799 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -64.28 -38.88 92.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.553 0.216 . . . . 0.0 110.954 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.68 83.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.372 0.269 . . . . 0.0 110.611 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.66 66.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.19 -57.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.26 -21.19 61.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -94.31 -60.3 1.76 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.85 -31.76 69.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -57.26 111.05 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.7 25.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.127 -0.818 . . . . 0.0 113.106 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.5 -171.8 2.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.674 1.237 . . . . 0.0 109.908 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.75 171.26 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.595 0.358 . . . . 0.0 110.447 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -127.19 -38.28 1.99 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.382 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.7 t -144.33 15.28 1.65 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.648 0.379 . . . . 0.0 110.098 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.64 -19.43 8.48 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.54 148.69 36.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.01 151.73 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 0.0 110.677 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.32 168.11 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 121.267 0.556 . . . . 0.0 110.66 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -133.62 155.45 49.64 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.17 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.8 t -144.35 147.04 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 122.867 0.467 . . . . 0.0 110.417 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.4 m -153.6 174.43 14.46 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -60.61 159.08 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.679 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.043 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.454 -0.847 0 C-N-CA 123.871 3.048 . . . . 0.0 112.308 176.805 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 111.228 0.084 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.8 m -99.42 147.8 24.89 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.3 pt -129.47 150.07 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 122.842 0.457 . . . . 0.0 110.115 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -105.02 149.44 25.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.0 t -134.16 148.82 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 123.219 0.607 . . . . 0.0 111.288 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -138.31 150.9 47.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.46 59.08 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 120.079 -0.289 . . . . 0.0 113.165 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.63 -55.84 28.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.14 0.576 . . . . 0.0 111.254 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.434 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.52 179.99 47.88 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.22 -11.42 59.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.74 0.816 . . . . 0.0 112.219 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.86 0.49 34.88 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.427 0.291 . . . . 0.0 111.323 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.59 155.24 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 112.666 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.4 168.16 28.14 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.7 mm -49.83 -39.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.294 1.037 . . . . 0.0 111.615 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -74.04 -28.47 61.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 121.254 -0.179 . . . . 0.0 111.011 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.6 t -75.44 -48.06 24.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.471 ' CG2' HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.4 -53.58 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.59 76.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.264 0.483 . . . . 0.0 110.898 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -76.41 -15.09 60.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.45 0.3 . . . . 0.0 111.219 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -95.09 -27.22 15.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -96.44 -20.32 18.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -65.56 -18.74 65.55 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.56 -21.55 66.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.3 mm -88.32 -24.12 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.765 0.316 . . . . 0.0 110.28 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.27 169.42 27.8 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.85 135.76 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.516 0.327 . . . . 0.0 111.186 -172.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.4 mm -77.03 137.27 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.419 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 36.9 ttmt -70.86 149.92 46.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.623 0.249 . . . . 0.0 110.485 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.231 0.124 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.331 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.55 155.49 47.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.312 2.008 . . . . 0.0 109.51 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 36.9 mtp -77.16 77.64 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.614 0.366 . . . . 0.0 111.118 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.471 HG21 ' CG2' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -135.63 158.3 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.724 -178.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -156.69 131.7 9.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.28 122.12 34.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -84.37 158.89 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 121.471 0.653 . . . . 0.0 112.603 -172.069 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.434 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.66 -0.88 59.69 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.55 150.31 21.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.344 0.572 . . . . 0.0 110.927 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.59 165.75 33.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.12 0.568 . . . . 0.0 109.606 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 122.74 20.61 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.02 125.65 73.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.8 t -98.06 129.48 44.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.557 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -87.24 147.74 25.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.02 -18.66 60.3 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -126.37 131.91 24.12 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 110.539 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.436 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 34.8 Cg_endo -67.71 -32.16 30.88 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.737 2.292 . . . . 0.0 114.347 -175.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -75.29 -19.65 17.06 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 121.411 1.54 . . . . 0.0 110.833 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -76.39 -29.76 57.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.647 0.203 . . . . 0.0 110.556 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.94 72.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.403 ' HA ' HD13 ' A' ' 351' ' ' ILE . 18.4 tptm -63.64 -38.81 92.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.484 0.183 . . . . 0.0 110.864 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.88 81.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.296 0.239 . . . . 0.0 110.894 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.22 65.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 348' ' ' LYS . 65.0 mt -72.25 -56.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.77 -21.24 62.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -93.83 -59.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.72 -32.56 71.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -56.59 112.27 1.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.19 -16.0 30.18 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.008 -0.884 . . . . 0.0 113.114 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -95.01 -172.63 2.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.75 1.275 . . . . 0.0 109.813 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.26 174.37 6.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.882 0.372 . . . . 0.0 110.47 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -129.95 -38.64 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.162 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.9 t -143.3 13.46 1.8 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.07 0.462 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.61 -22.37 7.79 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.97 147.97 33.82 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.37 151.6 76.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.256 2.637 . . . . 0.0 110.522 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.61 168.83 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.001 0.52 . . . . 0.0 110.911 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -133.89 156.73 47.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.6 t -144.78 146.65 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 123.703 0.627 . . . . 0.0 109.983 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 68.5 m -155.36 175.13 14.26 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.0 108.858 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -59.14 160.35 6.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.816 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 124.018 3.145 . . . . 0.0 112.388 178.426 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.7 m -131.51 151.14 51.83 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.577 0.351 . . . . 0.0 111.223 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.7 pt -126.6 148.82 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.063 0.545 . . . . 0.0 110.429 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -100.78 150.11 23.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.36 149.4 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.383 0.673 . . . . 0.0 111.042 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -139.75 150.22 44.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.97 58.28 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.954 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.63 -54.07 48.69 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.504 0.652 . . . . 0.0 111.678 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.59 -176.26 44.54 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -171.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -85.67 -7.23 58.93 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.551 0.741 . . . . 0.0 112.537 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -79.29 -2.69 42.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.431 -0.168 . . . . 0.0 111.056 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.74 158.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.769 0.828 . . . . 0.0 112.695 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.64 167.59 29.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.32 -39.73 17.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 124.344 1.057 . . . . 0.0 111.724 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.03 -29.07 63.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.248 -0.282 . . . . 0.0 111.094 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.6 -50.51 17.61 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 122.316 0.247 . . . . 0.0 110.479 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.7 m -60.86 -53.92 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.46 77.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 0.519 . . . . 0.0 110.921 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -75.9 -17.38 59.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 111.014 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -92.92 -26.77 17.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.409 ' CD1' HG22 ' A' ' 339' ' ' VAL . 45.4 m-85 -98.02 -20.08 17.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -66.11 -18.79 65.57 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.406 0.283 . . . . 0.0 111.649 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.41 -20.38 66.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -88.97 -26.06 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.759 0.254 . . . . 0.0 110.456 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.18 170.37 31.0 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.62 134.36 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 111.254 -172.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 8.3 mm -74.5 138.77 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.75 151.61 46.94 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.594 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.21 155.69 55.04 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.34 2.027 . . . . 0.0 109.812 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.9 mtp -77.62 75.93 4.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.044 0.538 . . . . 0.0 110.813 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.473 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.19 155.6 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.939 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -153.19 130.71 11.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.135 0.974 . . . . 0.0 109.017 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.73 118.33 31.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.1 157.32 24.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.57 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm . . . . . 0 CA--C 1.527 0.077 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.84 -5.22 66.37 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.94 147.44 25.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.006 0.403 . . . . 0.0 111.072 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.05 165.81 34.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.0 m -137.28 122.13 18.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.277 0.231 . . . . 0.0 111.046 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 305' ' ' PHE . 95.5 t -115.64 120.7 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 29.9 t -91.78 136.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.903 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -95.11 145.78 24.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.12 -15.2 61.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 88.2 m-20 -129.38 135.18 27.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.686 0.794 . . . . 0.0 111.433 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.432 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 22.8 Cg_endo -66.74 -33.77 33.59 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.837 2.358 . . . . 0.0 114.414 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 87.3 Cg_endo -76.91 -18.32 14.86 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.517 1.478 . . . . 0.0 111.307 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.7 m -76.33 -29.88 57.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.66 85.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.406 ' HA ' HD11 ' A' ' 351' ' ' ILE . 15.5 tptm -64.13 -40.86 97.08 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.457 0.17 . . . . 0.0 110.827 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.12 85.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.48 0.312 . . . . 0.0 110.68 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.77 -25.2 64.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 348' ' ' LYS . 63.7 mt -72.95 -57.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.41 -20.59 60.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -95.23 -60.53 1.65 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -69.69 -32.16 70.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.93 113.14 1.74 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.28 -15.82 32.66 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.893 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -95.04 -172.56 2.72 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.709 1.255 . . . . 0.0 109.838 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -101.18 173.7 6.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -128.06 -39.08 1.77 Allowed 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.9 t -143.07 8.49 1.65 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.729 0.412 . . . . 0.0 110.117 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.48 -20.62 5.21 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -102.86 149.3 36.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.24 150.55 76.71 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.359 2.706 . . . . 0.0 110.595 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.33 168.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-O 121.068 0.461 . . . . 0.0 110.763 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -131.79 156.87 45.24 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 54.4 t -145.71 146.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 110.396 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.4 m -154.53 172.71 17.36 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.06 162.91 6.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.216 -0.302 . . . . 0.0 111.771 170.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.81 0.338 . . . . 0.0 111.054 177.611 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 N--CA 1.456 -0.683 0 C-N-CA 123.382 2.721 . . . . 0.0 112.61 176.809 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 111.366 0.135 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.1 m -100.53 148.68 24.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.43 150.2 34.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.835 0.454 . . . . 0.0 109.945 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -106.26 148.85 27.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 t -133.73 148.28 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.105 0.562 . . . . 0.0 111.194 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -138.69 150.63 46.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.74 5.1 58.84 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.834 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.1 -57.22 12.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.322 0.649 . . . . 0.0 111.135 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.445 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.89 179.64 44.47 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.13 -10.64 59.53 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.907 0.883 . . . . 0.0 112.365 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.98 -0.85 45.97 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 111.556 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.03 155.78 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.16 168.24 27.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.0 mm -49.43 -40.18 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.362 1.065 . . . . 0.0 111.691 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.42 62.32 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.859 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -76.15 -48.89 18.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.379 0.272 . . . . 0.0 110.634 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.7 m -61.58 -53.68 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.01 -37.93 78.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.798 -0.563 . . . . 0.0 110.602 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.96 -15.84 60.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.721 0.237 . . . . 0.0 111.087 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.51 -26.78 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.403 ' CD1' HG23 ' A' ' 339' ' ' VAL . 45.9 m-85 -97.3 -20.19 18.03 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -66.16 -18.64 65.48 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.418 0.287 . . . . 0.0 111.697 -173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.21 -20.41 66.42 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.1 mm -88.62 -25.05 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.976 0.417 . . . . 0.0 110.156 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.64 169.08 27.74 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.06 136.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.713 -0.286 . . . . 0.0 111.256 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.1 mm -77.54 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 37.0 ttmt -69.55 136.53 51.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.142 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.71 152.23 75.43 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.895 1.73 . . . . 0.0 108.833 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.453 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.9 mtp -77.74 79.07 4.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.465 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.07 155.09 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.619 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.94 129.16 11.93 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.75 120.87 32.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.23 159.48 20.08 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 121.492 0.663 . . . . 0.0 112.53 -171.264 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.04 0.63 59.96 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -90.56 150.29 21.81 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 117.425 0.612 . . . . 0.0 110.903 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.43 165.87 32.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.073 0.549 . . . . 0.0 109.58 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 m -136.78 122.64 20.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.403 HG23 ' CD1' ' A' ' 305' ' ' PHE . 92.5 t -115.63 124.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -174.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.4 t -96.21 128.15 42.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.234 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.53 148.31 25.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -74.33 -21.42 59.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.4 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.6 m-20 -124.11 131.49 24.22 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.496 0.718 . . . . 0.0 110.91 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.441 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.8 Cg_endo -65.98 -33.09 43.11 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.768 2.312 . . . . 0.0 114.161 -175.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.74 -19.22 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.189 1.46 . . . . 0.0 111.142 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.2 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.787 0.267 . . . . 0.0 110.385 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.6 79.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.398 0.142 . . . . 0.0 110.672 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -63.41 -39.97 95.94 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 122.35 0.26 . . . . 0.0 110.756 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.1 81.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.984 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.72 -26.35 66.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -72.15 -57.72 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -60.92 -21.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -92.38 -59.74 2.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -70.02 -31.92 69.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -56.78 112.36 1.28 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.19 31.25 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.061 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.7 -172.35 2.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.705 1.253 . . . . 0.0 109.941 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.21 175.03 5.72 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.454 0.302 . . . . 0.0 110.535 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -130.72 -38.76 1.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.2 t -143.04 20.31 1.94 Allowed 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 122.585 0.354 . . . . 0.0 110.345 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.36 -2.22 31.04 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -121.81 146.5 46.05 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 123.996 0.918 . . . . 0.0 109.473 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.85 149.73 72.84 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.48 2.787 . . . . 0.0 110.779 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.62 169.4 18.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.087 0.555 . . . . 0.0 110.697 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -134.67 156.37 48.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.828 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -144.21 147.34 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.119 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 70.8 m -154.04 174.64 14.42 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -58.27 160.65 4.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.756 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.457 -0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.612 178.285 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -104.76 148.78 26.23 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.38 147.6 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.642 0.377 . . . . 0.0 110.441 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -102.73 149.01 24.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.9 t -134.12 148.24 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.298 0.639 . . . . 0.0 111.636 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -138.59 150.06 45.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.31 5.11 58.19 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.762 -0.466 . . . . 0.0 112.299 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.83 -56.06 23.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.541 0.67 . . . . 0.0 111.009 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.41 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.71 179.45 46.21 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -80.18 -7.22 58.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.738 0.815 . . . . 0.0 112.124 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -81.8 -1.6 47.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.374 0.27 . . . . 0.0 111.32 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.54 156.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.48 168.03 28.04 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.6 mm -48.57 -40.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.223 1.009 . . . . 0.0 111.762 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.4 -28.49 62.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.28 -0.263 . . . . 0.0 111.102 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.0 t -75.85 -48.84 19.86 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.475 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.64 45.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.6 -37.6 78.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.296 0.498 . . . . 0.0 110.783 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -75.81 -15.39 60.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -95.15 -26.78 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' A' ' 339' ' ' VAL . 46.2 m-85 -97.46 -20.62 17.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -65.13 -19.43 65.98 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -63.97 -21.49 66.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.2 mm -87.07 -27.19 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.8 170.6 31.89 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.7 mm -68.02 135.07 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.768 0.318 . . . . 0.0 111.047 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.5 mm -76.42 136.97 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.433 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.1 ttmm -68.4 135.84 52.37 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.692 0.282 . . . . 0.0 110.628 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.332 -0.178 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.769 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.98 151.96 82.97 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.089 1.86 . . . . 0.0 109.13 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 48.6 mtp -79.74 80.15 6.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.47 0.308 . . . . 0.0 111.235 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.475 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.4 OUTLIER -132.14 154.98 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.0 120.6 7.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.269 0.628 . . . . 0.0 109.693 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -88.59 122.14 31.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -80.27 164.43 23.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 121.246 0.546 . . . . 0.0 111.415 -177.073 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.41 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 93.48 15.51 50.11 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.57 154.09 34.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.403 0.601 . . . . 0.0 110.164 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.65 170.35 22.36 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.609 0.363 . . . . 0.0 110.287 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 32.3 m -134.51 127.56 31.63 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.865 0.466 . . . . 0.0 110.583 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.406 HG23 ' CD1' ' A' ' 305' ' ' PHE . 93.2 t -117.43 127.49 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.2 t -98.76 128.63 45.06 Favored 'General case' 0 C--N 1.337 0.05 0 O-C-N 121.962 -0.461 . . . . 0.0 110.324 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.65 147.64 25.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.61 -16.61 59.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -125.49 131.77 24.13 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 110.594 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.439 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 30.5 Cg_endo -66.46 -32.89 39.12 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.006 2.471 . . . . 0.0 114.446 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -76.9 -19.49 13.98 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 CA-C-N 121.208 1.467 . . . . 0.0 110.81 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -29.31 58.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.75 80.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -64.68 -38.45 91.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.462 -0.149 . . . . 0.0 110.635 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.89 -40.26 83.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.583 0.353 . . . . 0.0 110.943 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.6 -25.96 66.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 66.7 mt -72.62 -56.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.6 -20.87 61.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -94.51 -60.21 1.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.27 -32.47 71.68 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.91 110.42 0.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.16 -14.73 25.83 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.042 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -96.36 -171.01 2.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.872 1.336 . . . . 0.0 110.249 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.04 174.39 5.89 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 110.307 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -130.39 -39.32 1.32 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 109.941 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.39 -18.77 10.95 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.75 148.14 35.1 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 151.08 74.16 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.43 2.753 . . . . 0.0 110.508 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.02 168.64 21.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -134.35 155.69 49.81 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.803 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.95 146.76 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.047 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 m -154.4 174.64 14.58 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.754 0.822 . . . . 0.0 108.789 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -60.36 155.65 17.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 N--CA 1.453 -0.858 0 C-N-CA 123.863 3.042 . . . . 0.0 111.876 176.076 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.5 m -95.99 146.61 24.48 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.63 150.3 34.18 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 C-N-CA 122.729 0.411 . . . . 0.0 109.917 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -105.03 148.99 26.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.9 t -133.2 146.62 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 123.05 0.54 . . . . 0.0 111.376 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -137.33 148.54 46.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.71 57.3 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.974 -0.348 . . . . 0.0 112.597 173.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.05 -56.88 14.81 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.423 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.82 179.9 44.49 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.81 -10.0 59.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.671 0.789 . . . . 0.0 112.33 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -81.79 -2.29 50.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 117.562 0.165 . . . . 0.0 111.329 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -99.39 155.95 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.16 168.0 28.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.98 -39.73 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 124.403 1.081 . . . . 0.0 111.59 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.55 -29.09 63.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -75.35 -49.38 19.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.131 0.172 . . . . 0.0 110.643 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.459 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.8 m -61.33 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.52 77.27 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.193 0.452 . . . . 0.0 110.739 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.04 -15.78 60.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.984 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.72 -27.25 15.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -96.76 -20.37 18.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -66.16 -18.84 65.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.439 0.296 . . . . 0.0 111.763 -173.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -21.52 66.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.4 mm -87.12 -27.33 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.308 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.86 170.26 31.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.27 134.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.629 0.252 . . . . 0.0 111.347 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.2 mm -75.51 138.62 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.442 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 35.4 ttmt -68.46 144.58 54.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.331 -0.2 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.029 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.6 153.13 76.9 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.255 1.97 . . . . 0.0 109.126 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.442 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 54.7 mtp -79.1 79.24 5.51 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.516 0.326 . . . . 0.0 110.985 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.459 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.11 155.81 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.345 -178.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.34 127.32 11.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.75 119.92 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -81.25 160.67 24.2 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 111.753 -175.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.423 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 89.47 9.3 66.98 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.598 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -108.25 151.62 25.7 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.929 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.92 166.46 32.57 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.2 m -135.51 122.66 21.55 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.872 0.469 . . . . 0.0 111.508 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.06 124.62 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.4 t -96.23 128.64 43.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.215 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -86.29 148.22 25.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -73.94 -20.33 60.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 95.2 m-20 -127.73 133.35 25.01 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 123.855 0.862 . . . . 0.0 111.033 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.441 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.1 Cg_endo -66.14 -33.9 38.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.683 2.256 . . . . 0.0 114.195 -175.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.5 Cg_endo -74.94 -18.42 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.141 1.443 . . . . 0.0 110.822 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 71.0 m -76.7 -29.67 56.36 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.16 -46.42 80.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.947 0.154 . . . . 0.0 110.725 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -66.15 -37.3 85.33 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.38 -40.13 81.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.369 0.267 . . . . 0.0 110.854 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.48 -26.35 65.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.58 -56.95 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.41 -21.79 62.63 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -93.62 -59.49 1.99 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.7 -32.78 70.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -57.03 112.48 1.36 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.68 31.9 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.008 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.66 -172.45 2.75 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.477 1.138 . . . . 0.0 109.924 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -101.64 173.27 6.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.557 0.343 . . . . 0.0 110.457 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -128.51 -38.54 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.682 0.393 . . . . 0.0 110.262 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.1 t -144.54 17.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.981 0.512 . . . . 0.0 109.959 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.23 -20.2 16.65 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -96.12 140.49 22.28 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.98 151.4 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.997 2.464 . . . . 0.0 110.369 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.4 pt -138.12 168.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 122.608 0.363 . . . . 0.0 111.223 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -134.54 155.25 50.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.15 0.58 . . . . 0.0 110.765 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.63 146.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.998 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 37.4 m -155.44 172.99 17.3 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -57.02 156.84 6.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 C-N-CA 123.757 2.971 . . . . 0.0 112.587 177.069 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.2 m -100.01 147.7 25.32 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.5 pt -128.82 149.92 33.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -104.92 149.49 25.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.74 148.76 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.264 0.625 . . . . 0.0 110.752 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -139.3 150.18 45.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.27 57.95 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.86 -0.411 . . . . 0.0 112.659 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.2 mp -54.72 -54.45 41.72 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 117.55 0.675 . . . . 0.0 111.614 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.454 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.42 -175.86 44.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -171.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -86.86 -7.8 57.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.534 0.734 . . . . 0.0 112.286 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.84 -3.55 42.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.238 0.215 . . . . 0.0 110.954 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.38 158.98 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.739 0.816 . . . . 0.0 112.804 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.43 168.05 25.99 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.75 -39.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.019 0.928 . . . . 0.0 111.65 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -73.15 -28.89 62.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.318 -0.239 . . . . 0.0 111.064 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.9 t -75.12 -49.44 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.193 0.197 . . . . 0.0 110.797 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.462 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.6 m -61.11 -53.65 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.39 -37.33 77.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.719 -0.613 . . . . 0.0 110.78 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -76.9 -15.29 59.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.189 -0.32 . . . . 0.0 111.201 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.47 -27.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.0 m-85 -96.47 -20.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.8 pttt -65.08 -19.29 65.92 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.36 -20.85 66.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.52 -25.02 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 165.06 168.79 27.76 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.97 136.0 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.706 0.289 . . . . 0.0 111.081 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.5 mm -76.72 136.45 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.406 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.4 ttmm -68.93 142.8 54.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.673 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.15 152.02 81.79 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.653 1.569 . . . . 0.0 108.877 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.406 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 41.9 mtp -77.71 79.12 4.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.709 0.404 . . . . 0.0 110.955 -174.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.462 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.9 154.96 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 123.703 0.627 . . . . 0.0 110.849 -179.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.62 130.12 13.0 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.99 117.08 29.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.39 156.5 25.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 79.4 p . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.822 0.82 . . . . 0.0 112.083 -170.767 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.97 -4.76 63.18 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.52 145.49 26.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.143 0.471 . . . . 0.0 110.807 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.23 165.12 35.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.1 m -136.39 120.75 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.475 0.31 . . . . 0.0 111.829 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' A' ' 305' ' ' PHE . 94.8 t -114.96 124.17 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.2 t -95.78 128.12 42.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.268 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -85.1 147.07 26.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 172.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.76 -16.77 59.39 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -125.21 131.27 24.04 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.837 0.855 . . . . 0.0 110.688 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.431 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 30.7 Cg_endo -66.62 -32.69 38.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.67 2.247 . . . . 0.0 114.332 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 83.4 Cg_endo -76.26 -19.63 15.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-N 121.508 1.574 . . . . 0.0 110.85 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -75.51 -29.69 59.56 Favored 'General case' 0 CA--C 1.524 -0.041 0 O-C-N 122.391 -0.193 . . . . 0.0 110.547 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.55 -48.21 75.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.401 ' HA ' HD13 ' A' ' 351' ' ' ILE . 17.0 tptm -64.07 -38.68 91.95 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.6 82.92 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.484 0.314 . . . . 0.0 110.705 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.24 65.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 348' ' ' LYS . 66.5 mt -72.04 -57.32 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.43 -21.91 62.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -93.11 -60.38 1.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.62 -32.44 71.15 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.43 112.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.01 -15.35 31.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.091 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -94.67 -172.81 2.84 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.605 1.203 . . . . 0.0 109.946 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -102.65 170.77 7.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.477 0.311 . . . . 0.0 110.171 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -125.38 -38.54 2.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.371 0.268 . . . . 0.0 110.601 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t -143.84 8.04 1.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.329 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.08 -21.11 4.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -103.83 148.87 36.5 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.94 152.86 76.56 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.395 2.73 . . . . 0.0 110.581 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -139.12 169.14 17.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.96 0.409 . . . . 0.0 110.538 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -133.68 155.61 49.4 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.748 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -143.89 146.39 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 50.0 m -153.76 174.76 14.12 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.65 163.68 4.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.079 -0.388 . . . . 0.0 111.914 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.271 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.455 -0.737 0 C-N-CA 123.732 2.955 . . . . 0.0 112.496 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.185 0.069 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -99.26 147.57 25.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.99 150.24 34.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.867 0.467 . . . . 0.0 109.897 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -105.38 149.68 25.89 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.14 148.7 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.251 0.621 . . . . 0.0 111.238 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -138.55 150.59 46.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.08 5.79 59.37 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.74 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -55.36 -56.69 17.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 117.45 0.625 . . . . 0.0 111.29 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.43 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 90.15 -179.66 43.89 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.79 -11.57 59.85 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.786 0.835 . . . . 0.0 112.106 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.69 0.39 39.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.416 0.286 . . . . 0.0 111.275 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.33 154.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -157.58 168.38 27.46 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 32.5 mm -49.87 -40.16 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.406 1.082 . . . . 0.0 111.776 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.37 -28.74 63.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.55 -0.094 . . . . 0.0 111.059 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.3 t -75.23 -49.46 19.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.159 0.184 . . . . 0.0 110.817 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.466 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.7 m -61.38 -54.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.72 77.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.375 0.534 . . . . 0.0 110.699 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -76.17 -15.76 60.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.41 -27.42 16.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -96.5 -20.58 18.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -65.67 -18.72 65.53 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.341 0.257 . . . . 0.0 111.68 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -64.39 -21.9 66.78 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.3 mm -87.01 -27.99 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 168.28 170.44 32.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.73 135.74 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.879 0.34 . . . . 0.0 111.261 -172.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.9 mm -76.98 137.84 21.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -69.61 149.37 48.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.835 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.99 154.38 62.28 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.264 1.976 . . . . 0.0 109.47 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.6 mtp -77.14 76.94 3.68 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.63 0.372 . . . . 0.0 111.159 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.466 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.63 154.25 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.389 0.675 . . . . 0.0 110.747 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -150.99 130.33 12.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.684 0.794 . . . . 0.0 108.939 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -90.87 122.31 33.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.22 160.16 19.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.346 0.593 . . . . 0.0 111.661 -170.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 99.87 0.37 56.3 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -90.58 151.04 21.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.628 0.714 . . . . 0.0 110.902 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.36 166.21 31.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.316 0.646 . . . . 0.0 109.355 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.3 m -136.84 122.68 20.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.634 0.374 . . . . 0.0 111.603 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.22 125.09 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.2 t -96.83 128.35 43.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.573 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -85.59 147.82 26.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -76.1 -17.24 59.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -125.39 132.24 24.26 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.437 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 30.4 Cg_endo -66.88 -32.2 36.63 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.782 2.321 . . . . 0.0 114.562 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 92.5 Cg_endo -77.5 -18.79 13.54 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 121.135 1.441 . . . . 0.0 111.146 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.6 m -75.76 -29.27 58.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.24 -0.288 . . . . 0.0 110.478 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.99 -47.69 76.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.71 -39.81 95.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.484 0.314 . . . . 0.0 110.53 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.92 81.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 0.0 110.59 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.12 -26.14 65.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.62 -58.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -60.64 -21.3 62.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -92.99 -59.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -70.37 -32.34 69.97 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.24 112.01 1.12 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -15.59 30.61 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.063 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -94.76 -172.35 2.7 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.646 1.223 . . . . 0.0 110.03 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.5 174.07 6.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.708 0.29 . . . . 0.0 110.459 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -129.27 -37.78 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.518 0.327 . . . . 0.0 110.654 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.2 t -144.87 20.31 1.63 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.687 0.395 . . . . 0.0 110.043 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.07 0.01 31.56 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -125.32 146.6 54.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 123.801 0.84 . . . . 0.0 109.773 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.79 149.22 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.575 2.85 . . . . 0.0 110.93 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.46 169.21 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.067 0.547 . . . . 0.0 110.636 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -133.5 157.17 46.31 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.004 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 44.7 t -143.95 147.3 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.039 0.536 . . . . 0.0 110.223 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.9 m -154.73 172.86 17.24 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.64 159.11 6.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.038 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.008 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 N--CA 1.453 -0.871 0 C-N-CA 123.766 2.978 . . . . 0.0 112.246 177.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.6 m -87.26 144.42 26.82 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.8 pt -129.05 147.4 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -101.78 147.8 26.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.54 146.86 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 122.983 0.513 . . . . 0.0 111.062 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -137.51 149.88 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.19 58.24 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.8 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.36 -54.74 42.03 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.281 0.632 . . . . 0.0 111.022 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.445 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.54 179.6 46.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -78.33 -9.05 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.818 0.847 . . . . 0.0 111.989 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -82.64 0.06 44.85 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.31 0.244 . . . . 0.0 111.461 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.98 155.76 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.71 168.24 27.8 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.26 -40.25 13.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 124.385 1.074 . . . . 0.0 111.948 -174.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.54 -29.14 63.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.487 -0.085 . . . . 0.0 111.198 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.5 t -74.9 -49.47 20.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.194 0.197 . . . . 0.0 110.57 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.472 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.6 m -61.72 -54.18 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.27 78.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.29 0.496 . . . . 0.0 110.915 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' A' ' 306' ' ' LYS . 20.2 t0 -75.73 -15.15 60.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.788 0.327 . . . . 0.0 111.217 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -95.47 -26.79 15.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -97.27 -20.43 17.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.404 ' HE2' ' OD1' ' A' ' 303' ' ' ASP . 51.8 pttt -65.92 -18.98 65.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.11 -21.37 66.51 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.84 -25.74 5.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.32 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.15 170.03 30.53 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.54 136.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 122.674 -0.309 . . . . 0.0 111.167 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.7 mm -77.66 137.66 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.467 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.0 ttmm -68.84 148.46 50.23 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.521 -0.138 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.07 153.61 75.14 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.131 1.887 . . . . 0.0 109.264 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.467 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.7 mtp -79.46 79.57 5.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.472 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.84 156.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.49 0.716 . . . . 0.0 110.412 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -152.56 127.97 9.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.633 0.773 . . . . 0.0 109.199 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.84 121.67 34.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -84.45 158.58 21.0 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 26.2 p . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.279 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.11 4.84 68.42 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.406 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 151.09 21.74 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 117.906 0.853 . . . . 0.0 111.059 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.52 167.4 29.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.12 0.568 . . . . 0.0 109.713 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.7 m -138.19 123.81 19.73 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.763 0.425 . . . . 0.0 111.228 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 99.5 t -116.36 125.23 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.431 0.692 . . . . 0.0 109.233 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.4 t -96.78 125.53 41.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.084 -0.385 . . . . 0.0 110.466 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -82.4 150.1 27.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.37 -15.69 58.43 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 86.7 m-20 -129.55 136.1 28.58 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.417 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 17.9 Cg_endo -65.48 -36.67 33.3 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.774 2.316 . . . . 0.0 114.31 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 343' ' ' ASP . 85.8 Cg_endo -75.8 -18.66 16.9 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 120.935 1.37 . . . . 0.0 111.122 -175.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.0 m -75.9 -30.09 58.68 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.0 71.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.141 0.177 . . . . 0.0 110.871 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -64.12 -38.27 90.47 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.455 0.169 . . . . 0.0 110.643 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.5 83.02 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.555 0.342 . . . . 0.0 110.834 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -25.72 65.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.9 mt -72.71 -56.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -60.31 -20.95 61.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -94.99 -59.65 1.86 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.83 -31.5 69.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -57.76 112.81 1.58 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.49 -15.46 32.32 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.908 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.52 -172.14 2.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.742 1.271 . . . . 0.0 109.86 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -102.61 174.38 5.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.837 0.351 . . . . 0.0 110.347 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -130.02 -39.39 1.38 Allowed 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.3 t -143.34 18.18 1.89 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.993 0.517 . . . . 0.0 109.7 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.75 -18.81 24.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -97.11 140.2 21.94 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.27 151.27 81.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.997 2.465 . . . . 0.0 110.486 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.88 168.93 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.153 0.502 . . . . 0.0 111.041 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.82 155.64 49.47 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.901 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.43 146.79 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 122.939 0.495 . . . . 0.0 110.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.4 m -155.11 173.1 17.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.3 160.7 4.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.133 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 C-N-CA 123.642 2.894 . . . . 0.0 112.198 176.357 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.4 m -133.63 150.33 51.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.88 146.22 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.756 0.422 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -100.47 146.53 26.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.59 147.08 32.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 122.766 0.426 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.78 150.41 47.21 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.13 5.96 58.01 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.556 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.45 -57.32 12.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.499 0.72 . . . . 0.0 111.176 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.74 -179.1 45.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.02 -10.88 59.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.569 0.748 . . . . 0.0 112.405 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.8 -0.63 35.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.549 0.34 . . . . 0.0 111.355 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.58 155.58 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.95 168.4 27.25 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -48.67 -39.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.264 1.026 . . . . 0.0 111.825 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.89 -28.59 61.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.251 -0.281 . . . . 0.0 111.248 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -75.75 -48.33 22.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.474 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.6 m -61.89 -53.97 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.55 77.97 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.045 -0.409 . . . . 0.0 110.843 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.67 -15.6 59.76 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.241 -0.287 . . . . 0.0 111.105 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -94.46 -27.13 16.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.444 ' CD2' HG23 ' A' ' 339' ' ' VAL . 45.5 m-85 -97.03 -19.85 18.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -65.79 -18.91 65.67 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.05 -21.8 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.8 mm -87.39 -27.26 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 167.89 169.89 31.96 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.03 135.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.577 -0.366 . . . . 0.0 111.064 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 8.1 mm -75.41 138.6 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.12 153.64 43.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.15 153.46 69.4 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.963 1.775 . . . . 0.0 109.541 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.7 mtp -78.95 76.04 5.45 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.199 0.6 . . . . 0.0 111.128 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.474 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.4 OUTLIER -130.89 159.63 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.143 0.577 . . . . 0.0 110.617 -178.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -156.24 125.23 6.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.84 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.05 121.73 32.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -76.0 163.75 26.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.484 0.659 . . . . 0.0 111.106 -179.509 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.79 16.01 50.18 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -123.08 155.91 35.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.44 0.62 . . . . 0.0 110.388 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.68 173.39 16.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.906 0.482 . . . . 0.0 109.918 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.2 m -139.56 129.26 24.58 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.444 HG23 ' CD2' ' A' ' 305' ' ' PHE . 89.6 t -119.24 127.18 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 39.5 t -98.36 132.89 43.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.724 -0.39 . . . . 0.0 109.971 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.24 145.11 24.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.175 0.99 . . . . 0.0 113.201 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -72.08 -16.41 62.02 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.416 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 99.5 m-20 -125.61 134.09 25.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.785 0.834 . . . . 0.0 110.835 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.443 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 22.3 Cg_endo -66.14 -33.93 38.7 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.702 2.268 . . . . 0.0 114.055 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 93.9 Cg_endo -77.69 -19.03 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.499 1.466 . . . . 0.0 111.522 -177.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.7 m -74.35 -29.14 61.46 Favored 'General case' 0 C--N 1.335 -0.05 0 CA-C-N 117.774 0.261 . . . . 0.0 110.35 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.64 79.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.412 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.3 tptm -62.51 -40.11 95.68 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.402 -0.187 . . . . 0.0 111.111 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.361 0.265 . . . . 0.0 110.92 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.54 -24.96 64.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 348' ' ' LYS . 65.8 mt -73.9 -55.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -60.76 -20.86 62.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -95.36 -60.27 1.7 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.76 -32.4 70.9 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.33 111.8 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.7 -17.11 25.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.287 -0.729 . . . . 0.0 112.806 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -94.43 -171.73 2.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.53 1.165 . . . . 0.0 109.94 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -102.7 174.25 5.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -129.38 -38.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.565 0.346 . . . . 0.0 110.078 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.8 t -144.49 17.33 1.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.016 0.526 . . . . 0.0 109.738 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.89 16.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -94.71 140.29 22.54 Favored Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.96 151.38 82.23 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.102 2.534 . . . . 0.0 110.326 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.51 168.32 19.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 121.168 0.509 . . . . 0.0 111.092 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -133.81 155.64 49.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.268 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 56.9 t -144.63 147.43 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 O-C-N 123.412 0.445 . . . . 0.0 110.093 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.3 m -154.36 171.85 18.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.99 155.63 7.89 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.513 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.161 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 123.883 3.056 . . . . 0.0 111.834 176.83 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 m -105.75 147.83 28.14 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 15.6 pt -128.45 149.91 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.035 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -104.75 149.76 25.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.11 147.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.485 0.714 . . . . 0.0 111.12 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -139.38 150.13 44.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.05 57.83 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.995 -0.336 . . . . 0.0 112.801 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.64 -56.31 21.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.516 0.727 . . . . 0.0 111.288 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.433 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.72 -179.43 45.87 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.19 -10.41 59.39 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.704 0.802 . . . . 0.0 112.251 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -81.56 -0.69 43.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.242 0.217 . . . . 0.0 111.319 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.87 155.95 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.54 168.39 27.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -50.3 -40.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.324 1.05 . . . . 0.0 111.572 -174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -72.36 -28.83 63.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.405 -0.184 . . . . 0.0 111.102 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.5 -50.26 18.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.272 0.229 . . . . 0.0 110.456 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.7 m -61.25 -53.55 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.59 -37.39 78.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.531 0.605 . . . . 0.0 110.664 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' A' ' 306' ' ' LYS . 20.0 t0 -76.12 -15.81 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 111.109 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -94.52 -27.52 15.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -96.71 -20.68 18.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.401 ' HE2' ' OD1' ' A' ' 303' ' ' ASP . 52.6 pttt -65.31 -19.09 65.8 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.45 -20.76 66.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.0 mm -88.59 -24.65 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-O 120.665 0.269 . . . . 0.0 110.342 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.53 168.79 27.18 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.37 136.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.614 -0.345 . . . . 0.0 111.002 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.9 mm -78.22 137.58 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.428 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.8 ttmm -71.89 145.92 48.21 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 110.578 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.25 155.73 49.83 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.476 2.117 . . . . 0.0 109.856 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.428 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 59.2 mtp -76.79 76.64 3.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.956 0.502 . . . . 0.0 110.997 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.468 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.75 158.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -157.37 133.1 9.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -93.37 120.12 33.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.92 159.73 22.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 121.298 0.57 . . . . 0.0 111.77 -171.172 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.433 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.62 2.13 61.69 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.77 150.97 19.64 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.455 0.627 . . . . 0.0 111.119 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.47 33.68 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.003 0.521 . . . . 0.0 109.723 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.4 m -135.74 123.14 21.95 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.2 123.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 32.8 t -95.73 127.54 41.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.712 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.48 147.65 26.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -75.71 -17.5 59.92 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.413 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 90.5 m-20 -128.27 133.28 24.98 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.048 0.939 . . . . 0.0 110.834 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.434 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -67.12 -32.65 33.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.669 2.246 . . . . 0.0 114.6 -175.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 95.8 Cg_endo -75.17 -19.35 17.58 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 121.175 1.456 . . . . 0.0 110.753 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.5 m -76.98 -29.32 55.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.74 -47.56 74.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -64.92 -37.39 87.49 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.92 80.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.31 0.244 . . . . 0.0 110.483 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -25.27 65.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.7 mt -73.27 -56.07 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.93 -21.88 63.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -93.54 -60.78 1.69 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -69.22 -32.1 71.12 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.24 112.17 1.3 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.95 -16.06 30.78 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.945 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.76 -172.3 2.69 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.753 1.276 . . . . 0.0 109.969 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.91 174.22 6.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.588 0.355 . . . . 0.0 110.457 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -129.78 -38.37 1.49 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 15.57 1.74 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.698 0.399 . . . . 0.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 120.07 -18.7 9.63 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -104.22 148.77 36.47 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.02 151.11 73.31 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.483 2.789 . . . . 0.0 110.624 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.62 168.76 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.016 0.527 . . . . 0.0 110.873 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -134.1 155.39 50.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.139 0.576 . . . . 0.0 111.101 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.1 t -144.34 146.27 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 122.899 0.48 . . . . 0.0 110.221 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.3 m -154.23 172.91 16.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.69 160.01 6.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.894 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.241 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.939 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.452 -0.955 0 C-N-CA 123.914 3.076 . . . . 0.0 111.873 176.16 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.2 m -135.22 149.5 49.9 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -172.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.1 pt -131.95 146.95 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.582 0.353 . . . . 0.0 110.309 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.25 150.19 22.8 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.2 t -134.13 147.23 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.866 0.466 . . . . 0.0 111.783 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -136.74 149.85 48.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.72 6.15 58.4 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 120.005 -0.33 . . . . 0.0 112.361 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.76 -56.1 24.55 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.467 0.707 . . . . 0.0 110.857 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.408 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.82 -179.89 45.85 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -78.95 -10.35 59.79 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.873 0.869 . . . . 0.0 112.26 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.83 -1.63 43.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.352 0.261 . . . . 0.0 111.348 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.68 156.19 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -158.7 168.51 26.66 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.2 mm -49.32 -40.27 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.421 1.088 . . . . 0.0 111.728 -174.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.71 -29.14 63.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.348 -0.22 . . . . 0.0 111.209 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.68 -50.14 18.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.235 0.214 . . . . 0.0 110.594 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.484 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.7 m -61.18 -53.57 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.15 80.75 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.975 -0.453 . . . . 0.0 110.565 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -75.94 -15.46 60.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 111.028 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -94.39 -27.02 16.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.412 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.8 m-85 -97.66 -20.13 17.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -66.08 -18.9 65.64 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -63.77 -21.59 66.49 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -87.35 -24.06 6.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.968 0.349 . . . . 0.0 110.2 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 161.19 172.72 28.91 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 40.2 mm -66.41 137.39 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.1 mm -78.38 133.82 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 172.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.4 ' CE ' ' HA ' ' A' ' 342' ' ' ASP . 12.6 tppt? -64.55 133.01 51.47 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.333 -0.145 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 175.26 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.88 152.04 82.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.04 1.827 . . . . 0.0 109.047 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 71.1 mtp -78.27 80.69 4.67 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.579 0.352 . . . . 0.0 111.196 -175.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.484 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.4 OUTLIER -133.78 154.6 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -150.36 121.3 7.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.227 0.611 . . . . 0.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.41 121.83 31.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -79.26 162.21 25.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.108 0.48 . . . . 0.0 112.092 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.9 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.503 -178.117 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.408 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.96 16.88 31.78 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -119.81 154.96 33.49 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 117.398 0.599 . . . . 0.0 110.405 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.81 171.02 20.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.878 0.471 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 42.0 m -134.78 128.18 32.32 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.739 0.416 . . . . 0.0 110.262 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.1 t -118.23 128.39 75.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 321' ' ' MET . 43.7 t -98.92 132.91 43.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.73 176.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -90.86 148.28 22.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.4 ' HA ' ' CE ' ' A' ' 312' ' ' LYS . 47.4 t0 -70.96 -22.78 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.8 m-20 -124.82 135.82 27.2 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.318 0.647 . . . . 0.0 111.693 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.432 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 19.2 Cg_endo -64.05 -36.67 47.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.799 2.333 . . . . 0.0 113.925 -175.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 343' ' ' ASP . 94.5 Cg_endo -76.89 -16.42 16.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.579 1.519 . . . . 0.0 111.172 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.4 m -77.44 -29.53 52.9 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.87 81.58 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -64.52 -39.47 93.83 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 122.175 0.19 . . . . 0.0 110.742 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.37 83.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.565 0.346 . . . . 0.0 110.908 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -24.97 65.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.56 -57.72 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.85 -21.44 63.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -92.8 -59.15 2.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.76 -33.45 70.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.43 112.11 1.17 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.37 -16.46 29.45 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.188 -0.785 . . . . 0.0 113.046 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -93.83 -171.92 2.72 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.7 1.25 . . . . 0.0 109.695 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -102.8 172.21 6.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.696 0.284 . . . . 0.0 110.421 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -126.34 -38.92 2.08 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 26.4 t -142.59 6.29 1.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.834 0.454 . . . . 0.0 110.477 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.38 -22.27 3.97 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -101.76 149.37 36.4 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.73 152.29 77.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.474 2.782 . . . . 0.0 110.296 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.66 166.29 24.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 122.747 0.419 . . . . 0.0 110.792 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -131.46 156.1 46.23 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.155 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 45.3 t -144.86 147.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.453 0.471 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -156.53 173.21 17.25 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.809 0.843 . . . . 0.0 108.801 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -60.23 152.89 23.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.65 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 C-N-CA 123.999 3.132 . . . . 0.0 112.593 -179.898 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 m -92.57 147.33 22.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.26 147.89 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 122.939 0.496 . . . . 0.0 109.883 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -101.78 148.38 25.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.27 148.7 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.133 0.573 . . . . 0.0 111.125 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.33 149.35 45.54 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.23 5.6 58.06 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.943 -0.365 . . . . 0.0 112.849 172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.39 -53.86 51.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.655 0.727 . . . . 0.0 111.412 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.478 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.51 -176.61 44.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -170.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -86.87 -7.51 58.14 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.669 0.788 . . . . 0.0 112.519 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.01 -5.69 52.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 110.887 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.23 159.62 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.661 0.785 . . . . 0.0 112.303 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.05 168.03 26.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.07 -39.87 12.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.2 1.0 . . . . 0.0 111.712 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.47 -28.52 61.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.368 -0.208 . . . . 0.0 110.905 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.2 t -75.09 -49.5 19.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.104 0.161 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.7 m -60.98 -53.86 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.07 77.89 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.053 0.388 . . . . 0.0 110.751 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -75.89 -15.67 60.17 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.129 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.58 -27.49 15.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -96.98 -20.42 18.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.9 pttt -65.39 -19.04 65.77 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -173.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.57 -21.19 66.63 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.5 mm -88.11 -24.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.312 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.2 169.31 27.56 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.17 137.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 122.645 -0.327 . . . . 0.0 111.093 -172.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.7 mm -78.95 137.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.461 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 22.3 ttmm -69.42 149.7 48.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.299 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.34 154.02 70.75 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.368 2.045 . . . . 0.0 109.193 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 65.8 mtp -79.35 79.67 5.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.696 0.399 . . . . 0.0 110.928 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.453 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -135.15 155.53 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.668 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.98 129.53 13.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.08 119.83 32.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -83.94 157.33 21.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.532 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.478 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.13 -2.31 75.05 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.37 146.62 24.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.786 0.793 . . . . 0.0 111.136 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.77 166.64 32.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 10.3 m -138.56 121.32 16.42 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 122.556 0.342 . . . . 0.0 111.457 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.68 126.07 72.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.4 t -97.31 127.69 43.5 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.309 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.437 ' O ' ' HE2' ' A' ' 312' ' ' LYS . 42.2 m-85 -84.29 147.71 27.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.6 -18.66 59.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -126.06 133.79 25.29 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 110.685 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.438 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 27.5 Cg_endo -66.31 -33.68 37.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 114.405 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 84.8 Cg_endo -75.81 -20.1 15.61 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 121.2 1.464 . . . . 0.0 111.122 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 52.6 m -74.82 -29.61 61.13 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.8 78.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.13 0.172 . . . . 0.0 110.742 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -63.04 -39.75 95.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.404 0.282 . . . . 0.0 110.622 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.68 81.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.53 0.332 . . . . 0.0 110.842 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.04 65.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.4 -57.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -59.78 -21.93 61.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -93.82 -60.0 1.86 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.44 -31.94 70.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.43 111.73 1.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.45 -14.97 30.1 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.052 -0.86 . . . . 0.0 113.07 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -95.25 -171.99 2.55 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.748 1.274 . . . . 0.0 109.851 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.51 175.5 5.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.303 0.241 . . . . 0.0 110.606 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -131.08 -38.4 1.23 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -143.23 16.49 1.89 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.157 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.89 12.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.93 148.51 35.43 Favored Pre-proline 0 C--O 1.233 0.187 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.06 152.1 73.0 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.707 2.938 . . . . 0.0 110.722 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.36 168.3 20.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 122.821 0.448 . . . . 0.0 110.953 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.7 156.32 47.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.0 146.11 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.089 0.555 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 m -154.64 171.82 18.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -58.47 159.45 6.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.184 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 72.29 -171.49 48.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -64.27 -54.4 33.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -156.98 -178.51 7.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.937 0.895 . . . . 0.0 109.124 -174.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.68 -7.47 27.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -108.8 -3.24 17.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.805 0.275 . . . . 0.0 110.972 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.19 3.6 87.18 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.332 -0.704 . . . . 0.0 114.467 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 66.92 -158.18 50.48 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.015 1.408 . . . . 0.0 110.496 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.81 25.16 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.009 3.139 . . . . 0.0 111.932 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 267' ' ' GLY . 70.8 ttt-85 -78.27 -40.94 35.51 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.802 -0.561 . . . . 0.0 110.704 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -105.45 8.23 33.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.832 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -15.94 61.36 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 96.13 -118.05 5.86 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.606 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.1 t -79.53 16.79 0.98 Allowed 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.42 -5.78 5.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -86.82 -19.24 29.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.423 0.289 . . . . 0.0 111.211 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -125.73 4.15 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 75.1 m -148.65 147.75 29.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 109.639 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.66 9.23 33.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.971 0.508 . . . . 0.0 111.322 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -101.72 -109.15 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.79 22.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -153.59 161.79 41.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 43.3 t -156.18 -35.53 0.08 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.068 0.147 . . . . 0.0 110.7 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -93.4 13.46 21.51 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -132.62 45.2 2.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.335 0.654 . . . . 0.0 111.61 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -69.53 -0.75 7.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.506 0.322 . . . . 0.0 111.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.8 m -101.83 147.85 26.01 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.6 pt -128.84 149.22 33.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.006 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -103.68 149.77 24.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.3 147.96 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 123.105 0.562 . . . . 0.0 111.163 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -139.54 149.07 43.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.95 4.81 57.65 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.718 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.18 -54.46 43.09 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.339 0.57 . . . . 0.0 111.159 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.416 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.28 -179.23 48.08 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.12 -9.65 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.596 0.758 . . . . 0.0 112.299 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -81.59 -1.53 46.77 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.446 0.298 . . . . 0.0 111.44 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.34 156.77 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.45 168.18 27.65 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.83 -39.34 14.9 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.313 1.045 . . . . 0.0 111.71 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -73.92 -28.54 61.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.434 -0.166 . . . . 0.0 110.89 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.63 -49.84 20.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.266 0.226 . . . . 0.0 110.539 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.46 ' CG2' HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.53 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.32 79.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.187 0.449 . . . . 0.0 110.583 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -75.23 -15.7 60.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 111.272 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -95.03 -26.58 16.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -97.88 -20.0 17.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -66.22 -19.13 65.74 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -64.05 -21.07 66.37 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.4 mm -87.8 -28.34 5.55 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.444 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 168.49 170.05 32.68 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.8 mm -68.04 134.85 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 122.519 -0.401 . . . . 0.0 111.247 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.2 mm -76.97 137.09 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.436 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.7 ttmm -69.68 139.33 53.45 Favored 'General case' 0 C--O 1.23 0.041 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m -99.28 141.43 32.07 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -69.44 148.56 49.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.659 0.384 . . . . 0.0 110.186 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -81.8 -1.49 47.55 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -147.03 -24.24 0.4 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.02 0.827 . . . . 0.0 112.952 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 10.0 p -89.81 -16.43 30.18 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.25 -17.87 3.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.269 0.461 . . . . 0.0 112.881 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -81.47 161.82 60.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 117.865 0.833 . . . . 0.0 109.619 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.67 153.42 75.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.798 1.665 . . . . 0.0 109.027 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.436 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.5 mtp -78.69 79.35 5.11 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.786 0.434 . . . . 0.0 111.175 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.46 HG21 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.37 159.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.697 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -156.42 130.62 8.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.97 119.61 31.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -82.79 158.36 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 43.2 p -133.19 157.05 46.35 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.38 0.61 . . . . 0.0 112.085 -170.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -68.97 127.01 31.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.208 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -76.41 -7.41 54.98 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.469 0.307 . . . . 0.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.76 -7.73 36.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 4.1 t -149.67 -22.6 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.187 0.449 . . . . 0.0 110.922 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.41 27.07 33.98 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.126 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -132.6 169.82 16.08 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.986 0.893 . . . . 0.0 110.429 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.34 123.94 4.45 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.664 0.786 . . . . 0.0 111.598 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.532 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -84.04 -19.43 34.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.976 0.911 . . . . 0.0 109.71 174.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.22 1.71 58.1 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -94.32 150.9 19.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.331 0.566 . . . . 0.0 110.916 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.27 165.77 32.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.072 0.549 . . . . 0.0 109.59 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 7.1 m -136.47 122.55 20.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 96.2 t -114.99 124.01 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.7 t -96.29 126.6 41.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.253 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -84.09 148.32 26.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.84 -17.65 59.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 92.4 m-20 -128.13 134.08 25.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 110.687 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.432 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.8 Cg_endo -67.2 -32.94 32.45 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.689 2.259 . . . . 0.0 114.659 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.4 Cg_endo -75.13 -18.94 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 121.11 1.432 . . . . 0.0 110.831 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.8 m -77.19 -29.81 54.54 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.01 78.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -66.0 -37.03 84.89 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.397 -0.189 . . . . 0.0 110.629 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.48 -40.31 81.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.459 0.304 . . . . 0.0 110.969 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.17 -25.92 65.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.26 -56.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.13 -21.68 63.97 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -94.04 -58.67 2.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -70.92 -32.34 69.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.07 112.37 1.33 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.02 -16.48 30.33 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.837 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -94.26 -172.29 2.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.788 1.294 . . . . 0.0 110.07 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -101.73 173.7 6.29 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.622 0.369 . . . . 0.0 110.302 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -127.96 -38.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.3 t -141.73 4.8 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.05 -22.58 4.0 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.61 148.45 34.75 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 151.91 78.25 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.291 2.661 . . . . 0.0 110.74 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.34 169.36 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.629 0.371 . . . . 0.0 110.862 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -134.17 155.88 49.31 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.922 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.74 146.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.956 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.3 m -154.92 173.86 15.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 108.881 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -57.98 159.77 5.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 169.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -128.83 140.33 51.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 13.8 m -142.56 135.09 27.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.554 0.741 . . . . 0.0 110.174 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -49.15 119.12 3.05 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 122.668 0.387 . . . . 0.0 110.783 -169.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -30.73 70.16 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.62 75.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.665 -0.207 . . . . 0.0 110.934 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -66.99 -9.33 37.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.509 ' CD2' ' HE3' ' A' ' 264' ' ' LYS . 94.7 m-85 -106.26 -9.8 16.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.13 -41.8 0.09 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -81.16 -1.53 44.9 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.78 11.07 77.82 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.45 -168.71 53.98 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -76.9 172.29 55.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -145.28 155.94 43.52 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.058 0.543 . . . . 0.0 110.415 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.61 169.34 52.28 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -144.42 167.13 23.22 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.561 0.744 . . . . 0.0 110.722 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.2 170.55 47.52 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 163.86 -153.9 24.52 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -62.76 163.36 9.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.031 0.415 . . . . 0.0 110.587 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -138.79 172.36 23.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -60.54 142.93 54.75 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 122.604 0.362 . . . . 0.0 110.632 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.74 64.59 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.637 -1.646 . . . . 0.0 111.38 178.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 110.885 -3.077 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.455 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 N19-C1'-C2' 109.277 -2.577 . 0.796 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.455 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C4'-C3'-C2' 100.063 -2.637 . 0.848 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.422 " H5'" HO2' ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 C4'-C3'-C2' 100.117 -2.583 . 0.796 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 110.789 2.589 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 O4'-C1'-N19 111.278 3.078 . 0.844 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.599 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.655 0 O4'-C1'-N19 110.978 2.778 . 0.752 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.661 HO2' " H5'" ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 111.381 -2.746 . 0.805 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.661 " H5'" HO2' ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.856 0 C5'-C4'-C3' 110.999 -3.001 . 0.732 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.785 0 C5'-C4'-C3' 110.974 -3.017 . 0.67 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.426 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.089 0 C5'-C4'-C3' 111.489 -2.674 . 0.687 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.426 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.445 0 C5'-C4'-C3' 110.217 -3.522 . 0.409 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 1 C5'-C4'-C3' 109.492 -4.005 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.349 1 O4'-C1'-N19 113.116 4.916 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.532 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 110.04 -3.64 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.922 1 C3'-C2'-C1' 105.693 4.659 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.387 0 C5'-C4'-C3' 110.093 -3.604 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.975 0 C4'-C3'-C2' 100.71 -1.99 . 0.212 8d . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.425 HO2' " H5'" ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C5'-C4'-C3' 110.745 -3.17 . 0.425 1c . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.425 " H5'" HO2' ' B' ' 109' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 N19-C1'-C2' 109.303 -2.56 . 0.74 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.546 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 N19-C1'-C2' 108.979 -2.763 . 0.761 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.546 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 C4'-C3'-C2' 100.279 -2.421 . 0.681 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 112.154 -2.23 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.547 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 110.881 2.681 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.547 " H5'" HO2' ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 O4'-C1'-N19 110.671 2.471 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.561 HO2' " H5'" ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.241 -2.459 . 0.775 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.561 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.711 0 O4'-C1'-N19 110.634 2.434 . 0.803 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.535 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.717 0 O4'-C1'-N19 110.737 2.537 . 0.809 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.182 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.63 -177.54 47.92 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.98 176.25 2.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -68.2 -173.99 0.45 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.478 0.711 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.02 -14.28 53.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.183 0.593 . . . . 0.0 112.366 -178.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -97.02 -6.89 34.29 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.066 0.394 . . . . 0.0 110.901 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.17 8.69 83.38 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.067 -0.852 . . . . 0.0 114.785 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 69.01 -161.64 51.89 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.454 1.627 . . . . 0.0 110.888 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.572 ' HA ' HE22 ' A' ' 271' ' ' GLN . 58.7 Cg_endo -70.19 27.9 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.996 3.131 . . . . 0.0 112.343 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.472 ' H ' ' C ' ' A' ' 267' ' ' GLY . 77.0 ttt-85 -84.14 -19.55 33.98 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.664 0.386 . . . . 0.0 110.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -146.82 27.57 1.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.572 HE22 ' HA ' ' A' ' 268' ' ' PRO . 3.7 tp-100 -67.12 -13.87 62.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.797 0.439 . . . . 0.0 111.253 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 105.49 -119.42 6.12 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 79.7 p -73.37 18.22 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -2.98 9.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.864 0.757 . . . . 0.0 112.549 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -93.26 -15.61 25.66 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.395 0.278 . . . . 0.0 111.061 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -127.75 6.78 6.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 42.0 t -156.74 158.76 37.48 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.071 0.548 . . . . 0.0 109.593 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -99.88 2.01 43.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.055 0.542 . . . . 0.0 110.639 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -85.97 -80.51 0.23 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.08 0.552 . . . . 0.0 109.798 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 49.63 14.25 0.11 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -156.2 167.3 30.86 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.733 -0.604 . . . . 0.0 110.235 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.1 t -155.64 -35.84 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -95.94 7.4 46.45 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -125.38 45.23 2.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.184 0.593 . . . . 0.0 111.715 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -69.46 -1.18 7.83 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.245 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -98.43 147.16 25.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.44 149.88 34.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.018 0.527 . . . . 0.0 110.139 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -105.12 149.08 26.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.14 148.19 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 123.181 0.592 . . . . 0.0 111.056 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -138.45 149.55 45.57 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.58 57.61 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.848 -0.418 . . . . 0.0 112.599 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.06 -54.53 38.01 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.404 0.682 . . . . 0.0 111.639 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.474 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.68 -176.81 43.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -170.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -85.44 -9.17 57.86 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.773 0.829 . . . . 0.0 112.265 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -78.77 -5.2 52.67 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.184 -0.322 . . . . 0.0 111.209 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.51 158.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.547 0.739 . . . . 0.0 112.678 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.66 167.16 29.07 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.9 mm -49.32 -39.35 13.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.359 1.064 . . . . 0.0 111.731 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.14 -28.41 62.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.35 -0.219 . . . . 0.0 111.15 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.1 t -75.73 -48.73 20.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.303 0.241 . . . . 0.0 110.765 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.466 ' CG2' HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.44 -53.62 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.55 77.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.36 0.527 . . . . 0.0 110.52 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -75.96 -16.02 60.07 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.217 -0.302 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.98 -27.48 16.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -97.02 -19.86 18.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -65.27 -18.95 65.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.6 -21.59 66.75 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.5 mm -87.67 -25.76 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.047 0 CA-C-O 120.818 0.342 . . . . 0.0 110.313 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 165.81 169.81 29.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.52 135.86 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 O-C-N 122.646 -0.326 . . . . 0.0 110.993 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.2 mm -76.54 137.99 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.409 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.2 ttmm -69.97 147.51 50.07 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.9 m -127.78 131.94 49.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.35 149.5 42.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -81.87 -6.09 58.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 -1.41 1.32 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -90.09 -22.82 21.61 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.9 79.32 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -145.24 159.32 49.42 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 117.454 0.627 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.82 155.06 56.77 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.316 2.011 . . . . 0.0 109.413 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.409 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 49.3 mtp -76.9 76.99 3.48 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.723 0.409 . . . . 0.0 111.154 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.466 HG21 ' CG2' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -136.03 154.55 33.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.065 0 C-N-CA 123.283 0.633 . . . . 0.0 110.792 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -151.9 131.9 13.43 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.02 118.06 30.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -80.5 158.44 25.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 19.6 p -133.3 148.4 51.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.413 0.625 . . . . 0.0 112.59 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.61 128.33 35.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.822 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 328' ' ' ARG . 41.3 mtp85 -72.01 -4.82 30.82 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -100.65 -6.21 25.51 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.8 t -150.18 -24.34 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.498 0.59 . . . . 0.0 110.957 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.13 20.06 58.01 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.105 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -124.88 169.01 12.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.948 0.874 . . . . 0.0 109.547 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.6 mt -50.81 121.38 5.84 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 120.538 0.209 . . . . 0.0 110.771 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.657 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 12.9 ptmm? -83.43 2.38 36.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.021 0.529 . . . . 0.0 109.579 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.474 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.27 1.5 72.07 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.415 0.531 . . . . 0.0 111.911 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.17 148.5 24.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 117.808 0.804 . . . . 0.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.2 165.84 33.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.388 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 5.0 m -135.22 121.22 19.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.976 0.51 . . . . 0.0 111.943 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.08 125.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 33.3 t -96.66 129.68 44.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.49 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.48 147.27 26.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -76.72 -17.35 59.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -124.84 131.25 24.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.069 0.948 . . . . 0.0 110.525 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.428 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 29.9 Cg_endo -66.17 -33.3 40.53 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.798 2.332 . . . . 0.0 114.382 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 93.0 Cg_endo -75.53 -20.27 16.0 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 CA-C-N 121.372 1.526 . . . . 0.0 111.016 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -74.72 -29.81 61.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.52 -47.98 76.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.418 ' HA ' HD11 ' A' ' 351' ' ' ILE . 17.3 tptm -64.62 -38.15 90.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.346 0.117 . . . . 0.0 110.71 -177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.59 82.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.471 0.308 . . . . 0.0 110.808 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.91 -25.81 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 348' ' ' LYS . 66.4 mt -72.54 -57.92 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -59.67 -22.32 61.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -92.65 -60.35 1.84 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.72 -32.03 70.36 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.58 112.45 1.28 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.89 -15.81 31.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.149 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.47 -171.91 2.5 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.719 1.26 . . . . 0.0 109.861 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -101.12 174.68 5.89 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.427 0.291 . . . . 0.0 110.455 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -130.66 -37.38 1.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.617 0.367 . . . . 0.0 110.404 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.3 t -144.37 15.59 1.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.86 10.79 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.82 148.0 34.44 Favored Pre-proline 0 CA--C 1.53 0.175 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.26 151.22 76.77 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.485 2.79 . . . . 0.0 110.646 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.07 169.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 122.858 0.463 . . . . 0.0 110.705 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 156.27 49.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.698 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.06 147.87 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.068 0.547 . . . . 0.0 110.307 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 175.88 13.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.126 0.971 . . . . 0.0 108.809 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.23 163.84 3.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -131.98 137.58 47.95 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 10.3 m -141.64 134.37 28.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.203 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -47.42 115.98 1.28 Allowed 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.236 0.335 . . . . 0.0 110.448 -170.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -24.0 61.02 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.16 76.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.166 -0.334 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.37 -9.83 13.95 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.445 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 97.7 m-85 -107.43 -9.63 15.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.42 -41.68 0.09 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -82.14 -1.55 49.21 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 80.48 12.55 82.88 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 88.59 170.43 45.55 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.26 154.45 53.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -157.94 171.5 20.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.421 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.06 162.49 36.02 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -74.86 165.11 25.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.842 0.353 . . . . 0.0 110.374 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.77 139.7 29.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -89.65 175.28 42.05 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -66.9 135.39 53.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -101.1 -178.57 29.0 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -140.2 166.44 24.67 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.311 0.644 . . . . 0.0 110.43 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 75.15 -174.67 51.67 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.102 -1.944 . . . . 0.0 110.61 -179.47 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . 0.436 HO2' " H5'" ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 C5'-C4'-C3' 110.59 -3.274 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.436 " H5'" HO2' ' B' ' 91' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 N19-C1'-C2' 109.298 -2.564 . 0.772 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.434 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.369 0 N19-C1'-C2' 108.945 -2.784 . 0.838 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 N19-C1'-C2' 109.324 -2.547 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 C5'-C4'-C3' 111.44 -2.707 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.729 2.529 . 0.907 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.633 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 O4'-C1'-N19 110.877 2.677 . 0.832 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.633 " H5'" HO2' ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.465 0 O4'-C1'-N19 111.316 3.116 . 0.652 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.603 HO2' " H5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 O4'-C1'-N19 111.207 3.007 . 0.719 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.603 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.878 0 C5'-C4'-C3' 111.383 -2.745 . 0.671 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 C5'-C4'-C3' 111.272 -2.819 . 0.478 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.428 0 C5'-C4'-C3' 110.608 -3.261 . 0.278 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 109.785 -3.81 . 0.26 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 1 O4'-C1'-N19 112.694 4.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.657 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 C5'-C4'-C3' 109.929 -3.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.996 1 C3'-C2'-C1' 106.055 5.062 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.809 0 C5'-C4'-C3' 109.869 -3.754 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 0 C5'-C4'-C3' 110.846 -3.103 . 0.619 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 N19-C1'-C2' 109.125 -2.672 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.535 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 N19-C1'-C2' 109.653 -2.342 . 0.762 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.55 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 N19-C1'-C2' 109.358 -2.526 . 0.774 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.55 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 109.797 -2.252 . 0.699 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.519 HO2' " H5'" ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 C5'-C4'-C3' 111.798 -2.468 . 0.802 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.519 " H5'" HO2' ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 O4'-C1'-N19 110.86 2.66 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 O4'-C1'-N19 110.845 2.645 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.523 HO2' " H5'" ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.884 0 O4'-C1'-N19 110.837 2.637 . 0.758 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.545 HO2' " H5'" ' B' ' 118' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.705 2.505 . 0.793 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.545 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.501 2.301 . 0.827 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.022 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.33 -8.37 87.02 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -143.07 175.83 9.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -68.67 -174.29 0.55 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.594 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.02 -15.88 60.4 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.997 0.519 . . . . 0.0 112.097 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.87 -5.18 45.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.192 0.451 . . . . 0.0 111.304 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.09 83.76 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.135 -0.814 . . . . 0.0 114.098 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.92 -160.64 50.16 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 119.024 1.412 . . . . 0.0 110.788 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.67 20.96 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.787 2.991 . . . . 0.0 112.603 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.8 ttp180 -74.88 -41.96 58.78 Favored 'General case' 0 CA--C 1.527 0.07 0 O-C-N 121.815 -0.553 . . . . 0.0 110.188 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -105.45 11.36 32.69 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.133 0.573 . . . . 0.0 111.029 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -8.48 41.7 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.59 -107.98 2.99 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 81.0 p -72.43 12.37 0.47 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -3.52 14.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -87.73 -6.72 58.06 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.777 0.262 . . . . 0.0 111.411 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -150.19 22.82 0.84 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 48.5 t -155.79 154.47 31.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.919 -0.488 . . . . 0.0 110.138 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.69 -0.67 48.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.243 0.617 . . . . 0.0 110.155 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -90.13 -84.53 0.23 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.218 0.607 . . . . 0.0 110.082 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 48.96 17.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -155.47 168.63 26.5 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.5 t -149.53 -30.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.53 -11.04 14.51 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -92.11 54.41 2.37 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.937 0.495 . . . . 0.0 111.556 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -68.43 -10.74 57.3 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.56 0.344 . . . . 0.0 110.747 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.4 m -98.49 148.7 23.47 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.3 pt -128.98 149.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.335 0.654 . . . . 0.0 109.854 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -103.0 149.09 24.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.2 t -133.94 148.34 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.319 0.647 . . . . 0.0 110.892 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -139.14 151.09 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.1 5.34 59.56 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 120.013 -0.326 . . . . 0.0 112.797 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.5 mp -55.09 -55.22 33.51 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.428 0.614 . . . . 0.0 111.292 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.48 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.86 -176.99 44.62 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.03 -7.22 58.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.087 0.955 . . . . 0.0 112.368 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.29 -6.7 55.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.677 0.275 . . . . 0.0 110.805 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.73 159.76 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 163.63 39.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 44.3 mm -50.7 -37.1 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.009 0.924 . . . . 0.0 111.805 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -73.86 -28.59 61.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.251 -0.281 . . . . 0.0 110.991 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.6 t -74.0 -48.52 29.73 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 122.258 0.223 . . . . 0.0 110.548 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.3 m -61.71 -53.45 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.45 79.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.182 0.446 . . . . 0.0 110.884 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -75.33 -16.22 60.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 111.088 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -93.94 -27.56 16.29 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -96.85 -20.08 18.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -65.99 -19.09 65.74 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.31 -21.24 66.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.2 mm -87.99 -23.66 6.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 162.2 169.74 25.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.06 138.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 122.535 -0.391 . . . . 0.0 111.178 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.3 mm -78.9 135.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 15.5 ttpp -70.04 139.18 52.64 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m -107.32 143.23 35.89 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -70.69 143.2 51.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.75 -13.2 59.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 316' ' ' LYS . 6.8 mmpt? -125.46 -36.35 2.47 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.12 0.418 . . . . 0.0 111.839 -174.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.4 p -85.84 -18.17 33.61 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.43 -16.49 3.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.468 0.556 . . . . 0.0 113.421 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -80.83 160.02 67.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 117.984 0.892 . . . . 0.0 109.813 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.64 152.39 80.62 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.927 1.752 . . . . 0.0 108.913 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.453 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.2 mtp -78.09 79.8 4.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.004 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.436 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.5 OUTLIER -132.67 152.16 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.328 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -146.42 126.44 13.69 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 36.0 mt -96.07 113.46 25.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -79.25 156.09 28.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 35.7 p -130.47 156.25 45.09 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.736 0.779 . . . . 0.0 112.855 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 122.73 20.15 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.577 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.23 -4.0 30.28 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.372 0.269 . . . . 0.0 111.164 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.82 -6.17 29.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.494 0.717 . . . . 0.0 112.742 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.9 t -150.68 -24.29 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.272 0.487 . . . . 0.0 111.247 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 88.37 19.61 51.83 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.6 -0.556 . . . . 0.0 113.05 172.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -122.61 169.5 10.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.965 0.883 . . . . 0.0 110.228 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.61 126.43 15.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.031 0.443 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.565 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.9 ttmm -76.61 -14.6 59.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.067 0.947 . . . . 0.0 109.173 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.48 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.03 -5.69 61.58 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -87.23 144.98 26.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.76 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.83 166.49 33.23 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.7 m -138.64 119.24 13.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.705 0.402 . . . . 0.0 111.353 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.65 125.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.9 t -96.94 132.91 42.26 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.06 -0.4 . . . . 0.0 110.301 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.89 147.28 23.26 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -73.69 -20.49 60.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.402 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.4 m-20 -124.5 133.16 24.51 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 123.671 0.788 . . . . 0.0 110.706 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.434 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 26.2 Cg_endo -66.69 -33.78 34.07 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.724 2.283 . . . . 0.0 114.031 -175.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 85.5 Cg_endo -76.84 -18.93 14.55 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 CA-C-N 121.214 1.469 . . . . 0.0 111.032 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 56.2 m -75.49 -29.72 59.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.38 -48.03 79.58 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -64.64 -39.04 93.01 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-O 120.595 0.236 . . . . 0.0 110.714 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.72 -39.32 84.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.392 0.277 . . . . 0.0 110.642 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.1 -26.15 65.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -72.79 -57.25 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.68 -22.27 61.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -93.13 -60.37 1.81 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.77 -31.55 69.55 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -56.75 113.24 1.56 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.005 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.33 37.68 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.169 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -96.5 -172.48 2.52 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.545 1.173 . . . . 0.0 110.027 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.96 175.6 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.843 0.354 . . . . 0.0 110.559 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -131.45 -39.41 1.14 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 17.0 t -141.53 19.69 2.2 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.798 0.439 . . . . 0.0 110.101 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.79 -8.29 34.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -111.49 146.77 35.32 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 123.881 0.872 . . . . 0.0 109.587 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.49 149.42 68.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.563 2.842 . . . . 0.0 110.846 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.75 169.72 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.924 0.49 . . . . 0.0 110.878 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -135.83 156.5 48.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.127 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.4 t -144.7 147.55 19.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.09 0.556 . . . . 0.0 110.153 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 71.0 m -155.23 175.41 13.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.054 0.941 . . . . 0.0 108.833 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -59.8 163.81 4.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -136.04 141.73 44.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.3 m -144.94 139.04 27.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.838 0.855 . . . . 0.0 110.383 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -46.73 114.08 0.77 Allowed 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -72.8 -26.54 61.55 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.81 -30.85 71.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.446 -0.159 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.77 -8.27 14.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.481 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 96.6 m-85 -106.2 -11.66 15.99 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.05 -41.37 0.07 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -81.09 -3.14 50.98 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 72.73 45.07 36.49 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -59.86 -9.87 11.77 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.877 0.751 . . . . 0.0 112.969 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -75.6 -8.87 84.61 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 117.87 0.835 . . . . 0.0 111.814 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -70.52 169.52 14.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.284 0.634 . . . . 0.0 111.23 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -167.15 -166.74 26.76 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -142.57 159.37 42.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.974 0.51 . . . . 0.0 110.753 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -82.41 -177.11 51.74 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -174.11 155.35 21.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -70.95 119.84 15.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -79.74 151.14 33.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -71.18 150.85 44.95 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 71.54 1.39 44.43 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 CA-C-O 117.165 -1.908 . . . . 0.0 110.694 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . 0.435 HO2' " H5'" ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 C4'-C3'-C2' 100.58 -2.12 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.435 " H5'" HO2' ' B' ' 91' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 N19-C1'-C2' 109.276 -2.577 . 0.865 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.417 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 C4'-C3'-C2' 100.116 -2.584 . 0.835 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.482 HO2' " H5'" ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C4'-C3'-C2' 100.13 -2.57 . 0.807 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.482 " H5'" HO2' ' B' ' 94' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 O4'-C1'-N19 110.635 2.435 . 0.814 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 O4'-C1'-N19 111.015 2.815 . 0.865 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.619 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 O4'-C1'-N19 110.971 2.771 . 0.735 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.619 " H5'" HO2' ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 C5'-C4'-C3' 111.755 -2.497 . 0.82 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.498 HO2' " H5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -2.96 0 C5'-C4'-C3' 111.725 -2.517 . 0.707 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.498 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C5'-C4'-C3' 111.267 -2.822 . 0.611 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.45 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.963 0 C5'-C4'-C3' 111.473 -2.685 . 0.555 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.45 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 C5'-C4'-C3' 110.814 -3.124 . 0.425 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 C5'-C4'-C3' 109.998 -3.668 . 0.306 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.253 1 O4'-C1'-N19 112.835 4.635 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.565 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 C5'-C4'-C3' 109.871 -3.752 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 C3'-C2'-C1' 105.637 4.597 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C5'-C4'-C3' 109.968 -3.688 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 C5'-C4'-C3' 109.565 -3.957 . 0.508 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.52 HO2' " H5'" ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.579 0 N19-C1'-C2' 109.651 -2.343 . 0.339 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.596 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 N19-C1'-C2' 109.646 -2.346 . 0.658 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.596 " H5'" HO2' ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 N19-C1'-C2' 109.668 -2.333 . 0.713 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.506 HO2' " H5'" ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.385 0 N19-C1'-C2' 109.954 -2.154 . 0.747 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.506 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 C5'-C4'-C3' 112.331 -2.112 . 0.798 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.453 " H5'" HO2' ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 O4'-C1'-N19 110.657 2.457 . 0.775 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.571 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 C4'-C3'-C2' 100.282 -2.418 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.571 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 O4'-C1'-N19 110.647 2.447 . 0.728 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.551 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 O4'-C1'-N19 110.425 2.225 . 0.791 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.543 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.66 0 O4'-C1'-N19 110.707 2.507 . 0.807 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 73.19 -171.69 50.81 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -64.18 -53.85 42.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -157.31 -178.96 7.74 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.128 0.971 . . . . 0.0 109.267 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.553 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -67.28 -7.54 25.09 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 119.774 -0.155 . . . . 0.0 111.323 176.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.31 -3.58 18.24 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.7 0.227 . . . . 0.0 111.152 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.96 5.7 89.07 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.18 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.74 -160.3 50.04 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.926 1.363 . . . . 0.0 110.404 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.44 19.84 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.81 3.007 . . . . 0.0 112.377 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 267' ' ' GLY . 59.5 ttt85 -78.05 -31.89 50.59 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.76 -0.588 . . . . 0.0 110.535 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -113.87 11.05 17.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.397 0.679 . . . . 0.0 111.84 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -11.46 58.22 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 84.93 -105.09 2.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 88.5 p -73.57 14.17 0.39 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -170.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -0.21 7.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.581 0.628 . . . . 0.0 112.644 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -95.19 -14.55 24.0 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.824 0.284 . . . . 0.0 110.989 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -126.57 6.16 6.85 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 43.1 t -152.65 152.76 32.15 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.644 0.259 . . . . 0.0 110.92 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -90.67 0.29 57.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.048 0.539 . . . . 0.0 110.613 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -90.89 -81.84 0.3 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.92 0.488 . . . . 0.0 110.284 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.95 15.47 0.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.572 1.549 . . . . 0.0 115.144 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -151.71 162.6 40.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.9 t -156.75 -32.55 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.372 0.13 . . . . 0.0 111.331 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -88.88 -0.53 57.45 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.56 153.52 32.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.485 0.714 . . . . 0.0 109.925 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -158.66 17.99 0.2 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.019 0.528 . . . . 0.0 110.525 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 26.7 m -132.71 150.79 52.11 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.662 0.385 . . . . 0.0 111.146 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.1 pt -128.42 148.84 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.876 0.47 . . . . 0.0 110.271 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -101.15 149.82 23.58 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.4 148.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.362 0.665 . . . . 0.0 110.902 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -138.77 149.53 45.11 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.47 5.59 57.83 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.971 -0.349 . . . . 0.0 112.869 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.91 -56.67 17.82 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 117.479 0.639 . . . . 0.0 111.408 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.86 -179.61 44.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.84 -10.0 59.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.626 0.77 . . . . 0.0 112.281 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -82.17 2.48 31.34 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.386 0.274 . . . . 0.0 111.553 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.91 155.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -158.49 168.91 25.65 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.7 mm -49.62 -40.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.391 1.077 . . . . 0.0 111.645 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.59 -28.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.449 -0.157 . . . . 0.0 110.876 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.7 t -75.08 -49.84 18.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.221 0.208 . . . . 0.0 110.611 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.464 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.8 m -61.09 -53.71 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.1 78.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.212 0.46 . . . . 0.0 110.718 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.4 ' OD2' ' HE2' ' A' ' 306' ' ' LYS . 19.8 t0 -76.07 -15.81 60.04 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.803 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -94.14 -27.63 16.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.411 ' CD2' HG23 ' A' ' 339' ' ' VAL . 45.4 m-85 -97.23 -19.99 18.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HE2' ' OD2' ' A' ' 303' ' ' ASP . 53.1 pttt -65.65 -19.05 65.75 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -173.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.27 -21.02 66.45 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -88.34 -26.04 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.732 0.301 . . . . 0.0 110.474 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.34 170.7 31.58 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 52.1 mm -68.4 134.63 29.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 O-C-N 122.662 -0.316 . . . . 0.0 111.348 -172.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.8 mm -76.19 137.34 22.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.44 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.8 ttmm -67.78 147.37 52.68 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -121.96 138.05 54.56 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -71.59 145.78 48.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -81.29 -2.37 48.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -142.29 4.7 1.62 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.8 p -124.2 -18.25 5.91 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.31 -17.12 3.3 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.778 -0.457 . . . . 0.0 112.895 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -87.32 158.31 52.22 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 117.797 0.798 . . . . 0.0 109.862 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.7 153.87 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.173 1.915 . . . . 0.0 109.102 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.44 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.9 mtp -79.65 78.52 6.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 122.476 0.31 . . . . 0.0 111.001 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.464 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.6 156.86 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.36 0.664 . . . . 0.0 110.71 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -152.76 130.57 11.66 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.918 0.887 . . . . 0.0 109.455 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -94.07 119.49 33.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -84.03 160.09 21.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 42.7 p -135.76 159.07 42.77 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 121.763 0.792 . . . . 0.0 110.357 -171.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.27 124.59 23.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.588 172.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -72.27 -8.24 53.77 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.411 0.285 . . . . 0.0 111.681 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.96 -13.76 43.68 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.2 t -157.2 -18.93 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.97 61.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.19 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -91.1 162.83 14.52 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.237 1.019 . . . . 0.0 110.549 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.33 118.74 4.68 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.53 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -78.18 -19.51 53.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.526 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.52 0.22 59.46 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.81 149.44 21.98 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.396 0.598 . . . . 0.0 110.927 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.13 165.83 32.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.378 0.671 . . . . 0.0 109.75 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.0 m -136.9 121.74 18.73 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 305' ' ' PHE . 98.2 t -114.16 121.45 66.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.8 t -92.72 126.42 37.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.17 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -84.46 147.39 27.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.05 -14.81 59.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.427 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 94.0 m-20 -127.64 135.75 27.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 111.221 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.423 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 24.1 Cg_endo -65.82 -35.37 36.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.025 2.484 . . . . 0.0 114.422 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 343' ' ' ASP . 87.8 Cg_endo -76.46 -20.34 14.16 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.719 1.613 . . . . 0.0 111.358 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -74.19 -30.67 62.33 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 122.297 -0.252 . . . . 0.0 110.431 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.73 93.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -65.07 -41.15 95.35 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 120.547 0.213 . . . . 0.0 110.834 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.98 86.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.354 0.262 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -25.08 64.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.6 mt -73.4 -56.59 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -60.36 -21.63 62.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -94.06 -59.92 1.86 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -70.78 -32.52 69.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.46 113.74 1.92 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.16 -17.09 32.14 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.949 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -93.76 -172.88 3.0 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.648 1.224 . . . . 0.0 109.808 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -100.33 173.72 6.46 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.34 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -127.31 -38.7 1.94 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.437 0.295 . . . . 0.0 110.277 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.6 t -143.2 6.61 1.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 110.363 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.48 -22.27 4.18 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.41 149.25 35.92 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 109.463 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.65 151.95 74.7 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.538 2.825 . . . . 0.0 110.388 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.62 168.28 21.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.076 0.55 . . . . 0.0 110.851 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 156.17 47.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.917 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 51.4 t -145.2 146.77 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 123.636 0.585 . . . . 0.0 110.224 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.0 m -155.26 171.65 19.48 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -59.01 162.24 4.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -138.29 144.59 40.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.228 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 10.7 m -148.38 139.88 23.55 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.404 1.082 . . . . 0.0 109.67 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -43.52 121.36 2.26 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.371 0.669 . . . . 0.0 110.806 -172.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -68.35 -32.94 73.4 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -175.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.16 -31.93 73.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.977 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -64.57 -10.53 26.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.553 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.5 m-85 -104.56 -13.73 15.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.94 -41.64 0.09 Allowed 'General case' 0 C--N 1.34 0.188 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -78.88 -0.29 30.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.69 11.57 79.41 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.93 52.78 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -72.9 165.4 54.75 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -158.17 172.28 18.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.07 -167.85 27.33 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -136.58 163.83 29.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.149 0.58 . . . . 0.0 109.99 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.02 149.72 46.49 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.75 42.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -73.9 170.7 14.84 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.606 0.362 . . . . 0.0 110.565 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -63.81 162.45 34.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -69.69 161.13 30.34 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.575 0.35 . . . . 0.0 110.647 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.71 86.66 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.917 -2.046 . . . . 0.0 110.368 179.503 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . 0.416 HO2' " H5'" ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 C5'-C4'-C3' 110.854 -3.097 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.416 " H5'" HO2' ' B' ' 91' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 N19-C1'-C2' 109.523 -2.423 . 0.769 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.488 0 N19-C1'-C2' 109.156 -2.653 . 0.867 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.465 HO2' " H5'" ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 N19-C1'-C2' 109.263 -2.586 . 0.834 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.486 HO2' " H5'" ' B' ' 96' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.973 2.773 . 0.872 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.486 " H5'" HO2' ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 O4'-C1'-N19 110.927 2.727 . 0.874 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.764 0 O4'-C1'-N19 111.016 2.816 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.69 HO2' " H5'" ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 111.272 3.072 . 0.812 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.69 " H5'" HO2' ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C5'-C4'-C3' 111.792 -2.472 . 0.698 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.495 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.888 0 C5'-C4'-C3' 111.592 -2.605 . 0.643 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 C5'-C4'-C3' 111.074 -2.95 . 0.349 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 C5'-C4'-C3' 110.613 -3.258 . 0.248 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.448 1 C5'-C4'-C3' 109.349 -4.101 . 0.293 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.102 1 O4'-C1'-N19 112.611 4.411 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.53 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 C5'-C4'-C3' 110.109 -3.594 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.823 1 C3'-C2'-C1' 105.374 4.304 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 110.362 -3.425 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 C5'-C4'-C3' 112.291 -2.14 . 0.168 8d . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.483 HO2' " H5'" ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.426 -2.26 0 C5'-C4'-C3' 110.8 -3.133 . 0.319 1c . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.483 " H5'" HO2' ' B' ' 109' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 N19-C1'-C2' 109.001 -2.749 . 0.794 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.568 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.239 -2.6 . 0.79 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.598 HO2' " H5'" ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 N19-C1'-C2' 109.479 -2.451 . 0.738 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.598 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 C4'-C3'-C2' 100.41 -2.29 . 0.804 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.507 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 O4'-C1'-N19 110.548 2.348 . 0.785 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.507 " H5'" HO2' ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 C4'-C3'-C2' 100.192 -2.508 . 0.73 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.555 HO2' " H5'" ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.859 0 O4'-C1'-N19 110.826 2.626 . 0.757 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.555 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.521 2.321 . 0.78 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.546 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 110.779 2.579 . 0.828 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.76 174.11 46.45 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -60.93 -52.78 63.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -156.35 -179.73 8.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.048 0.939 . . . . 0.0 108.923 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -66.52 -10.33 43.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.752 -0.166 . . . . 0.0 111.214 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.59 -4.26 21.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.756 0.253 . . . . 0.0 111.245 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.34 5.68 84.9 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.495 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 68.08 -156.35 52.87 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.24 1.52 . . . . 0.0 110.088 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.17 22.6 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.913 3.075 . . . . 0.0 112.003 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 267' ' ' GLY . 72.0 ttt-85 -76.65 -41.22 46.5 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.852 -0.53 . . . . 0.0 110.908 -175.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -104.5 8.3 35.52 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.732 0.413 . . . . 0.0 111.198 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -15.29 61.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.96 -117.47 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -79.05 17.1 0.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -6.53 6.94 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -85.48 -7.22 59.02 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.468 0.307 . . . . 0.0 111.021 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -146.1 20.7 1.41 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 36.7 t -154.81 143.17 20.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.51 0.324 . . . . 0.0 110.197 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.75 6.29 21.72 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.17 0.588 . . . . 0.0 110.211 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -103.34 -111.5 0.24 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . 0.25 2.9 m-20 50.17 23.87 1.28 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -152.42 161.25 42.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.2 p -154.27 -36.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 122.431 0.292 . . . . 0.0 110.522 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -98.39 14.09 29.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.106 0.562 . . . . 0.0 112.152 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -132.4 44.65 2.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.413 0.685 . . . . 0.0 111.346 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.69 -0.6 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.764 0.426 . . . . 0.0 111.361 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -98.79 148.44 23.89 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 11.1 pt -131.39 146.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.697 0.399 . . . . 0.0 110.575 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -100.78 149.6 23.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.87 147.32 30.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.111 0.564 . . . . 0.0 111.817 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.73 151.03 48.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 109.811 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.28 5.89 59.06 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 120.025 -0.319 . . . . 0.0 112.699 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.61 -57.68 10.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.397 0.679 . . . . 0.0 111.1 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.418 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.28 -178.57 44.71 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -77.89 -10.87 59.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.974 0.909 . . . . 0.0 112.109 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.02 0.2 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.25 0.22 . . . . 0.0 111.484 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.95 155.59 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.41 168.49 26.81 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.52 -39.73 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.897 0.879 . . . . 0.0 111.878 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.61 62.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.526 -0.109 . . . . 0.0 111.158 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.25 -49.52 19.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.729 -0.1 . . . . 0.0 110.729 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.478 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.5 m -61.56 -53.88 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.36 -37.44 77.92 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.249 0.477 . . . . 0.0 110.804 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -76.07 -15.83 60.04 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 111.099 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.56 -26.96 16.18 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 339' ' ' VAL . 46.6 m-85 -97.17 -20.22 18.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -65.68 -18.85 65.63 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.44 -21.16 66.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.6 mm -87.96 -25.47 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 110.161 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.92 170.28 29.67 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.91 135.24 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 O-C-N 122.478 -0.425 . . . . 0.0 111.135 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.9 mm -76.01 138.08 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -69.15 148.97 49.16 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m -122.57 134.51 54.53 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -74.09 134.74 42.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.47 -22.23 59.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.592 0.357 . . . . 0.0 111.173 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -101.34 -9.06 21.51 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 p -130.13 -17.6 3.43 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.03 -15.69 5.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.273 0.463 . . . . 0.0 113.557 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.19 159.71 56.11 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 117.968 0.884 . . . . 0.0 109.619 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.9 151.96 81.57 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.845 1.697 . . . . 0.0 109.005 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.9 mtp -77.91 78.69 4.4 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.77 0.428 . . . . 0.0 111.206 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.478 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.25 155.3 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 0.0 110.527 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -150.24 121.89 8.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.524 0.73 . . . . 0.0 109.326 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.14 121.67 30.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.624 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 73.9 m-85 -77.64 162.83 26.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.8 p -140.18 157.3 45.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -67.22 117.39 9.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.206 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -68.4 -7.75 34.38 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -14.37 51.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 13.8 t -156.22 -20.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.87 57.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.26 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -91.89 162.08 14.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 118.492 1.146 . . . . 0.0 110.56 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.66 120.44 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.594 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -77.47 -18.86 56.73 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.087 0.555 . . . . 0.0 109.783 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.418 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.61 16.62 36.11 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.37 156.83 31.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.783 0.791 . . . . 0.0 110.23 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.74 171.2 19.96 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.802 0.441 . . . . 0.0 110.262 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 70.8 m -136.33 129.07 30.82 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.412 HG22 ' CD1' ' A' ' 305' ' ' PHE . 93.8 t -118.67 127.89 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.5 t -98.98 127.91 45.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.997 0.362 . . . . 0.0 110.513 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.18 147.95 26.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -75.85 -17.26 59.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.419 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 91.2 m-20 -127.54 133.89 25.59 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.979 0.912 . . . . 0.0 110.987 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.43 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -66.64 -33.79 34.54 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.646 2.231 . . . . 0.0 114.463 -175.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 88.7 Cg_endo -74.81 -19.79 18.0 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 CA-C-N 121.052 1.412 . . . . 0.0 110.843 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.9 m -75.89 -29.45 58.47 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.32 -0.237 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.47 73.34 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -65.33 -36.99 85.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.425 0.155 . . . . 0.0 110.593 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.38 82.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.493 0.317 . . . . 0.0 110.943 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.55 65.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.81 -56.09 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.69 -22.08 63.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -93.92 -59.99 1.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.82 -32.76 71.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.03 110.74 0.87 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.41 -16.09 24.57 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.035 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.6 -171.52 2.39 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.824 1.312 . . . . 0.0 109.902 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.53 173.94 6.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.664 0.269 . . . . 0.0 110.322 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -128.44 -37.44 1.81 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.608 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -145.0 11.05 1.35 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.682 0.393 . . . . 0.0 109.988 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.47 -20.3 6.18 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -103.12 148.64 35.94 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 151.97 75.13 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.388 2.725 . . . . 0.0 110.451 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.18 167.74 21.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.873 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.15 156.47 46.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.803 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.68 146.48 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.047 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 47.1 m -155.05 174.23 15.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.19 150.66 29.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.541 ' HA ' ' H22' ' B' ' 106' ' ' ' G' . . . -120.63 137.31 54.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 7.6 m -141.95 134.17 27.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.255 0.622 . . . . 0.0 110.599 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -46.29 110.33 0.26 Allowed 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.358 0.663 . . . . 0.0 110.489 -170.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.419 HH21 ' P ' ' B' ' 105' ' ' ' U' . 0.6 OUTLIER -70.17 -29.35 66.21 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.155 -174.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.31 -31.66 72.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 110.743 -0.095 . . . . 0.0 110.743 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -65.44 -10.45 34.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.552 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.5 m-85 -104.04 -10.52 17.99 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.45 -43.55 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -77.31 -5.14 48.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.273 0.488 . . . . 0.0 111.909 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.46 12.13 76.26 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.34 -176.22 53.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.63 168.92 54.5 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.48 170.8 20.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -162.52 166.58 36.68 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -77.07 173.58 11.66 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 122.745 0.418 . . . . 0.0 110.238 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -78.73 151.87 36.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.65 162.2 37.5 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -77.64 159.97 28.82 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.302 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -77.37 179.54 50.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -134.59 164.18 28.06 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 179.98 179.0 48.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.371 -1.794 . . . . 0.0 110.584 179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . 0.437 HO2' " H5'" ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 110.867 -3.089 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.437 " H5'" HO2' ' B' ' 91' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 109.22 -2.613 . 0.785 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 N19-C1'-C2' 109.119 -2.676 . 0.863 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 N19-C1'-C2' 109.41 -2.494 . 0.842 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 O4'-C1'-N19 110.861 2.661 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 0 O4'-C1'-N19 110.905 2.705 . 0.826 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.621 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 O4'-C1'-N19 110.702 2.502 . 0.801 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.621 " H5'" HO2' ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.992 0 O4'-C1'-N19 111.129 2.929 . 0.732 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.554 HO2' " H5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 111.358 -2.761 . 0.755 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.554 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.678 0 C5'-C4'-C3' 111.116 -2.923 . 0.707 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.407 HO2' " H5'" ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 C5'-C4'-C3' 110.877 -3.082 . 0.302 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.407 " H5'" HO2' ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C5'-C4'-C3' 110.066 -3.623 . 0.242 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.706 -3.863 . 0.254 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.174 1 O4'-C1'-N19 112.995 4.795 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.624 " H1'" ' CD1' ' A' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.332 1 C5'-C4'-C3' 109.288 -4.141 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.541 ' H22' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.593 1 C3'-C2'-C1' 105.886 4.874 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 109.924 -3.718 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C5'-C4'-C3' 109.965 -3.69 . 0.431 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 C5'-C4'-C3' 110.479 -3.347 . 0.063 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.54 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 N19-C1'-C2' 109.301 -2.562 . 0.74 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.54 " H5'" HO2' ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 N19-C1'-C2' 109.251 -2.593 . 0.773 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.531 HO2' " H5'" ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C4'-C3'-C2' 100.405 -2.295 . 0.74 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.531 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 C5'-C4'-C3' 111.96 -2.36 . 0.759 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.547 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 110.581 2.381 . 0.76 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.605 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 110.81 2.61 . 0.686 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.605 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O4'-C1'-N19 110.98 2.78 . 0.737 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.572 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 O4'-C1'-N19 110.803 2.603 . 0.791 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.537 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 O4'-C1'-N19 110.762 2.562 . 0.813 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.01 -177.68 48.4 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.11 176.29 3.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -68.18 -174.97 0.55 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.41 0.684 . . . . 0.0 110.655 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.583 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -63.64 -14.8 55.24 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.273 0.629 . . . . 0.0 112.156 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -96.93 -5.82 37.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.217 0.462 . . . . 0.0 111.262 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.03 79.49 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.06 -0.856 . . . . 0.0 114.509 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.66 -159.49 50.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.242 1.521 . . . . 0.0 110.818 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.97 18.85 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.486 2.791 . . . . 0.0 112.775 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.1 ttp180 -74.47 -41.36 60.91 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.846 -0.534 . . . . 0.0 110.254 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -106.2 11.84 30.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.178 0.591 . . . . 0.0 110.89 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -9.68 53.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.84 -106.1 2.82 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.8 p -73.62 13.13 0.52 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -1.76 10.02 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -91.05 -15.81 28.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.739 0.245 . . . . 0.0 110.969 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -127.98 7.69 6.12 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.0 t -152.55 155.51 37.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.488 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -95.87 1.73 53.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.09 0.556 . . . . 0.0 110.309 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -89.89 -83.01 0.25 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 49.22 15.99 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.46 170.83 21.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 83.7 p -149.39 -33.7 0.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.515 -0.116 . . . . 0.0 111.229 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -113.94 1.35 14.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.25 0.62 . . . . 0.0 112.194 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.72 35.15 1.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.303 0.641 . . . . 0.0 109.715 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -68.27 -0.03 4.31 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.923 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.6 m -101.74 150.2 23.38 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.89 147.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 122.545 0.338 . . . . 0.0 110.101 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -102.57 147.94 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.28 147.53 31.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.076 0.551 . . . . 0.0 112.079 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -138.71 151.3 47.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.84 59.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.84 -57.08 13.54 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.359 0.664 . . . . 0.0 111.033 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.402 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.43 -178.05 45.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.62 -10.65 59.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.849 0.86 . . . . 0.0 112.178 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -80.54 -0.55 38.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.321 -0.237 . . . . 0.0 111.234 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.29 156.28 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.06 168.39 26.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.3 mm -48.67 -39.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 124.421 1.088 . . . . 0.0 111.861 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.92 -29.75 63.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.345 -0.222 . . . . 0.0 111.217 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.05 -48.61 23.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.154 0.182 . . . . 0.0 110.679 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.477 ' CG2' HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.57 -54.22 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.8 79.04 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.969 -0.457 . . . . 0.0 110.875 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.95 -15.82 60.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.252 -0.28 . . . . 0.0 110.932 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -94.32 -27.54 16.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.43 ' CD2' HG22 ' A' ' 339' ' ' VAL . 44.3 m-85 -96.59 -19.91 18.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -66.35 -18.63 65.47 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.74 -20.82 66.56 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.7 mm -87.93 -26.28 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.14 170.48 31.11 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.05 134.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 122.58 -0.365 . . . . 0.0 111.299 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.7 mm -76.3 138.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.445 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.7 ttmm -69.08 148.58 49.81 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 134.51 42.68 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -76.27 150.66 36.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.73 -18.05 52.1 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.39 -34.09 5.06 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 4.2 p -73.94 -22.0 59.83 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 70.96 17.05 75.16 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -139.4 158.47 68.67 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-N 117.35 0.575 . . . . 0.0 109.695 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 155.03 61.98 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.518 2.145 . . . . 0.0 109.935 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.445 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.7 mtp -79.28 77.44 5.81 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 122.791 0.436 . . . . 0.0 110.81 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.477 HG21 ' CG2' ' A' ' 301' ' ' VAL . 0.5 OUTLIER -130.91 159.26 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.428 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -155.93 124.73 6.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.787 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.13 120.96 31.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.657 ' HH ' " H5'" ' B' ' 106' ' ' ' G' . 70.1 m-85 -73.36 162.68 29.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.518 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 39.5 p -140.79 155.78 46.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.656 0.741 . . . . 0.0 109.33 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -64.57 123.86 20.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.887 172.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.38 -6.76 45.7 Favored 'General case' 0 N--CA 1.458 -0.045 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.13 -15.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.2 t -156.24 -17.78 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 92.07 10.69 60.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.944 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -90.72 163.66 14.41 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 118.17 0.985 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.65 120.83 7.29 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.515 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -77.7 -19.43 55.3 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.708 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.0 18.86 28.12 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.7 156.08 38.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.417 0.609 . . . . 0.0 110.553 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.96 173.48 16.42 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.71 0.404 . . . . 0.0 110.288 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.0 m -139.92 128.14 22.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 122.658 0.383 . . . . 0.0 109.969 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 305' ' ' PHE . 94.6 t -118.11 127.12 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 124.024 0.93 . . . . 0.0 109.064 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.6 t -97.68 128.01 44.05 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.89 -0.506 . . . . 0.0 110.207 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -85.64 147.26 26.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -76.24 -18.2 59.13 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.407 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 96.9 m-20 -124.88 133.36 24.73 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 123.704 0.802 . . . . 0.0 110.72 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.428 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.4 Cg_endo -66.24 -34.31 36.51 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.818 2.346 . . . . 0.0 114.215 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.79 -19.54 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 121.168 1.453 . . . . 0.0 111.104 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 41.9 m -75.55 -30.52 59.75 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.26 78.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.58 -0.075 . . . . 0.0 110.799 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -64.28 -38.88 92.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.553 0.216 . . . . 0.0 110.954 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.68 83.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.372 0.269 . . . . 0.0 110.611 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.66 66.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.19 -57.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.26 -21.19 61.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -94.31 -60.3 1.76 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.85 -31.76 69.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -57.26 111.05 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.7 25.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.127 -0.818 . . . . 0.0 113.106 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.5 -171.8 2.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.674 1.237 . . . . 0.0 109.908 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.75 171.26 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.595 0.358 . . . . 0.0 110.447 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -127.19 -38.28 1.99 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.382 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.7 t -144.33 15.28 1.65 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.648 0.379 . . . . 0.0 110.098 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.64 -19.43 8.48 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.54 148.69 36.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.01 151.73 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 0.0 110.677 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.32 168.11 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 121.267 0.556 . . . . 0.0 110.66 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -133.62 155.45 49.64 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.17 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.8 t -144.35 147.04 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 122.867 0.467 . . . . 0.0 110.417 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.4 m -153.6 174.43 14.46 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -60.61 159.08 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.643 ' HA ' ' H22' ' B' ' 106' ' ' ' G' . . . -132.11 138.19 48.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 4.3 m -143.73 137.81 28.39 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.414 0.686 . . . . 0.0 109.893 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -43.81 109.71 0.16 Allowed 'General case' 0 C--N 1.338 0.074 0 C-N-CA 122.635 0.374 . . . . 0.0 110.977 -171.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -25.39 59.44 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.44 -30.1 70.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 122.441 -0.162 . . . . 0.0 110.676 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -67.22 -11.47 57.5 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.546 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 95.8 m-85 -98.92 -10.53 22.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.23 -40.97 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -81.78 1.86 32.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.262 0.483 . . . . 0.0 112.074 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 86.06 8.14 79.31 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 80.98 7.3 88.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 117.496 0.648 . . . . 0.0 112.035 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 83.92 165.76 39.34 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 117.497 0.649 . . . . 0.0 111.64 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.74 177.67 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 0.0 110.11 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -163.59 156.53 28.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -78.49 162.62 26.22 Favored 'General case' 0 CA--C 1.523 -0.079 0 O-C-N 122.669 -0.312 . . . . 0.0 110.262 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.05 151.64 49.16 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -80.1 173.94 55.0 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -65.15 150.72 47.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.749 0.42 . . . . 0.0 109.901 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -61.04 142.91 48.62 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -160.24 156.34 26.33 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.495 0.318 . . . . 0.0 110.343 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.92 40.78 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.006 -1.997 . . . . 0.0 110.911 178.86 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 C5'-C4'-C3' 111.039 -2.974 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.466 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.402 0 N19-C1'-C2' 109.633 -2.354 . 0.819 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.466 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 N19-C1'-C2' 109.138 -2.664 . 0.833 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.696 0 C4'-C3'-C2' 100.11 -2.59 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.431 HO2' " H5'" ' B' ' 96' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.795 0 C5'-C4'-C3' 111.41 -2.727 . 0.824 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.431 " H5'" HO2' ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 111.131 2.931 . 0.932 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.598 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 111.139 2.939 . 0.809 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.598 " H5'" HO2' ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 O4'-C1'-N19 111.285 3.085 . 0.76 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.487 HO2' " H5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 C5'-C4'-C3' 111.903 -2.398 . 0.725 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.487 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.942 0 C5'-C4'-C3' 111.271 -2.819 . 0.614 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.403 " C5'" HO2' ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 C5'-C4'-C3' 111.687 -2.542 . 0.596 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.401 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 110.428 -3.381 . 0.384 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 1 C5'-C4'-C3' 109.453 -4.031 . 0.277 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.3 1 O4'-C1'-N19 112.679 4.479 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.515 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.062 1 C5'-C4'-C3' 109.48 -4.013 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.657 " H5'" ' HH ' ' A' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.423 -2.478 1 C3'-C2'-C1' 105.7 4.667 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.802 0 C5'-C4'-C3' 110.321 -3.453 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 1 C5'-C4'-C3' 109.29 -4.14 OUTLIER-DELTA 0.065 2h . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 C5'-C4'-C3' 110.087 -3.609 . 0.0 OUTLIER '7D dist 1c' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.492 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 N19-C1'-C2' 109.339 -2.538 . 0.64 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.637 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.58 0 N19-C1'-C2' 109.07 -2.706 . 0.767 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.637 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 C4'-C3'-C2' 100.365 -2.335 . 0.667 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.526 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 C4'-C3'-C2' 100.389 -2.311 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.481 " H5'" HO2' ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 110.924 2.724 . 0.74 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.553 0 O4'-C1'-N19 110.846 2.646 . 0.731 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.705 0 O4'-C1'-N19 110.827 2.627 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 O4'-C1'-N19 110.253 2.053 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.659 2.459 . 0.843 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.88 -175.66 46.09 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -70.62 176.89 3.81 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -65.73 -177.94 0.51 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.271 1.028 . . . . 0.0 110.713 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.58 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -65.13 -14.02 59.53 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -94.92 -5.65 44.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.052 0.387 . . . . 0.0 111.651 175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.05 11.74 78.15 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.321 170.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 68.03 -160.61 50.4 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 118.792 1.296 . . . . 0.0 110.82 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.54 21.8 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.871 3.048 . . . . 0.0 112.308 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 267' ' ' GLY . 63.1 ttm-85 -79.09 -33.36 44.54 Favored 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.677 -0.64 . . . . 0.0 110.377 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -110.05 9.3 24.2 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.074 0.55 . . . . 0.0 112.047 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -7.83 35.81 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 86.85 -104.57 2.95 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 86.5 p -77.21 18.32 0.4 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.618 ' HD3' ' H ' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -68.48 -3.04 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.304 0.502 . . . . 0.0 112.315 -175.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -96.97 -12.98 22.66 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.614 0.365 . . . . 0.0 111.32 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -125.25 5.35 7.78 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.7 t -154.75 158.48 39.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.62 -1.04 47.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.02 0.528 . . . . 0.0 110.248 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -87.04 -81.37 0.23 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.976 0.51 . . . . 0.0 110.125 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 48.62 15.68 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -156.7 167.7 29.66 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.249 0.477 . . . . 0.0 110.21 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 -36.11 0.08 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.285 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -93.76 8.11 42.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -127.76 47.07 2.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.188 0.595 . . . . 0.0 111.528 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -69.12 -1.79 8.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.228 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.8 m -99.42 147.8 24.89 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.3 pt -129.47 150.07 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 122.842 0.457 . . . . 0.0 110.115 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -105.02 149.44 25.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.0 t -134.16 148.82 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 123.219 0.607 . . . . 0.0 111.288 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -138.31 150.9 47.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.46 59.08 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 120.079 -0.289 . . . . 0.0 113.165 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.63 -55.84 28.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.14 0.576 . . . . 0.0 111.254 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.434 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.52 179.99 47.88 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.22 -11.42 59.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.74 0.816 . . . . 0.0 112.219 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.86 0.49 34.88 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.427 0.291 . . . . 0.0 111.323 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.59 155.24 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 112.666 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.4 168.16 28.14 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.7 mm -49.83 -39.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.294 1.037 . . . . 0.0 111.615 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -74.04 -28.47 61.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 121.254 -0.179 . . . . 0.0 111.011 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.6 t -75.44 -48.06 24.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.471 ' CG2' HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.4 -53.58 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.59 76.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.264 0.483 . . . . 0.0 110.898 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -76.41 -15.09 60.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.45 0.3 . . . . 0.0 111.219 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -95.09 -27.22 15.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -96.44 -20.32 18.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -65.56 -18.74 65.55 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.56 -21.55 66.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.3 mm -88.32 -24.12 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.765 0.316 . . . . 0.0 110.28 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.27 169.42 27.8 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.85 135.76 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.516 0.327 . . . . 0.0 111.186 -172.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.4 mm -77.03 137.27 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.419 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 36.9 ttmt -70.86 149.92 46.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.623 0.249 . . . . 0.0 110.485 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.2 m -127.22 135.4 50.59 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -73.15 158.53 35.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -86.16 -4.66 59.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -146.27 -5.29 0.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.0 p -86.06 -20.82 28.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.805 0.729 . . . . 0.0 112.87 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.94 16.7 78.29 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.21 159.73 48.16 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 117.367 0.583 . . . . 0.0 109.732 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.55 155.49 47.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.312 2.008 . . . . 0.0 109.51 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 36.9 mtp -77.16 77.64 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.614 0.366 . . . . 0.0 111.118 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.471 HG21 ' CG2' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -135.63 158.3 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.724 -178.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -156.69 131.7 9.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.28 122.12 34.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -84.37 158.89 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 29.1 p -134.79 151.96 51.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.471 0.653 . . . . 0.0 112.603 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.66 134.52 56.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.954 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -8.92 58.19 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.676 0.39 . . . . 0.0 111.374 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.24 -4.3 25.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.282 0.633 . . . . 0.0 112.572 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.0 t -150.85 -22.38 0.22 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.706 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.28 24.84 50.22 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.709 -0.495 . . . . 0.0 112.508 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -132.22 170.53 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.784 0.792 . . . . 0.0 110.266 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.43 121.35 2.94 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.77 0.828 . . . . 0.0 111.356 -173.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.512 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -81.17 -19.7 42.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.987 0.915 . . . . 0.0 109.418 174.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.434 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.66 -0.88 59.69 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.55 150.31 21.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.344 0.572 . . . . 0.0 110.927 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.59 165.75 33.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.12 0.568 . . . . 0.0 109.606 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 122.74 20.61 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.02 125.65 73.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.8 t -98.06 129.48 44.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.557 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -87.24 147.74 25.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.02 -18.66 60.3 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -126.37 131.91 24.12 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 110.539 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.436 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 34.8 Cg_endo -67.71 -32.16 30.88 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.737 2.292 . . . . 0.0 114.347 -175.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -75.29 -19.65 17.06 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 121.411 1.54 . . . . 0.0 110.833 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -76.39 -29.76 57.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.647 0.203 . . . . 0.0 110.556 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.94 72.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.403 ' HA ' HD13 ' A' ' 351' ' ' ILE . 18.4 tptm -63.64 -38.81 92.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.484 0.183 . . . . 0.0 110.864 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.88 81.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.296 0.239 . . . . 0.0 110.894 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.22 65.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 348' ' ' LYS . 65.0 mt -72.25 -56.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.77 -21.24 62.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -93.83 -59.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.72 -32.56 71.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -56.59 112.27 1.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.19 -16.0 30.18 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.008 -0.884 . . . . 0.0 113.114 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -95.01 -172.63 2.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.75 1.275 . . . . 0.0 109.813 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.26 174.37 6.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.882 0.372 . . . . 0.0 110.47 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -129.95 -38.64 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.162 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.9 t -143.3 13.46 1.8 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.07 0.462 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.61 -22.37 7.79 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.97 147.97 33.82 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.37 151.6 76.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.256 2.637 . . . . 0.0 110.522 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.61 168.83 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.001 0.52 . . . . 0.0 110.911 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -133.89 156.73 47.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.6 t -144.78 146.65 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 123.703 0.627 . . . . 0.0 109.983 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 68.5 m -155.36 175.13 14.26 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.0 108.858 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -59.14 160.35 6.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -128.58 137.58 51.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 14.2 m -140.74 135.69 31.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.734 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -48.03 118.16 2.24 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 123.247 0.342 . . . . 0.0 110.217 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.41 72.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.41 73.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.306 0.242 . . . . 0.0 111.136 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -66.66 -10.68 48.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.58 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.9 m-85 -102.4 -11.49 18.58 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.95 -40.84 0.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.3 -1.78 46.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.193 0.451 . . . . 0.0 112.012 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 86.15 14.94 65.67 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.74 -173.27 55.09 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -78.48 149.39 33.57 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -151.54 167.32 28.43 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.717 0.807 . . . . 0.0 110.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -172.46 170.53 43.58 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -76.75 168.45 20.07 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.918 0.487 . . . . 0.0 111.112 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -73.71 178.31 42.83 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -73.51 166.39 54.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -156.0 155.04 32.03 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.265 0.626 . . . . 0.0 109.428 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -68.78 159.33 52.53 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -60.84 125.94 25.56 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.648 0.779 . . . . 0.0 110.135 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.7 45.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 117.176 -1.902 . . . . 0.0 110.952 -178.073 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . 0.429 HO2' " H5'" ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 C5'-C4'-C3' 110.812 -3.126 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.429 " H5'" HO2' ' B' ' 91' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 N19-C1'-C2' 109.249 -2.594 . 0.781 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.477 HO2' " H5'" ' B' ' 94' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 N19-C1'-C2' 109.336 -2.54 . 0.856 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.477 " H5'" HO2' ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 N19-C1'-C2' 109.177 -2.64 . 0.781 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 O4'-C1'-N19 111.044 2.844 . 0.84 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.56 HO2' " H5'" ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 O4'-C1'-N19 110.916 2.716 . 0.91 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.56 " H5'" HO2' ' B' ' 96' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.766 0 O4'-C1'-N19 111.026 2.826 . 0.783 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 O4'-C1'-N19 110.512 2.312 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.45 HO2' " C5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -3.04 0 C5'-C4'-C3' 111.692 -2.539 . 0.743 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.45 " C5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 110.908 -3.061 . 0.562 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.425 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.56 0 C5'-C4'-C3' 111.273 -2.818 . 0.435 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.425 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 C5'-C4'-C3' 110.369 -3.42 . 0.383 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C5'-C4'-C3' 109.642 -3.906 . 0.29 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.116 1 O4'-C1'-N19 112.763 4.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.512 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.855 -3.763 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.999 1 C3'-C2'-C1' 105.549 4.498 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 C5'-C4'-C3' 109.847 -3.769 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.328 0 C5'-C4'-C3' 110.47 -3.354 . 0.584 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.493 HO2' " H5'" ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.379 0 N19-C1'-C2' 109.631 -2.356 . 0.507 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.493 " H5'" HO2' ' B' ' 109' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 N19-C1'-C2' 109.183 -2.636 . 0.789 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.596 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.647 0 N19-C1'-C2' 109.178 -2.639 . 0.744 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.596 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 C4'-C3'-C2' 100.257 -2.443 . 0.706 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.491 HO2' " H5'" ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.528 0 C5'-C4'-C3' 112.061 -2.293 . 0.8 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.491 " H5'" HO2' ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 O4'-C1'-N19 110.698 2.498 . 0.766 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.601 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 110.752 2.552 . 0.734 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.601 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 O4'-C1'-N19 110.869 2.669 . 0.739 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.544 HO2' " H5'" ' B' ' 118' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 O4'-C1'-N19 110.374 2.174 . 0.834 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.544 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 110.644 2.444 . 0.843 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.46 -178.6 48.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.89 -53.51 53.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -157.49 -178.53 7.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.971 0.908 . . . . 0.0 108.652 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.6 -8.68 36.37 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.341 -0.224 . . . . 0.0 111.589 176.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -106.56 -4.31 19.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.428 0.156 . . . . 0.0 110.776 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 86.38 0.63 86.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.219 -0.767 . . . . 0.0 114.825 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 65.77 -163.67 40.11 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 119.332 1.566 . . . . 0.0 110.507 -178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.55 23.51 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.018 3.145 . . . . 0.0 112.388 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 267' ' ' GLY . 15.9 tpt180 -75.07 -26.89 59.7 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.856 -0.528 . . . . 0.0 111.03 -173.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -137.45 21.53 2.94 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.018 0.527 . . . . 0.0 111.331 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -7.86 7.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.273 0.629 . . . . 0.0 112.51 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 93.44 -112.56 4.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 14.9 t -75.8 17.48 0.31 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.472 0.709 . . . . 0.0 112.815 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -5.33 18.16 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 121.65 -0.656 . . . . 0.0 112.259 -176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -86.25 -6.93 58.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.441 0.296 . . . . 0.0 111.144 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -150.72 25.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 46.2 t -152.44 148.5 27.51 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -91.13 4.86 51.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.074 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -102.59 -88.98 0.39 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.695 0.398 . . . . 0.0 110.512 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.8 p30 48.68 16.61 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.412 1.485 . . . . 0.0 114.639 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.39 160.7 43.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.6 t -157.09 -34.28 0.08 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.296 0.094 . . . . 0.0 110.949 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.33 5.27 35.46 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -124.08 154.94 39.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.681 0.792 . . . . 0.0 109.699 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -158.97 15.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.647 0.379 . . . . 0.0 110.548 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.7 m -131.51 151.14 51.83 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.577 0.351 . . . . 0.0 111.223 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.7 pt -126.6 148.82 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.063 0.545 . . . . 0.0 110.429 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -100.78 150.11 23.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.36 149.4 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.383 0.673 . . . . 0.0 111.042 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -139.75 150.22 44.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.97 58.28 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.954 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.63 -54.07 48.69 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.504 0.652 . . . . 0.0 111.678 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.59 -176.26 44.54 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -171.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -85.67 -7.23 58.93 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.551 0.741 . . . . 0.0 112.537 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -79.29 -2.69 42.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.431 -0.168 . . . . 0.0 111.056 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.74 158.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.769 0.828 . . . . 0.0 112.695 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.64 167.59 29.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.32 -39.73 17.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 124.344 1.057 . . . . 0.0 111.724 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.03 -29.07 63.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.248 -0.282 . . . . 0.0 111.094 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.6 -50.51 17.61 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 122.316 0.247 . . . . 0.0 110.479 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.7 m -60.86 -53.92 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.46 77.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 0.519 . . . . 0.0 110.921 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -75.9 -17.38 59.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 111.014 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -92.92 -26.77 17.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.409 ' CD1' HG22 ' A' ' 339' ' ' VAL . 45.4 m-85 -98.02 -20.08 17.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -66.11 -18.79 65.57 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.406 0.283 . . . . 0.0 111.649 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.41 -20.38 66.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -88.97 -26.06 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.759 0.254 . . . . 0.0 110.456 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.18 170.37 31.0 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.62 134.36 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 111.254 -172.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 8.3 mm -74.5 138.77 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.75 151.61 46.94 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m -134.04 135.92 43.67 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -74.7 160.28 30.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -92.41 -0.27 57.38 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -147.13 -5.18 0.52 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.3 p -88.05 -21.6 24.66 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 74.44 16.29 80.03 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -143.28 160.35 52.17 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 117.388 0.594 . . . . 0.0 109.706 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.21 155.69 55.04 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.34 2.027 . . . . 0.0 109.812 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.9 mtp -77.62 75.93 4.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.044 0.538 . . . . 0.0 110.813 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.473 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.19 155.6 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.939 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -153.19 130.71 11.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.135 0.974 . . . . 0.0 109.017 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.73 118.33 31.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.1 157.32 24.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 31.5 p -130.25 156.87 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -72.48 127.87 33.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.35 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -73.32 -5.06 37.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.066 0.547 . . . . 0.0 111.284 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.51 -5.95 23.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.7 t -151.0 -23.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.23 0.468 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.78 50.1 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.984 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -127.85 171.13 12.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.883 0.841 . . . . 0.0 109.781 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.8 mt -49.87 126.8 14.9 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.182 0.515 . . . . 0.0 110.991 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.546 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.6 ttmm -76.69 -13.63 60.03 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.056 0.942 . . . . 0.0 109.577 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.84 -5.22 66.37 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.94 147.44 25.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.006 0.403 . . . . 0.0 111.072 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.05 165.81 34.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.0 m -137.28 122.13 18.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.277 0.231 . . . . 0.0 111.046 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 305' ' ' PHE . 95.5 t -115.64 120.7 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 29.9 t -91.78 136.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.903 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -95.11 145.78 24.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.12 -15.2 61.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 88.2 m-20 -129.38 135.18 27.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.686 0.794 . . . . 0.0 111.433 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.432 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 22.8 Cg_endo -66.74 -33.77 33.59 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.837 2.358 . . . . 0.0 114.414 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 87.3 Cg_endo -76.91 -18.32 14.86 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.517 1.478 . . . . 0.0 111.307 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.7 m -76.33 -29.88 57.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.66 85.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.406 ' HA ' HD11 ' A' ' 351' ' ' ILE . 15.5 tptm -64.13 -40.86 97.08 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.457 0.17 . . . . 0.0 110.827 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.12 85.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.48 0.312 . . . . 0.0 110.68 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.77 -25.2 64.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 348' ' ' LYS . 63.7 mt -72.95 -57.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.41 -20.59 60.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -95.23 -60.53 1.65 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -69.69 -32.16 70.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.93 113.14 1.74 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.28 -15.82 32.66 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.893 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -95.04 -172.56 2.72 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.709 1.255 . . . . 0.0 109.838 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -101.18 173.7 6.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -128.06 -39.08 1.77 Allowed 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.9 t -143.07 8.49 1.65 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.729 0.412 . . . . 0.0 110.117 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.48 -20.62 5.21 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -102.86 149.3 36.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.24 150.55 76.71 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.359 2.706 . . . . 0.0 110.595 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.33 168.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-O 121.068 0.461 . . . . 0.0 110.763 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -131.79 156.87 45.24 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 54.4 t -145.71 146.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 110.396 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.4 m -154.53 172.71 17.36 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.06 162.91 6.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.216 -0.302 . . . . 0.0 111.771 170.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.405 ' HA ' ' H22' ' B' ' 106' ' ' ' G' . . . -137.16 144.8 43.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.81 0.338 . . . . 0.0 111.054 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 26.4 m -146.08 140.45 26.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.085 0.954 . . . . 0.0 109.359 175.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -47.36 120.2 3.08 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.605 0.362 . . . . 0.0 110.532 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -32.95 73.91 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.043 0.537 . . . . 0.0 109.663 -175.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.01 -32.01 73.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.142 0.177 . . . . 0.0 111.073 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.09 -9.29 21.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.496 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.3 m-85 -105.93 -13.08 15.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.98 -41.41 0.09 Allowed 'General case' 0 C--N 1.341 0.196 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -79.74 -1.76 40.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.169 0.441 . . . . 0.0 111.934 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.67 75.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.25 -174.9 54.63 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -73.22 166.58 54.54 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -157.46 172.31 18.79 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 169.14 -172.53 43.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -146.29 161.63 39.88 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.565 0.746 . . . . 0.0 110.057 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.05 163.12 29.12 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -176.24 160.99 29.11 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -155.5 167.6 29.85 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 122.904 0.482 . . . . 0.0 110.159 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -77.82 157.08 45.01 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -69.99 134.09 47.94 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.83 0.452 . . . . 0.0 110.313 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -103.88 -10.6 34.54 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.115 -1.936 . . . . 0.0 110.807 179.776 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 C5'-C4'-C3' 110.645 -3.237 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.444 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.711 0 N19-C1'-C2' 109.429 -2.482 . 0.798 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.444 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 C4'-C3'-C2' 100.037 -2.663 . 0.83 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.52 HO2' " H5'" ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.608 0 N19-C1'-C2' 109.202 -2.624 . 0.833 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.52 " H5'" HO2' ' B' ' 94' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 C5'-C4'-C3' 111.437 -2.708 . 0.835 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.403 " H5'" HO2' ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 O4'-C1'-N19 111.147 2.947 . 0.894 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.581 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 O4'-C1'-N19 110.865 2.665 . 0.812 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.715 HO2' " H5'" ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.527 0 O4'-C1'-N19 111.324 3.124 . 0.77 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.715 " H5'" HO2' ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.854 0 O4'-C1'-N19 111.057 2.857 . 0.426 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.487 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 C5'-C4'-C3' 111.507 -2.662 . 0.663 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.4 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.655 0 C5'-C4'-C3' 111.358 -2.761 . 0.494 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.4 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.371 0 C5'-C4'-C3' 110.759 -3.161 . 0.394 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.772 1 C5'-C4'-C3' 109.083 -4.278 . 0.267 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.104 1 O4'-C1'-N19 112.621 4.421 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.546 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 C5'-C4'-C3' 109.731 -3.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.405 ' H22' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.866 1 C3'-C2'-C1' 105.86 4.844 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.599 0 C5'-C4'-C3' 110.105 -3.597 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.379 0 C5'-C4'-C3' 110.225 -3.516 . 0.532 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.553 HO2' " H5'" ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 N19-C1'-C2' 109.162 -2.649 . 0.496 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.553 " H5'" HO2' ' B' ' 109' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 N19-C1'-C2' 109.528 -2.42 . 0.711 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.54 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 109.76 -2.275 . 0.737 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.54 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.255 0 N19-C1'-C2' 109.462 -2.461 . 0.722 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.489 HO2' " H5'" ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.487 -2.213 . 0.813 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.513 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 O4'-C1'-N19 110.916 2.716 . 0.73 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.588 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.748 2.548 . 0.677 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.588 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 O4'-C1'-N19 110.915 2.715 . 0.745 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.549 HO2' " H5'" ' B' ' 118' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 O4'-C1'-N19 110.578 2.378 . 0.813 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.549 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.841 0 O4'-C1'-N19 110.701 2.501 . 0.823 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.36 170.09 53.72 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -143.74 176.96 8.85 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.431 ' ND2' ' H21' ' B' ' 106' ' ' ' G' . 10.1 m-80 -68.74 -173.92 0.52 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.692 0.797 . . . . 0.0 110.598 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.557 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.628 0.371 . . . . 0.0 111.789 -176.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -95.19 -4.77 45.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.903 0.319 . . . . 0.0 110.609 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.08 9.44 85.21 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.185 -0.786 . . . . 0.0 115.05 169.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 66.67 -161.57 46.11 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 119.408 1.604 . . . . 0.0 111.053 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.24 19.6 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.382 2.721 . . . . 0.0 112.61 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.473 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.6 ttp180 -74.77 -41.6 59.73 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.89 -0.507 . . . . 0.0 110.355 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -105.73 11.61 31.9 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.122 0.569 . . . . 0.0 111.085 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -7.7 34.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 84.0 -112.74 3.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 74.8 m -74.17 18.98 0.13 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -3.35 12.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.799 0.727 . . . . 0.0 111.929 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -89.42 -15.12 33.93 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.854 0.297 . . . . 0.0 110.824 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -123.82 8.76 8.79 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 92.4 p -156.77 167.38 30.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.39 15.25 17.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.242 173.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -92.1 -83.2 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.1 p30 48.7 15.5 0.09 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -155.67 169.22 24.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 110.035 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.6 t -155.64 -34.31 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.458 0.303 . . . . 0.0 110.187 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -97.86 9.27 43.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.94 0.496 . . . . 0.0 112.268 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -126.72 48.28 2.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.168 0.587 . . . . 0.0 111.463 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -70.73 -0.39 8.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.829 0.452 . . . . 0.0 111.366 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.1 m -100.53 148.68 24.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.43 150.2 34.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.835 0.454 . . . . 0.0 109.945 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -106.26 148.85 27.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 t -133.73 148.28 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.105 0.562 . . . . 0.0 111.194 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -138.69 150.63 46.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.74 5.1 58.84 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.834 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.1 -57.22 12.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.322 0.649 . . . . 0.0 111.135 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.445 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.89 179.64 44.47 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.13 -10.64 59.53 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.907 0.883 . . . . 0.0 112.365 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.98 -0.85 45.97 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 111.556 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.03 155.78 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.16 168.24 27.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.0 mm -49.43 -40.18 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.362 1.065 . . . . 0.0 111.691 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.42 62.32 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.859 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -76.15 -48.89 18.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.379 0.272 . . . . 0.0 110.634 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.7 m -61.58 -53.68 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.01 -37.93 78.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.798 -0.563 . . . . 0.0 110.602 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.96 -15.84 60.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.721 0.237 . . . . 0.0 111.087 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.51 -26.78 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.403 ' CD1' HG23 ' A' ' 339' ' ' VAL . 45.9 m-85 -97.3 -20.19 18.03 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -66.16 -18.64 65.48 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.418 0.287 . . . . 0.0 111.697 -173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.21 -20.41 66.42 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.1 mm -88.62 -25.05 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.976 0.417 . . . . 0.0 110.156 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.64 169.08 27.74 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.06 136.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.713 -0.286 . . . . 0.0 111.256 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.1 mm -77.54 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 37.0 ttmt -69.55 136.53 51.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m -97.76 138.63 34.84 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.9 139.55 53.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.62 -4.42 51.54 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -133.26 -35.46 1.03 Allowed 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.244 0.475 . . . . 0.0 111.848 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -90.5 -16.36 29.03 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 77.49 -19.57 3.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.328 0.489 . . . . 0.0 113.167 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.45 163.02 56.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 117.883 0.841 . . . . 0.0 109.429 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.71 152.23 75.43 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.895 1.73 . . . . 0.0 108.833 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.453 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.9 mtp -77.74 79.07 4.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.465 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.07 155.09 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.619 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.94 129.16 11.93 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.75 120.87 32.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.23 159.48 20.08 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 40.4 p -132.83 157.19 45.65 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.492 0.663 . . . . 0.0 112.53 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.46 133.23 48.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.416 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -77.5 -9.11 58.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.625 0.37 . . . . 0.0 110.913 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -98.52 -6.15 30.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.7 t -150.55 -22.11 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.088 0.403 . . . . 0.0 111.008 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.56 22.78 52.84 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.683 -0.509 . . . . 0.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -130.27 172.97 11.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 117.931 0.865 . . . . 0.0 110.334 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.76 123.37 4.34 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 123.769 0.828 . . . . 0.0 111.629 -173.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.599 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -83.77 -19.53 34.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.737 173.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.04 0.63 59.96 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -90.56 150.29 21.81 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 117.425 0.612 . . . . 0.0 110.903 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.43 165.87 32.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.073 0.549 . . . . 0.0 109.58 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 m -136.78 122.64 20.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.403 HG23 ' CD1' ' A' ' 305' ' ' PHE . 92.5 t -115.63 124.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -174.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.4 t -96.21 128.15 42.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.234 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.53 148.31 25.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -74.33 -21.42 59.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.4 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.6 m-20 -124.11 131.49 24.22 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.496 0.718 . . . . 0.0 110.91 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.441 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.8 Cg_endo -65.98 -33.09 43.11 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.768 2.312 . . . . 0.0 114.161 -175.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.74 -19.22 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.189 1.46 . . . . 0.0 111.142 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.2 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.787 0.267 . . . . 0.0 110.385 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.6 79.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.398 0.142 . . . . 0.0 110.672 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -63.41 -39.97 95.94 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 122.35 0.26 . . . . 0.0 110.756 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.1 81.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.984 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.72 -26.35 66.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -72.15 -57.72 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -60.92 -21.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -92.38 -59.74 2.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -70.02 -31.92 69.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -56.78 112.36 1.28 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.19 31.25 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.061 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.7 -172.35 2.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.705 1.253 . . . . 0.0 109.941 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.21 175.03 5.72 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.454 0.302 . . . . 0.0 110.535 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -130.72 -38.76 1.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.2 t -143.04 20.31 1.94 Allowed 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 122.585 0.354 . . . . 0.0 110.345 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.36 -2.22 31.04 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -121.81 146.5 46.05 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 123.996 0.918 . . . . 0.0 109.473 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.85 149.73 72.84 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.48 2.787 . . . . 0.0 110.779 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.62 169.4 18.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.087 0.555 . . . . 0.0 110.697 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -134.67 156.37 48.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.828 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -144.21 147.34 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.119 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 70.8 m -154.04 174.64 14.42 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -58.27 160.65 4.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -130.93 138.16 49.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.6 m -141.12 137.04 32.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.309 0.643 . . . . 0.0 110.71 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 43.3 mtp85 -42.51 113.32 0.44 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.409 0.684 . . . . 0.0 110.509 -173.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -33.86 73.5 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.02 71.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.38 -11.65 44.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.48 -8.61 19.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.7 -40.0 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -84.09 3.35 35.15 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 80.69 9.09 86.8 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.64 0.54 89.94 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.788 -0.451 . . . . 0.0 112.304 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 77.96 163.45 21.47 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -150.49 172.75 14.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.717 0.807 . . . . 0.0 110.091 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -171.08 166.04 39.19 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -157.15 164.48 37.78 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.787 0.435 . . . . 0.0 110.194 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 156.57 -9.12 0.26 Allowed Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -66.1 160.37 45.77 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -157.68 169.44 24.64 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.957 0.503 . . . . 0.0 110.068 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -70.83 153.15 51.14 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -144.49 163.5 33.67 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.38 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 179.03 179.49 48.72 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 117.207 -1.885 . . . . 0.0 111.039 -179.612 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 111.024 -2.984 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 N19-C1'-C2' 109.288 -2.57 . 0.806 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 N19-C1'-C2' 109.098 -2.689 . 0.871 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.468 HO2' " H5'" ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 C4'-C3'-C2' 100.312 -2.388 . 0.809 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.468 " H5'" HO2' ' B' ' 94' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 O4'-C1'-N19 110.859 2.659 . 0.809 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.957 2.757 . 0.893 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 111.019 2.819 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.569 HO2' " H5'" ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 111.28 3.08 . 0.719 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.569 " H5'" HO2' ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -2.991 0 O4'-C1'-N19 110.691 2.491 . 0.768 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.537 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 111.427 -2.715 . 0.692 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.466 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.931 0 C5'-C4'-C3' 111.428 -2.714 . 0.59 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.466 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 C5'-C4'-C3' 110.631 -3.246 . 0.483 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 1 C5'-C4'-C3' 109.297 -4.135 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . 0.476 " H1'" " H4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.427 -2.128 1 O4'-C1'-N19 113.683 5.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.599 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.84 0 C5'-C4'-C3' 111.063 -2.958 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.431 ' H21' ' ND2' ' A' ' 263' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.778 1 C3'-C2'-C1' 105.348 4.275 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.433 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 C5'-C4'-C3' 109.663 -3.891 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . 0.527 HO2' " H5'" ' B' ' 109' ' ' ' G' . . . . . . . . 0 P--O5' 1.619 2.637 0 C4'-C3'-C2' 100.257 -2.443 . 0.079 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.527 " H5'" HO2' ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 N19-C1'-C2' 108.784 -2.885 . 0.736 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.544 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 N19-C1'-C2' 108.924 -2.797 . 0.745 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.6 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.908 0 N19-C1'-C2' 109.098 -2.689 . 0.77 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.6 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.528 0 N19-C1'-C2' 109.655 -2.34 . 0.737 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.588 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 110.11 -2.056 . 0.771 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.584 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 O4'-C1'-N19 110.716 2.516 . 0.747 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.599 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 110.75 2.55 . 0.717 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.599 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.625 0 O4'-C1'-N19 110.785 2.585 . 0.769 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.498 2.298 . 0.836 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 O4'-C1'-N19 110.585 2.385 . 0.825 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.125 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.68 87.09 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -144.24 -179.88 6.8 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.405 ' CG ' ' H21' ' B' ' 106' ' ' ' G' . 38.8 m-80 -66.17 -178.44 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.778 0.831 . . . . 0.0 111.267 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.639 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -65.25 -14.09 59.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.78 0.432 . . . . 0.0 111.933 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -95.8 -3.92 44.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.972 0.351 . . . . 0.0 111.746 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.15 77.27 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.35 -0.695 . . . . 0.0 113.913 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 66.6 -156.33 51.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.696 1.248 . . . . 0.0 110.883 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.91 18.74 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.612 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 267' ' ' GLY . 71.5 ttt-85 -74.98 -38.84 61.56 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.728 -0.608 . . . . 0.0 110.725 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -105.56 10.17 33.17 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.866 0.467 . . . . 0.0 111.128 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -10.18 54.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.93 -105.95 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 85.9 p -74.01 13.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 348' ' ' LYS . 0.2 OUTLIER -69.9 -0.48 7.39 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -93.71 -16.05 24.63 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.873 0.306 . . . . 0.0 111.144 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -126.59 7.45 6.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 48.4 t -152.21 154.06 35.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.681 0.393 . . . . 0.0 110.25 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.67 -1.0 55.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.092 0.557 . . . . 0.0 110.581 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -87.65 -82.01 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.161 0.584 . . . . 0.0 110.082 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 48.8 16.36 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -155.1 168.02 28.43 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.989 -0.445 . . . . 0.0 109.835 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.0 p -153.14 -32.79 0.12 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.551 0.34 . . . . 0.0 110.6 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -107.32 16.21 24.19 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.548 0.739 . . . . 0.0 112.198 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.75 48.87 2.37 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.119 0.568 . . . . 0.0 111.615 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -71.56 3.19 4.14 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.517 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -104.76 148.78 26.23 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.38 147.6 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.642 0.377 . . . . 0.0 110.441 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -102.73 149.01 24.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.9 t -134.12 148.24 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.298 0.639 . . . . 0.0 111.636 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -138.59 150.06 45.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.31 5.11 58.19 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.762 -0.466 . . . . 0.0 112.299 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.83 -56.06 23.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.541 0.67 . . . . 0.0 111.009 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.41 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.71 179.45 46.21 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -80.18 -7.22 58.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.738 0.815 . . . . 0.0 112.124 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -81.8 -1.6 47.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.374 0.27 . . . . 0.0 111.32 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.54 156.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.48 168.03 28.04 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.6 mm -48.57 -40.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.223 1.009 . . . . 0.0 111.762 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.4 -28.49 62.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.28 -0.263 . . . . 0.0 111.102 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.0 t -75.85 -48.84 19.86 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.475 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.64 45.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.6 -37.6 78.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.296 0.498 . . . . 0.0 110.783 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -75.81 -15.39 60.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -95.15 -26.78 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' A' ' 339' ' ' VAL . 46.2 m-85 -97.46 -20.62 17.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -65.13 -19.43 65.98 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -63.97 -21.49 66.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.2 mm -87.07 -27.19 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.8 170.6 31.89 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.7 mm -68.02 135.07 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.768 0.318 . . . . 0.0 111.047 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.5 mm -76.42 136.97 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.433 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.1 ttmm -68.4 135.84 52.37 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.692 0.282 . . . . 0.0 110.628 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.7 m -94.1 139.88 30.43 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -66.95 149.95 49.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -70.84 -20.0 62.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -142.71 -19.59 0.67 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.5 p -86.87 -15.58 38.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.85 0.75 . . . . 0.0 112.88 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.77 -17.88 3.35 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.351 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -81.54 160.97 63.3 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 117.867 0.833 . . . . 0.0 109.812 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.98 151.96 82.97 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.089 1.86 . . . . 0.0 109.13 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 48.6 mtp -79.74 80.15 6.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.47 0.308 . . . . 0.0 111.235 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.475 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.4 OUTLIER -132.14 154.98 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.0 120.6 7.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.269 0.628 . . . . 0.0 109.693 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -88.59 122.14 31.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.479 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 77.1 m-85 -80.27 164.43 23.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 70.0 p -137.13 155.73 49.24 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.246 0.546 . . . . 0.0 111.415 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -69.27 130.13 41.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.28 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -75.02 -6.94 52.1 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 122.66 0.384 . . . . 0.0 111.162 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.38 -7.11 26.65 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 4.9 t -150.04 -21.23 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.211 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.04 17.38 61.3 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.552 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -122.39 172.73 8.12 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 117.878 0.839 . . . . 0.0 110.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -45.67 123.81 4.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.884 0.874 . . . . 0.0 111.298 -175.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.583 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.5 ttmm -79.56 -17.99 52.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.648 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.41 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 93.48 15.51 50.11 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.57 154.09 34.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.403 0.601 . . . . 0.0 110.164 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.65 170.35 22.36 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.609 0.363 . . . . 0.0 110.287 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 32.3 m -134.51 127.56 31.63 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.865 0.466 . . . . 0.0 110.583 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.406 HG23 ' CD1' ' A' ' 305' ' ' PHE . 93.2 t -117.43 127.49 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.2 t -98.76 128.63 45.06 Favored 'General case' 0 C--N 1.337 0.05 0 O-C-N 121.962 -0.461 . . . . 0.0 110.324 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.65 147.64 25.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.61 -16.61 59.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -125.49 131.77 24.13 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 110.594 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.439 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 30.5 Cg_endo -66.46 -32.89 39.12 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.006 2.471 . . . . 0.0 114.446 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -76.9 -19.49 13.98 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 CA-C-N 121.208 1.467 . . . . 0.0 110.81 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -29.31 58.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.75 80.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.416 ' HZ3' ' HB2' ' A' ' 274' ' ' ARG . 17.1 tptm -64.68 -38.45 91.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.462 -0.149 . . . . 0.0 110.635 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.89 -40.26 83.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.583 0.353 . . . . 0.0 110.943 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.6 -25.96 66.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 66.7 mt -72.62 -56.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.6 -20.87 61.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -94.51 -60.21 1.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.27 -32.47 71.68 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.91 110.42 0.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.16 -14.73 25.83 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.042 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -96.36 -171.01 2.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.872 1.336 . . . . 0.0 110.249 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.04 174.39 5.89 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 110.307 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -130.39 -39.32 1.32 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 109.941 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.39 -18.77 10.95 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.75 148.14 35.1 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 151.08 74.16 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.43 2.753 . . . . 0.0 110.508 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.02 168.64 21.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -134.35 155.69 49.81 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.803 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.95 146.76 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.047 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 m -154.4 174.64 14.58 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.754 0.822 . . . . 0.0 108.789 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -60.36 155.65 17.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.59 ' HA ' ' H22' ' B' ' 106' ' ' ' G' . . . -123.91 137.7 54.59 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 8.9 m -142.93 136.47 28.61 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.519 0.727 . . . . 0.0 110.28 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -45.27 112.16 0.41 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 122.979 0.511 . . . . 0.0 110.404 -170.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -29.5 66.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.856 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.83 -34.16 75.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 122.378 -0.201 . . . . 0.0 111.07 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -67.56 -6.77 21.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.473 0.309 . . . . 0.0 110.369 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.639 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 95.9 m-85 -108.41 -9.36 15.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -151.96 -41.81 0.11 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -81.32 -1.83 46.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.79 2.79 89.7 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 69.89 19.57 75.35 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -66.1 173.9 22.53 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.233 0.517 . . . . 0.0 111.898 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -141.97 153.17 44.11 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.867 0.467 . . . . 0.0 110.416 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -101.49 158.39 18.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.53 ' HB3' HO2' ' B' ' 109' ' ' ' G' . 31.1 ptt-85 -162.77 167.26 23.19 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.705 0.402 . . . . 0.0 110.586 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -178.34 20.2 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.587 -0.563 . . . . 0.0 112.569 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.48 178.69 34.67 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 117.802 0.801 . . . . 0.0 111.766 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -60.85 156.81 16.43 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.739 0.415 . . . . 0.0 111.284 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -94.26 -178.91 38.54 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -60.88 142.55 56.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.577 0.351 . . . . 0.0 110.347 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.98 34.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 CA-C-O 117.301 -1.833 . . . . 0.0 110.503 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 C5'-C4'-C3' 110.637 -3.242 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.444 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 109.231 -2.606 . 0.82 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.444 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 C4'-C3'-C2' 99.829 -2.871 . 0.823 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.516 HO2' " H5'" ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 C4'-C3'-C2' 100.276 -2.424 . 0.805 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.516 " H5'" HO2' ' B' ' 94' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 C5'-C4'-C3' 111.494 -2.671 . 0.819 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.545 HO2' " H5'" ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 O4'-C1'-N19 110.882 2.682 . 0.883 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.545 " H5'" HO2' ' B' ' 96' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 O4'-C1'-N19 110.825 2.625 . 0.815 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 O4'-C1'-N19 111.167 2.967 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.513 HO2' " C5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 O4'-C1'-N19 110.793 2.593 . 0.639 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.513 " C5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -3.003 0 C5'-C4'-C3' 110.972 -3.019 . 0.67 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.444 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.051 0 C5'-C4'-C3' 111.385 -2.743 . 0.811 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.444 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 C5'-C4'-C3' 110.88 -3.08 . 0.466 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 C5'-C4'-C3' 109.553 -3.965 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.138 1 O4'-C1'-N19 112.735 4.535 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.583 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.833 0 C5'-C4'-C3' 109.565 -3.956 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.59 ' H22' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.749 1 C3'-C2'-C1' 105.625 4.583 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.448 " H3'" H5'' ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 109.687 -3.876 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . 0.448 H5'' " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.044 0 C4'-C3'-C2' 100.021 -2.679 . 0.079 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.53 HO2' ' HB3' ' A' ' 383' ' ' ARG . . . . . . . . 0 O4'--C4' 1.422 -2.546 0 C5'-C4'-C3' 111.067 -2.955 . 0.656 1c . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 N19-C1'-C2' 109.607 -2.371 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.479 -2.45 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.508 HO2' " H5'" ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.466 -2.458 . 0.787 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.508 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C5'-C4'-C3' 112.257 -2.162 . 0.79 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.818 2.618 . 0.784 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.627 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 110.738 2.538 . 0.722 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.627 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 O4'-C1'-N19 110.879 2.679 . 0.736 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.587 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 O4'-C1'-N19 110.819 2.619 . 0.798 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.749 0 O4'-C1'-N19 110.638 2.438 . 0.847 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 74.95 -171.18 53.96 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -71.12 178.67 3.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -65.42 -178.7 0.54 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.105 0.962 . . . . 0.0 110.886 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.56 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -66.46 -14.61 62.45 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -93.81 -3.26 52.33 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.915 0.325 . . . . 0.0 110.91 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.36 77.33 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.293 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.71 -160.25 50.03 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.059 1.429 . . . . 0.0 110.829 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.531 ' HA ' HE22 ' A' ' 271' ' ' GLN . 58.5 Cg_endo -71.95 36.25 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.863 3.042 . . . . 0.0 111.876 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 267' ' ' GLY . 48.8 ttp180 -88.34 -42.51 12.16 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.174 -0.329 . . . . 0.0 110.401 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -109.1 16.21 22.71 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.233 0.613 . . . . 0.0 110.332 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.531 HE22 ' HA ' ' A' ' 268' ' ' PRO . 4.3 tp-100 -67.61 -22.28 65.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.856 0.462 . . . . 0.0 111.386 -173.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 112.66 -129.6 9.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 9.1 t -79.46 20.88 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.439 0.696 . . . . 0.0 112.106 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -7.38 3.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.066 0.547 . . . . 0.0 112.382 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -83.07 -6.53 59.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.28 21.46 0.95 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 37.4 t -155.33 144.87 21.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.915 -0.491 . . . . 0.0 110.421 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -84.97 5.71 28.1 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.132 0.573 . . . . 0.0 110.256 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -103.13 -112.03 0.23 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . 0.256 8.7 m-20 52.67 17.78 0.88 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -148.12 162.27 39.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.9 p -155.52 -37.3 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -97.02 15.88 21.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.232 0.613 . . . . 0.0 112.28 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.83 41.89 3.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.464 0.706 . . . . 0.0 111.374 -176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -67.38 -4.8 12.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.866 0.466 . . . . 0.0 111.142 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.5 m -95.99 146.61 24.48 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.63 150.3 34.18 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 C-N-CA 122.729 0.411 . . . . 0.0 109.917 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -105.03 148.99 26.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.9 t -133.2 146.62 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 123.05 0.54 . . . . 0.0 111.376 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -137.33 148.54 46.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.71 57.3 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.974 -0.348 . . . . 0.0 112.597 173.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.05 -56.88 14.81 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.423 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.82 179.9 44.49 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.81 -10.0 59.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.671 0.789 . . . . 0.0 112.33 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -81.79 -2.29 50.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 117.562 0.165 . . . . 0.0 111.329 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -99.39 155.95 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.16 168.0 28.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.98 -39.73 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 124.403 1.081 . . . . 0.0 111.59 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.55 -29.09 63.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -75.35 -49.38 19.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.131 0.172 . . . . 0.0 110.643 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.459 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.8 m -61.33 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.52 77.27 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.193 0.452 . . . . 0.0 110.739 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.04 -15.78 60.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.984 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.72 -27.25 15.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -96.76 -20.37 18.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -66.16 -18.84 65.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.439 0.296 . . . . 0.0 111.763 -173.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -21.52 66.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.4 mm -87.12 -27.33 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.308 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.86 170.26 31.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.27 134.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.629 0.252 . . . . 0.0 111.347 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.2 mm -75.51 138.62 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.442 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 35.4 ttmt -68.46 144.58 54.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -123.71 135.51 53.91 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -75.19 140.89 43.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.19 -19.3 56.93 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.709 0.403 . . . . 0.0 111.654 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -115.62 0.25 13.22 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.6 p -125.09 -20.34 4.93 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.9 -17.46 3.68 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.383 0.516 . . . . 0.0 113.007 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -86.72 157.96 54.41 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.661 0.73 . . . . 0.0 109.673 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.6 153.13 76.9 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.255 1.97 . . . . 0.0 109.126 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.442 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 54.7 mtp -79.1 79.24 5.51 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.516 0.326 . . . . 0.0 110.985 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.459 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.11 155.81 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.345 -178.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.34 127.32 11.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.75 119.92 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -81.25 160.67 24.2 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.7 p -136.46 146.96 46.92 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 111.753 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.35 131.69 50.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.412 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -73.86 -6.8 49.38 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.393 0.277 . . . . 0.0 111.643 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.31 -5.63 27.13 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.8 t -151.18 -23.32 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.499 0.59 . . . . 0.0 111.245 -176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.46 19.58 58.25 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.158 172.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -124.94 169.06 12.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.996 0.898 . . . . 0.0 110.1 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.46 117.94 1.79 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.46 0.704 . . . . 0.0 110.678 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.622 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 13.2 ptmm? -87.63 0.32 55.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.162 174.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.423 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 89.47 9.3 66.98 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.598 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -108.25 151.62 25.7 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.929 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.92 166.46 32.57 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.2 m -135.51 122.66 21.55 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.872 0.469 . . . . 0.0 111.508 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.06 124.62 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.4 t -96.23 128.64 43.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.215 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -86.29 148.22 25.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -73.94 -20.33 60.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 95.2 m-20 -127.73 133.35 25.01 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 123.855 0.862 . . . . 0.0 111.033 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.441 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.1 Cg_endo -66.14 -33.9 38.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.683 2.256 . . . . 0.0 114.195 -175.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.5 Cg_endo -74.94 -18.42 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.141 1.443 . . . . 0.0 110.822 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 71.0 m -76.7 -29.67 56.36 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.16 -46.42 80.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.947 0.154 . . . . 0.0 110.725 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -66.15 -37.3 85.33 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.38 -40.13 81.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.369 0.267 . . . . 0.0 110.854 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.48 -26.35 65.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.58 -56.95 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.41 -21.79 62.63 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -93.62 -59.49 1.99 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.7 -32.78 70.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -57.03 112.48 1.36 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.68 31.9 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.008 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.66 -172.45 2.75 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.477 1.138 . . . . 0.0 109.924 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -101.64 173.27 6.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.557 0.343 . . . . 0.0 110.457 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -128.51 -38.54 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.682 0.393 . . . . 0.0 110.262 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.1 t -144.54 17.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.981 0.512 . . . . 0.0 109.959 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.23 -20.2 16.65 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -96.12 140.49 22.28 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.98 151.4 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.997 2.464 . . . . 0.0 110.369 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.4 pt -138.12 168.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 122.608 0.363 . . . . 0.0 111.223 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -134.54 155.25 50.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.15 0.58 . . . . 0.0 110.765 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.63 146.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.998 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 37.4 m -155.44 172.99 17.3 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -57.02 156.84 6.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -124.44 139.53 53.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.0 m -144.36 137.23 26.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.759 0.824 . . . . 0.0 109.879 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -49.0 119.76 3.44 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.798 -171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -34.03 75.22 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.35 71.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.036 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -67.14 -10.06 46.3 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.56 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.1 m-85 -102.67 -10.76 18.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.44 -39.98 0.08 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -83.39 1.79 39.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.056 0.389 . . . . 0.0 111.798 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.0 7.18 85.83 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.56 0.34 83.78 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.75 -168.26 54.13 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -154.34 158.23 39.79 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.605 0.362 . . . . 0.0 110.531 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -87.67 -177.27 48.2 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -144.45 155.98 43.99 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.225 0.61 . . . . 0.0 109.488 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -82.05 151.59 30.36 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -83.31 166.66 44.24 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -65.78 155.03 37.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -62.58 154.44 42.34 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -156.19 165.02 37.62 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.019 0.528 . . . . 0.0 110.204 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 167.63 -6.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.184 -1.898 . . . . 0.0 110.815 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 C5'-C4'-C3' 111.066 -2.956 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.44 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 N19-C1'-C2' 109.345 -2.535 . 0.829 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.44 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 C4'-C3'-C2' 99.795 -2.905 . 0.839 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.507 HO2' " H5'" ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C4'-C3'-C2' 100.101 -2.599 . 0.781 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.507 " H5'" HO2' ' B' ' 94' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.534 0 O4'-C1'-N19 110.879 2.679 . 0.838 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 111.079 2.879 . 0.891 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.744 0 O4'-C1'-N19 111.002 2.802 . 0.782 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 O4'-C1'-N19 111.21 3.01 . 0.759 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.503 HO2' " H5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 C5'-C4'-C3' 111.551 -2.633 . 0.613 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.503 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.791 0 C5'-C4'-C3' 111.269 -2.821 . 0.65 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.43 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.882 0 C5'-C4'-C3' 110.968 -3.022 . 0.561 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.43 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 C5'-C4'-C3' 110.667 -3.222 . 0.562 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . 0.68 HO2' " C5'" ' B' ' 104' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 C5'-C4'-C3' 110.78 -3.147 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . 0.68 " C5'" HO2' ' B' ' 103' ' ' ' A' . . . . . . . . 0 P--O5' 1.616 2.287 1 O4'-C1'-N19 113.369 5.169 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.622 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.041 0 C5'-C4'-C3' 110.138 -3.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.068 1 C3'-C2'-C1' 105.775 4.75 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.413 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 C5'-C4'-C3' 109.872 -3.752 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . 0.413 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C4'-C3'-C2' 100.043 -2.657 . 0.111 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 110.898 2.698 . 0.713 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.584 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 O4'-C1'-N19 110.645 2.445 . 0.592 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.584 " H5'" HO2' ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C5'-C4'-C3' 111.796 -2.469 . 0.754 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.553 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 C5'-C4'-C3' 112.325 -2.117 . 0.738 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.55 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 C5'-C4'-C3' 112.075 -2.283 . 0.771 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.526 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 O4'-C1'-N19 110.697 2.497 . 0.746 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.526 " H5'" HO2' ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 O4'-C1'-N19 111.012 2.812 . 0.706 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.564 0 O4'-C1'-N19 110.641 2.441 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.355 0 O4'-C1'-N19 110.484 2.284 . 0.858 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.731 2.531 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.04 179.41 48.91 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -70.34 174.88 5.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -66.95 -173.87 0.28 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.611 0.764 . . . . 0.0 110.635 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.583 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.06 -15.1 58.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -95.49 -6.06 41.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.123 0.42 . . . . 0.0 110.878 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.0 10.12 84.37 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.224 -0.764 . . . . 0.0 114.724 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.77 -162.41 48.17 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.817 1.309 . . . . 0.0 110.911 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.91 22.57 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.757 2.971 . . . . 0.0 112.587 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 267' ' ' GLY . 16.1 tpt180 -79.18 -33.62 43.78 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.811 -0.555 . . . . 0.0 110.708 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -110.6 10.49 22.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.228 0.611 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -7.74 34.64 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 82.89 -108.35 2.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 82.0 p -72.37 13.05 0.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.43 ' HB2' ' HZ2' ' A' ' 348' ' ' LYS . 0.2 OUTLIER -69.86 -3.81 17.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.496 0.589 . . . . 0.0 112.468 -174.116 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -88.03 -6.33 58.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.467 0.307 . . . . 0.0 111.405 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -151.05 24.06 0.74 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.9 t -156.01 154.23 30.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.76 -0.16 51.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 0.0 110.213 174.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -91.43 -85.12 0.24 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.007 0.523 . . . . 0.0 110.183 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 49.1 16.43 0.13 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.95 168.79 25.79 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.779 -0.575 . . . . 0.0 110.075 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.7 p -153.75 -32.07 0.12 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.29 0.236 . . . . 0.0 111.018 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -108.55 13.24 25.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.359 0.664 . . . . 0.0 112.304 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -126.56 46.43 2.47 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.069 0.548 . . . . 0.0 111.245 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -70.0 -0.62 7.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.39 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.2 m -100.01 147.7 25.32 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.5 pt -128.82 149.92 33.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -104.92 149.49 25.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.74 148.76 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.264 0.625 . . . . 0.0 110.752 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -139.3 150.18 45.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.27 57.95 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.86 -0.411 . . . . 0.0 112.659 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.2 mp -54.72 -54.45 41.72 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 117.55 0.675 . . . . 0.0 111.614 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.454 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.42 -175.86 44.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -171.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -86.86 -7.8 57.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.534 0.734 . . . . 0.0 112.286 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.84 -3.55 42.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.238 0.215 . . . . 0.0 110.954 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.38 158.98 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.739 0.816 . . . . 0.0 112.804 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.43 168.05 25.99 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.75 -39.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.019 0.928 . . . . 0.0 111.65 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -73.15 -28.89 62.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.318 -0.239 . . . . 0.0 111.064 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.9 t -75.12 -49.44 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.193 0.197 . . . . 0.0 110.797 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.462 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.6 m -61.11 -53.65 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.39 -37.33 77.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.719 -0.613 . . . . 0.0 110.78 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -76.9 -15.29 59.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.189 -0.32 . . . . 0.0 111.201 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.47 -27.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.0 m-85 -96.47 -20.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.8 pttt -65.08 -19.29 65.92 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.36 -20.85 66.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.52 -25.02 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 165.06 168.79 27.76 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.97 136.0 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.706 0.289 . . . . 0.0 111.081 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.5 mm -76.72 136.45 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.406 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.4 ttmm -68.93 142.8 54.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -108.62 136.2 48.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.33 132.6 43.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -74.46 -20.68 59.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.91 0.484 . . . . 0.0 111.364 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.53 -8.39 18.06 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.1 p -131.91 -15.96 2.95 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.28 -15.3 5.65 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.394 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -84.23 162.19 52.33 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 118.204 1.002 . . . . 0.0 109.333 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.15 152.02 81.79 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.653 1.569 . . . . 0.0 108.877 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.406 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 41.9 mtp -77.71 79.12 4.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.709 0.404 . . . . 0.0 110.955 -174.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.462 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.9 154.96 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 123.703 0.627 . . . . 0.0 110.849 -179.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.62 130.12 13.0 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.99 117.08 29.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.448 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 97.3 m-85 -81.39 156.5 25.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 79.4 p -130.88 158.15 41.0 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.822 0.82 . . . . 0.0 112.083 -170.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -68.88 119.96 14.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.183 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -70.11 -6.53 34.63 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 122.237 0.215 . . . . 0.0 111.454 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -88.96 -13.9 37.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 14.9 t -155.59 -20.01 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.36 9.73 60.08 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.507 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -91.82 164.09 13.81 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.461 1.131 . . . . 0.0 109.633 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.2 mt -56.43 123.66 15.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.568 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.9 ttmm -74.23 -13.94 60.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.454 0.702 . . . . 0.0 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.97 -4.76 63.18 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.52 145.49 26.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.143 0.471 . . . . 0.0 110.807 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.23 165.12 35.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.1 m -136.39 120.75 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.475 0.31 . . . . 0.0 111.829 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' A' ' 305' ' ' PHE . 94.8 t -114.96 124.17 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.2 t -95.78 128.12 42.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.268 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -85.1 147.07 26.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 172.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.76 -16.77 59.39 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -125.21 131.27 24.04 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.837 0.855 . . . . 0.0 110.688 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.431 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 30.7 Cg_endo -66.62 -32.69 38.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.67 2.247 . . . . 0.0 114.332 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 83.4 Cg_endo -76.26 -19.63 15.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-N 121.508 1.574 . . . . 0.0 110.85 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -75.51 -29.69 59.56 Favored 'General case' 0 CA--C 1.524 -0.041 0 O-C-N 122.391 -0.193 . . . . 0.0 110.547 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.55 -48.21 75.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.43 ' HZ2' ' HB2' ' A' ' 274' ' ' ARG . 17.0 tptm -64.07 -38.68 91.95 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.6 82.92 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.484 0.314 . . . . 0.0 110.705 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.24 65.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 348' ' ' LYS . 66.5 mt -72.04 -57.32 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.43 -21.91 62.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -93.11 -60.38 1.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.62 -32.44 71.15 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.43 112.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.01 -15.35 31.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.091 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -94.67 -172.81 2.84 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.605 1.203 . . . . 0.0 109.946 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -102.65 170.77 7.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.477 0.311 . . . . 0.0 110.171 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -125.38 -38.54 2.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.371 0.268 . . . . 0.0 110.601 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t -143.84 8.04 1.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.329 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.08 -21.11 4.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -103.83 148.87 36.5 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.94 152.86 76.56 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.395 2.73 . . . . 0.0 110.581 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -139.12 169.14 17.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.96 0.409 . . . . 0.0 110.538 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -133.68 155.61 49.4 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.748 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -143.89 146.39 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 50.0 m -153.76 174.76 14.12 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.65 163.68 4.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.079 -0.388 . . . . 0.0 111.914 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -132.59 137.16 46.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.0 m -140.7 134.12 29.89 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.676 0.79 . . . . 0.0 110.469 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -48.97 118.09 2.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -26.95 63.58 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.8 74.36 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.424 -0.173 . . . . 0.0 110.843 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.56 -8.73 15.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.44 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 98.8 m-85 -107.67 -10.0 15.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.92 -40.33 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -79.29 -8.76 59.3 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.847 0.294 . . . . 0.0 111.66 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.56 14.8 69.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 86.24 -178.59 49.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.98 160.26 52.6 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -148.85 169.94 19.37 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.399 0.68 . . . . 0.0 110.496 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -170.49 168.15 41.22 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -73.48 168.04 20.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.875 0.47 . . . . 0.0 110.199 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -74.21 149.93 41.49 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.24 83.71 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 60.0 ttm-85 -153.68 149.6 27.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.242 0.521 . . . . 0.0 109.719 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -73.15 172.61 49.64 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . 0.49 ' HG2' ' H ' ' A' ' 390' ' ' GLY . 21.1 ttt180 -152.62 149.83 28.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.998 0.519 . . . . 0.0 109.718 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -80.4 8.65 52.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 122.999 0.333 . . . . 0.0 112.274 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . 0.49 ' H ' ' HG2' ' A' ' 388' ' ' ARG . . . . . . . . 0 C--O 1.251 1.2 0 CA-C-O 117.407 -1.774 . . . . 0.0 110.702 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . 0.434 HO2' " H5'" ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.403 0 C5'-C4'-C3' 111.007 -2.995 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.434 " H5'" HO2' ' B' ' 91' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 N19-C1'-C2' 109.212 -2.618 . 0.769 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.462 HO2' " H5'" ' B' ' 94' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C4'-C3'-C2' 99.94 -2.76 . 0.859 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.498 HO2' " H5'" ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 N19-C1'-C2' 109.414 -2.491 . 0.807 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.542 HO2' " H5'" ' B' ' 96' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 O4'-C1'-N19 110.94 2.74 . 0.816 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.542 " H5'" HO2' ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.562 0 O4'-C1'-N19 111.211 3.011 . 0.839 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.706 0 O4'-C1'-N19 111.103 2.903 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.567 HO2' " H5'" ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 O4'-C1'-N19 111.09 2.89 . 0.694 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.567 " H5'" HO2' ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 C5'-C4'-C3' 111.512 -2.659 . 0.71 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.812 0 C5'-C4'-C3' 111.237 -2.842 . 0.723 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 C5'-C4'-C3' 111.386 -2.742 . 0.631 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 C5'-C4'-C3' 110.586 -3.276 . 0.383 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 C5'-C4'-C3' 109.064 -4.291 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.168 1 O4'-C1'-N19 113.032 4.832 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.568 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 C5'-C4'-C3' 110.641 -3.239 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.828 1 C3'-C2'-C1' 105.859 4.843 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.904 0 C5'-C4'-C3' 110.122 -3.585 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 0 C5'-C4'-C3' 110.927 -3.049 . 0.66 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.326 0 N19-C1'-C2' 109.284 -2.572 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.553 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 N19-C1'-C2' 108.893 -2.817 . 0.761 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.553 " H5'" HO2' ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.455 0 N19-C1'-C2' 109.279 -2.576 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.563 HO2' " H5'" ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 N19-C1'-C2' 109.461 -2.462 . 0.753 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.563 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.575 0 C4'-C3'-C2' 100.483 -2.217 . 0.738 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.571 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.878 0 O4'-C1'-N19 110.541 2.341 . 0.722 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.619 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.624 2.424 . 0.694 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.619 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O4'-C1'-N19 110.614 2.414 . 0.743 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.546 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.416 -3.058 0 C5'-C4'-C3' 112.031 -2.312 . 0.794 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.523 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.89 0 O4'-C1'-N19 110.771 2.571 . 0.815 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 179.77 -177.95 48.36 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -69.98 176.4 3.77 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.422 ' ND2' ' H21' ' B' ' 106' ' ' ' G' . 12.4 m-80 -68.93 -174.4 0.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.622 0.769 . . . . 0.0 110.469 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.576 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -63.81 -16.59 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.617 0.367 . . . . 0.0 111.775 -177.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -95.96 -3.75 44.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.933 0.333 . . . . 0.0 111.021 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.15 85.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.885 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.63 -158.84 51.04 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.373 1.586 . . . . 0.0 110.496 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.99 15.62 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.732 2.955 . . . . 0.0 112.496 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 267' ' ' GLY . 72.5 ttt-85 -75.81 -40.55 54.79 Favored 'General case' 0 C--N 1.334 -0.075 0 O-C-N 122.051 -0.406 . . . . 0.0 110.122 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -95.97 3.54 53.42 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.749 0.419 . . . . 0.0 111.709 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.32 168.07 13.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.914 0.486 . . . . 0.0 111.104 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -77.49 -115.59 0.17 Allowed Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.146 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.3 t -77.12 30.76 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.751 0.82 . . . . 0.0 112.552 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -5.56 9.77 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.545 -0.722 . . . . 0.0 111.774 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -89.32 -19.66 25.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.835 0.454 . . . . 0.0 111.194 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -128.47 6.34 5.73 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 39.0 t -154.98 160.85 41.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.112 0.565 . . . . 0.0 109.697 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -108.94 14.0 24.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.879 0.471 . . . . 0.0 110.375 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -89.05 -82.67 0.24 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.57 13.87 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.004 1.721 . . . . 0.0 115.105 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -149.98 160.35 43.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.879 -0.513 . . . . 0.0 109.949 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.1 t -147.27 0.91 0.72 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.512 0.196 . . . . 0.0 111.144 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -151.04 24.14 0.74 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -136.21 44.83 2.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.113 0.565 . . . . 0.0 110.919 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -69.7 -1.2 8.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.946 0.499 . . . . 0.0 111.185 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -99.26 147.57 25.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.99 150.24 34.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.867 0.467 . . . . 0.0 109.897 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -105.38 149.68 25.89 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.14 148.7 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.251 0.621 . . . . 0.0 111.238 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -138.55 150.59 46.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.08 5.79 59.37 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.74 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -55.36 -56.69 17.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 117.45 0.625 . . . . 0.0 111.29 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.43 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 90.15 -179.66 43.89 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.79 -11.57 59.85 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.786 0.835 . . . . 0.0 112.106 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.69 0.39 39.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.416 0.286 . . . . 0.0 111.275 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.33 154.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -157.58 168.38 27.46 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 32.5 mm -49.87 -40.16 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.406 1.082 . . . . 0.0 111.776 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.37 -28.74 63.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.55 -0.094 . . . . 0.0 111.059 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.3 t -75.23 -49.46 19.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.159 0.184 . . . . 0.0 110.817 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.466 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.7 m -61.38 -54.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.72 77.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.375 0.534 . . . . 0.0 110.699 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -76.17 -15.76 60.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.41 -27.42 16.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -96.5 -20.58 18.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -65.67 -18.72 65.53 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.341 0.257 . . . . 0.0 111.68 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -64.39 -21.9 66.78 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.3 mm -87.01 -27.99 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 168.28 170.44 32.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.73 135.74 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.879 0.34 . . . . 0.0 111.261 -172.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.9 mm -76.98 137.84 21.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -69.61 149.37 48.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m -128.32 132.65 48.62 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -72.34 150.14 43.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -81.51 -6.58 59.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -139.97 -5.22 1.32 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.0 p -91.09 -20.95 21.49 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.57 15.99 79.12 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -141.09 158.77 63.84 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 117.415 0.608 . . . . 0.0 109.707 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.99 154.38 62.28 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.264 1.976 . . . . 0.0 109.47 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.6 mtp -77.14 76.94 3.68 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.63 0.372 . . . . 0.0 111.159 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.466 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.63 154.25 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.389 0.675 . . . . 0.0 110.747 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -150.99 130.33 12.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.684 0.794 . . . . 0.0 108.939 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -90.87 122.31 33.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.464 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 97.1 m-85 -86.22 160.16 19.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 48.8 p -134.81 161.35 35.44 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.346 0.593 . . . . 0.0 111.661 -170.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -71.86 117.8 13.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.985 170.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -73.64 -4.86 36.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.438 -0.164 . . . . 0.0 111.195 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -94.39 -6.77 43.4 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.265 0.626 . . . . 0.0 112.533 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.9 t -150.02 -23.0 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.44 0.564 . . . . 0.0 111.14 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.13 32.59 16.81 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.962 171.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -135.55 166.18 23.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 117.852 0.826 . . . . 0.0 110.756 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.77 122.87 5.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.74 0.816 . . . . 0.0 111.262 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.635 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.3 ttmm -83.64 -20.86 32.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.3 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 99.87 0.37 56.3 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -90.58 151.04 21.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.628 0.714 . . . . 0.0 110.902 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.36 166.21 31.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.316 0.646 . . . . 0.0 109.355 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.3 m -136.84 122.68 20.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.634 0.374 . . . . 0.0 111.603 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.22 125.09 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.2 t -96.83 128.35 43.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.573 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -85.59 147.82 26.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -76.1 -17.24 59.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -125.39 132.24 24.26 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.437 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 30.4 Cg_endo -66.88 -32.2 36.63 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.782 2.321 . . . . 0.0 114.562 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 92.5 Cg_endo -77.5 -18.79 13.54 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 121.135 1.441 . . . . 0.0 111.146 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.6 m -75.76 -29.27 58.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.24 -0.288 . . . . 0.0 110.478 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.99 -47.69 76.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.71 -39.81 95.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.484 0.314 . . . . 0.0 110.53 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.92 81.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 0.0 110.59 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.12 -26.14 65.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.62 -58.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -60.64 -21.3 62.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -92.99 -59.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -70.37 -32.34 69.97 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.24 112.01 1.12 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -15.59 30.61 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.063 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -94.76 -172.35 2.7 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.646 1.223 . . . . 0.0 110.03 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.5 174.07 6.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.708 0.29 . . . . 0.0 110.459 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -129.27 -37.78 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.518 0.327 . . . . 0.0 110.654 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.2 t -144.87 20.31 1.63 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.687 0.395 . . . . 0.0 110.043 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.07 0.01 31.56 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -125.32 146.6 54.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 123.801 0.84 . . . . 0.0 109.773 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.79 149.22 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.575 2.85 . . . . 0.0 110.93 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.46 169.21 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.067 0.547 . . . . 0.0 110.636 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -133.5 157.17 46.31 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.004 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 44.7 t -143.95 147.3 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.039 0.536 . . . . 0.0 110.223 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.9 m -154.73 172.86 17.24 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.64 159.11 6.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.422 ' HA ' ' H22' ' B' ' 106' ' ' ' G' . . . -127.77 134.93 49.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.5 m -138.99 136.3 35.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.628 0.771 . . . . 0.0 110.002 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -47.39 112.49 0.55 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.022 0.529 . . . . 0.0 110.105 -170.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -28.42 64.9 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.83 74.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.47 -0.144 . . . . 0.0 110.786 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.56 -9.51 19.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.407 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.8 m-85 -106.87 -7.94 16.9 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.71 -40.88 0.07 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -84.12 2.57 38.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.211 0.46 . . . . 0.0 112.023 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.04 81.69 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 88.75 1.77 79.76 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 76.29 177.98 44.34 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.347 0.574 . . . . 0.0 111.871 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -158.54 162.12 37.37 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 172.05 141.89 3.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -146.9 162.02 39.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.13 0.465 . . . . 0.0 110.847 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -157.07 176.08 34.39 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 161.48 25.71 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 CA-C-N 117.333 0.567 . . . . 0.0 112.671 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -60.36 144.34 50.96 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.777 0.788 . . . . 0.0 110.003 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -71.88 165.71 53.72 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -153.73 146.77 24.54 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.323 0.649 . . . . 0.0 109.925 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.01 85.15 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.224 -1.876 . . . . 0.0 110.888 179.658 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 N19-C1'-C2' 109.785 -2.26 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 N19-C1'-C2' 109.464 -2.46 . 0.88 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C4'-C3'-C2' 99.951 -2.749 . 0.885 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 N19-C1'-C2' 109.073 -2.704 . 0.836 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.361 -2.759 . 0.821 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.536 HO2' " H5'" ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.689 0 C4'-C3'-C2' 100.345 -2.355 . 0.9 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.585 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.499 0 C4'-C3'-C2' 100.068 -2.632 . 0.833 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.585 " H5'" HO2' ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.66 0 O4'-C1'-N19 111.51 3.31 . 0.766 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.556 HO2' " H5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 C5'-C4'-C3' 111.742 -2.505 . 0.676 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.556 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.876 0 C5'-C4'-C3' 111.138 -2.908 . 0.647 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.418 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 C5'-C4'-C3' 111.2 -2.866 . 0.794 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.418 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 C5'-C4'-C3' 110.268 -3.488 . 0.414 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 C5'-C4'-C3' 109.939 -3.707 . 0.205 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.188 1 O4'-C1'-N19 112.505 4.305 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.635 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.723 1 C5'-C4'-C3' 109.216 -4.189 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.422 ' H21' ' ND2' ' A' ' 263' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.042 1 C3'-C2'-C1' 105.64 4.6 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 C5'-C4'-C3' 109.777 -3.815 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 110.291 -3.473 . 0.496 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 C5'-C4'-C3' 110.633 -3.245 . 0.153 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 N19-C1'-C2' 109.601 -2.375 . 0.724 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.529 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.54 0 N19-C1'-C2' 109.541 -2.412 . 0.824 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.529 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 N19-C1'-C2' 109.45 -2.468 . 0.73 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.528 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 C5'-C4'-C3' 111.997 -2.335 . 0.768 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.547 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 O4'-C1'-N19 110.968 2.768 . 0.745 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.61 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 C4'-C3'-C2' 100.012 -2.688 . 0.697 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.61 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.794 0 O4'-C1'-N19 110.669 2.469 . 0.73 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.543 HO2' " H5'" ' B' ' 118' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 O4'-C1'-N19 110.706 2.506 . 0.819 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.543 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.863 0 N19-C1'-C2' 109.628 -2.357 . 0.809 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.106 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.94 -174.85 54.21 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.52 -53.22 51.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -157.35 -178.02 7.04 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 108.884 -173.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -68.64 -7.02 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 176.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -109.1 -2.98 17.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.76 88.75 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.03 -0.872 . . . . 0.0 114.811 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 66.24 -156.5 50.25 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.405 1.603 . . . . 0.0 110.118 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.08 17.88 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.766 2.978 . . . . 0.0 112.246 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 267' ' ' GLY . 71.6 ttt-85 -77.17 -40.48 45.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 122.26 -0.275 . . . . 0.0 110.267 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.1 3.48 53.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.798 0.439 . . . . 0.0 111.356 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.09 170.16 12.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.706 0.402 . . . . 0.0 111.271 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -79.18 -118.69 0.27 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.776 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.7 t -77.5 23.34 0.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.106 0.963 . . . . 0.0 111.831 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -7.01 4.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -86.6 -5.99 58.99 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.277 0.631 . . . . 0.0 111.156 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.9 22.3 0.88 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 39.1 t -158.45 150.66 21.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -96.57 14.9 23.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.077 0.551 . . . . 0.0 110.026 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.95 -113.03 0.26 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.327 0.651 . . . . 0.0 109.372 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.22 24.68 2.11 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.78 162.88 40.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 78.6 p -155.04 -29.94 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.077 0.151 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -108.14 18.2 21.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.257 0.623 . . . . 0.0 112.274 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -134.04 48.79 2.31 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.328 0.651 . . . . 0.0 111.233 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -67.24 -12.62 60.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.6 m -87.26 144.42 26.82 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.8 pt -129.05 147.4 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -101.78 147.8 26.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.54 146.86 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 122.983 0.513 . . . . 0.0 111.062 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -137.51 149.88 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.19 58.24 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.8 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.36 -54.74 42.03 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.281 0.632 . . . . 0.0 111.022 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.445 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.54 179.6 46.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -78.33 -9.05 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.818 0.847 . . . . 0.0 111.989 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -82.64 0.06 44.85 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.31 0.244 . . . . 0.0 111.461 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.98 155.76 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.71 168.24 27.8 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.26 -40.25 13.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 124.385 1.074 . . . . 0.0 111.948 -174.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.54 -29.14 63.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.487 -0.085 . . . . 0.0 111.198 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.5 t -74.9 -49.47 20.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.194 0.197 . . . . 0.0 110.57 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.472 ' CG2' HG23 ' A' ' 322' ' ' ILE . 2.6 m -61.72 -54.18 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.27 78.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.29 0.496 . . . . 0.0 110.915 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' A' ' 306' ' ' LYS . 20.2 t0 -75.73 -15.15 60.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.788 0.327 . . . . 0.0 111.217 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -95.47 -26.79 15.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -97.27 -20.43 17.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.404 ' HE2' ' OD1' ' A' ' 303' ' ' ASP . 51.8 pttt -65.92 -18.98 65.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.11 -21.37 66.51 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.84 -25.74 5.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.32 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.15 170.03 30.53 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.54 136.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 122.674 -0.309 . . . . 0.0 111.167 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.7 mm -77.66 137.66 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.467 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.0 ttmm -68.84 148.46 50.23 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m -119.21 139.82 51.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -70.84 144.95 50.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.76 -0.12 46.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -144.45 5.63 1.24 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.8 p -124.73 -18.27 5.66 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.49 -17.22 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.404 0.526 . . . . 0.0 113.028 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -85.06 158.94 57.96 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.864 0.832 . . . . 0.0 109.524 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.07 153.61 75.14 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.131 1.887 . . . . 0.0 109.264 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.467 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.7 mtp -79.46 79.57 5.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.472 HG23 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.84 156.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.49 0.716 . . . . 0.0 110.412 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -152.56 127.97 9.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.633 0.773 . . . . 0.0 109.199 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.84 121.67 34.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -84.45 158.58 21.0 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 26.2 p -135.43 145.18 46.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -57.78 139.4 54.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -77.89 -13.21 59.96 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -94.12 -5.24 47.69 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.1 t -150.81 -23.08 0.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.942 0.337 . . . . 0.0 110.849 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 82.14 19.69 64.37 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.561 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -126.4 168.15 14.58 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.23 118.72 1.38 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.769 0.828 . . . . 0.0 111.109 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.615 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 10.2 ptpt -88.0 -2.22 58.48 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.06 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.11 4.84 68.42 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.406 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 151.09 21.74 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 117.906 0.853 . . . . 0.0 111.059 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.52 167.4 29.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.12 0.568 . . . . 0.0 109.713 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.7 m -138.19 123.81 19.73 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.763 0.425 . . . . 0.0 111.228 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 99.5 t -116.36 125.23 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.431 0.692 . . . . 0.0 109.233 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.4 t -96.78 125.53 41.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.084 -0.385 . . . . 0.0 110.466 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -82.4 150.1 27.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.37 -15.69 58.43 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 86.7 m-20 -129.55 136.1 28.58 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.417 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 17.9 Cg_endo -65.48 -36.67 33.3 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.774 2.316 . . . . 0.0 114.31 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 343' ' ' ASP . 85.8 Cg_endo -75.8 -18.66 16.9 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 120.935 1.37 . . . . 0.0 111.122 -175.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.0 m -75.9 -30.09 58.68 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.0 71.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.141 0.177 . . . . 0.0 110.871 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -64.12 -38.27 90.47 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.455 0.169 . . . . 0.0 110.643 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.5 83.02 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.555 0.342 . . . . 0.0 110.834 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -25.72 65.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.9 mt -72.71 -56.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -60.31 -20.95 61.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -94.99 -59.65 1.86 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.83 -31.5 69.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -57.76 112.81 1.58 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.49 -15.46 32.32 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.908 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.52 -172.14 2.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.742 1.271 . . . . 0.0 109.86 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -102.61 174.38 5.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.837 0.351 . . . . 0.0 110.347 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -130.02 -39.39 1.38 Allowed 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.3 t -143.34 18.18 1.89 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.993 0.517 . . . . 0.0 109.7 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.75 -18.81 24.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -97.11 140.2 21.94 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.27 151.27 81.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.997 2.465 . . . . 0.0 110.486 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.88 168.93 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.153 0.502 . . . . 0.0 111.041 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.82 155.64 49.47 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.901 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.43 146.79 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 122.939 0.495 . . . . 0.0 110.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.4 m -155.11 173.1 17.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.3 160.7 4.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.404 ' HA ' ' H22' ' B' ' 106' ' ' ' G' . . . -130.8 139.23 50.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 17.3 m -141.05 135.97 31.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.957 0.903 . . . . 0.0 109.866 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -48.1 123.13 5.87 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.444 0.297 . . . . 0.0 110.666 -170.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -29.72 68.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.981 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -64.25 -8.77 13.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.527 ' CD1' ' HE3' ' A' ' 264' ' ' LYS . 90.2 m-85 -112.19 -8.88 13.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.51 -41.39 0.1 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -82.22 -0.33 44.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.048 0.385 . . . . 0.0 111.846 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 81.6 6.7 88.93 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.77 -4.91 72.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.266 0.46 . . . . 0.0 112.291 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.69 177.07 34.53 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.712 0.756 . . . . 0.0 111.401 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -146.45 152.48 39.09 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.981 0.513 . . . . 0.0 110.571 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -94.6 -171.29 37.61 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.43 ' HD2' " H1'" ' B' ' 100' ' ' ' C' . 10.2 ptp85 -158.07 163.43 37.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.728 0.411 . . . . 0.0 109.93 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -73.81 147.89 39.06 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.76 154.55 29.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -76.51 163.25 27.1 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 122.743 0.417 . . . . 0.0 110.182 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -74.9 174.01 51.83 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -153.09 152.53 31.42 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.282 0.633 . . . . 0.0 109.712 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -163.61 -173.48 32.36 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.377 -1.791 . . . . 0.0 110.767 179.38 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . 0.438 HO2' " H5'" ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 C5'-C4'-C3' 110.859 -3.094 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.471 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.366 -2.521 . 0.772 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.471 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 C4'-C3'-C2' 100.13 -2.57 . 0.85 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.432 " H5'" HO2' ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.697 0 N19-C1'-C2' 109.097 -2.69 . 0.821 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.451 0 O4'-C1'-N19 110.858 2.658 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 110.927 2.727 . 0.9 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 O4'-C1'-N19 110.922 2.722 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.726 HO2' " H5'" ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 110.921 2.721 . 0.81 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.726 " H5'" HO2' ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.415 -3.203 0 C5'-C4'-C3' 111.297 -2.802 . 0.68 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.43 " H1'" ' HD2' ' A' ' 383' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 C5'-C4'-C3' 111.052 -2.965 . 0.632 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.429 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 111.145 -2.903 . 0.708 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.429 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 C5'-C4'-C3' 110.241 -3.506 . 0.491 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . 0.634 HO2' " C5'" ' B' ' 104' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.304 0 C5'-C4'-C3' 109.632 -3.912 OUTLIER-DELTA 0.0 OUTLIER '7D dist 4s' 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . 0.634 " C5'" HO2' ' B' ' 103' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.235 1 O4'-C1'-N19 113.536 5.336 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.615 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 110.151 -3.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.404 ' H22' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C3'-C2'-C1' 105.718 4.687 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.57 0 C5'-C4'-C3' 109.962 -3.692 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.646 0 C5'-C4'-C3' 112.467 -2.022 . 0.207 8d . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.578 HO2' " H5'" ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C5'-C4'-C3' 110.716 -3.189 . 0.615 1c . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.578 " H5'" HO2' ' B' ' 109' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 110.49 2.29 . 0.688 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.56 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 109.566 -2.396 . 0.812 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.56 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 N19-C1'-C2' 109.449 -2.47 . 0.751 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 0 C4'-C3'-C2' 100.646 -2.054 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.503 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 C4'-C3'-C2' 100.275 -2.425 . 0.775 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.607 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 O4'-C1'-N19 110.796 2.596 . 0.71 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.607 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.57 0 C4'-C3'-C2' 100.232 -2.468 . 0.711 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.591 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.868 0 O4'-C1'-N19 110.536 2.336 . 0.817 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.55 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.69 0 N19-C1'-C2' 109.573 -2.392 . 0.823 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.113 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 74.94 -172.84 52.98 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.28 178.19 3.49 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.19 -177.12 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.02 0.928 . . . . 0.0 110.542 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.563 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -65.61 -12.54 54.13 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -96.9 -8.95 29.51 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.132 0.423 . . . . 0.0 110.667 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 88.93 7.78 70.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 64.31 -167.22 28.17 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.478 1.639 . . . . 0.0 111.0 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.59 21.43 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.642 2.894 . . . . 0.0 112.198 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 267' ' ' GLY . 78.4 ttt-85 -76.16 -24.56 54.82 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 122.16 -0.337 . . . . 0.0 110.978 -172.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.0 p30 -137.54 21.38 2.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.155 0.582 . . . . 0.0 111.211 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.95 -7.1 7.31 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.328 0.651 . . . . 0.0 112.461 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.73 -115.43 4.86 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 62.5 m -76.05 22.02 0.16 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -3.94 10.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.617 0.644 . . . . 0.0 112.244 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -92.4 -13.41 30.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.528 0.331 . . . . 0.0 111.219 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -127.33 6.23 6.37 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 41.6 t -152.05 150.1 29.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -87.96 -0.02 56.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.026 0.531 . . . . 0.0 110.542 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -91.4 -83.42 0.28 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.582 0.353 . . . . 0.0 110.077 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p30 49.03 15.73 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.727 1.611 . . . . 0.0 114.582 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -151.81 164.59 36.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -155.92 -34.43 0.09 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.484 0.183 . . . . 0.0 111.087 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.41 6.68 42.26 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -123.7 142.14 51.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.822 0.449 . . . . 0.0 110.025 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -145.17 15.41 1.5 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.733 0.813 . . . . 0.0 110.124 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.4 m -133.63 150.33 51.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.88 146.22 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.756 0.422 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -100.47 146.53 26.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.59 147.08 32.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 122.766 0.426 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.78 150.41 47.21 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.13 5.96 58.01 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.556 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.45 -57.32 12.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.499 0.72 . . . . 0.0 111.176 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.74 -179.1 45.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.02 -10.88 59.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.569 0.748 . . . . 0.0 112.405 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.8 -0.63 35.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.549 0.34 . . . . 0.0 111.355 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.58 155.58 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.95 168.4 27.25 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -48.67 -39.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.264 1.026 . . . . 0.0 111.825 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.89 -28.59 61.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.251 -0.281 . . . . 0.0 111.248 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -75.75 -48.33 22.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.474 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.6 m -61.89 -53.97 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.55 77.97 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.045 -0.409 . . . . 0.0 110.843 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.67 -15.6 59.76 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.241 -0.287 . . . . 0.0 111.105 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -94.46 -27.13 16.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.444 ' CD2' HG23 ' A' ' 339' ' ' VAL . 45.5 m-85 -97.03 -19.85 18.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -65.79 -18.91 65.67 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.05 -21.8 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.8 mm -87.39 -27.26 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 167.89 169.89 31.96 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.03 135.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.577 -0.366 . . . . 0.0 111.064 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 8.1 mm -75.41 138.6 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.12 153.64 43.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.82 137.76 50.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -76.13 137.46 40.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.19 -19.58 56.55 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.94 -48.43 4.89 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.705 0.23 . . . . 0.0 110.7 -176.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.8 p -85.13 -21.52 29.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.36 -16.5 4.78 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.528 -0.596 . . . . 0.0 113.141 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.31 160.45 65.16 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 118.178 0.989 . . . . 0.0 109.803 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.15 153.46 69.4 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.963 1.775 . . . . 0.0 109.541 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.7 mtp -78.95 76.04 5.45 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.199 0.6 . . . . 0.0 111.128 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.474 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.4 OUTLIER -130.89 159.63 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.143 0.577 . . . . 0.0 110.617 -178.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -156.24 125.23 6.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.84 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.05 121.73 32.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.592 ' HH ' " H5'" ' B' ' 106' ' ' ' G' . 65.3 m-85 -76.0 163.75 26.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.1 p -137.77 156.61 47.79 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.484 0.659 . . . . 0.0 111.106 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.44 131.9 44.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.31 1.044 . . . . 0.0 112.081 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 62.8 mtt-85 -79.34 -7.74 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.605 0.362 . . . . 0.0 111.718 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.64 -5.7 34.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.436 HG22 ' HE3' ' A' ' 332' ' ' LYS . 2.8 t -151.62 -25.27 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.964 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.33 51.88 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.041 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.436 ' HE3' HG22 ' A' ' 330' ' ' THR . 0.0 OUTLIER -120.42 174.64 6.41 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.907 0.854 . . . . 0.0 110.452 178.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.36 122.54 7.12 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.215 0.606 . . . . 0.0 111.132 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.488 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -76.52 -16.49 59.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.488 0.715 . . . . 0.0 109.691 174.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.79 16.01 50.18 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -123.08 155.91 35.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.44 0.62 . . . . 0.0 110.388 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.68 173.39 16.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.906 0.482 . . . . 0.0 109.918 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.2 m -139.56 129.26 24.58 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.444 HG23 ' CD2' ' A' ' 305' ' ' PHE . 89.6 t -119.24 127.18 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 39.5 t -98.36 132.89 43.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.724 -0.39 . . . . 0.0 109.971 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.24 145.11 24.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.175 0.99 . . . . 0.0 113.201 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -72.08 -16.41 62.02 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.416 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 99.5 m-20 -125.61 134.09 25.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.785 0.834 . . . . 0.0 110.835 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.443 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 22.3 Cg_endo -66.14 -33.93 38.7 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.702 2.268 . . . . 0.0 114.055 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 93.9 Cg_endo -77.69 -19.03 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.499 1.466 . . . . 0.0 111.522 -177.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.7 m -74.35 -29.14 61.46 Favored 'General case' 0 C--N 1.335 -0.05 0 CA-C-N 117.774 0.261 . . . . 0.0 110.35 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.64 79.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.412 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.3 tptm -62.51 -40.11 95.68 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.402 -0.187 . . . . 0.0 111.111 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.361 0.265 . . . . 0.0 110.92 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.54 -24.96 64.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 348' ' ' LYS . 65.8 mt -73.9 -55.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -60.76 -20.86 62.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -95.36 -60.27 1.7 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.76 -32.4 70.9 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.33 111.8 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.7 -17.11 25.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.287 -0.729 . . . . 0.0 112.806 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -94.43 -171.73 2.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.53 1.165 . . . . 0.0 109.94 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -102.7 174.25 5.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -129.38 -38.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.565 0.346 . . . . 0.0 110.078 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.8 t -144.49 17.33 1.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.016 0.526 . . . . 0.0 109.738 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.89 16.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -94.71 140.29 22.54 Favored Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.96 151.38 82.23 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.102 2.534 . . . . 0.0 110.326 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.51 168.32 19.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 121.168 0.509 . . . . 0.0 111.092 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -133.81 155.64 49.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.268 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 56.9 t -144.63 147.43 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 O-C-N 123.412 0.445 . . . . 0.0 110.093 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.3 m -154.36 171.85 18.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.99 155.63 7.89 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.588 ' HA ' ' H22' ' B' ' 106' ' ' ' G' . . . -124.71 135.18 52.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.0 m -135.28 132.76 38.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.282 0.633 . . . . 0.0 109.698 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -46.7 113.97 0.74 Allowed 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.067 0.547 . . . . 0.0 110.355 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.86 74.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.53 71.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.049 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -66.01 -10.25 37.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.563 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.3 m-85 -104.29 -9.7 18.37 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.68 -42.11 0.09 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.56 -9.15 59.57 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.38 13.82 72.68 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.62 177.29 50.38 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.6 163.29 54.34 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -160.83 174.53 13.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.113 0.565 . . . . 0.0 110.563 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -163.95 174.88 40.13 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -78.49 171.2 15.45 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.895 0.478 . . . . 0.0 110.435 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -74.98 162.08 53.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -79.56 -173.58 45.04 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -149.52 148.76 29.77 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 123.187 0.595 . . . . 0.0 109.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -74.46 162.47 54.1 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.76 162.04 38.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.927 0.491 . . . . 0.0 109.988 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 178.15 177.48 46.91 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 117.296 -1.835 . . . . 0.0 110.93 179.824 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 N19-C1'-C2' 109.847 -2.22 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.475 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 C4'-C3'-C2' 100.12 -2.58 . 0.873 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.475 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 N19-C1'-C2' 109.267 -2.583 . 0.837 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.462 " H5'" HO2' ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.759 0 N19-C1'-C2' 109.165 -2.647 . 0.779 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 O4'-C1'-N19 111.003 2.803 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.583 HO2' " H5'" ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.971 2.771 . 0.868 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.583 " H5'" HO2' ' B' ' 96' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 O4'-C1'-N19 110.935 2.735 . 0.744 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.624 HO2' " H5'" ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.562 0 O4'-C1'-N19 110.898 2.698 . 0.753 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.624 " H5'" HO2' ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.782 0 C5'-C4'-C3' 111.723 -2.518 . 0.725 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.496 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -2.964 0 C5'-C4'-C3' 111.129 -2.914 . 0.647 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.525 0 C5'-C4'-C3' 111.431 -2.713 . 0.577 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 110.647 -3.236 . 0.367 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 C5'-C4'-C3' 109.462 -4.025 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . 0.48 " H1'" " H4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.26 1 O4'-C1'-N19 112.782 4.582 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.509 " H1'" ' CD2' ' A' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.866 0 C5'-C4'-C3' 110.456 -3.363 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.592 " H5'" ' HH ' ' A' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 C3'-C2'-C1' 105.805 4.783 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.412 HO2' ' P ' ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 O4'-C1'-N19 110.926 2.726 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . 0.412 ' P ' HO2' ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 C5'-C4'-C3' 110.744 -3.17 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 0 C5'-C4'-C3' 109.902 -3.732 . 0.41 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.506 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 N19-C1'-C2' 109.348 -2.532 . 0.688 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.577 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 N19-C1'-C2' 109.089 -2.694 . 0.77 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.577 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 N19-C1'-C2' 109.362 -2.524 . 0.641 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.512 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.29 -2.41 . 0.759 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.482 " H5'" HO2' ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 110.793 2.593 . 0.746 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.858 2.658 . 0.708 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.538 HO2' " H5'" ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 O4'-C1'-N19 110.702 2.502 . 0.768 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.544 HO2' " H5'" ' B' ' 118' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.521 2.321 . 0.78 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.544 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.684 2.484 . 0.797 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.239 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.19 174.78 44.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -62.65 -51.41 67.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -157.3 -178.23 7.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.106 0.962 . . . . 0.0 108.986 -173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.518 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.95 -8.4 36.69 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.435 -0.165 . . . . 0.0 111.301 176.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -107.7 -5.13 17.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.003 0.365 . . . . 0.0 110.326 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 87.55 2.13 82.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.002 -0.888 . . . . 0.0 115.215 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 64.95 -157.31 46.3 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 119.549 1.675 . . . . 0.0 110.739 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.59 42.27 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.883 3.056 . . . . 0.0 111.834 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -91.02 -24.92 19.92 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 122.152 -0.342 . . . . 0.0 111.028 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -142.31 22.39 2.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.251 0.621 . . . . 0.0 110.683 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.51 -21.43 66.32 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.308 0.643 . . . . 0.0 111.204 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.51 -133.38 10.03 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.2 t -78.61 20.36 0.44 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.679 0.791 . . . . 0.0 111.541 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -7.52 3.54 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.942 0.497 . . . . 0.0 112.263 -174.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -85.07 -19.52 31.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.78 0.432 . . . . 0.0 110.822 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.19 0.95 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 58.4 m -144.95 150.65 37.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.97 0.508 . . . . 0.0 110.585 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -88.57 2.12 53.66 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -98.51 -110.09 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 54.27 15.27 0.91 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -149.24 160.23 43.56 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 41.0 t -157.24 -33.91 0.08 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -91.27 5.14 50.35 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.82 0.848 . . . . 0.0 112.92 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.44 44.51 2.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.198 0.599 . . . . 0.0 111.088 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.42 3.98 2.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.197 0.599 . . . . 0.0 111.694 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 m -105.75 147.83 28.14 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 15.6 pt -128.45 149.91 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.035 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -104.75 149.76 25.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.11 147.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.485 0.714 . . . . 0.0 111.12 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -139.38 150.13 44.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.05 57.83 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.995 -0.336 . . . . 0.0 112.801 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.64 -56.31 21.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.516 0.727 . . . . 0.0 111.288 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.433 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.72 -179.43 45.87 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.19 -10.41 59.39 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.704 0.802 . . . . 0.0 112.251 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -81.56 -0.69 43.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.242 0.217 . . . . 0.0 111.319 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.87 155.95 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.54 168.39 27.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -50.3 -40.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.324 1.05 . . . . 0.0 111.572 -174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -72.36 -28.83 63.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.405 -0.184 . . . . 0.0 111.102 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.5 -50.26 18.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.272 0.229 . . . . 0.0 110.456 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.7 m -61.25 -53.55 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.59 -37.39 78.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.531 0.605 . . . . 0.0 110.664 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' A' ' 306' ' ' LYS . 20.0 t0 -76.12 -15.81 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 111.109 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -94.52 -27.52 15.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -96.71 -20.68 18.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.401 ' HE2' ' OD1' ' A' ' 303' ' ' ASP . 52.6 pttt -65.31 -19.09 65.8 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.45 -20.76 66.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.0 mm -88.59 -24.65 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-O 120.665 0.269 . . . . 0.0 110.342 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.53 168.79 27.18 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.37 136.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.614 -0.345 . . . . 0.0 111.002 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.9 mm -78.22 137.58 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.428 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.8 ttmm -71.89 145.92 48.21 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 110.578 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.22 142.65 38.17 Favored 'General case' 0 N--CA 1.458 -0.075 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -74.53 -14.55 60.82 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 58.94 7.66 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -134.73 -30.46 1.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.928 0.785 . . . . 0.0 112.007 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 74.6 p -95.81 -9.98 30.19 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.467 0.307 . . . . 0.0 110.658 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.11 79.76 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -140.05 161.28 56.57 Favored Pre-proline 0 C--O 1.231 0.096 0 CA-C-N 117.449 0.625 . . . . 0.0 109.687 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.25 155.73 49.83 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.476 2.117 . . . . 0.0 109.856 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.428 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 59.2 mtp -76.79 76.64 3.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.956 0.502 . . . . 0.0 110.997 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.468 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.75 158.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -157.37 133.1 9.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -93.37 120.12 33.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.92 159.73 22.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 57.4 p -133.8 157.11 46.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.298 0.57 . . . . 0.0 111.77 -171.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.57 127.89 34.55 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.184 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 328' ' ' ARG . 35.0 mtp85 -76.24 -6.86 53.3 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.33 0.252 . . . . 0.0 111.132 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -98.74 -5.56 31.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.6 t -149.93 -23.0 0.26 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.742 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.71 25.76 40.86 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.717 -0.491 . . . . 0.0 112.992 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -131.46 170.65 14.4 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 117.646 0.723 . . . . 0.0 110.414 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.57 122.87 5.16 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.901 0.881 . . . . 0.0 111.269 -173.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.551 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.7 ttmm -81.65 -18.76 43.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.983 0.913 . . . . 0.0 109.782 174.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.433 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.62 2.13 61.69 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.77 150.97 19.64 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.455 0.627 . . . . 0.0 111.119 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.47 33.68 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.003 0.521 . . . . 0.0 109.723 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.4 m -135.74 123.14 21.95 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.2 123.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 32.8 t -95.73 127.54 41.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.712 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.48 147.65 26.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -75.71 -17.5 59.92 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.413 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 90.5 m-20 -128.27 133.28 24.98 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.048 0.939 . . . . 0.0 110.834 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.434 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -67.12 -32.65 33.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.669 2.246 . . . . 0.0 114.6 -175.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 344' ' ' PRO . 95.8 Cg_endo -75.17 -19.35 17.58 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 121.175 1.456 . . . . 0.0 110.753 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.5 m -76.98 -29.32 55.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.74 -47.56 74.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -64.92 -37.39 87.49 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.92 80.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.31 0.244 . . . . 0.0 110.483 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -25.27 65.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.7 mt -73.27 -56.07 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.93 -21.88 63.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -93.54 -60.78 1.69 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -69.22 -32.1 71.12 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.24 112.17 1.3 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.95 -16.06 30.78 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.945 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.76 -172.3 2.69 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.753 1.276 . . . . 0.0 109.969 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.91 174.22 6.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.588 0.355 . . . . 0.0 110.457 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -129.78 -38.37 1.49 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 15.57 1.74 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.698 0.399 . . . . 0.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 120.07 -18.7 9.63 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -104.22 148.77 36.47 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.02 151.11 73.31 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.483 2.789 . . . . 0.0 110.624 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.62 168.76 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.016 0.527 . . . . 0.0 110.873 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -134.1 155.39 50.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.139 0.576 . . . . 0.0 111.101 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.1 t -144.34 146.27 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 122.899 0.48 . . . . 0.0 110.221 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.3 m -154.23 172.91 16.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.69 160.01 6.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.894 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -130.96 137.54 49.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 12.7 m -140.21 135.6 32.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 109.932 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -47.52 120.47 3.3 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.285 0.366 . . . . 0.0 110.936 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -69.16 -28.74 66.7 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.27 75.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.904 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.28 -7.92 28.06 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.501 ' CD2' ' HE3' ' A' ' 264' ' ' LYS . 93.8 m-85 -108.08 -9.2 15.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.93 -40.45 0.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -83.22 -2.8 56.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.802 0.274 . . . . 0.0 111.718 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.2 4.36 88.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.39 63.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 117.413 0.607 . . . . 0.0 112.263 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -80.72 160.99 43.82 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 117.618 0.709 . . . . 0.0 111.483 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -150.17 169.12 22.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.486 0.715 . . . . 0.0 110.361 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -75.17 167.47 54.88 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -154.52 -177.49 6.51 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.176 0.512 . . . . 0.0 110.604 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.499 ' N ' ' H22' ' B' ' 109' ' ' ' G' . . . -173.8 -161.04 23.23 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -176.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 159.78 -1.9 0.09 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 46.9 ttm105 -150.67 148.87 29.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -58.52 148.23 38.35 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -67.55 148.3 51.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.656 0.383 . . . . 0.0 110.236 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 178.56 -179.33 48.72 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 117.334 -1.815 . . . . 0.0 110.978 -179.579 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C5'-C4'-C3' 110.767 -3.156 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.453 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.373 -2.517 . 0.758 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.453 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 N19-C1'-C2' 109.107 -2.683 . 0.848 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 N19-C1'-C2' 109.333 -2.542 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 110.907 2.707 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 O4'-C1'-N19 110.724 2.524 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.598 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.85 0 O4'-C1'-N19 110.83 2.63 . 0.754 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.598 " H5'" HO2' ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.82 0 C5'-C4'-C3' 111.542 -2.639 . 0.829 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.524 HO2' " H5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.871 0 C5'-C4'-C3' 111.739 -2.507 . 0.762 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.524 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.923 0 C5'-C4'-C3' 110.563 -3.291 . 0.676 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.451 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.051 0 C5'-C4'-C3' 111.575 -2.617 . 0.529 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.451 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.427 -2.175 0 C5'-C4'-C3' 110.707 -3.195 . 0.445 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 C5'-C4'-C3' 109.411 -4.059 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 1 O4'-C1'-N19 112.994 4.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.551 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 C5'-C4'-C3' 109.73 -3.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 1 C3'-C2'-C1' 105.621 4.579 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . 0.404 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.746 0 C5'-C4'-C3' 109.969 -3.688 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . 0.404 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 C4'-C3'-C2' 100.309 -2.391 . 0.132 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.568 HO2' " H5'" ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C4'-C3'-C2' 100.0 -2.7 . 0.721 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.568 " H5'" HO2' ' B' ' 109' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 O4'-C1'-N19 110.777 2.577 . 0.751 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.601 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 N19-C1'-C2' 109.154 -2.654 . 0.814 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.601 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 C4'-C3'-C2' 100.267 -2.433 . 0.733 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 C5'-C4'-C3' 112.202 -2.199 . 0.794 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 O4'-C1'-N19 110.66 2.46 . 0.777 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 110.648 2.448 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.568 HO2' " H5'" ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 O4'-C1'-N19 110.707 2.507 . 0.799 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.568 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 O4'-C1'-N19 110.591 2.391 . 0.811 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.83 0 O4'-C1'-N19 110.764 2.564 . 0.848 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.45 -171.53 54.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -72.16 178.56 3.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.438 ' CG ' ' H21' ' B' ' 106' ' ' ' G' . 23.8 m-80 -67.0 -176.45 0.52 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.529 0.731 . . . . 0.0 110.656 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.436 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -62.36 -19.11 63.04 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.613 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -95.3 -4.45 45.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.702 0.228 . . . . 0.0 110.865 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.44 10.24 77.54 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.464 169.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 68.12 -161.37 49.99 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.972 1.386 . . . . 0.0 110.572 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.513 ' HA ' HE22 ' A' ' 271' ' ' GLN . 55.6 Cg_endo -71.11 35.56 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.914 3.076 . . . . 0.0 111.873 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 267' ' ' GLY . 71.2 ttt-85 -89.42 -39.05 13.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.928 -0.482 . . . . 0.0 110.527 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -112.58 16.26 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.988 0.515 . . . . 0.0 110.343 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' A' ' 268' ' ' PRO . 4.6 tp-100 -67.61 -23.81 65.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.842 0.457 . . . . 0.0 111.529 -172.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 114.35 -130.43 9.27 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 9.8 t -78.2 20.71 0.38 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.644 0.777 . . . . 0.0 112.117 -174.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -5.43 3.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.029 0.531 . . . . 0.0 112.307 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -86.93 -19.81 28.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.559 0.344 . . . . 0.0 111.09 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -123.38 2.34 9.08 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 57.8 m -151.72 156.83 41.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 109.08 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -104.42 16.81 25.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.42 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -100.09 -108.76 0.21 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 54.84 13.73 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -146.82 151.6 37.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.2 t -156.09 -33.73 0.09 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.556 0.162 . . . . 0.0 110.75 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.81 7.38 8.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.648 0.261 . . . . 0.0 111.523 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.62 147.88 52.56 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.934 0.894 . . . . 0.0 109.499 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -154.75 27.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.2 m -135.22 149.5 49.9 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -172.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.1 pt -131.95 146.95 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.582 0.353 . . . . 0.0 110.309 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.25 150.19 22.8 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.2 t -134.13 147.23 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.866 0.466 . . . . 0.0 111.783 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -136.74 149.85 48.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.72 6.15 58.4 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 120.005 -0.33 . . . . 0.0 112.361 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.76 -56.1 24.55 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.467 0.707 . . . . 0.0 110.857 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.408 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.82 -179.89 45.85 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -78.95 -10.35 59.79 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.873 0.869 . . . . 0.0 112.26 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.83 -1.63 43.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.352 0.261 . . . . 0.0 111.348 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.68 156.19 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -158.7 168.51 26.66 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.2 mm -49.32 -40.27 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.421 1.088 . . . . 0.0 111.728 -174.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.71 -29.14 63.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.348 -0.22 . . . . 0.0 111.209 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.68 -50.14 18.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.235 0.214 . . . . 0.0 110.594 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.484 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.7 m -61.18 -53.57 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.15 80.75 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.975 -0.453 . . . . 0.0 110.565 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -75.94 -15.46 60.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 111.028 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -94.39 -27.02 16.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.412 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.8 m-85 -97.66 -20.13 17.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -66.08 -18.9 65.64 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -63.77 -21.59 66.49 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -87.35 -24.06 6.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.968 0.349 . . . . 0.0 110.2 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 161.19 172.72 28.91 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 40.2 mm -66.41 137.39 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 7.1 mm -78.38 133.82 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 172.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.4 ' CE ' ' HA ' ' A' ' 342' ' ' ASP . 12.6 tppt? -64.55 133.01 51.47 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.8 m -89.96 141.38 28.72 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.7 152.48 45.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -72.16 -23.21 61.25 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -146.35 -13.51 0.46 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.4 p -87.16 -14.56 40.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.746 0.703 . . . . 0.0 112.508 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.15 -19.62 2.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.649 0.642 . . . . 0.0 113.395 171.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -80.78 161.99 61.77 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 117.761 0.78 . . . . 0.0 110.039 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.88 152.04 82.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.04 1.827 . . . . 0.0 109.047 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 71.1 mtp -78.27 80.69 4.67 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.579 0.352 . . . . 0.0 111.196 -175.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.484 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.4 OUTLIER -133.78 154.6 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -150.36 121.3 7.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.227 0.611 . . . . 0.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.41 121.83 31.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.489 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 77.6 m-85 -79.26 162.21 25.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.108 0.48 . . . . 0.0 112.092 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.9 p -137.42 153.57 50.12 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.503 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -63.28 135.53 57.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.607 0.763 . . . . 0.0 112.305 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.12 -13.11 59.99 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.286 -0.259 . . . . 0.0 110.405 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -93.44 -5.72 48.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.0 t -150.2 -23.81 0.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.025 0.375 . . . . 0.0 110.588 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.64 17.58 63.57 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.808 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -119.94 169.67 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.967 0.884 . . . . 0.0 110.299 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.98 122.55 3.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.534 0.733 . . . . 0.0 111.469 -174.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.501 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.2 ttmm -80.62 -21.43 41.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.596 174.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.408 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.96 16.88 31.78 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -119.81 154.96 33.49 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 117.398 0.599 . . . . 0.0 110.405 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.81 171.02 20.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.878 0.471 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 42.0 m -134.78 128.18 32.32 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.739 0.416 . . . . 0.0 110.262 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.1 t -118.23 128.39 75.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 321' ' ' MET . 43.7 t -98.92 132.91 43.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.73 176.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -90.86 148.28 22.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.4 ' HA ' ' CE ' ' A' ' 312' ' ' LYS . 47.4 t0 -70.96 -22.78 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.8 m-20 -124.82 135.82 27.2 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.318 0.647 . . . . 0.0 111.693 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.432 ' N ' ' CD ' ' A' ' 345' ' ' PRO . 19.2 Cg_endo -64.05 -36.67 47.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.799 2.333 . . . . 0.0 113.925 -175.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 343' ' ' ASP . 94.5 Cg_endo -76.89 -16.42 16.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.579 1.519 . . . . 0.0 111.172 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.4 m -77.44 -29.53 52.9 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.87 81.58 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -64.52 -39.47 93.83 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 122.175 0.19 . . . . 0.0 110.742 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.37 83.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.565 0.346 . . . . 0.0 110.908 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -24.97 65.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.56 -57.72 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.85 -21.44 63.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -92.8 -59.15 2.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.76 -33.45 70.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.43 112.11 1.17 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.37 -16.46 29.45 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.188 -0.785 . . . . 0.0 113.046 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -93.83 -171.92 2.72 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.7 1.25 . . . . 0.0 109.695 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -102.8 172.21 6.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.696 0.284 . . . . 0.0 110.421 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -126.34 -38.92 2.08 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 26.4 t -142.59 6.29 1.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.834 0.454 . . . . 0.0 110.477 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.38 -22.27 3.97 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -101.76 149.37 36.4 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.73 152.29 77.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.474 2.782 . . . . 0.0 110.296 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.66 166.29 24.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 122.747 0.419 . . . . 0.0 110.792 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -131.46 156.1 46.23 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.155 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 45.3 t -144.86 147.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.453 0.471 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -156.53 173.21 17.25 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.809 0.843 . . . . 0.0 108.801 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -60.23 152.89 23.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.616 ' HA ' ' H22' ' B' ' 106' ' ' ' G' . . . -123.95 137.16 54.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 7.4 m -142.71 139.52 31.16 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -44.13 109.57 0.16 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.117 0.567 . . . . 0.0 110.533 -173.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -31.03 67.89 Favored 'General case' 0 C--N 1.337 0.054 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.84 -32.0 73.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.131 0.172 . . . . 0.0 110.803 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.8 -8.81 11.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.78 -7.54 15.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.25 -41.84 0.11 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -80.71 -9.13 59.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.178 0.445 . . . . 0.0 111.569 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.69 72.08 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.48 47.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -71.72 163.36 54.33 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.71 169.42 24.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.967 0.507 . . . . 0.0 110.618 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -170.35 164.18 37.46 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -78.14 159.12 28.81 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 122.687 0.395 . . . . 0.0 110.498 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -68.1 139.49 34.37 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -95.81 171.27 28.65 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -64.76 137.94 58.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -81.79 132.06 10.88 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -79.04 151.13 31.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -72.94 -165.64 9.18 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.532 -1.705 . . . . 0.0 110.938 178.319 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 N19-C1'-C2' 109.689 -2.32 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C4'-C3'-C2' 100.174 -2.526 . 0.882 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 N19-C1'-C2' 109.177 -2.639 . 0.867 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 N19-C1'-C2' 109.034 -2.729 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.417 HO2' " H5'" ' B' ' 96' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.56 0 C5'-C4'-C3' 111.713 -2.524 . 0.819 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.417 " H5'" HO2' ' B' ' 95' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.951 0 O4'-C1'-N19 110.911 2.711 . 0.89 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.585 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 110.831 2.631 . 0.799 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.585 " H5'" HO2' ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.903 2.703 . 0.799 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.467 HO2' " C5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 O4'-C1'-N19 110.917 2.717 . 0.662 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.467 " C5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 C5'-C4'-C3' 111.426 -2.716 . 0.627 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.527 0 C5'-C4'-C3' 111.014 -2.991 . 0.396 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C5'-C4'-C3' 110.507 -3.329 . 0.361 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.888 0 C5'-C4'-C3' 109.663 -3.891 . 0.255 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . 0.469 " H1'" " H4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 P--O5' 1.615 2.211 1 O4'-C1'-N19 113.249 5.049 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.501 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 C5'-C4'-C3' 110.513 -3.325 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . 0.616 ' H22' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.601 1 C3'-C2'-C1' 105.647 4.608 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.868 -3.755 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.564 0 C5'-C4'-C3' 110.305 -3.464 . 0.454 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . 0.502 HO2' " H5'" ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C4'-C3'-C2' 100.071 -2.629 . 0.378 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.537 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 N19-C1'-C2' 109.147 -2.658 . 0.749 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.537 " H5'" HO2' ' B' ' 110' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 N19-C1'-C2' 109.106 -2.684 . 0.797 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.52 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.416 0 N19-C1'-C2' 109.696 -2.315 . 0.752 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.498 HO2' " H5'" ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 C5'-C4'-C3' 112.428 -2.048 . 0.774 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.562 HO2' " H5'" ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.029 2.829 . 0.743 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.594 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 111.181 2.981 . 0.674 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.594 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 110.956 2.756 . 0.718 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.563 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -2.962 0 O4'-C1'-N19 110.994 2.794 . 0.809 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 O4'-C1'-N19 110.734 2.534 . 0.841 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.06 172.09 51.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -69.72 108.0 3.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 58.55 -167.21 0.15 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.163 0.585 . . . . 0.0 110.783 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.57 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -78.63 -1.62 35.1 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 -175.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -116.48 -8.79 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.069 0.395 . . . . 0.0 109.967 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.85 87.03 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.962 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 65.36 -149.29 51.63 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.95 1.375 . . . . 0.0 110.56 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.77 16.05 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.999 3.132 . . . . 0.0 112.593 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 267' ' ' GLY . 49.6 tpt85 -82.69 -24.73 33.53 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.217 -0.302 . . . . 0.0 110.58 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -108.96 3.64 22.45 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.16 167.3 19.64 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.745 0.418 . . . . 0.0 110.863 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -79.27 -113.54 0.23 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.759 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 74.5 m -75.54 29.28 0.1 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.808 0.843 . . . . 0.0 113.139 -174.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.56 -6.12 10.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.237 0.471 . . . . 0.0 112.036 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -89.54 -17.9 27.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.791 0.436 . . . . 0.0 111.068 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -129.52 -0.03 4.99 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.4 m -144.46 155.05 43.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.82 0.73 56.41 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.315 0.646 . . . . 0.0 111.207 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -89.43 -82.65 0.25 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.442 0.297 . . . . 0.0 110.355 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p30 49.62 15.03 0.13 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.142 1.777 . . . . 0.0 114.853 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -152.7 158.43 42.33 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 34.1 t -149.46 2.35 0.54 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 110.632 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -140.46 10.15 2.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.765 0.826 . . . . 0.0 112.425 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -133.2 56.18 1.86 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.296 0.639 . . . . 0.0 110.854 -172.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.4 -12.48 60.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.608 0.363 . . . . 0.0 110.39 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 m -92.57 147.33 22.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.26 147.89 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 122.939 0.496 . . . . 0.0 109.883 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -101.78 148.38 25.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.27 148.7 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.133 0.573 . . . . 0.0 111.125 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.33 149.35 45.54 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.23 5.6 58.06 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.943 -0.365 . . . . 0.0 112.849 172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.39 -53.86 51.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.655 0.727 . . . . 0.0 111.412 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.478 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.51 -176.61 44.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -170.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -86.87 -7.51 58.14 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.669 0.788 . . . . 0.0 112.519 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.01 -5.69 52.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 110.887 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.23 159.62 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.661 0.785 . . . . 0.0 112.303 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.05 168.03 26.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.07 -39.87 12.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.2 1.0 . . . . 0.0 111.712 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.47 -28.52 61.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.368 -0.208 . . . . 0.0 110.905 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.2 t -75.09 -49.5 19.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.104 0.161 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 322' ' ' ILE . 2.7 m -60.98 -53.86 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.07 77.89 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.053 0.388 . . . . 0.0 110.751 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -75.89 -15.67 60.17 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.129 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.58 -27.49 15.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -96.98 -20.42 18.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.9 pttt -65.39 -19.04 65.77 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -173.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.57 -21.19 66.63 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.5 mm -88.11 -24.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.312 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.2 169.31 27.56 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.17 137.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 122.645 -0.327 . . . . 0.0 111.093 -172.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 6.7 mm -78.95 137.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.461 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 22.3 ttmm -69.42 149.7 48.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -125.04 138.46 54.2 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -71.1 141.04 50.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -77.08 -18.43 58.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -112.88 -38.55 4.5 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.151 0.432 . . . . 0.0 111.904 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.8 p -85.1 -20.27 30.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.81 -15.49 4.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.3 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -83.95 158.56 61.68 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 117.837 0.818 . . . . 0.0 109.52 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.34 154.02 70.75 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.368 2.045 . . . . 0.0 109.193 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 65.8 mtp -79.35 79.67 5.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.696 0.399 . . . . 0.0 110.928 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.453 HG22 ' CG2' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -135.15 155.53 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.668 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.98 129.53 13.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.08 119.83 32.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.407 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 97.4 m-85 -83.94 157.33 21.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 18.9 p -132.33 155.17 48.86 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -69.64 122.61 19.44 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.19 170.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -74.03 -5.22 40.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.522 0.201 . . . . 0.0 110.728 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.36 -6.78 36.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.475 0.71 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.5 t -149.01 -23.72 0.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.533 0.606 . . . . 0.0 110.81 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.97 41.33 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.796 -0.446 . . . . 0.0 112.816 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -129.29 166.4 19.52 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.756 0.778 . . . . 0.0 109.845 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.9 mt -50.23 126.24 14.33 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.522 0.201 . . . . 0.0 110.783 -173.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.692 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 0.1 OUTLIER -85.02 1.81 45.98 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.478 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.13 -2.31 75.05 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.37 146.62 24.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.786 0.793 . . . . 0.0 111.136 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.77 166.64 32.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 10.3 m -138.56 121.32 16.42 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 122.556 0.342 . . . . 0.0 111.457 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.68 126.07 72.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.4 t -97.31 127.69 43.5 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.309 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.437 ' O ' ' HE2' ' A' ' 312' ' ' LYS . 42.2 m-85 -84.29 147.71 27.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.6 -18.66 59.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -126.06 133.79 25.29 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 110.685 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.438 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 27.5 Cg_endo -66.31 -33.68 37.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 114.405 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 84.8 Cg_endo -75.81 -20.1 15.61 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 121.2 1.464 . . . . 0.0 111.122 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 52.6 m -74.82 -29.61 61.13 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.8 78.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.13 0.172 . . . . 0.0 110.742 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -63.04 -39.75 95.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.404 0.282 . . . . 0.0 110.622 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.68 81.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.53 0.332 . . . . 0.0 110.842 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.04 65.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.4 -57.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -59.78 -21.93 61.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -93.82 -60.0 1.86 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.44 -31.94 70.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.43 111.73 1.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.45 -14.97 30.1 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.052 -0.86 . . . . 0.0 113.07 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -95.25 -171.99 2.55 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.748 1.274 . . . . 0.0 109.851 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.51 175.5 5.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.303 0.241 . . . . 0.0 110.606 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -131.08 -38.4 1.23 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -143.23 16.49 1.89 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.157 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.89 12.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.93 148.51 35.43 Favored Pre-proline 0 C--O 1.233 0.187 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.06 152.1 73.0 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.707 2.938 . . . . 0.0 110.722 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.36 168.3 20.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 122.821 0.448 . . . . 0.0 110.953 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.7 156.32 47.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.0 146.11 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.089 0.555 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 m -154.64 171.82 18.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -58.47 159.45 6.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -130.36 138.24 50.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 4.1 m -141.8 136.69 30.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -48.09 109.34 0.22 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 122.895 0.478 . . . . 0.0 110.413 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -31.26 66.53 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.002 0.521 . . . . 0.0 109.923 -173.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.47 71.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.447 -0.158 . . . . 0.0 110.807 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -67.21 -11.56 57.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.459 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 96.5 m-85 -97.09 -13.08 22.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.09 -40.48 0.08 Allowed 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 37.9 mmm-85 -82.9 -2.13 54.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.37 12.09 73.82 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.8 -158.41 35.14 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -73.25 -170.76 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -150.02 169.57 20.9 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.921 0.488 . . . . 0.0 109.707 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -175.25 169.2 42.0 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -135.88 164.23 28.41 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.189 0.596 . . . . 0.0 109.462 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.28 133.81 26.35 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -92.37 175.5 37.73 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -68.89 141.18 55.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -79.79 172.07 54.76 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -67.79 147.22 52.88 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -72.07 174.34 43.94 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 117.158 -1.912 . . . . 0.0 110.818 -179.78 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ' G' . . . . . 0.44 HO2' " H5'" ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.41 0 C5'-C4'-C3' 110.849 -3.101 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ' G' . . . . . 0.47 HO2' " H5'" ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.699 0 C4'-C3'-C2' 100.235 -2.465 . 0.785 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ' G' . . . . . 0.47 " H5'" HO2' ' B' ' 92' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 C4'-C3'-C2' 100.102 -2.598 . 0.837 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ' A' . . . . . 0.44 " H5'" HO2' ' B' ' 93' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 O4'-C1'-N19 110.848 2.648 . 0.783 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ' U' . . . . . 0.457 HO2' " H5'" ' B' ' 96' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.708 2.508 . 0.846 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ' U' . . . . . 0.614 HO2' " H5'" ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 O4'-C1'-N19 110.795 2.595 . 0.867 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' ' U' . . . . . 0.635 HO2' " H5'" ' B' ' 98' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O4'-C1'-N19 111.216 3.016 . 0.737 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ' C' . . . . . 0.635 " H5'" HO2' ' B' ' 97' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.709 0 O4'-C1'-N19 111.2 3.0 . 0.739 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' ' C' . . . . . 0.463 HO2' " H5'" ' B' ' 100' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.906 0 O4'-C1'-N19 110.58 2.38 . 0.773 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ' C' . . . . . 0.463 " H5'" HO2' ' B' ' 99' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C5'-C4'-C3' 111.007 -2.995 . 0.574 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ' C' . . . . . 0.423 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.913 0 C5'-C4'-C3' 111.343 -2.771 . 0.774 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' ' A' . . . . . 0.423 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C5'-C4'-C3' 110.503 -3.331 . 0.404 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.563 0 C5'-C4'-C3' 109.626 -3.916 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.886 1 O4'-C1'-N19 112.64 4.44 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ' U' . . . . . 0.692 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.737 1 C5'-C4'-C3' 109.399 -4.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.8 1 C3'-C2'-C1' 105.795 4.772 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 109.929 -3.714 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 C5'-C4'-C3' 110.928 -3.048 . 0.353 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.393 0 N19-C1'-C2' 109.059 -2.713 . 0.718 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' ' G' . . . . . 0.539 HO2' " H5'" ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 N19-C1'-C2' 109.29 -2.569 . 0.805 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ' A' . . . . . 0.607 HO2' " H5'" ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.584 0 N19-C1'-C2' 109.24 -2.6 . 0.783 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' ' A' . . . . . 0.607 " H5'" HO2' ' B' ' 111' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 N19-C1'-C2' 108.999 -2.75 . 0.697 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ' A' . . . . . 0.541 " H5'" HO2' ' B' ' 112' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 C5'-C4'-C3' 112.095 -2.27 . 0.746 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ' C' . . . . . 0.482 " H5'" HO2' ' B' ' 113' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O4'-C1'-N19 110.786 2.586 . 0.748 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' ' U' . . . . . 0.588 HO2' " H5'" ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.508 0 O4'-C1'-N19 110.715 2.515 . 0.737 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' ' C' . . . . . 0.588 " H5'" HO2' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 110.383 2.183 . 0.701 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' ' C' . . . . . 0.557 " H5'" HO2' ' B' ' 116' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.787 0 C4'-C3'-C2' 100.445 -2.255 . 0.781 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' ' C' . . . . . 0.534 " H5'" HO2' ' B' ' 117' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.678 0 N19-C1'-C2' 109.627 -2.358 . 0.818 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.824 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 C-N-CA 124.009 3.139 . . . . 0.0 111.932 178.005 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.8 m -101.83 147.85 26.01 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.6 pt -128.84 149.22 33.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.006 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -103.68 149.77 24.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.3 147.96 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 123.105 0.562 . . . . 0.0 111.163 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -139.54 149.07 43.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.95 4.81 57.65 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.718 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.18 -54.46 43.09 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.339 0.57 . . . . 0.0 111.159 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.466 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.28 -179.23 48.08 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.12 -9.65 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.596 0.758 . . . . 0.0 112.299 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -81.59 -1.53 46.77 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.446 0.298 . . . . 0.0 111.44 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.34 156.77 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.45 168.18 27.65 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.83 -39.34 14.9 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.313 1.045 . . . . 0.0 111.71 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -73.92 -28.54 61.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.434 -0.166 . . . . 0.0 110.89 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.63 -49.84 20.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.266 0.226 . . . . 0.0 110.539 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.53 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.431 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -38.32 79.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.187 0.449 . . . . 0.0 110.583 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -75.23 -15.7 60.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 111.272 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -95.03 -26.58 16.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -97.88 -20.0 17.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.6 pttt -66.22 -19.13 65.74 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.8 pt20 -64.05 -21.07 66.37 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.4 mm -87.8 -28.34 5.55 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.444 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 168.49 170.05 32.68 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.8 mm -68.04 134.85 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 122.519 -0.401 . . . . 0.0 111.247 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 322' ' ' ILE . 6.2 mm -76.97 137.09 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.429 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.7 ttmm -69.68 139.33 53.45 Favored 'General case' 0 C--O 1.23 0.041 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.106 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.67 153.42 75.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.798 1.665 . . . . 0.0 109.027 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.5 mtp -78.69 79.35 5.11 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.786 0.434 . . . . 0.0 111.175 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.803 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.37 159.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.697 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -156.42 130.62 8.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.7 mm? -91.97 119.61 31.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -82.79 158.36 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.38 0.61 . . . . 0.0 112.085 -170.733 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.22 1.71 58.1 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -94.32 150.9 19.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.331 0.566 . . . . 0.0 110.916 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.27 165.77 32.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.072 0.549 . . . . 0.0 109.59 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 7.1 m -136.47 122.55 20.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 96.2 t -114.99 124.01 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.7 t -96.29 126.6 41.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.253 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -84.09 148.32 26.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.84 -17.65 59.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 92.4 m-20 -128.13 134.08 25.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 110.687 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.8 Cg_endo -67.2 -32.94 32.45 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.689 2.259 . . . . 0.0 114.659 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.4 Cg_endo -75.13 -18.94 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 121.11 1.432 . . . . 0.0 110.831 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.8 m -77.19 -29.81 54.54 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.01 78.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -66.0 -37.03 84.89 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.397 -0.189 . . . . 0.0 110.629 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.48 -40.31 81.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.459 0.304 . . . . 0.0 110.969 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.17 -25.92 65.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.26 -56.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.13 -21.68 63.97 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -94.04 -58.67 2.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -70.92 -32.34 69.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.07 112.37 1.33 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.02 -16.48 30.33 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.837 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -94.26 -172.29 2.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.788 1.294 . . . . 0.0 110.07 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -101.73 173.7 6.29 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.622 0.369 . . . . 0.0 110.302 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.608 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.5 t80 -127.96 -38.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.3 t -141.73 4.8 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.05 -22.58 4.0 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.61 148.45 34.75 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 151.91 78.25 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.291 2.661 . . . . 0.0 110.74 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.34 169.36 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.629 0.371 . . . . 0.0 110.862 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -134.17 155.88 49.31 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.922 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.74 146.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.956 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.3 m -154.92 173.86 15.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 108.881 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -57.98 159.77 5.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 169.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.676 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 123.996 3.131 . . . . 0.0 112.343 177.087 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -98.43 147.16 25.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.44 149.88 34.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.018 0.527 . . . . 0.0 110.139 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -105.12 149.08 26.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.14 148.19 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 123.181 0.592 . . . . 0.0 111.056 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -138.45 149.55 45.57 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.58 57.61 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.848 -0.418 . . . . 0.0 112.599 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.06 -54.53 38.01 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.404 0.682 . . . . 0.0 111.639 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.51 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.68 -176.81 43.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -170.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -85.44 -9.17 57.86 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.773 0.829 . . . . 0.0 112.265 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -78.77 -5.2 52.67 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.184 -0.322 . . . . 0.0 111.209 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.51 158.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.547 0.739 . . . . 0.0 112.678 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.66 167.16 29.07 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.9 mm -49.32 -39.35 13.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.359 1.064 . . . . 0.0 111.731 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.14 -28.41 62.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.35 -0.219 . . . . 0.0 111.15 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.1 t -75.73 -48.73 20.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.303 0.241 . . . . 0.0 110.765 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.792 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.44 -53.62 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.425 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.22 -37.55 77.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.36 0.527 . . . . 0.0 110.52 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -75.96 -16.02 60.07 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.217 -0.302 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.98 -27.48 16.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -97.02 -19.86 18.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -65.27 -18.95 65.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.5 pt20 -64.6 -21.59 66.75 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.5 mm -87.67 -25.76 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.047 0 CA-C-O 120.818 0.342 . . . . 0.0 110.313 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 165.81 169.81 29.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.52 135.86 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 O-C-N 122.646 -0.326 . . . . 0.0 110.993 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.482 HG21 HD11 ' A' ' 322' ' ' ILE . 7.2 mm -76.54 137.99 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.402 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.2 ttmm -69.97 147.51 50.07 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.821 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 C--O 1.232 0.184 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.82 155.06 56.77 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.316 2.011 . . . . 0.0 109.413 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.402 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 49.3 mtp -76.9 76.99 3.48 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.723 0.409 . . . . 0.0 111.154 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.792 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -136.03 154.55 33.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.065 0 C-N-CA 123.283 0.633 . . . . 0.0 110.792 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -151.9 131.9 13.43 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.8 mm? -93.02 118.06 30.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -80.5 158.44 25.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 CA--C 1.513 -0.462 0 CA-C-O 121.413 0.625 . . . . 0.0 112.59 -173.093 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.27 1.5 72.07 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.415 0.531 . . . . 0.0 111.911 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.17 148.5 24.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 117.808 0.804 . . . . 0.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.2 165.84 33.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.388 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 5.0 m -135.22 121.22 19.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.976 0.51 . . . . 0.0 111.943 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.08 125.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 33.3 t -96.66 129.68 44.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.49 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.48 147.27 26.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -76.72 -17.35 59.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -124.84 131.25 24.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.069 0.948 . . . . 0.0 110.525 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.9 Cg_endo -66.17 -33.3 40.53 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.798 2.332 . . . . 0.0 114.382 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 93.0 Cg_endo -75.53 -20.27 16.0 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 CA-C-N 121.372 1.526 . . . . 0.0 111.016 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -74.72 -29.81 61.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.52 -47.98 76.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.411 ' HA ' HD12 ' A' ' 351' ' ' ILE . 17.3 tptm -64.62 -38.15 90.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.346 0.117 . . . . 0.0 110.71 -177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.59 82.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.471 0.308 . . . . 0.0 110.808 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.91 -25.81 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 348' ' ' LYS . 66.4 mt -72.54 -57.92 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -59.67 -22.32 61.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -92.65 -60.35 1.84 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.72 -32.03 70.36 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.58 112.45 1.28 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.89 -15.81 31.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.149 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.47 -171.91 2.5 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.719 1.26 . . . . 0.0 109.861 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -101.12 174.68 5.89 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.427 0.291 . . . . 0.0 110.455 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.602 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.1 t80 -130.66 -37.38 1.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.617 0.367 . . . . 0.0 110.404 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.3 t -144.37 15.59 1.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.86 10.79 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.82 148.0 34.44 Favored Pre-proline 0 CA--C 1.53 0.175 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.26 151.22 76.77 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.485 2.79 . . . . 0.0 110.646 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.602 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.07 169.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 122.858 0.463 . . . . 0.0 110.705 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 156.27 49.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.698 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.06 147.87 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.068 0.547 . . . . 0.0 110.307 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 175.88 13.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.126 0.971 . . . . 0.0 108.809 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.23 163.84 3.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.206 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.456 -0.684 0 C-N-CA 123.787 2.991 . . . . 0.0 112.603 177.304 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.581 ' N ' HD21 ' A' ' 285' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.4 m -98.49 148.7 23.47 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.3 pt -128.98 149.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.335 0.654 . . . . 0.0 109.854 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -103.0 149.09 24.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.2 t -133.94 148.34 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.319 0.647 . . . . 0.0 110.892 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -139.14 151.09 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.1 5.34 59.56 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 120.013 -0.326 . . . . 0.0 112.797 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.5 mp -55.09 -55.22 33.51 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.428 0.614 . . . . 0.0 111.292 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.507 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.86 -176.99 44.62 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.03 -7.22 58.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.087 0.955 . . . . 0.0 112.368 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.29 -6.7 55.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.677 0.275 . . . . 0.0 110.805 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.73 159.76 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 163.63 39.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 44.3 mm -50.7 -37.1 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.009 0.924 . . . . 0.0 111.805 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -73.86 -28.59 61.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.251 -0.281 . . . . 0.0 110.991 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.6 t -74.0 -48.52 29.73 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 122.258 0.223 . . . . 0.0 110.548 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.825 HG21 HG21 ' A' ' 322' ' ' ILE . 2.3 m -61.71 -53.45 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.434 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -38.45 79.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.182 0.446 . . . . 0.0 110.884 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -75.33 -16.22 60.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 111.088 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -93.94 -27.56 16.29 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -96.85 -20.08 18.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.2 pttt -65.99 -19.09 65.74 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -173.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.4 pt20 -64.31 -21.24 66.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.2 mm -87.99 -23.66 6.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 162.2 169.74 25.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.06 138.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 122.535 -0.391 . . . . 0.0 111.178 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.462 HG21 HD11 ' A' ' 322' ' ' ILE . 7.3 mm -78.9 135.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.455 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 15.5 ttpp -70.04 139.18 52.64 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -176.442 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.64 152.39 80.62 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.927 1.752 . . . . 0.0 108.913 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.2 mtp -78.09 79.8 4.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.004 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.825 HG21 HG21 ' A' ' 301' ' ' VAL . 0.5 OUTLIER -132.67 152.16 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.328 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -146.42 126.44 13.69 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 36.0 mt -96.07 113.46 25.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -79.25 156.09 28.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 CA--C 1.514 -0.415 0 CA-C-O 121.736 0.779 . . . . 0.0 112.855 -170.08 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.03 -5.69 61.58 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -87.23 144.98 26.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.76 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.83 166.49 33.23 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.7 m -138.64 119.24 13.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.705 0.402 . . . . 0.0 111.353 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.65 125.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.9 t -96.94 132.91 42.26 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.06 -0.4 . . . . 0.0 110.301 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.89 147.28 23.26 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -73.69 -20.49 60.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -124.5 133.16 24.51 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 123.671 0.788 . . . . 0.0 110.706 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 26.2 Cg_endo -66.69 -33.78 34.07 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.724 2.283 . . . . 0.0 114.031 -175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 85.5 Cg_endo -76.84 -18.93 14.55 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 CA-C-N 121.214 1.469 . . . . 0.0 111.032 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 56.2 m -75.49 -29.72 59.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.38 -48.03 79.58 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -64.64 -39.04 93.01 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-O 120.595 0.236 . . . . 0.0 110.714 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.72 -39.32 84.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.392 0.277 . . . . 0.0 110.642 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.1 -26.15 65.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -72.79 -57.25 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.68 -22.27 61.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -93.13 -60.37 1.81 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.77 -31.55 69.55 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -56.75 113.24 1.56 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.005 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.33 37.68 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.169 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -96.5 -172.48 2.52 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.545 1.173 . . . . 0.0 110.027 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.96 175.6 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.843 0.354 . . . . 0.0 110.559 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.4 t80 -131.45 -39.41 1.14 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 17.0 t -141.53 19.69 2.2 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.798 0.439 . . . . 0.0 110.101 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.79 -8.29 34.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -111.49 146.77 35.32 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 123.881 0.872 . . . . 0.0 109.587 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.49 149.42 68.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.563 2.842 . . . . 0.0 110.846 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.75 169.72 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.924 0.49 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -135.83 156.5 48.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.127 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.4 t -144.7 147.55 19.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.09 0.556 . . . . 0.0 110.153 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 71.0 m -155.23 175.41 13.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.054 0.941 . . . . 0.0 108.833 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -59.8 163.81 4.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.887 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 C-N-CA 123.81 3.007 . . . . 0.0 112.377 178.23 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 26.7 m -132.71 150.79 52.11 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.662 0.385 . . . . 0.0 111.146 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.1 pt -128.42 148.84 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.876 0.47 . . . . 0.0 110.271 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -101.15 149.82 23.58 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.4 148.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.362 0.665 . . . . 0.0 110.902 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -138.77 149.53 45.11 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.47 5.59 57.83 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.971 -0.349 . . . . 0.0 112.869 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.91 -56.67 17.82 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 117.479 0.639 . . . . 0.0 111.408 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.452 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.86 -179.61 44.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.84 -10.0 59.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.626 0.77 . . . . 0.0 112.281 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -82.17 2.48 31.34 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.386 0.274 . . . . 0.0 111.553 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.91 155.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -158.49 168.91 25.65 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.7 mm -49.62 -40.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.391 1.077 . . . . 0.0 111.645 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.59 -28.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.449 -0.157 . . . . 0.0 110.876 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.7 t -75.08 -49.84 18.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.221 0.208 . . . . 0.0 110.611 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 322' ' ' ILE . 2.8 m -61.09 -53.71 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.441 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.04 -38.1 78.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.212 0.46 . . . . 0.0 110.718 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -76.07 -15.81 60.04 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -94.14 -27.63 16.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 339' ' ' VAL . 45.4 m-85 -97.23 -19.99 18.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -65.65 -19.05 65.75 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.27 -21.02 66.45 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -88.34 -26.04 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.732 0.301 . . . . 0.0 110.474 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.34 170.7 31.58 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 52.1 mm -68.4 134.63 29.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 O-C-N 122.662 -0.316 . . . . 0.0 111.348 -172.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 322' ' ' ILE . 6.8 mm -76.19 137.34 22.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.431 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.8 ttmm -67.78 147.37 52.68 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.874 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.7 153.87 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.173 1.915 . . . . 0.0 109.102 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.431 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.9 mtp -79.65 78.52 6.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 122.476 0.31 . . . . 0.0 111.001 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.809 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.6 156.86 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.36 0.664 . . . . 0.0 110.71 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -152.76 130.57 11.66 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.918 0.887 . . . . 0.0 109.455 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.7 mm? -94.07 119.49 33.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -84.03 160.09 21.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--N 1.339 0.147 0 CA-C-O 121.763 0.792 . . . . 0.0 110.357 -171.198 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.52 0.22 59.46 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.81 149.44 21.98 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.396 0.598 . . . . 0.0 110.927 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.13 165.83 32.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.378 0.671 . . . . 0.0 109.75 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.0 m -136.9 121.74 18.73 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 305' ' ' PHE . 98.2 t -114.16 121.45 66.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.8 t -92.72 126.42 37.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.17 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -84.46 147.39 27.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.05 -14.81 59.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 94.0 m-20 -127.64 135.75 27.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 111.221 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.457 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 24.1 Cg_endo -65.82 -35.37 36.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.025 2.484 . . . . 0.0 114.422 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.8 Cg_endo -76.46 -20.34 14.16 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.719 1.613 . . . . 0.0 111.358 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -74.19 -30.67 62.33 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 122.297 -0.252 . . . . 0.0 110.431 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.73 93.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -65.07 -41.15 95.35 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 120.547 0.213 . . . . 0.0 110.834 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.98 86.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.354 0.262 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -25.08 64.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.6 mt -73.4 -56.59 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -60.36 -21.63 62.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -94.06 -59.92 1.86 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -70.78 -32.52 69.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.46 113.74 1.92 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.16 -17.09 32.14 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.949 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -93.76 -172.88 3.0 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.648 1.224 . . . . 0.0 109.808 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -100.33 173.72 6.46 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.34 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.613 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -127.31 -38.7 1.94 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.437 0.295 . . . . 0.0 110.277 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.6 t -143.2 6.61 1.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 110.363 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.48 -22.27 4.18 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.41 149.25 35.92 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 109.463 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.65 151.95 74.7 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.538 2.825 . . . . 0.0 110.388 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.62 168.28 21.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.076 0.55 . . . . 0.0 110.851 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 156.17 47.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.917 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 51.4 t -145.2 146.77 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 123.636 0.585 . . . . 0.0 110.224 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.0 m -155.26 171.65 19.48 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -59.01 162.24 4.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.228 177.917 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 C-N-CA 123.913 3.075 . . . . 0.0 112.003 178.534 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -98.79 148.44 23.89 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 11.1 pt -131.39 146.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.697 0.399 . . . . 0.0 110.575 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -100.78 149.6 23.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.87 147.32 30.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.111 0.564 . . . . 0.0 111.817 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.73 151.03 48.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 109.811 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.28 5.89 59.06 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 120.025 -0.319 . . . . 0.0 112.699 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.61 -57.68 10.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.397 0.679 . . . . 0.0 111.1 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.464 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.28 -178.57 44.71 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -77.89 -10.87 59.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.974 0.909 . . . . 0.0 112.109 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.02 0.2 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.25 0.22 . . . . 0.0 111.484 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.95 155.59 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.41 168.49 26.81 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.52 -39.73 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.897 0.879 . . . . 0.0 111.878 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.61 62.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.526 -0.109 . . . . 0.0 111.158 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.25 -49.52 19.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.729 -0.1 . . . . 0.0 110.729 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.821 HG21 HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.56 -53.88 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.36 -37.44 77.92 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.249 0.477 . . . . 0.0 110.804 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -76.07 -15.83 60.04 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 111.099 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.56 -26.96 16.18 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.6 m-85 -97.17 -20.22 18.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -65.68 -18.85 65.63 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.6 pt20 -64.44 -21.16 66.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.6 mm -87.96 -25.47 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 110.161 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.92 170.28 29.67 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.91 135.24 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 O-C-N 122.478 -0.425 . . . . 0.0 111.135 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.477 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -76.01 138.08 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -69.15 148.97 49.16 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.091 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.706 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.9 151.96 81.57 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.845 1.697 . . . . 0.0 109.005 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.9 mtp -77.91 78.69 4.4 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.77 0.428 . . . . 0.0 111.206 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.821 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.25 155.3 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 0.0 110.527 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -150.24 121.89 8.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.524 0.73 . . . . 0.0 109.326 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.6 mm? -88.14 121.67 30.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -77.64 162.83 26.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.61 16.62 36.11 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.37 156.83 31.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.783 0.791 . . . . 0.0 110.23 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.74 171.2 19.96 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.802 0.441 . . . . 0.0 110.262 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 70.8 m -136.33 129.07 30.82 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.8 t -118.67 127.89 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.5 t -98.98 127.91 45.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.997 0.362 . . . . 0.0 110.513 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.18 147.95 26.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -75.85 -17.26 59.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 91.2 m-20 -127.54 133.89 25.59 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.979 0.912 . . . . 0.0 110.987 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.465 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -66.64 -33.79 34.54 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.646 2.231 . . . . 0.0 114.463 -175.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 88.7 Cg_endo -74.81 -19.79 18.0 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 CA-C-N 121.052 1.412 . . . . 0.0 110.843 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.9 m -75.89 -29.45 58.47 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.32 -0.237 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.47 73.34 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -65.33 -36.99 85.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.425 0.155 . . . . 0.0 110.593 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.38 82.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.493 0.317 . . . . 0.0 110.943 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.55 65.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.81 -56.09 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.69 -22.08 63.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -93.92 -59.99 1.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.82 -32.76 71.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.03 110.74 0.87 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.41 -16.09 24.57 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.035 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.6 -171.52 2.39 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.824 1.312 . . . . 0.0 109.902 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.53 173.94 6.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.664 0.269 . . . . 0.0 110.322 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.6 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.1 t80 -128.44 -37.44 1.81 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.608 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -145.0 11.05 1.35 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.682 0.393 . . . . 0.0 109.988 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.47 -20.3 6.18 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -103.12 148.64 35.94 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 151.97 75.13 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.388 2.725 . . . . 0.0 110.451 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.18 167.74 21.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.873 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.15 156.47 46.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.803 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.68 146.48 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.047 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 47.1 m -155.05 174.23 15.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.19 150.66 29.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.643 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 C-N-CA 123.486 2.791 . . . . 0.0 112.775 177.423 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.6 m -101.74 150.2 23.38 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.89 147.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 122.545 0.338 . . . . 0.0 110.101 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -102.57 147.94 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.28 147.53 31.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.076 0.551 . . . . 0.0 112.079 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -138.71 151.3 47.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.84 59.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.84 -57.08 13.54 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.359 0.664 . . . . 0.0 111.033 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.457 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.43 -178.05 45.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.62 -10.65 59.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.849 0.86 . . . . 0.0 112.178 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -80.54 -0.55 38.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.321 -0.237 . . . . 0.0 111.234 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.29 156.28 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.06 168.39 26.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.3 mm -48.67 -39.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 124.421 1.088 . . . . 0.0 111.861 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.92 -29.75 63.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.345 -0.222 . . . . 0.0 111.217 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.05 -48.61 23.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.154 0.182 . . . . 0.0 110.679 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.57 -54.22 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.446 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.44 -37.8 79.04 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.969 -0.457 . . . . 0.0 110.875 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.95 -15.82 60.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.252 -0.28 . . . . 0.0 110.932 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -94.32 -27.54 16.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.426 ' CD2' HG21 ' A' ' 339' ' ' VAL . 44.3 m-85 -96.59 -19.91 18.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.2 pttt -66.35 -18.63 65.47 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -173.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.404 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.74 -20.82 66.56 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.7 mm -87.93 -26.28 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.14 170.48 31.11 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.05 134.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 122.58 -0.365 . . . . 0.0 111.299 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.468 HG21 HD11 ' A' ' 322' ' ' ILE . 7.7 mm -76.3 138.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.438 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.7 ttmm -69.08 148.58 49.81 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.1 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.958 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 155.03 61.98 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.518 2.145 . . . . 0.0 109.935 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.7 mtp -79.28 77.44 5.81 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 122.791 0.436 . . . . 0.0 110.81 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.816 HG21 HG21 ' A' ' 301' ' ' VAL . 0.5 OUTLIER -130.91 159.26 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.428 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -155.93 124.73 6.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.787 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.6 mm? -90.13 120.96 31.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -73.36 162.68 29.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.518 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.656 0.741 . . . . 0.0 109.33 -178.944 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.457 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.0 18.86 28.12 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.7 156.08 38.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.417 0.609 . . . . 0.0 110.553 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.96 173.48 16.42 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.71 0.404 . . . . 0.0 110.288 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.0 m -139.92 128.14 22.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 122.658 0.383 . . . . 0.0 109.969 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 305' ' ' PHE . 94.6 t -118.11 127.12 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 124.024 0.93 . . . . 0.0 109.064 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.6 t -97.68 128.01 44.05 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.89 -0.506 . . . . 0.0 110.207 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -85.64 147.26 26.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -76.24 -18.2 59.13 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -124.88 133.36 24.73 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 123.704 0.802 . . . . 0.0 110.72 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.4 Cg_endo -66.24 -34.31 36.51 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.818 2.346 . . . . 0.0 114.215 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.79 -19.54 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 121.168 1.453 . . . . 0.0 111.104 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 41.9 m -75.55 -30.52 59.75 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.26 78.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.58 -0.075 . . . . 0.0 110.799 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -64.28 -38.88 92.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.553 0.216 . . . . 0.0 110.954 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.68 83.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.372 0.269 . . . . 0.0 110.611 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.66 66.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.19 -57.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.26 -21.19 61.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -94.31 -60.3 1.76 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.85 -31.76 69.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -57.26 111.05 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.7 25.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.127 -0.818 . . . . 0.0 113.106 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.5 -171.8 2.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.674 1.237 . . . . 0.0 109.908 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.75 171.26 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.595 0.358 . . . . 0.0 110.447 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.606 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.4 t80 -127.19 -38.28 1.99 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.382 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.7 t -144.33 15.28 1.65 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.648 0.379 . . . . 0.0 110.098 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.64 -19.43 8.48 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.54 148.69 36.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.01 151.73 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 0.0 110.677 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.1 pt -138.32 168.11 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 121.267 0.556 . . . . 0.0 110.66 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -133.62 155.45 49.64 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.17 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.8 t -144.35 147.04 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 122.867 0.467 . . . . 0.0 110.417 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.4 m -153.6 174.43 14.46 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -60.61 159.08 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.679 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.043 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.454 -0.847 0 C-N-CA 123.871 3.048 . . . . 0.0 112.308 176.805 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 111.228 0.084 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.8 m -99.42 147.8 24.89 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.3 pt -129.47 150.07 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 122.842 0.457 . . . . 0.0 110.115 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -105.02 149.44 25.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.0 t -134.16 148.82 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 123.219 0.607 . . . . 0.0 111.288 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -138.31 150.9 47.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.46 59.08 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 120.079 -0.289 . . . . 0.0 113.165 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.63 -55.84 28.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.14 0.576 . . . . 0.0 111.254 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.471 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.52 179.99 47.88 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.22 -11.42 59.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.74 0.816 . . . . 0.0 112.219 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.86 0.49 34.88 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.427 0.291 . . . . 0.0 111.323 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.59 155.24 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 112.666 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.4 168.16 28.14 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.7 mm -49.83 -39.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.294 1.037 . . . . 0.0 111.615 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -74.04 -28.47 61.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 121.254 -0.179 . . . . 0.0 111.011 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.6 t -75.44 -48.06 24.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.786 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.4 -53.58 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.43 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.89 -37.59 76.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.264 0.483 . . . . 0.0 110.898 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -76.41 -15.09 60.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.45 0.3 . . . . 0.0 111.219 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -95.09 -27.22 15.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -96.44 -20.32 18.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.9 pttt -65.56 -18.74 65.55 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.4 pt20 -64.56 -21.55 66.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.3 mm -88.32 -24.12 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.765 0.316 . . . . 0.0 110.28 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.27 169.42 27.8 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.85 135.76 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.516 0.327 . . . . 0.0 111.186 -172.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 322' ' ' ILE . 7.4 mm -77.03 137.27 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.417 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 36.9 ttmt -70.86 149.92 46.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.623 0.249 . . . . 0.0 110.485 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.231 0.124 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.331 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.55 155.49 47.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.312 2.008 . . . . 0.0 109.51 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.417 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 36.9 mtp -77.16 77.64 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.614 0.366 . . . . 0.0 111.118 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.786 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -135.63 158.3 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.724 -178.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -156.69 131.7 9.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.5 mm? -92.28 122.12 34.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -84.37 158.89 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 121.471 0.653 . . . . 0.0 112.603 -172.069 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.66 -0.88 59.69 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.55 150.31 21.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.344 0.572 . . . . 0.0 110.927 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.59 165.75 33.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.12 0.568 . . . . 0.0 109.606 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 122.74 20.61 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.02 125.65 73.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.8 t -98.06 129.48 44.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.557 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -87.24 147.74 25.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.02 -18.66 60.3 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -126.37 131.91 24.12 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 110.539 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 34.8 Cg_endo -67.71 -32.16 30.88 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.737 2.292 . . . . 0.0 114.347 -175.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -75.29 -19.65 17.06 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 121.411 1.54 . . . . 0.0 110.833 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -76.39 -29.76 57.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.647 0.203 . . . . 0.0 110.556 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.94 72.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -63.64 -38.81 92.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.484 0.183 . . . . 0.0 110.864 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.88 81.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.296 0.239 . . . . 0.0 110.894 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.22 65.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.25 -56.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.77 -21.24 62.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -93.83 -59.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.72 -32.56 71.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -56.59 112.27 1.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.19 -16.0 30.18 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.008 -0.884 . . . . 0.0 113.114 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -95.01 -172.63 2.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.75 1.275 . . . . 0.0 109.813 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.26 174.37 6.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.882 0.372 . . . . 0.0 110.47 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.614 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.5 t80 -129.95 -38.64 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.162 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.9 t -143.3 13.46 1.8 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.07 0.462 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.61 -22.37 7.79 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.97 147.97 33.82 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.37 151.6 76.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.256 2.637 . . . . 0.0 110.522 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.614 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.61 168.83 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.001 0.52 . . . . 0.0 110.911 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -133.89 156.73 47.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.6 t -144.78 146.65 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 123.703 0.627 . . . . 0.0 109.983 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 68.5 m -155.36 175.13 14.26 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.0 108.858 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -59.14 160.35 6.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.816 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 124.018 3.145 . . . . 0.0 112.388 178.426 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.7 m -131.51 151.14 51.83 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.577 0.351 . . . . 0.0 111.223 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.7 pt -126.6 148.82 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.063 0.545 . . . . 0.0 110.429 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -100.78 150.11 23.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.36 149.4 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.383 0.673 . . . . 0.0 111.042 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -139.75 150.22 44.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.97 58.28 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.954 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.4 ' HB3' HG21 ' A' ' 296' ' ' VAL . 5.0 mp -55.63 -54.07 48.69 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.504 0.652 . . . . 0.0 111.678 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.51 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.59 -176.26 44.54 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -171.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -85.67 -7.23 58.93 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.551 0.741 . . . . 0.0 112.537 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -79.29 -2.69 42.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.431 -0.168 . . . . 0.0 111.056 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 292' ' ' LEU . 1.6 t -97.74 158.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.769 0.828 . . . . 0.0 112.695 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.64 167.59 29.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.32 -39.73 17.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 124.344 1.057 . . . . 0.0 111.724 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.03 -29.07 63.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.248 -0.282 . . . . 0.0 111.094 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.6 -50.51 17.61 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 122.316 0.247 . . . . 0.0 110.479 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.805 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -60.86 -53.92 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.437 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -37.46 77.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 0.519 . . . . 0.0 110.921 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -75.9 -17.38 59.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 111.014 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -92.92 -26.77 17.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.4 m-85 -98.02 -20.08 17.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.5 pttt -66.11 -18.79 65.57 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.406 0.283 . . . . 0.0 111.649 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -64.41 -20.38 66.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -88.97 -26.06 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.759 0.254 . . . . 0.0 110.456 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.18 170.37 31.0 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.62 134.36 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 111.254 -172.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 322' ' ' ILE . 8.3 mm -74.5 138.77 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.75 151.61 46.94 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.594 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.21 155.69 55.04 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.34 2.027 . . . . 0.0 109.812 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.9 mtp -77.62 75.93 4.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.044 0.538 . . . . 0.0 110.813 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.805 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.19 155.6 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.939 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -153.19 130.71 11.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.135 0.974 . . . . 0.0 109.017 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.6 mm? -93.73 118.33 31.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.1 157.32 24.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.57 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm . . . . . 0 CA--C 1.527 0.077 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.84 -5.22 66.37 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.94 147.44 25.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.006 0.403 . . . . 0.0 111.072 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.05 165.81 34.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.0 m -137.28 122.13 18.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.277 0.231 . . . . 0.0 111.046 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 305' ' ' PHE . 95.5 t -115.64 120.7 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 29.9 t -91.78 136.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.903 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -95.11 145.78 24.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.12 -15.2 61.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.419 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 88.2 m-20 -129.38 135.18 27.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.686 0.794 . . . . 0.0 111.433 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 22.8 Cg_endo -66.74 -33.77 33.59 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.837 2.358 . . . . 0.0 114.414 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.3 Cg_endo -76.91 -18.32 14.86 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.517 1.478 . . . . 0.0 111.307 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.7 m -76.33 -29.88 57.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.66 85.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.403 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.5 tptm -64.13 -40.86 97.08 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.457 0.17 . . . . 0.0 110.827 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.12 85.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.48 0.312 . . . . 0.0 110.68 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.77 -25.2 64.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 348' ' ' LYS . 63.7 mt -72.95 -57.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.41 -20.59 60.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -95.23 -60.53 1.65 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -69.69 -32.16 70.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.93 113.14 1.74 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.28 -15.82 32.66 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.893 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -95.04 -172.56 2.72 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.709 1.255 . . . . 0.0 109.838 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -101.18 173.7 6.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.612 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.9 t80 -128.06 -39.08 1.77 Allowed 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.9 t -143.07 8.49 1.65 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.729 0.412 . . . . 0.0 110.117 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.48 -20.62 5.21 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -102.86 149.3 36.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.24 150.55 76.71 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.359 2.706 . . . . 0.0 110.595 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -136.33 168.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-O 121.068 0.461 . . . . 0.0 110.763 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -131.79 156.87 45.24 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 54.4 t -145.71 146.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 110.396 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.4 m -154.53 172.71 17.36 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.06 162.91 6.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.216 -0.302 . . . . 0.0 111.771 170.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.81 0.338 . . . . 0.0 111.054 177.611 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 N--CA 1.456 -0.683 0 C-N-CA 123.382 2.721 . . . . 0.0 112.61 176.809 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 111.366 0.135 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.1 m -100.53 148.68 24.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.43 150.2 34.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.835 0.454 . . . . 0.0 109.945 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -106.26 148.85 27.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 t -133.73 148.28 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.105 0.562 . . . . 0.0 111.194 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -138.69 150.63 46.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.74 5.1 58.84 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.834 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.1 -57.22 12.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.322 0.649 . . . . 0.0 111.135 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.472 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.89 179.64 44.47 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.13 -10.64 59.53 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.907 0.883 . . . . 0.0 112.365 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.98 -0.85 45.97 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 111.556 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.03 155.78 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.16 168.24 27.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.0 mm -49.43 -40.18 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.362 1.065 . . . . 0.0 111.691 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.42 62.32 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.859 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -76.15 -48.89 18.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.379 0.272 . . . . 0.0 110.634 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.808 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.58 -53.68 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.439 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.01 -37.93 78.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.798 -0.563 . . . . 0.0 110.602 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.96 -15.84 60.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.721 0.237 . . . . 0.0 111.087 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.51 -26.78 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.4 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.9 m-85 -97.3 -20.19 18.03 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.9 pttt -66.16 -18.64 65.48 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.418 0.287 . . . . 0.0 111.697 -173.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 7.1 pt20 -65.21 -20.41 66.42 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.1 mm -88.62 -25.05 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.976 0.417 . . . . 0.0 110.156 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.64 169.08 27.74 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.06 136.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.713 -0.286 . . . . 0.0 111.256 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 322' ' ' ILE . 7.1 mm -77.54 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.456 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 37.0 ttmt -69.55 136.53 51.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.142 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.71 152.23 75.43 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.895 1.73 . . . . 0.0 108.833 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.456 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.9 mtp -77.74 79.07 4.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.808 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.07 155.09 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.619 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.94 129.16 11.93 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.8 mm? -91.75 120.87 32.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.23 159.48 20.08 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 121.492 0.663 . . . . 0.0 112.53 -171.264 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.472 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.04 0.63 59.96 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -90.56 150.29 21.81 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 117.425 0.612 . . . . 0.0 110.903 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.43 165.87 32.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.073 0.549 . . . . 0.0 109.58 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 m -136.78 122.64 20.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 305' ' ' PHE . 92.5 t -115.63 124.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -174.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.4 t -96.21 128.15 42.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.234 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.53 148.31 25.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -74.33 -21.42 59.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -124.11 131.49 24.22 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.496 0.718 . . . . 0.0 110.91 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.8 Cg_endo -65.98 -33.09 43.11 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.768 2.312 . . . . 0.0 114.161 -175.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.74 -19.22 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.189 1.46 . . . . 0.0 111.142 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.2 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.787 0.267 . . . . 0.0 110.385 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.6 79.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.398 0.142 . . . . 0.0 110.672 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -63.41 -39.97 95.94 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 122.35 0.26 . . . . 0.0 110.756 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.1 81.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.984 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.72 -26.35 66.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -72.15 -57.72 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -60.92 -21.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -92.38 -59.74 2.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -70.02 -31.92 69.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -56.78 112.36 1.28 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.19 31.25 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.061 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.7 -172.35 2.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.705 1.253 . . . . 0.0 109.941 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.21 175.03 5.72 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.454 0.302 . . . . 0.0 110.535 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.593 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.8 t80 -130.72 -38.76 1.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.2 t -143.04 20.31 1.94 Allowed 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 122.585 0.354 . . . . 0.0 110.345 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.36 -2.22 31.04 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -121.81 146.5 46.05 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 123.996 0.918 . . . . 0.0 109.473 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.85 149.73 72.84 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.48 2.787 . . . . 0.0 110.779 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.593 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.62 169.4 18.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.087 0.555 . . . . 0.0 110.697 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -134.67 156.37 48.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.828 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -144.21 147.34 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.119 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 70.8 m -154.04 174.64 14.42 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -58.27 160.65 4.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.756 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.457 -0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.612 178.285 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -104.76 148.78 26.23 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.38 147.6 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.642 0.377 . . . . 0.0 110.441 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -102.73 149.01 24.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.9 t -134.12 148.24 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.298 0.639 . . . . 0.0 111.636 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -138.59 150.06 45.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.31 5.11 58.19 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.762 -0.466 . . . . 0.0 112.299 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.83 -56.06 23.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.541 0.67 . . . . 0.0 111.009 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.461 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.71 179.45 46.21 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -80.18 -7.22 58.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.738 0.815 . . . . 0.0 112.124 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -81.8 -1.6 47.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.374 0.27 . . . . 0.0 111.32 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.54 156.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.48 168.03 28.04 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.6 mm -48.57 -40.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.223 1.009 . . . . 0.0 111.762 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.4 -28.49 62.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.28 -0.263 . . . . 0.0 111.102 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.0 t -75.85 -48.84 19.86 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.823 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.64 45.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.436 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.6 -37.6 78.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.296 0.498 . . . . 0.0 110.783 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -75.81 -15.39 60.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -95.15 -26.78 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.404 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.2 m-85 -97.46 -20.62 17.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.5 pttt -65.13 -19.43 65.98 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -63.97 -21.49 66.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.2 mm -87.07 -27.19 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.8 170.6 31.89 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.7 mm -68.02 135.07 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.768 0.318 . . . . 0.0 111.047 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 322' ' ' ILE . 7.5 mm -76.42 136.97 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.423 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.1 ttmm -68.4 135.84 52.37 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.692 0.282 . . . . 0.0 110.628 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.332 -0.178 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.769 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.98 151.96 82.97 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.089 1.86 . . . . 0.0 109.13 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.423 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 48.6 mtp -79.74 80.15 6.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.47 0.308 . . . . 0.0 111.235 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.823 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -132.14 154.98 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.0 120.6 7.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.269 0.628 . . . . 0.0 109.693 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.7 mm? -88.59 122.14 31.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -80.27 164.43 23.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 121.246 0.546 . . . . 0.0 111.415 -177.073 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.461 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 93.48 15.51 50.11 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.57 154.09 34.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.403 0.601 . . . . 0.0 110.164 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.65 170.35 22.36 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.609 0.363 . . . . 0.0 110.287 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 32.3 m -134.51 127.56 31.63 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.865 0.466 . . . . 0.0 110.583 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.404 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.2 t -117.43 127.49 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.2 t -98.76 128.63 45.06 Favored 'General case' 0 C--N 1.337 0.05 0 O-C-N 121.962 -0.461 . . . . 0.0 110.324 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.65 147.64 25.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.61 -16.61 59.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -125.49 131.77 24.13 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 110.594 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.455 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.5 Cg_endo -66.46 -32.89 39.12 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.006 2.471 . . . . 0.0 114.446 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -76.9 -19.49 13.98 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 CA-C-N 121.208 1.467 . . . . 0.0 110.81 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -29.31 58.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.75 80.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -64.68 -38.45 91.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.462 -0.149 . . . . 0.0 110.635 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.89 -40.26 83.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.583 0.353 . . . . 0.0 110.943 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.6 -25.96 66.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 66.7 mt -72.62 -56.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.6 -20.87 61.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -94.51 -60.21 1.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.27 -32.47 71.68 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.91 110.42 0.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.16 -14.73 25.83 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.042 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -96.36 -171.01 2.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.872 1.336 . . . . 0.0 110.249 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.04 174.39 5.89 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 110.307 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.618 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.5 t80 -130.39 -39.32 1.32 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 109.941 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.39 -18.77 10.95 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.75 148.14 35.1 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 151.08 74.16 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.43 2.753 . . . . 0.0 110.508 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.618 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.02 168.64 21.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -134.35 155.69 49.81 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.803 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.95 146.76 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.047 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 m -154.4 174.64 14.58 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.754 0.822 . . . . 0.0 108.789 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -60.36 155.65 17.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 N--CA 1.453 -0.858 0 C-N-CA 123.863 3.042 . . . . 0.0 111.876 176.076 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.5 m -95.99 146.61 24.48 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.63 150.3 34.18 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 C-N-CA 122.729 0.411 . . . . 0.0 109.917 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -105.03 148.99 26.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.9 t -133.2 146.62 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 123.05 0.54 . . . . 0.0 111.376 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -137.33 148.54 46.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.71 57.3 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.974 -0.348 . . . . 0.0 112.597 173.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.05 -56.88 14.81 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.82 179.9 44.49 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.81 -10.0 59.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.671 0.789 . . . . 0.0 112.33 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -81.79 -2.29 50.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 117.562 0.165 . . . . 0.0 111.329 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -99.39 155.95 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.16 168.0 28.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.98 -39.73 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 124.403 1.081 . . . . 0.0 111.59 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.55 -29.09 63.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -75.35 -49.38 19.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.131 0.172 . . . . 0.0 110.643 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 322' ' ' ILE . 2.8 m -61.33 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.07 -37.52 77.27 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.193 0.452 . . . . 0.0 110.739 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.04 -15.78 60.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.984 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.72 -27.25 15.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -96.76 -20.37 18.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -66.16 -18.84 65.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.439 0.296 . . . . 0.0 111.763 -173.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -21.52 66.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 353' ' ' TRP . 12.4 mm -87.12 -27.33 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.308 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.86 170.26 31.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.27 134.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.629 0.252 . . . . 0.0 111.347 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 322' ' ' ILE . 7.2 mm -75.51 138.62 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.443 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 35.4 ttmt -68.46 144.58 54.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.331 -0.2 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.029 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.6 153.13 76.9 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.255 1.97 . . . . 0.0 109.126 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.443 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 54.7 mtp -79.1 79.24 5.51 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.516 0.326 . . . . 0.0 110.985 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.812 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.11 155.81 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.345 -178.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.34 127.32 11.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.7 mm? -90.75 119.92 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -81.25 160.67 24.2 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 111.753 -175.964 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 89.47 9.3 66.98 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.598 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -108.25 151.62 25.7 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.929 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.92 166.46 32.57 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.2 m -135.51 122.66 21.55 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.872 0.469 . . . . 0.0 111.508 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.06 124.62 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.4 t -96.23 128.64 43.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.215 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -86.29 148.22 25.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -73.94 -20.33 60.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 95.2 m-20 -127.73 133.35 25.01 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 123.855 0.862 . . . . 0.0 111.033 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.1 Cg_endo -66.14 -33.9 38.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.683 2.256 . . . . 0.0 114.195 -175.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.5 Cg_endo -74.94 -18.42 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.141 1.443 . . . . 0.0 110.822 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 71.0 m -76.7 -29.67 56.36 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.16 -46.42 80.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.947 0.154 . . . . 0.0 110.725 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -66.15 -37.3 85.33 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.38 -40.13 81.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.369 0.267 . . . . 0.0 110.854 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.48 -26.35 65.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.58 -56.95 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.41 -21.79 62.63 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.403 ' CD1' HD11 ' A' ' 308' ' ' ILE . 48.2 t-105 -93.62 -59.49 1.99 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.7 -32.78 70.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -57.03 112.48 1.36 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.68 31.9 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.008 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.66 -172.45 2.75 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.477 1.138 . . . . 0.0 109.924 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -101.64 173.27 6.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.557 0.343 . . . . 0.0 110.457 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.6 t80 -128.51 -38.54 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.682 0.393 . . . . 0.0 110.262 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.1 t -144.54 17.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.981 0.512 . . . . 0.0 109.959 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.23 -20.2 16.65 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -96.12 140.49 22.28 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.98 151.4 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.997 2.464 . . . . 0.0 110.369 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.4 pt -138.12 168.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 122.608 0.363 . . . . 0.0 111.223 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -134.54 155.25 50.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.15 0.58 . . . . 0.0 110.765 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.63 146.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.998 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 37.4 m -155.44 172.99 17.3 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -57.02 156.84 6.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.514 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 C-N-CA 123.757 2.971 . . . . 0.0 112.587 177.069 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.2 m -100.01 147.7 25.32 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.5 pt -128.82 149.92 33.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -104.92 149.49 25.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.74 148.76 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.264 0.625 . . . . 0.0 110.752 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -139.3 150.18 45.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.27 57.95 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.86 -0.411 . . . . 0.0 112.659 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.2 mp -54.72 -54.45 41.72 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 117.55 0.675 . . . . 0.0 111.614 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.481 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.42 -175.86 44.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -171.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -86.86 -7.8 57.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.534 0.734 . . . . 0.0 112.286 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.84 -3.55 42.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.238 0.215 . . . . 0.0 110.954 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.38 158.98 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.739 0.816 . . . . 0.0 112.804 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.43 168.05 25.99 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.75 -39.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.019 0.928 . . . . 0.0 111.65 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -73.15 -28.89 62.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.318 -0.239 . . . . 0.0 111.064 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.9 t -75.12 -49.44 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.193 0.197 . . . . 0.0 110.797 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.11 -53.65 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.441 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.39 -37.33 77.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.719 -0.613 . . . . 0.0 110.78 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -76.9 -15.29 59.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.189 -0.32 . . . . 0.0 111.201 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.47 -27.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.4 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.0 m-85 -96.47 -20.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.8 pttt -65.08 -19.29 65.92 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.36 -20.85 66.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.52 -25.02 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 165.06 168.79 27.76 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.97 136.0 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.706 0.289 . . . . 0.0 111.081 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 322' ' ' ILE . 6.5 mm -76.72 136.45 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -68.93 142.8 54.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.673 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.15 152.02 81.79 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.653 1.569 . . . . 0.0 108.877 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 41.9 mtp -77.71 79.12 4.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.709 0.404 . . . . 0.0 110.955 -174.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.815 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.9 154.96 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 123.703 0.627 . . . . 0.0 110.849 -179.104 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.62 130.12 13.0 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.8 mm? -92.99 117.08 29.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.39 156.5 25.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 79.4 p . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.822 0.82 . . . . 0.0 112.083 -170.767 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.481 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.97 -4.76 63.18 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.52 145.49 26.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.143 0.471 . . . . 0.0 110.807 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.23 165.12 35.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.1 m -136.39 120.75 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.475 0.31 . . . . 0.0 111.829 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 305' ' ' PHE . 94.8 t -114.96 124.17 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.2 t -95.78 128.12 42.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.268 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -85.1 147.07 26.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 172.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.76 -16.77 59.39 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -125.21 131.27 24.04 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.837 0.855 . . . . 0.0 110.688 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.454 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.7 Cg_endo -66.62 -32.69 38.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.67 2.247 . . . . 0.0 114.332 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.4 Cg_endo -76.26 -19.63 15.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-N 121.508 1.574 . . . . 0.0 110.85 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -75.51 -29.69 59.56 Favored 'General case' 0 CA--C 1.524 -0.041 0 O-C-N 122.391 -0.193 . . . . 0.0 110.547 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.55 -48.21 75.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 351' ' ' ILE . 17.0 tptm -64.07 -38.68 91.95 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.6 82.92 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.484 0.314 . . . . 0.0 110.705 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.24 65.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 348' ' ' LYS . 66.5 mt -72.04 -57.32 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.43 -21.91 62.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -93.11 -60.38 1.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.62 -32.44 71.15 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.43 112.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.01 -15.35 31.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.091 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -94.67 -172.81 2.84 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.605 1.203 . . . . 0.0 109.946 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -102.65 170.77 7.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.477 0.311 . . . . 0.0 110.171 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.9 t80 -125.38 -38.54 2.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.371 0.268 . . . . 0.0 110.601 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t -143.84 8.04 1.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.329 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.08 -21.11 4.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -103.83 148.87 36.5 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.94 152.86 76.56 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.395 2.73 . . . . 0.0 110.581 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -139.12 169.14 17.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.96 0.409 . . . . 0.0 110.538 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -133.68 155.61 49.4 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.748 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -143.89 146.39 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 50.0 m -153.76 174.76 14.12 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.65 163.68 4.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.079 -0.388 . . . . 0.0 111.914 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.271 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.455 -0.737 0 C-N-CA 123.732 2.955 . . . . 0.0 112.496 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.185 0.069 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -99.26 147.57 25.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.99 150.24 34.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.867 0.467 . . . . 0.0 109.897 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -105.38 149.68 25.89 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.14 148.7 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.251 0.621 . . . . 0.0 111.238 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -138.55 150.59 46.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.08 5.79 59.37 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.74 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -55.36 -56.69 17.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 117.45 0.625 . . . . 0.0 111.29 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.46 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 90.15 -179.66 43.89 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.79 -11.57 59.85 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.786 0.835 . . . . 0.0 112.106 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.69 0.39 39.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.416 0.286 . . . . 0.0 111.275 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.33 154.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -157.58 168.38 27.46 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 32.5 mm -49.87 -40.16 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.406 1.082 . . . . 0.0 111.776 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.37 -28.74 63.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.55 -0.094 . . . . 0.0 111.059 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.3 t -75.23 -49.46 19.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.159 0.184 . . . . 0.0 110.817 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.38 -54.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.436 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.81 -37.72 77.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.375 0.534 . . . . 0.0 110.699 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -76.17 -15.76 60.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.41 -27.42 16.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -96.5 -20.58 18.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.1 pttt -65.67 -18.72 65.53 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.341 0.257 . . . . 0.0 111.68 -172.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.2 pt20 -64.39 -21.9 66.78 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.3 mm -87.01 -27.99 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 168.28 170.44 32.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.73 135.74 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.879 0.34 . . . . 0.0 111.261 -172.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -76.98 137.84 21.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -69.61 149.37 48.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.835 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.99 154.38 62.28 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.264 1.976 . . . . 0.0 109.47 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.6 mtp -77.14 76.94 3.68 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.63 0.372 . . . . 0.0 111.159 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.63 154.25 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.389 0.675 . . . . 0.0 110.747 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -150.99 130.33 12.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.684 0.794 . . . . 0.0 108.939 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.463 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.8 mm? -90.87 122.31 33.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.22 160.16 19.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.346 0.593 . . . . 0.0 111.661 -170.982 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 99.87 0.37 56.3 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -90.58 151.04 21.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.628 0.714 . . . . 0.0 110.902 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.36 166.21 31.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.316 0.646 . . . . 0.0 109.355 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.3 m -136.84 122.68 20.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.634 0.374 . . . . 0.0 111.603 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.22 125.09 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.2 t -96.83 128.35 43.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.573 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -85.59 147.82 26.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -76.1 -17.24 59.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -125.39 132.24 24.26 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.453 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.4 Cg_endo -66.88 -32.2 36.63 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.782 2.321 . . . . 0.0 114.562 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 92.5 Cg_endo -77.5 -18.79 13.54 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 121.135 1.441 . . . . 0.0 111.146 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.6 m -75.76 -29.27 58.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.24 -0.288 . . . . 0.0 110.478 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.99 -47.69 76.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.71 -39.81 95.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.484 0.314 . . . . 0.0 110.53 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.92 81.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 0.0 110.59 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.12 -26.14 65.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.62 -58.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -60.64 -21.3 62.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -92.99 -59.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -70.37 -32.34 69.97 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.24 112.01 1.12 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -15.59 30.61 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.063 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -94.76 -172.35 2.7 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.646 1.223 . . . . 0.0 110.03 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.5 174.07 6.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.708 0.29 . . . . 0.0 110.459 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.609 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.6 t80 -129.27 -37.78 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.518 0.327 . . . . 0.0 110.654 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.2 t -144.87 20.31 1.63 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.687 0.395 . . . . 0.0 110.043 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.07 0.01 31.56 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -125.32 146.6 54.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 123.801 0.84 . . . . 0.0 109.773 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.79 149.22 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.575 2.85 . . . . 0.0 110.93 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.46 169.21 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.067 0.547 . . . . 0.0 110.636 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -133.5 157.17 46.31 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.004 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 44.7 t -143.95 147.3 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.039 0.536 . . . . 0.0 110.223 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.9 m -154.73 172.86 17.24 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.64 159.11 6.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.038 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.008 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 N--CA 1.453 -0.871 0 C-N-CA 123.766 2.978 . . . . 0.0 112.246 177.96 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.6 m -87.26 144.42 26.82 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -177.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.8 pt -129.05 147.4 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -101.78 147.8 26.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.54 146.86 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 122.983 0.513 . . . . 0.0 111.062 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -137.51 149.88 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.19 58.24 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.8 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.36 -54.74 42.03 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.281 0.632 . . . . 0.0 111.022 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.497 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.54 179.6 46.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -78.33 -9.05 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.818 0.847 . . . . 0.0 111.989 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -82.64 0.06 44.85 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.31 0.244 . . . . 0.0 111.461 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.98 155.76 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.71 168.24 27.8 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.26 -40.25 13.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 124.385 1.074 . . . . 0.0 111.948 -174.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.54 -29.14 63.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.487 -0.085 . . . . 0.0 111.198 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.5 t -74.9 -49.47 20.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.194 0.197 . . . . 0.0 110.57 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.8 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.72 -54.18 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.445 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.84 -38.27 78.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.29 0.496 . . . . 0.0 110.915 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -75.73 -15.15 60.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.788 0.327 . . . . 0.0 111.217 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -95.47 -26.79 15.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -97.27 -20.43 17.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.8 pttt -65.92 -18.98 65.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -64.11 -21.37 66.51 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.84 -25.74 5.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.32 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.15 170.03 30.53 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.54 136.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 122.674 -0.309 . . . . 0.0 111.167 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 322' ' ' ILE . 6.7 mm -77.66 137.66 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.46 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.0 ttmm -68.84 148.46 50.23 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.521 -0.138 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.07 153.61 75.14 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.131 1.887 . . . . 0.0 109.264 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.46 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.7 mtp -79.46 79.57 5.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.8 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.84 156.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.49 0.716 . . . . 0.0 110.412 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -152.56 127.97 9.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.633 0.773 . . . . 0.0 109.199 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.474 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.7 mm? -92.84 121.67 34.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -84.45 158.58 21.0 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 26.2 p . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.279 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.497 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.11 4.84 68.42 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.406 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 151.09 21.74 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 117.906 0.853 . . . . 0.0 111.059 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.52 167.4 29.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.12 0.568 . . . . 0.0 109.713 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.7 m -138.19 123.81 19.73 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.763 0.425 . . . . 0.0 111.228 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 99.5 t -116.36 125.23 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.431 0.692 . . . . 0.0 109.233 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.4 t -96.78 125.53 41.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.084 -0.385 . . . . 0.0 110.466 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -82.4 150.1 27.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.37 -15.69 58.43 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 86.7 m-20 -129.55 136.1 28.58 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.447 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 17.9 Cg_endo -65.48 -36.67 33.3 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.774 2.316 . . . . 0.0 114.31 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 85.8 Cg_endo -75.8 -18.66 16.9 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 120.935 1.37 . . . . 0.0 111.122 -175.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.0 m -75.9 -30.09 58.68 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.0 71.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.141 0.177 . . . . 0.0 110.871 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -64.12 -38.27 90.47 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.455 0.169 . . . . 0.0 110.643 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.5 83.02 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.555 0.342 . . . . 0.0 110.834 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -25.72 65.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.9 mt -72.71 -56.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -60.31 -20.95 61.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -94.99 -59.65 1.86 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.83 -31.5 69.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -57.76 112.81 1.58 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.49 -15.46 32.32 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.908 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.52 -172.14 2.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.742 1.271 . . . . 0.0 109.86 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -102.61 174.38 5.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.837 0.351 . . . . 0.0 110.347 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.589 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.1 t80 -130.02 -39.39 1.38 Allowed 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.3 t -143.34 18.18 1.89 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.993 0.517 . . . . 0.0 109.7 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.75 -18.81 24.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -175.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -97.11 140.2 21.94 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.27 151.27 81.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.997 2.465 . . . . 0.0 110.486 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.589 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.5 pt -136.88 168.93 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.153 0.502 . . . . 0.0 111.041 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.82 155.64 49.47 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.901 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.43 146.79 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 122.939 0.495 . . . . 0.0 110.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.4 m -155.11 173.1 17.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.3 160.7 4.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.133 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 C-N-CA 123.642 2.894 . . . . 0.0 112.198 176.357 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.4 m -133.63 150.33 51.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.88 146.22 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.756 0.422 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -100.47 146.53 26.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.59 147.08 32.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 122.766 0.426 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -137.78 150.41 47.21 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.13 5.96 58.01 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.556 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.45 -57.32 12.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.499 0.72 . . . . 0.0 111.176 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.473 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.74 -179.1 45.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.02 -10.88 59.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.569 0.748 . . . . 0.0 112.405 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.8 -0.63 35.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.549 0.34 . . . . 0.0 111.355 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.58 155.58 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.95 168.4 27.25 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -48.67 -39.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.264 1.026 . . . . 0.0 111.825 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.89 -28.59 61.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.251 -0.281 . . . . 0.0 111.248 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -75.75 -48.33 22.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.89 -53.97 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.434 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.28 -37.55 77.97 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.045 -0.409 . . . . 0.0 110.843 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.67 -15.6 59.76 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.241 -0.287 . . . . 0.0 111.105 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -94.46 -27.13 16.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 339' ' ' VAL . 45.5 m-85 -97.03 -19.85 18.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.2 pttt -65.79 -18.91 65.67 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.3 pt20 -64.05 -21.8 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.8 mm -87.39 -27.26 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 167.89 169.89 31.96 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.03 135.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.577 -0.366 . . . . 0.0 111.064 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.496 HG21 HD11 ' A' ' 322' ' ' ILE . 8.1 mm -75.41 138.6 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.12 153.64 43.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.15 153.46 69.4 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.963 1.775 . . . . 0.0 109.541 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.7 mtp -78.95 76.04 5.45 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.199 0.6 . . . . 0.0 111.128 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -130.89 159.63 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.143 0.577 . . . . 0.0 110.617 -178.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -156.24 125.23 6.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.84 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.474 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.6 mm? -90.05 121.73 32.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -76.0 163.75 26.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.484 0.659 . . . . 0.0 111.106 -179.509 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.473 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.79 16.01 50.18 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -123.08 155.91 35.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.44 0.62 . . . . 0.0 110.388 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.68 173.39 16.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.906 0.482 . . . . 0.0 109.918 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.2 m -139.56 129.26 24.58 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 305' ' ' PHE . 89.6 t -119.24 127.18 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 39.5 t -98.36 132.89 43.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.724 -0.39 . . . . 0.0 109.971 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.24 145.11 24.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.175 0.99 . . . . 0.0 113.201 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -72.08 -16.41 62.02 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 99.5 m-20 -125.61 134.09 25.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.785 0.834 . . . . 0.0 110.835 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 22.3 Cg_endo -66.14 -33.93 38.7 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.702 2.268 . . . . 0.0 114.055 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 93.9 Cg_endo -77.69 -19.03 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.499 1.466 . . . . 0.0 111.522 -177.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.7 m -74.35 -29.14 61.46 Favored 'General case' 0 C--N 1.335 -0.05 0 CA-C-N 117.774 0.261 . . . . 0.0 110.35 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.64 79.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.3 tptm -62.51 -40.11 95.68 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.402 -0.187 . . . . 0.0 111.111 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.361 0.265 . . . . 0.0 110.92 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.54 -24.96 64.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 348' ' ' LYS . 65.8 mt -73.9 -55.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -60.76 -20.86 62.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -95.36 -60.27 1.7 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.76 -32.4 70.9 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.33 111.8 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.7 -17.11 25.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.287 -0.729 . . . . 0.0 112.806 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -94.43 -171.73 2.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.53 1.165 . . . . 0.0 109.94 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -102.7 174.25 5.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.582 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.3 t80 -129.38 -38.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.565 0.346 . . . . 0.0 110.078 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.8 t -144.49 17.33 1.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.016 0.526 . . . . 0.0 109.738 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.89 16.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -94.71 140.29 22.54 Favored Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.96 151.38 82.23 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.102 2.534 . . . . 0.0 110.326 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.582 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.2 pt -138.51 168.32 19.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 121.168 0.509 . . . . 0.0 111.092 -177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -133.81 155.64 49.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.268 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 56.9 t -144.63 147.43 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 O-C-N 123.412 0.445 . . . . 0.0 110.093 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.3 m -154.36 171.85 18.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.99 155.63 7.89 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.513 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.161 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 123.883 3.056 . . . . 0.0 111.834 176.83 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 m -105.75 147.83 28.14 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 15.6 pt -128.45 149.91 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.035 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -104.75 149.76 25.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.11 147.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.485 0.714 . . . . 0.0 111.12 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -139.38 150.13 44.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.05 57.83 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.995 -0.336 . . . . 0.0 112.801 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.64 -56.31 21.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.516 0.727 . . . . 0.0 111.288 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.72 -179.43 45.87 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.19 -10.41 59.39 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.704 0.802 . . . . 0.0 112.251 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -81.56 -0.69 43.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.242 0.217 . . . . 0.0 111.319 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.87 155.95 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.54 168.39 27.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -50.3 -40.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.324 1.05 . . . . 0.0 111.572 -174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -72.36 -28.83 63.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.405 -0.184 . . . . 0.0 111.102 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.5 -50.26 18.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.272 0.229 . . . . 0.0 110.456 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.25 -53.55 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.428 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.59 -37.39 78.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.531 0.605 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -76.12 -15.81 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 111.109 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -94.52 -27.52 15.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -96.71 -20.68 18.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.6 pttt -65.31 -19.09 65.8 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.45 -20.76 66.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.0 mm -88.59 -24.65 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-O 120.665 0.269 . . . . 0.0 110.342 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.53 168.79 27.18 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.37 136.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.614 -0.345 . . . . 0.0 111.002 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -78.22 137.58 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.419 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.8 ttmm -71.89 145.92 48.21 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 110.578 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.4 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 3.4 pt20 . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 319' ' ' GLN . 20.9 Cg_endo -61.25 155.73 49.83 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.476 2.117 . . . . 0.0 109.856 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 59.2 mtp -76.79 76.64 3.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.956 0.502 . . . . 0.0 110.997 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.799 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.75 158.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -157.37 133.1 9.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.5 mm? -93.37 120.12 33.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.92 159.73 22.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 121.298 0.57 . . . . 0.0 111.77 -171.172 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.62 2.13 61.69 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.77 150.97 19.64 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.455 0.627 . . . . 0.0 111.119 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.47 33.68 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.003 0.521 . . . . 0.0 109.723 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.4 m -135.74 123.14 21.95 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.2 123.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 32.8 t -95.73 127.54 41.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.712 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.48 147.65 26.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -75.71 -17.5 59.92 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 90.5 m-20 -128.27 133.28 24.98 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.048 0.939 . . . . 0.0 110.834 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -67.12 -32.65 33.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.669 2.246 . . . . 0.0 114.6 -175.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 95.8 Cg_endo -75.17 -19.35 17.58 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 121.175 1.456 . . . . 0.0 110.753 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.5 m -76.98 -29.32 55.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.74 -47.56 74.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -64.92 -37.39 87.49 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.92 80.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.31 0.244 . . . . 0.0 110.483 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -25.27 65.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.7 mt -73.27 -56.07 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.93 -21.88 63.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -93.54 -60.78 1.69 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -69.22 -32.1 71.12 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.24 112.17 1.3 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.95 -16.06 30.78 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.945 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.76 -172.3 2.69 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.753 1.276 . . . . 0.0 109.969 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.91 174.22 6.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.588 0.355 . . . . 0.0 110.457 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.619 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -129.78 -38.37 1.49 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 15.57 1.74 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.698 0.399 . . . . 0.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 120.07 -18.7 9.63 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -104.22 148.77 36.47 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.02 151.11 73.31 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.483 2.789 . . . . 0.0 110.624 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.62 168.76 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.016 0.527 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -134.1 155.39 50.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.139 0.576 . . . . 0.0 111.101 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.1 t -144.34 146.27 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 122.899 0.48 . . . . 0.0 110.221 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.3 m -154.23 172.91 16.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.69 160.01 6.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.894 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.241 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.939 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.452 -0.955 0 C-N-CA 123.914 3.076 . . . . 0.0 111.873 176.16 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.2 m -135.22 149.5 49.9 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -172.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.1 pt -131.95 146.95 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.582 0.353 . . . . 0.0 110.309 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.25 150.19 22.8 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.2 t -134.13 147.23 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.866 0.466 . . . . 0.0 111.783 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -136.74 149.85 48.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.72 6.15 58.4 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 120.005 -0.33 . . . . 0.0 112.361 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.76 -56.1 24.55 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.467 0.707 . . . . 0.0 110.857 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.469 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.82 -179.89 45.85 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -78.95 -10.35 59.79 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.873 0.869 . . . . 0.0 112.26 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.83 -1.63 43.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.352 0.261 . . . . 0.0 111.348 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.68 156.19 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -158.7 168.51 26.66 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.2 mm -49.32 -40.27 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.421 1.088 . . . . 0.0 111.728 -174.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.71 -29.14 63.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.348 -0.22 . . . . 0.0 111.209 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.68 -50.14 18.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.235 0.214 . . . . 0.0 110.594 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.837 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.18 -53.57 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.435 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.68 -38.15 80.75 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.975 -0.453 . . . . 0.0 110.565 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -75.94 -15.46 60.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 111.028 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -94.39 -27.02 16.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.8 m-85 -97.66 -20.13 17.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.3 pttt -66.08 -18.9 65.64 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -173.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -63.77 -21.59 66.49 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -87.35 -24.06 6.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.968 0.349 . . . . 0.0 110.2 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 161.19 172.72 28.91 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 40.2 mm -66.41 137.39 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 322' ' ' ILE . 7.1 mm -78.38 133.82 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 342' ' ' ASP . 12.6 tppt? -64.55 133.01 51.47 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.333 -0.145 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 175.26 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.88 152.04 82.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.04 1.827 . . . . 0.0 109.047 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 71.1 mtp -78.27 80.69 4.67 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.579 0.352 . . . . 0.0 111.196 -175.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.837 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -133.78 154.6 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -150.36 121.3 7.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.227 0.611 . . . . 0.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.6 mm? -88.41 121.83 31.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -79.26 162.21 25.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.108 0.48 . . . . 0.0 112.092 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.9 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.503 -178.117 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.96 16.88 31.78 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -119.81 154.96 33.49 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 117.398 0.599 . . . . 0.0 110.405 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.81 171.02 20.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.878 0.471 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 42.0 m -134.78 128.18 32.32 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.739 0.416 . . . . 0.0 110.262 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.411 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.1 t -118.23 128.39 75.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 321' ' ' MET . 43.7 t -98.92 132.91 43.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.73 176.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -90.86 148.28 22.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HA ' ' CE ' ' A' ' 312' ' ' LYS . 47.4 t0 -70.96 -22.78 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.44 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.8 m-20 -124.82 135.82 27.2 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.318 0.647 . . . . 0.0 111.693 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 19.2 Cg_endo -64.05 -36.67 47.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.799 2.333 . . . . 0.0 113.925 -175.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 94.5 Cg_endo -76.89 -16.42 16.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.579 1.519 . . . . 0.0 111.172 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.4 m -77.44 -29.53 52.9 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.87 81.58 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -64.52 -39.47 93.83 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 122.175 0.19 . . . . 0.0 110.742 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.37 83.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.565 0.346 . . . . 0.0 110.908 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -24.97 65.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.56 -57.72 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.85 -21.44 63.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -92.8 -59.15 2.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.76 -33.45 70.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.43 112.11 1.17 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.37 -16.46 29.45 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.188 -0.785 . . . . 0.0 113.046 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -93.83 -171.92 2.72 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.7 1.25 . . . . 0.0 109.695 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -102.8 172.21 6.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.696 0.284 . . . . 0.0 110.421 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.6 t80 -126.34 -38.92 2.08 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 26.4 t -142.59 6.29 1.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.834 0.454 . . . . 0.0 110.477 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.38 -22.27 3.97 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -101.76 149.37 36.4 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.73 152.29 77.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.474 2.782 . . . . 0.0 110.296 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.66 166.29 24.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 122.747 0.419 . . . . 0.0 110.792 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -131.46 156.1 46.23 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.155 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 45.3 t -144.86 147.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.453 0.471 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -156.53 173.21 17.25 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.809 0.843 . . . . 0.0 108.801 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -60.23 152.89 23.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.65 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 C-N-CA 123.999 3.132 . . . . 0.0 112.593 -179.898 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.634 ' N ' HD21 ' A' ' 285' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 m -92.57 147.33 22.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.26 147.89 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 122.939 0.496 . . . . 0.0 109.883 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -101.78 148.38 25.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.27 148.7 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.133 0.573 . . . . 0.0 111.125 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.33 149.35 45.54 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.23 5.6 58.06 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.943 -0.365 . . . . 0.0 112.849 172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.39 -53.86 51.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.655 0.727 . . . . 0.0 111.412 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.509 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.51 -176.61 44.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -170.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -86.87 -7.51 58.14 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.669 0.788 . . . . 0.0 112.519 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.01 -5.69 52.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 110.887 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.23 159.62 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.661 0.785 . . . . 0.0 112.303 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.05 168.03 26.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.07 -39.87 12.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.2 1.0 . . . . 0.0 111.712 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.47 -28.52 61.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.368 -0.208 . . . . 0.0 110.905 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.2 t -75.09 -49.5 19.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.104 0.161 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.808 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -60.98 -53.86 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.447 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.84 -38.07 77.89 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.053 0.388 . . . . 0.0 110.751 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -75.89 -15.67 60.17 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.129 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.58 -27.49 15.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -96.98 -20.42 18.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.9 pttt -65.39 -19.04 65.77 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -173.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.6 pt20 -64.57 -21.19 66.63 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.5 mm -88.11 -24.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.312 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.2 169.31 27.56 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.17 137.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 122.645 -0.327 . . . . 0.0 111.093 -172.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.451 HG21 HD11 ' A' ' 322' ' ' ILE . 6.7 mm -78.95 137.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 22.3 ttmm -69.42 149.7 48.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.299 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.34 154.02 70.75 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.368 2.045 . . . . 0.0 109.193 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.453 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 65.8 mtp -79.35 79.67 5.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.696 0.399 . . . . 0.0 110.928 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.808 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -135.15 155.53 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.668 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.98 129.53 13.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.7 mm? -92.08 119.83 32.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -83.94 157.33 21.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.532 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.13 -2.31 75.05 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.37 146.62 24.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.786 0.793 . . . . 0.0 111.136 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.77 166.64 32.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 10.3 m -138.56 121.32 16.42 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 122.556 0.342 . . . . 0.0 111.457 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.68 126.07 72.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.4 t -97.31 127.69 43.5 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.309 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.439 ' O ' ' HE2' ' A' ' 312' ' ' LYS . 42.2 m-85 -84.29 147.71 27.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.6 -18.66 59.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -126.06 133.79 25.29 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 110.685 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 27.5 Cg_endo -66.31 -33.68 37.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 114.405 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 84.8 Cg_endo -75.81 -20.1 15.61 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 121.2 1.464 . . . . 0.0 111.122 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 52.6 m -74.82 -29.61 61.13 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.8 78.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.13 0.172 . . . . 0.0 110.742 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -63.04 -39.75 95.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.404 0.282 . . . . 0.0 110.622 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.68 81.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.53 0.332 . . . . 0.0 110.842 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.04 65.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.4 -57.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -59.78 -21.93 61.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -93.82 -60.0 1.86 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.44 -31.94 70.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.43 111.73 1.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.45 -14.97 30.1 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.052 -0.86 . . . . 0.0 113.07 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -95.25 -171.99 2.55 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.748 1.274 . . . . 0.0 109.851 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.51 175.5 5.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.303 0.241 . . . . 0.0 110.606 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.606 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -131.08 -38.4 1.23 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -143.23 16.49 1.89 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.157 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.89 12.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.93 148.51 35.43 Favored Pre-proline 0 C--O 1.233 0.187 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.06 152.1 73.0 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.707 2.938 . . . . 0.0 110.722 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.36 168.3 20.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 122.821 0.448 . . . . 0.0 110.953 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.7 156.32 47.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.0 146.11 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.089 0.555 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 m -154.64 171.82 18.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -58.47 159.45 6.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.184 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 72.29 -171.49 48.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -64.27 -54.4 33.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -156.98 -178.51 7.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.937 0.895 . . . . 0.0 109.124 -174.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.541 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.68 -7.47 27.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -108.8 -3.24 17.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.805 0.275 . . . . 0.0 110.972 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.19 3.6 87.18 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.332 -0.704 . . . . 0.0 114.467 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 66.92 -158.18 50.48 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.015 1.408 . . . . 0.0 110.496 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.81 25.16 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.009 3.139 . . . . 0.0 111.932 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -78.27 -40.94 35.51 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.802 -0.561 . . . . 0.0 110.704 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -105.45 8.23 33.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.832 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -15.94 61.36 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 96.13 -118.05 5.86 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.606 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.1 t -79.53 16.79 0.98 Allowed 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -170.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.42 -5.78 5.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -86.82 -19.24 29.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.423 0.289 . . . . 0.0 111.211 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -125.73 4.15 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 75.1 m -148.65 147.75 29.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 109.639 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.66 9.23 33.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.971 0.508 . . . . 0.0 111.322 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -101.72 -109.15 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.79 22.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -153.59 161.79 41.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 43.3 t -156.18 -35.53 0.08 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.068 0.147 . . . . 0.0 110.7 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -93.4 13.46 21.51 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -132.62 45.2 2.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.335 0.654 . . . . 0.0 111.61 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -69.53 -0.75 7.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.506 0.322 . . . . 0.0 111.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.8 m -101.83 147.85 26.01 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.6 pt -128.84 149.22 33.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.006 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -103.68 149.77 24.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.3 147.96 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 123.105 0.562 . . . . 0.0 111.163 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -139.54 149.07 43.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.95 4.81 57.65 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.718 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.18 -54.46 43.09 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.339 0.57 . . . . 0.0 111.159 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.466 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.28 -179.23 48.08 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.12 -9.65 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.596 0.758 . . . . 0.0 112.299 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -81.59 -1.53 46.77 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.446 0.298 . . . . 0.0 111.44 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.34 156.77 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.45 168.18 27.65 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.83 -39.34 14.9 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.313 1.045 . . . . 0.0 111.71 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -73.92 -28.54 61.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.434 -0.166 . . . . 0.0 110.89 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.63 -49.84 20.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.266 0.226 . . . . 0.0 110.539 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.53 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.431 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -38.32 79.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.187 0.449 . . . . 0.0 110.583 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -75.23 -15.7 60.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 111.272 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -95.03 -26.58 16.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -97.88 -20.0 17.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.6 pttt -66.22 -19.13 65.74 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.8 pt20 -64.05 -21.07 66.37 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.4 mm -87.8 -28.34 5.55 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.444 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 168.49 170.05 32.68 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.8 mm -68.04 134.85 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 122.519 -0.401 . . . . 0.0 111.247 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 322' ' ' ILE . 6.2 mm -76.97 137.09 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.429 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.7 ttmm -69.68 139.33 53.45 Favored 'General case' 0 C--O 1.23 0.041 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m -99.28 141.43 32.07 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -69.44 148.56 49.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.659 0.384 . . . . 0.0 110.186 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -81.8 -1.49 47.55 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -147.03 -24.24 0.4 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.02 0.827 . . . . 0.0 112.952 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 10.0 p -89.81 -16.43 30.18 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.25 -17.87 3.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.269 0.461 . . . . 0.0 112.881 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -81.47 161.82 60.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 117.865 0.833 . . . . 0.0 109.619 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.67 153.42 75.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.798 1.665 . . . . 0.0 109.027 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.5 mtp -78.69 79.35 5.11 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.786 0.434 . . . . 0.0 111.175 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.803 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.37 159.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.697 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -156.42 130.62 8.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -91.97 119.61 31.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -82.79 158.36 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 43.2 p -133.19 157.05 46.35 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.38 0.61 . . . . 0.0 112.085 -170.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -68.97 127.01 31.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.208 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -76.41 -7.41 54.98 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.469 0.307 . . . . 0.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.76 -7.73 36.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 4.1 t -149.67 -22.6 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.187 0.449 . . . . 0.0 110.922 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.41 27.07 33.98 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.126 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -132.6 169.82 16.08 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.986 0.893 . . . . 0.0 110.429 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -45.34 123.94 4.45 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.664 0.786 . . . . 0.0 111.598 -174.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.545 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -84.04 -19.43 34.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.976 0.911 . . . . 0.0 109.71 174.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.22 1.71 58.1 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -94.32 150.9 19.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.331 0.566 . . . . 0.0 110.916 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.27 165.77 32.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.072 0.549 . . . . 0.0 109.59 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 7.1 m -136.47 122.55 20.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 96.2 t -114.99 124.01 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.7 t -96.29 126.6 41.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.253 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -84.09 148.32 26.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.84 -17.65 59.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 92.4 m-20 -128.13 134.08 25.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 110.687 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.8 Cg_endo -67.2 -32.94 32.45 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.689 2.259 . . . . 0.0 114.659 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.4 Cg_endo -75.13 -18.94 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 121.11 1.432 . . . . 0.0 110.831 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.8 m -77.19 -29.81 54.54 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.01 78.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -66.0 -37.03 84.89 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.397 -0.189 . . . . 0.0 110.629 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.48 -40.31 81.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.459 0.304 . . . . 0.0 110.969 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.17 -25.92 65.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.26 -56.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.13 -21.68 63.97 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -94.04 -58.67 2.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -70.92 -32.34 69.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.07 112.37 1.33 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.02 -16.48 30.33 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.837 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -94.26 -172.29 2.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.788 1.294 . . . . 0.0 110.07 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -101.73 173.7 6.29 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.622 0.369 . . . . 0.0 110.302 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.608 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.5 t80 -127.96 -38.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.3 t -141.73 4.8 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.05 -22.58 4.0 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.61 148.45 34.75 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 151.91 78.25 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.291 2.661 . . . . 0.0 110.74 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.34 169.36 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.629 0.371 . . . . 0.0 110.862 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -134.17 155.88 49.31 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.922 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.74 146.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.956 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.3 m -154.92 173.86 15.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 108.881 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -57.98 159.77 5.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 169.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.403 ' HB1' " H1'" ' B' ' 106' ' ' ' G' . . . -128.83 140.33 51.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 13.8 m -142.56 135.09 27.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.554 0.741 . . . . 0.0 110.174 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -49.15 119.12 3.05 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 122.668 0.387 . . . . 0.0 110.783 -169.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -30.73 70.16 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.62 75.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.665 -0.207 . . . . 0.0 110.934 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -66.99 -9.33 37.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.519 ' CD2' ' HE3' ' A' ' 264' ' ' LYS . 94.7 m-85 -106.26 -9.8 16.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.13 -41.8 0.09 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -81.16 -1.53 44.9 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.78 11.07 77.82 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.45 -168.71 53.98 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -76.9 172.29 55.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -145.28 155.94 43.52 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.058 0.543 . . . . 0.0 110.415 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.61 169.34 52.28 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -144.42 167.13 23.22 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.561 0.744 . . . . 0.0 110.722 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.2 170.55 47.52 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 163.86 -153.9 24.52 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -62.76 163.36 9.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.031 0.415 . . . . 0.0 110.587 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -138.79 172.36 23.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -60.54 142.93 54.75 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 122.604 0.362 . . . . 0.0 110.632 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.74 64.59 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.637 -1.646 . . . . 0.0 111.38 178.986 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 110.885 -3.077 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 N19-C1'-C2' 109.277 -2.577 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C4'-C3'-C2' 100.063 -2.637 . 0.848 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 C4'-C3'-C2' 100.117 -2.583 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 110.789 2.589 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 O4'-C1'-N19 111.278 3.078 . 0.844 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.655 0 O4'-C1'-N19 110.978 2.778 . 0.752 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 111.381 -2.746 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.856 0 C5'-C4'-C3' 110.999 -3.001 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.785 0 C5'-C4'-C3' 110.974 -3.017 . 0.67 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.435 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.089 0 C5'-C4'-C3' 111.489 -2.674 . 0.687 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.435 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.445 0 C5'-C4'-C3' 110.217 -3.522 . 0.409 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 1 C5'-C4'-C3' 109.492 -4.005 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.349 1 O4'-C1'-N19 113.116 4.916 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.545 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 110.04 -3.64 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.403 " H1'" ' HB1' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.922 1 C3'-C2'-C1' 105.693 4.659 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.457 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.387 0 C5'-C4'-C3' 110.093 -3.604 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . 0.457 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.975 0 C4'-C3'-C2' 100.71 -1.99 . 0.212 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C5'-C4'-C3' 110.745 -3.17 . 0.425 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 N19-C1'-C2' 109.303 -2.56 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 N19-C1'-C2' 108.979 -2.763 . 0.761 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 C4'-C3'-C2' 100.279 -2.421 . 0.681 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 112.154 -2.23 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . 0.41 " H2'" ' C6 ' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 110.881 2.681 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . 0.41 ' C6 ' " H2'" ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 O4'-C1'-N19 110.671 2.471 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.241 -2.459 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.711 0 O4'-C1'-N19 110.634 2.434 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.717 0 O4'-C1'-N19 110.737 2.537 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.182 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.63 -177.54 47.92 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.98 176.25 2.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -68.2 -173.99 0.45 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.478 0.711 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.02 -14.28 53.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.183 0.593 . . . . 0.0 112.366 -178.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -97.02 -6.89 34.29 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.066 0.394 . . . . 0.0 110.901 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.17 8.69 83.38 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.067 -0.852 . . . . 0.0 114.785 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 69.01 -161.64 51.89 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.454 1.627 . . . . 0.0 110.888 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 271' ' ' GLN . 58.7 Cg_endo -70.19 27.9 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.996 3.131 . . . . 0.0 112.343 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 267' ' ' GLY . 77.0 ttt-85 -84.14 -19.55 33.98 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.664 0.386 . . . . 0.0 110.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -146.82 27.57 1.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 268' ' ' PRO . 17.1 tp60 -67.12 -13.87 62.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.797 0.439 . . . . 0.0 111.253 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 105.49 -119.42 6.12 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 79.7 p -73.37 18.22 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -2.98 9.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.864 0.757 . . . . 0.0 112.549 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -93.26 -15.61 25.66 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.395 0.278 . . . . 0.0 111.061 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -127.75 6.78 6.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 42.0 t -156.74 158.76 37.48 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.071 0.548 . . . . 0.0 109.593 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -99.88 2.01 43.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.055 0.542 . . . . 0.0 110.639 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -85.97 -80.51 0.23 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.08 0.552 . . . . 0.0 109.798 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 49.63 14.25 0.11 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -156.2 167.3 30.86 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.733 -0.604 . . . . 0.0 110.235 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.1 t -155.64 -35.84 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -95.94 7.4 46.45 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -125.38 45.23 2.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.184 0.593 . . . . 0.0 111.715 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -69.46 -1.18 7.83 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.245 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -98.43 147.16 25.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.44 149.88 34.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.018 0.527 . . . . 0.0 110.139 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -105.12 149.08 26.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.14 148.19 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 123.181 0.592 . . . . 0.0 111.056 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -138.45 149.55 45.57 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.58 57.61 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.848 -0.418 . . . . 0.0 112.599 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.06 -54.53 38.01 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.404 0.682 . . . . 0.0 111.639 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.51 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.68 -176.81 43.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -170.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -85.44 -9.17 57.86 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.773 0.829 . . . . 0.0 112.265 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -78.77 -5.2 52.67 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.184 -0.322 . . . . 0.0 111.209 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.51 158.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.547 0.739 . . . . 0.0 112.678 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.66 167.16 29.07 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.9 mm -49.32 -39.35 13.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.359 1.064 . . . . 0.0 111.731 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.14 -28.41 62.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.35 -0.219 . . . . 0.0 111.15 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.1 t -75.73 -48.73 20.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.303 0.241 . . . . 0.0 110.765 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.792 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.44 -53.62 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.425 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.22 -37.55 77.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.36 0.527 . . . . 0.0 110.52 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -75.96 -16.02 60.07 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.217 -0.302 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.98 -27.48 16.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -97.02 -19.86 18.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -65.27 -18.95 65.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.5 pt20 -64.6 -21.59 66.75 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.5 mm -87.67 -25.76 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.047 0 CA-C-O 120.818 0.342 . . . . 0.0 110.313 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 165.81 169.81 29.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.52 135.86 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 O-C-N 122.646 -0.326 . . . . 0.0 110.993 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.482 HG21 HD11 ' A' ' 322' ' ' ILE . 7.2 mm -76.54 137.99 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.402 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.2 ttmm -69.97 147.51 50.07 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.9 m -127.78 131.94 49.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.35 149.5 42.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -81.87 -6.09 58.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 -1.41 1.32 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -90.09 -22.82 21.61 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.9 79.32 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -145.24 159.32 49.42 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 117.454 0.627 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.82 155.06 56.77 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.316 2.011 . . . . 0.0 109.413 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.402 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 49.3 mtp -76.9 76.99 3.48 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.723 0.409 . . . . 0.0 111.154 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.792 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -136.03 154.55 33.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.065 0 C-N-CA 123.283 0.633 . . . . 0.0 110.792 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -151.9 131.9 13.43 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.8 mm? -93.02 118.06 30.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -80.5 158.44 25.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 333' ' ' LEU . 19.6 p -133.3 148.4 51.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.413 0.625 . . . . 0.0 112.59 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.61 128.33 35.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.822 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 328' ' ' ARG . 41.3 mtp85 -72.01 -4.82 30.82 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -100.65 -6.21 25.51 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.8 t -150.18 -24.34 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.498 0.59 . . . . 0.0 110.957 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.13 20.06 58.01 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.105 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -124.88 169.01 12.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.948 0.874 . . . . 0.0 109.547 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 293' ' ' GLY . 3.6 mt -50.81 121.38 5.84 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 120.538 0.209 . . . . 0.0 110.771 -173.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.664 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 12.9 ptmm? -83.43 2.38 36.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.021 0.529 . . . . 0.0 109.579 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.27 1.5 72.07 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.415 0.531 . . . . 0.0 111.911 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.17 148.5 24.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 117.808 0.804 . . . . 0.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.2 165.84 33.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.388 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 5.0 m -135.22 121.22 19.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.976 0.51 . . . . 0.0 111.943 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.08 125.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 33.3 t -96.66 129.68 44.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.49 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.48 147.27 26.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -76.72 -17.35 59.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -124.84 131.25 24.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.069 0.948 . . . . 0.0 110.525 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.9 Cg_endo -66.17 -33.3 40.53 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.798 2.332 . . . . 0.0 114.382 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 93.0 Cg_endo -75.53 -20.27 16.0 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 CA-C-N 121.372 1.526 . . . . 0.0 111.016 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -74.72 -29.81 61.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.52 -47.98 76.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.411 ' HA ' HD12 ' A' ' 351' ' ' ILE . 17.3 tptm -64.62 -38.15 90.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.346 0.117 . . . . 0.0 110.71 -177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.59 82.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.471 0.308 . . . . 0.0 110.808 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.91 -25.81 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 348' ' ' LYS . 66.4 mt -72.54 -57.92 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -59.67 -22.32 61.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -92.65 -60.35 1.84 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.72 -32.03 70.36 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.58 112.45 1.28 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.89 -15.81 31.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.149 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.47 -171.91 2.5 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.719 1.26 . . . . 0.0 109.861 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -101.12 174.68 5.89 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.427 0.291 . . . . 0.0 110.455 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.602 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.1 t80 -130.66 -37.38 1.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.617 0.367 . . . . 0.0 110.404 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.3 t -144.37 15.59 1.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.86 10.79 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.82 148.0 34.44 Favored Pre-proline 0 CA--C 1.53 0.175 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.26 151.22 76.77 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.485 2.79 . . . . 0.0 110.646 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.602 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.07 169.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 122.858 0.463 . . . . 0.0 110.705 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 156.27 49.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.698 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.06 147.87 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.068 0.547 . . . . 0.0 110.307 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 175.88 13.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.126 0.971 . . . . 0.0 108.809 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.23 163.84 3.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -131.98 137.58 47.95 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 10.3 m -141.64 134.37 28.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.203 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -47.42 115.98 1.28 Allowed 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.236 0.335 . . . . 0.0 110.448 -170.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -24.0 61.02 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.16 76.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.166 -0.334 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.37 -9.83 13.95 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.445 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 97.7 m-85 -107.43 -9.63 15.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.42 -41.68 0.09 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -82.14 -1.55 49.21 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 80.48 12.55 82.88 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 88.59 170.43 45.55 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.26 154.45 53.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -157.94 171.5 20.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.421 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.06 162.49 36.02 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -74.86 165.11 25.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.842 0.353 . . . . 0.0 110.374 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.77 139.7 29.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -89.65 175.28 42.05 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -66.9 135.39 53.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -101.1 -178.57 29.0 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -140.2 166.44 24.67 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.311 0.644 . . . . 0.0 110.43 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 75.15 -174.67 51.67 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.102 -1.944 . . . . 0.0 110.61 -179.47 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 C5'-C4'-C3' 110.59 -3.274 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 N19-C1'-C2' 109.298 -2.564 . 0.772 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.369 0 N19-C1'-C2' 108.945 -2.784 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 N19-C1'-C2' 109.324 -2.547 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 C5'-C4'-C3' 111.44 -2.707 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.729 2.529 . 0.907 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 O4'-C1'-N19 110.877 2.677 . 0.832 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.465 0 O4'-C1'-N19 111.316 3.116 . 0.652 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 O4'-C1'-N19 111.207 3.007 . 0.719 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.878 0 C5'-C4'-C3' 111.383 -2.745 . 0.671 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 C5'-C4'-C3' 111.272 -2.819 . 0.478 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.428 0 C5'-C4'-C3' 110.608 -3.261 . 0.278 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 109.785 -3.81 . 0.26 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 1 O4'-C1'-N19 112.694 4.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.664 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 C5'-C4'-C3' 109.929 -3.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.996 1 C3'-C2'-C1' 106.055 5.062 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.809 0 C5'-C4'-C3' 109.869 -3.754 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 0 C5'-C4'-C3' 110.846 -3.103 . 0.619 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 N19-C1'-C2' 109.125 -2.672 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 N19-C1'-C2' 109.653 -2.342 . 0.762 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 N19-C1'-C2' 109.358 -2.526 . 0.774 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 109.797 -2.252 . 0.699 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 C5'-C4'-C3' 111.798 -2.468 . 0.802 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 O4'-C1'-N19 110.86 2.66 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 O4'-C1'-N19 110.845 2.645 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.884 0 O4'-C1'-N19 110.837 2.637 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.705 2.505 . 0.793 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.501 2.301 . 0.827 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.022 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.33 -8.37 87.02 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -143.07 175.83 9.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -68.67 -174.29 0.55 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.02 -15.88 60.4 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.997 0.519 . . . . 0.0 112.097 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.87 -5.18 45.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.192 0.451 . . . . 0.0 111.304 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.09 83.76 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.135 -0.814 . . . . 0.0 114.098 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.92 -160.64 50.16 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 119.024 1.412 . . . . 0.0 110.788 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.67 20.96 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.787 2.991 . . . . 0.0 112.603 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.8 ttp180 -74.88 -41.96 58.78 Favored 'General case' 0 CA--C 1.527 0.07 0 O-C-N 121.815 -0.553 . . . . 0.0 110.188 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -105.45 11.36 32.69 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.133 0.573 . . . . 0.0 111.029 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -8.48 41.7 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.59 -107.98 2.99 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 81.0 p -72.43 12.37 0.47 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -3.52 14.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -87.73 -6.72 58.06 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.777 0.262 . . . . 0.0 111.411 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -150.19 22.82 0.84 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 48.5 t -155.79 154.47 31.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.919 -0.488 . . . . 0.0 110.138 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.69 -0.67 48.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.243 0.617 . . . . 0.0 110.155 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -90.13 -84.53 0.23 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.218 0.607 . . . . 0.0 110.082 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 48.96 17.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -155.47 168.63 26.5 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.5 t -149.53 -30.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.53 -11.04 14.51 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -92.11 54.41 2.37 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.937 0.495 . . . . 0.0 111.556 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -68.43 -10.74 57.3 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.56 0.344 . . . . 0.0 110.747 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.4 m -98.49 148.7 23.47 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.3 pt -128.98 149.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.335 0.654 . . . . 0.0 109.854 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -103.0 149.09 24.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.2 t -133.94 148.34 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.319 0.647 . . . . 0.0 110.892 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -139.14 151.09 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.1 5.34 59.56 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 120.013 -0.326 . . . . 0.0 112.797 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.5 mp -55.09 -55.22 33.51 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.428 0.614 . . . . 0.0 111.292 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.507 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.86 -176.99 44.62 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.03 -7.22 58.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.087 0.955 . . . . 0.0 112.368 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.29 -6.7 55.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.677 0.275 . . . . 0.0 110.805 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.73 159.76 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 163.63 39.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 44.3 mm -50.7 -37.1 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.009 0.924 . . . . 0.0 111.805 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -73.86 -28.59 61.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.251 -0.281 . . . . 0.0 110.991 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.6 t -74.0 -48.52 29.73 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 122.258 0.223 . . . . 0.0 110.548 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.825 HG21 HG21 ' A' ' 322' ' ' ILE . 2.3 m -61.71 -53.45 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.434 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -38.45 79.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.182 0.446 . . . . 0.0 110.884 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -75.33 -16.22 60.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 111.088 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -93.94 -27.56 16.29 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -96.85 -20.08 18.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.2 pttt -65.99 -19.09 65.74 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -173.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.4 pt20 -64.31 -21.24 66.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.2 mm -87.99 -23.66 6.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 162.2 169.74 25.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.06 138.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 122.535 -0.391 . . . . 0.0 111.178 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.462 HG21 HD11 ' A' ' 322' ' ' ILE . 7.3 mm -78.9 135.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.455 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 15.5 ttpp -70.04 139.18 52.64 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m -107.32 143.23 35.89 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -70.69 143.2 51.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.75 -13.2 59.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 316' ' ' LYS . 6.8 mmpt? -125.46 -36.35 2.47 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.12 0.418 . . . . 0.0 111.839 -174.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.4 p -85.84 -18.17 33.61 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.43 -16.49 3.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.468 0.556 . . . . 0.0 113.421 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -80.83 160.02 67.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 117.984 0.892 . . . . 0.0 109.813 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.64 152.39 80.62 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.927 1.752 . . . . 0.0 108.913 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.2 mtp -78.09 79.8 4.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.004 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.825 HG21 HG21 ' A' ' 301' ' ' VAL . 0.5 OUTLIER -132.67 152.16 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.328 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -146.42 126.44 13.69 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 36.0 mt -96.07 113.46 25.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -79.25 156.09 28.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 35.7 p -130.47 156.25 45.09 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.736 0.779 . . . . 0.0 112.855 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 122.73 20.15 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.577 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.23 -4.0 30.28 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.372 0.269 . . . . 0.0 111.164 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.82 -6.17 29.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.494 0.717 . . . . 0.0 112.742 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.9 t -150.68 -24.29 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.272 0.487 . . . . 0.0 111.247 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 88.37 19.61 51.83 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.6 -0.556 . . . . 0.0 113.05 172.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -122.61 169.5 10.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.965 0.883 . . . . 0.0 110.228 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.61 126.43 15.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.031 0.443 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.584 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.9 ttmm -76.61 -14.6 59.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.067 0.947 . . . . 0.0 109.173 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.03 -5.69 61.58 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -87.23 144.98 26.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.76 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.83 166.49 33.23 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.7 m -138.64 119.24 13.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.705 0.402 . . . . 0.0 111.353 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.65 125.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.9 t -96.94 132.91 42.26 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.06 -0.4 . . . . 0.0 110.301 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.89 147.28 23.26 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -73.69 -20.49 60.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -124.5 133.16 24.51 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 123.671 0.788 . . . . 0.0 110.706 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 26.2 Cg_endo -66.69 -33.78 34.07 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.724 2.283 . . . . 0.0 114.031 -175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 85.5 Cg_endo -76.84 -18.93 14.55 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 CA-C-N 121.214 1.469 . . . . 0.0 111.032 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 56.2 m -75.49 -29.72 59.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.38 -48.03 79.58 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -64.64 -39.04 93.01 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-O 120.595 0.236 . . . . 0.0 110.714 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.72 -39.32 84.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.392 0.277 . . . . 0.0 110.642 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.1 -26.15 65.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -72.79 -57.25 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.68 -22.27 61.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -93.13 -60.37 1.81 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.77 -31.55 69.55 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -56.75 113.24 1.56 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.005 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.33 37.68 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.169 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -96.5 -172.48 2.52 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.545 1.173 . . . . 0.0 110.027 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.96 175.6 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.843 0.354 . . . . 0.0 110.559 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.4 t80 -131.45 -39.41 1.14 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 17.0 t -141.53 19.69 2.2 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.798 0.439 . . . . 0.0 110.101 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.79 -8.29 34.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -111.49 146.77 35.32 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 123.881 0.872 . . . . 0.0 109.587 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.49 149.42 68.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.563 2.842 . . . . 0.0 110.846 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.75 169.72 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.924 0.49 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -135.83 156.5 48.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.127 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.4 t -144.7 147.55 19.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.09 0.556 . . . . 0.0 110.153 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 71.0 m -155.23 175.41 13.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.054 0.941 . . . . 0.0 108.833 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -59.8 163.81 4.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.412 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -136.04 141.73 44.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.3 m -144.94 139.04 27.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.838 0.855 . . . . 0.0 110.383 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -46.73 114.08 0.77 Allowed 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -72.8 -26.54 61.55 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.81 -30.85 71.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.446 -0.159 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.77 -8.27 14.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.48 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 96.6 m-85 -106.2 -11.66 15.99 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.05 -41.37 0.07 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -81.09 -3.14 50.98 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 72.73 45.07 36.49 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -59.86 -9.87 11.77 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.877 0.751 . . . . 0.0 112.969 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -75.6 -8.87 84.61 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 117.87 0.835 . . . . 0.0 111.814 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -70.52 169.52 14.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.284 0.634 . . . . 0.0 111.23 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -167.15 -166.74 26.76 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -142.57 159.37 42.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.974 0.51 . . . . 0.0 110.753 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -82.41 -177.11 51.74 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -174.11 155.35 21.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -70.95 119.84 15.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -79.74 151.14 33.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -71.18 150.85 44.95 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 71.54 1.39 44.43 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 CA-C-O 117.165 -1.908 . . . . 0.0 110.694 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 C4'-C3'-C2' 100.58 -2.12 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 N19-C1'-C2' 109.276 -2.577 . 0.865 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 C4'-C3'-C2' 100.116 -2.584 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C4'-C3'-C2' 100.13 -2.57 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 O4'-C1'-N19 110.635 2.435 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 O4'-C1'-N19 111.015 2.815 . 0.865 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 O4'-C1'-N19 110.971 2.771 . 0.735 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 C5'-C4'-C3' 111.755 -2.497 . 0.82 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.96 0 C5'-C4'-C3' 111.725 -2.517 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C5'-C4'-C3' 111.267 -2.822 . 0.611 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.46 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.963 0 C5'-C4'-C3' 111.473 -2.685 . 0.555 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.46 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 C5'-C4'-C3' 110.814 -3.124 . 0.425 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 C5'-C4'-C3' 109.998 -3.668 . 0.306 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . 0.4 " H1'" " O4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.253 1 O4'-C1'-N19 112.835 4.635 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.584 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 C5'-C4'-C3' 109.871 -3.752 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.412 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 C3'-C2'-C1' 105.637 4.597 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C5'-C4'-C3' 109.968 -3.688 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 C5'-C4'-C3' 109.565 -3.957 . 0.508 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.579 0 N19-C1'-C2' 109.651 -2.343 . 0.339 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 N19-C1'-C2' 109.646 -2.346 . 0.658 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 N19-C1'-C2' 109.668 -2.333 . 0.713 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 0 N19-C1'-C2' 109.954 -2.154 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 C5'-C4'-C3' 112.331 -2.112 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 O4'-C1'-N19 110.657 2.457 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 C4'-C3'-C2' 100.282 -2.418 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 O4'-C1'-N19 110.647 2.447 . 0.728 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 O4'-C1'-N19 110.425 2.225 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.66 0 O4'-C1'-N19 110.707 2.507 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 73.19 -171.69 50.81 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -64.18 -53.85 42.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -157.31 -178.96 7.74 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.128 0.971 . . . . 0.0 109.267 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.566 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.28 -7.54 25.09 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 119.774 -0.155 . . . . 0.0 111.323 176.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.31 -3.58 18.24 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.7 0.227 . . . . 0.0 111.152 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.96 5.7 89.07 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.18 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.74 -160.3 50.04 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.926 1.363 . . . . 0.0 110.404 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.44 19.84 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.81 3.007 . . . . 0.0 112.377 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 267' ' ' GLY . 59.5 ttt85 -78.05 -31.89 50.59 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.76 -0.588 . . . . 0.0 110.535 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -113.87 11.05 17.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.397 0.679 . . . . 0.0 111.84 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -11.46 58.22 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 84.93 -105.09 2.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 88.5 p -73.57 14.17 0.39 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -170.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -0.21 7.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.581 0.628 . . . . 0.0 112.644 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -95.19 -14.55 24.0 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.824 0.284 . . . . 0.0 110.989 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -126.57 6.16 6.85 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 43.1 t -152.65 152.76 32.15 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.644 0.259 . . . . 0.0 110.92 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -90.67 0.29 57.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.048 0.539 . . . . 0.0 110.613 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -90.89 -81.84 0.3 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.92 0.488 . . . . 0.0 110.284 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.95 15.47 0.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.572 1.549 . . . . 0.0 115.144 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -151.71 162.6 40.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.9 t -156.75 -32.55 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.372 0.13 . . . . 0.0 111.331 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -88.88 -0.53 57.45 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.56 153.52 32.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.485 0.714 . . . . 0.0 109.925 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -158.66 17.99 0.2 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.019 0.528 . . . . 0.0 110.525 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 26.7 m -132.71 150.79 52.11 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.662 0.385 . . . . 0.0 111.146 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.1 pt -128.42 148.84 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.876 0.47 . . . . 0.0 110.271 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -101.15 149.82 23.58 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.4 148.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.362 0.665 . . . . 0.0 110.902 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -138.77 149.53 45.11 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.47 5.59 57.83 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.971 -0.349 . . . . 0.0 112.869 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.91 -56.67 17.82 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 117.479 0.639 . . . . 0.0 111.408 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.452 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.86 -179.61 44.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.84 -10.0 59.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.626 0.77 . . . . 0.0 112.281 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -82.17 2.48 31.34 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.386 0.274 . . . . 0.0 111.553 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.91 155.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -158.49 168.91 25.65 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.7 mm -49.62 -40.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.391 1.077 . . . . 0.0 111.645 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.59 -28.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.449 -0.157 . . . . 0.0 110.876 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.7 t -75.08 -49.84 18.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.221 0.208 . . . . 0.0 110.611 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 322' ' ' ILE . 2.8 m -61.09 -53.71 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.441 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.04 -38.1 78.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.212 0.46 . . . . 0.0 110.718 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -76.07 -15.81 60.04 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -94.14 -27.63 16.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 339' ' ' VAL . 45.4 m-85 -97.23 -19.99 18.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -65.65 -19.05 65.75 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.27 -21.02 66.45 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -88.34 -26.04 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.732 0.301 . . . . 0.0 110.474 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.34 170.7 31.58 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 52.1 mm -68.4 134.63 29.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 O-C-N 122.662 -0.316 . . . . 0.0 111.348 -172.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 322' ' ' ILE . 6.8 mm -76.19 137.34 22.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.431 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.8 ttmm -67.78 147.37 52.68 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -121.96 138.05 54.56 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -71.59 145.78 48.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -81.29 -2.37 48.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -142.29 4.7 1.62 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.8 p -124.2 -18.25 5.91 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.31 -17.12 3.3 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.778 -0.457 . . . . 0.0 112.895 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -87.32 158.31 52.22 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 117.797 0.798 . . . . 0.0 109.862 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.7 153.87 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.173 1.915 . . . . 0.0 109.102 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.431 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.9 mtp -79.65 78.52 6.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 122.476 0.31 . . . . 0.0 111.001 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.809 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.6 156.86 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.36 0.664 . . . . 0.0 110.71 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -152.76 130.57 11.66 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.918 0.887 . . . . 0.0 109.455 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -94.07 119.49 33.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -84.03 160.09 21.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 42.7 p -135.76 159.07 42.77 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 121.763 0.792 . . . . 0.0 110.357 -171.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.27 124.59 23.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.588 172.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -72.27 -8.24 53.77 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.411 0.285 . . . . 0.0 111.681 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.96 -13.76 43.68 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.2 t -157.2 -18.93 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.97 61.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.19 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -91.1 162.83 14.52 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.237 1.019 . . . . 0.0 110.549 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -55.33 118.74 4.68 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.55 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -78.18 -19.51 53.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.526 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.52 0.22 59.46 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.81 149.44 21.98 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.396 0.598 . . . . 0.0 110.927 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.13 165.83 32.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.378 0.671 . . . . 0.0 109.75 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.0 m -136.9 121.74 18.73 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 305' ' ' PHE . 98.2 t -114.16 121.45 66.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.8 t -92.72 126.42 37.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.17 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -84.46 147.39 27.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.05 -14.81 59.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 94.0 m-20 -127.64 135.75 27.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 111.221 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.457 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 24.1 Cg_endo -65.82 -35.37 36.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.025 2.484 . . . . 0.0 114.422 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.8 Cg_endo -76.46 -20.34 14.16 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.719 1.613 . . . . 0.0 111.358 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -74.19 -30.67 62.33 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 122.297 -0.252 . . . . 0.0 110.431 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.73 93.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -65.07 -41.15 95.35 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 120.547 0.213 . . . . 0.0 110.834 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.98 86.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.354 0.262 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -25.08 64.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.6 mt -73.4 -56.59 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -60.36 -21.63 62.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -94.06 -59.92 1.86 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -70.78 -32.52 69.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.46 113.74 1.92 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.16 -17.09 32.14 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.949 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -93.76 -172.88 3.0 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.648 1.224 . . . . 0.0 109.808 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -100.33 173.72 6.46 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.34 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.613 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -127.31 -38.7 1.94 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.437 0.295 . . . . 0.0 110.277 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.6 t -143.2 6.61 1.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 110.363 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.48 -22.27 4.18 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.41 149.25 35.92 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 109.463 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.65 151.95 74.7 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.538 2.825 . . . . 0.0 110.388 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.62 168.28 21.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.076 0.55 . . . . 0.0 110.851 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 156.17 47.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.917 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 51.4 t -145.2 146.77 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 123.636 0.585 . . . . 0.0 110.224 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.0 m -155.26 171.65 19.48 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -59.01 162.24 4.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -138.29 144.59 40.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.228 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 10.7 m -148.38 139.88 23.55 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.404 1.082 . . . . 0.0 109.67 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -43.52 121.36 2.26 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.371 0.669 . . . . 0.0 110.806 -172.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -68.35 -32.94 73.4 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -175.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.16 -31.93 73.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.977 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -64.57 -10.53 26.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.564 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.5 m-85 -104.56 -13.73 15.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.94 -41.64 0.09 Allowed 'General case' 0 C--N 1.34 0.188 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -78.88 -0.29 30.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.69 11.57 79.41 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.93 52.78 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -72.9 165.4 54.75 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -158.17 172.28 18.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.07 -167.85 27.33 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -136.58 163.83 29.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.149 0.58 . . . . 0.0 109.99 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.02 149.72 46.49 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.75 42.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -73.9 170.7 14.84 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.606 0.362 . . . . 0.0 110.565 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -63.81 162.45 34.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -69.69 161.13 30.34 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.575 0.35 . . . . 0.0 110.647 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.71 86.66 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.917 -2.046 . . . . 0.0 110.368 179.503 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 C5'-C4'-C3' 110.854 -3.097 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 N19-C1'-C2' 109.523 -2.423 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.488 0 N19-C1'-C2' 109.156 -2.653 . 0.867 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 N19-C1'-C2' 109.263 -2.586 . 0.834 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.973 2.773 . 0.872 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 O4'-C1'-N19 110.927 2.727 . 0.874 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.764 0 O4'-C1'-N19 111.016 2.816 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 111.272 3.072 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C5'-C4'-C3' 111.792 -2.472 . 0.698 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.888 0 C5'-C4'-C3' 111.592 -2.605 . 0.643 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 C5'-C4'-C3' 111.074 -2.95 . 0.349 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 C5'-C4'-C3' 110.613 -3.258 . 0.248 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.448 1 C5'-C4'-C3' 109.349 -4.101 . 0.293 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.102 1 O4'-C1'-N19 112.611 4.411 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.55 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 C5'-C4'-C3' 110.109 -3.594 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.823 1 C3'-C2'-C1' 105.374 4.304 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.463 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 110.362 -3.425 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . 0.463 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 C5'-C4'-C3' 112.291 -2.14 . 0.168 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.26 0 C5'-C4'-C3' 110.8 -3.133 . 0.319 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 N19-C1'-C2' 109.001 -2.749 . 0.794 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.239 -2.6 . 0.79 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 N19-C1'-C2' 109.479 -2.451 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 C4'-C3'-C2' 100.41 -2.29 . 0.804 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 O4'-C1'-N19 110.548 2.348 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 C4'-C3'-C2' 100.192 -2.508 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.859 0 O4'-C1'-N19 110.826 2.626 . 0.757 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.521 2.321 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 110.779 2.579 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.76 174.11 46.45 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -60.93 -52.78 63.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -156.35 -179.73 8.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.048 0.939 . . . . 0.0 108.923 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.66 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -66.52 -10.33 43.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.752 -0.166 . . . . 0.0 111.214 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.59 -4.26 21.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.756 0.253 . . . . 0.0 111.245 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.34 5.68 84.9 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.495 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 68.08 -156.35 52.87 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.24 1.52 . . . . 0.0 110.088 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.17 22.6 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.913 3.075 . . . . 0.0 112.003 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -76.65 -41.22 46.5 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.852 -0.53 . . . . 0.0 110.908 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -104.5 8.3 35.52 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.732 0.413 . . . . 0.0 111.198 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -15.29 61.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.96 -117.47 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -79.05 17.1 0.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -6.53 6.94 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -85.48 -7.22 59.02 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.468 0.307 . . . . 0.0 111.021 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -146.1 20.7 1.41 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 36.7 t -154.81 143.17 20.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.51 0.324 . . . . 0.0 110.197 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.75 6.29 21.72 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.17 0.588 . . . . 0.0 110.211 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -103.34 -111.5 0.24 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . 0.25 2.9 m-20 50.17 23.87 1.28 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -152.42 161.25 42.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.2 p -154.27 -36.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 122.431 0.292 . . . . 0.0 110.522 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -98.39 14.09 29.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.106 0.562 . . . . 0.0 112.152 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -132.4 44.65 2.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.413 0.685 . . . . 0.0 111.346 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.69 -0.6 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.764 0.426 . . . . 0.0 111.361 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -98.79 148.44 23.89 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 11.1 pt -131.39 146.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.697 0.399 . . . . 0.0 110.575 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -100.78 149.6 23.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.87 147.32 30.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.111 0.564 . . . . 0.0 111.817 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.73 151.03 48.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 109.811 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.28 5.89 59.06 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 120.025 -0.319 . . . . 0.0 112.699 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.61 -57.68 10.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.397 0.679 . . . . 0.0 111.1 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.464 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.28 -178.57 44.71 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -77.89 -10.87 59.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.974 0.909 . . . . 0.0 112.109 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.02 0.2 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.25 0.22 . . . . 0.0 111.484 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.95 155.59 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.41 168.49 26.81 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.52 -39.73 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.897 0.879 . . . . 0.0 111.878 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.61 62.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.526 -0.109 . . . . 0.0 111.158 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.25 -49.52 19.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.729 -0.1 . . . . 0.0 110.729 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.821 HG21 HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.56 -53.88 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.36 -37.44 77.92 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.249 0.477 . . . . 0.0 110.804 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -76.07 -15.83 60.04 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 111.099 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.56 -26.96 16.18 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.6 m-85 -97.17 -20.22 18.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -65.68 -18.85 65.63 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.6 pt20 -64.44 -21.16 66.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.6 mm -87.96 -25.47 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 110.161 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.92 170.28 29.67 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.91 135.24 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 O-C-N 122.478 -0.425 . . . . 0.0 111.135 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.477 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -76.01 138.08 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -69.15 148.97 49.16 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m -122.57 134.51 54.53 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -74.09 134.74 42.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.47 -22.23 59.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.592 0.357 . . . . 0.0 111.173 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -101.34 -9.06 21.51 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 p -130.13 -17.6 3.43 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.03 -15.69 5.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.273 0.463 . . . . 0.0 113.557 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.19 159.71 56.11 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 117.968 0.884 . . . . 0.0 109.619 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.9 151.96 81.57 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.845 1.697 . . . . 0.0 109.005 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.9 mtp -77.91 78.69 4.4 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.77 0.428 . . . . 0.0 111.206 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.821 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.25 155.3 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 0.0 110.527 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -150.24 121.89 8.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.524 0.73 . . . . 0.0 109.326 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -88.14 121.67 30.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.632 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 73.9 m-85 -77.64 162.83 26.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.8 p -140.18 157.3 45.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -67.22 117.39 9.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.206 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -68.4 -7.75 34.38 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -14.37 51.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 13.8 t -156.22 -20.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.87 57.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.26 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -91.89 162.08 14.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 118.492 1.146 . . . . 0.0 110.56 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -54.66 120.44 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.367 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.615 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -77.47 -18.86 56.73 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.087 0.555 . . . . 0.0 109.783 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.61 16.62 36.11 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.37 156.83 31.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.783 0.791 . . . . 0.0 110.23 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.74 171.2 19.96 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.802 0.441 . . . . 0.0 110.262 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 70.8 m -136.33 129.07 30.82 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.8 t -118.67 127.89 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.5 t -98.98 127.91 45.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.997 0.362 . . . . 0.0 110.513 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.18 147.95 26.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -75.85 -17.26 59.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 91.2 m-20 -127.54 133.89 25.59 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.979 0.912 . . . . 0.0 110.987 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.465 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -66.64 -33.79 34.54 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.646 2.231 . . . . 0.0 114.463 -175.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 88.7 Cg_endo -74.81 -19.79 18.0 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 CA-C-N 121.052 1.412 . . . . 0.0 110.843 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.9 m -75.89 -29.45 58.47 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.32 -0.237 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.47 73.34 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -65.33 -36.99 85.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.425 0.155 . . . . 0.0 110.593 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.38 82.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.493 0.317 . . . . 0.0 110.943 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.55 65.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.81 -56.09 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.69 -22.08 63.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -93.92 -59.99 1.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.82 -32.76 71.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.03 110.74 0.87 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.41 -16.09 24.57 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.035 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.6 -171.52 2.39 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.824 1.312 . . . . 0.0 109.902 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.53 173.94 6.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.664 0.269 . . . . 0.0 110.322 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.6 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.1 t80 -128.44 -37.44 1.81 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.608 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -145.0 11.05 1.35 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.682 0.393 . . . . 0.0 109.988 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.47 -20.3 6.18 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -103.12 148.64 35.94 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 151.97 75.13 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.388 2.725 . . . . 0.0 110.451 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.18 167.74 21.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.873 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.15 156.47 46.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.803 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.68 146.48 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.047 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 47.1 m -155.05 174.23 15.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.19 150.66 29.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.528 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -120.63 137.31 54.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 7.6 m -141.95 134.17 27.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.255 0.622 . . . . 0.0 110.599 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -46.29 110.33 0.26 Allowed 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.358 0.663 . . . . 0.0 110.489 -170.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.435 HH21 ' P ' ' B' ' 105' ' ' ' U' . 0.6 OUTLIER -70.17 -29.35 66.21 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.155 -174.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.31 -31.66 72.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 110.743 -0.095 . . . . 0.0 110.743 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -65.44 -10.45 34.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.56 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.5 m-85 -104.04 -10.52 17.99 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.45 -43.55 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -77.31 -5.14 48.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.273 0.488 . . . . 0.0 111.909 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.46 12.13 76.26 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.34 -176.22 53.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.63 168.92 54.5 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.48 170.8 20.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -162.52 166.58 36.68 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -77.07 173.58 11.66 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 122.745 0.418 . . . . 0.0 110.238 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -78.73 151.87 36.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.65 162.2 37.5 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -77.64 159.97 28.82 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.302 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -77.37 179.54 50.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -134.59 164.18 28.06 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 179.98 179.0 48.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.371 -1.794 . . . . 0.0 110.584 179.926 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 110.867 -3.089 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 109.22 -2.613 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 N19-C1'-C2' 109.119 -2.676 . 0.863 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 N19-C1'-C2' 109.41 -2.494 . 0.842 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 O4'-C1'-N19 110.861 2.661 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 0 O4'-C1'-N19 110.905 2.705 . 0.826 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 O4'-C1'-N19 110.702 2.502 . 0.801 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.992 0 O4'-C1'-N19 111.129 2.929 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 111.358 -2.761 . 0.755 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.678 0 C5'-C4'-C3' 111.116 -2.923 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 C5'-C4'-C3' 110.877 -3.082 . 0.302 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C5'-C4'-C3' 110.066 -3.623 . 0.242 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.706 -3.863 . 0.254 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . 0.405 " H1'" " O4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.427 -2.174 1 O4'-C1'-N19 112.995 4.795 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.632 " H1'" ' CD1' ' A' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.332 1 C5'-C4'-C3' 109.288 -4.141 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.528 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.593 1 C3'-C2'-C1' 105.886 4.874 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 109.924 -3.718 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C5'-C4'-C3' 109.965 -3.69 . 0.431 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 C5'-C4'-C3' 110.479 -3.347 . 0.063 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 N19-C1'-C2' 109.301 -2.562 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 N19-C1'-C2' 109.251 -2.593 . 0.773 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C4'-C3'-C2' 100.405 -2.295 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 C5'-C4'-C3' 111.96 -2.36 . 0.759 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 110.581 2.381 . 0.76 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 110.81 2.61 . 0.686 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O4'-C1'-N19 110.98 2.78 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 O4'-C1'-N19 110.803 2.603 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 O4'-C1'-N19 110.762 2.562 . 0.813 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.01 -177.68 48.4 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.11 176.29 3.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -68.18 -174.97 0.55 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.41 0.684 . . . . 0.0 110.655 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.637 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -63.64 -14.8 55.24 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.273 0.629 . . . . 0.0 112.156 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -96.93 -5.82 37.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.217 0.462 . . . . 0.0 111.262 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.03 79.49 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.06 -0.856 . . . . 0.0 114.509 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.66 -159.49 50.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.242 1.521 . . . . 0.0 110.818 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.97 18.85 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.486 2.791 . . . . 0.0 112.775 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.1 ttp180 -74.47 -41.36 60.91 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.846 -0.534 . . . . 0.0 110.254 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -106.2 11.84 30.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.178 0.591 . . . . 0.0 110.89 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -9.68 53.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.84 -106.1 2.82 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.8 p -73.62 13.13 0.52 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -1.76 10.02 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -91.05 -15.81 28.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.739 0.245 . . . . 0.0 110.969 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -127.98 7.69 6.12 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.0 t -152.55 155.51 37.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.488 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -95.87 1.73 53.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.09 0.556 . . . . 0.0 110.309 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -89.89 -83.01 0.25 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 49.22 15.99 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.46 170.83 21.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 83.7 p -149.39 -33.7 0.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.515 -0.116 . . . . 0.0 111.229 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -113.94 1.35 14.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.25 0.62 . . . . 0.0 112.194 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -95.72 35.15 1.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.303 0.641 . . . . 0.0 109.715 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -68.27 -0.03 4.31 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.923 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.6 m -101.74 150.2 23.38 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.89 147.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 122.545 0.338 . . . . 0.0 110.101 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -102.57 147.94 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.28 147.53 31.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.076 0.551 . . . . 0.0 112.079 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -138.71 151.3 47.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.84 59.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.84 -57.08 13.54 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.359 0.664 . . . . 0.0 111.033 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.457 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.43 -178.05 45.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.62 -10.65 59.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.849 0.86 . . . . 0.0 112.178 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -80.54 -0.55 38.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.321 -0.237 . . . . 0.0 111.234 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.29 156.28 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.06 168.39 26.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.3 mm -48.67 -39.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 124.421 1.088 . . . . 0.0 111.861 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.92 -29.75 63.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.345 -0.222 . . . . 0.0 111.217 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.05 -48.61 23.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.154 0.182 . . . . 0.0 110.679 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.57 -54.22 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.446 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.44 -37.8 79.04 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.969 -0.457 . . . . 0.0 110.875 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.95 -15.82 60.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.252 -0.28 . . . . 0.0 110.932 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -94.32 -27.54 16.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.426 ' CD2' HG21 ' A' ' 339' ' ' VAL . 44.3 m-85 -96.59 -19.91 18.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.2 pttt -66.35 -18.63 65.47 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -173.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.404 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.74 -20.82 66.56 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.7 mm -87.93 -26.28 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.14 170.48 31.11 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.05 134.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 122.58 -0.365 . . . . 0.0 111.299 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.468 HG21 HD11 ' A' ' 322' ' ' ILE . 7.7 mm -76.3 138.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.438 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.7 ttmm -69.08 148.58 49.81 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 134.51 42.68 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -76.27 150.66 36.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.73 -18.05 52.1 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.39 -34.09 5.06 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 4.2 p -73.94 -22.0 59.83 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 70.96 17.05 75.16 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -139.4 158.47 68.67 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-N 117.35 0.575 . . . . 0.0 109.695 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 155.03 61.98 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.518 2.145 . . . . 0.0 109.935 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.7 mtp -79.28 77.44 5.81 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 122.791 0.436 . . . . 0.0 110.81 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.816 HG21 HG21 ' A' ' 301' ' ' VAL . 0.5 OUTLIER -130.91 159.26 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.428 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -155.93 124.73 6.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.787 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -90.13 120.96 31.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.473 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 70.1 m-85 -73.36 162.68 29.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.518 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 39.5 p -140.79 155.78 46.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.656 0.741 . . . . 0.0 109.33 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -64.57 123.86 20.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.887 172.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.38 -6.76 45.7 Favored 'General case' 0 N--CA 1.458 -0.045 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.13 -15.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.2 t -156.24 -17.78 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 92.07 10.69 60.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.944 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -90.72 163.66 14.41 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 118.17 0.985 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -54.65 120.83 7.29 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.537 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -77.7 -19.43 55.3 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.708 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.457 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.0 18.86 28.12 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.7 156.08 38.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.417 0.609 . . . . 0.0 110.553 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.96 173.48 16.42 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.71 0.404 . . . . 0.0 110.288 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.0 m -139.92 128.14 22.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 122.658 0.383 . . . . 0.0 109.969 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 305' ' ' PHE . 94.6 t -118.11 127.12 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 124.024 0.93 . . . . 0.0 109.064 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.6 t -97.68 128.01 44.05 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.89 -0.506 . . . . 0.0 110.207 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -85.64 147.26 26.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -76.24 -18.2 59.13 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -124.88 133.36 24.73 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 123.704 0.802 . . . . 0.0 110.72 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.4 Cg_endo -66.24 -34.31 36.51 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.818 2.346 . . . . 0.0 114.215 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.79 -19.54 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 121.168 1.453 . . . . 0.0 111.104 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 41.9 m -75.55 -30.52 59.75 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.26 78.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.58 -0.075 . . . . 0.0 110.799 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -64.28 -38.88 92.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.553 0.216 . . . . 0.0 110.954 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.68 83.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.372 0.269 . . . . 0.0 110.611 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.66 66.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.19 -57.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.26 -21.19 61.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -94.31 -60.3 1.76 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.85 -31.76 69.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -57.26 111.05 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.7 25.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.127 -0.818 . . . . 0.0 113.106 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.5 -171.8 2.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.674 1.237 . . . . 0.0 109.908 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.75 171.26 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.595 0.358 . . . . 0.0 110.447 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.606 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.4 t80 -127.19 -38.28 1.99 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.382 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.7 t -144.33 15.28 1.65 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.648 0.379 . . . . 0.0 110.098 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.64 -19.43 8.48 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.54 148.69 36.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.01 151.73 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 0.0 110.677 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.1 pt -138.32 168.11 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 121.267 0.556 . . . . 0.0 110.66 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -133.62 155.45 49.64 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.17 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.8 t -144.35 147.04 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 122.867 0.467 . . . . 0.0 110.417 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.4 m -153.6 174.43 14.46 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -60.61 159.08 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.638 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -132.11 138.19 48.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 4.3 m -143.73 137.81 28.39 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.414 0.686 . . . . 0.0 109.893 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -43.81 109.71 0.16 Allowed 'General case' 0 C--N 1.338 0.074 0 C-N-CA 122.635 0.374 . . . . 0.0 110.977 -171.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -25.39 59.44 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.44 -30.1 70.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 122.441 -0.162 . . . . 0.0 110.676 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -67.22 -11.47 57.5 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.545 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 95.8 m-85 -98.92 -10.53 22.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.23 -40.97 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -81.78 1.86 32.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.262 0.483 . . . . 0.0 112.074 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 86.06 8.14 79.31 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 80.98 7.3 88.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 117.496 0.648 . . . . 0.0 112.035 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 83.92 165.76 39.34 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 117.497 0.649 . . . . 0.0 111.64 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.74 177.67 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 0.0 110.11 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -163.59 156.53 28.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -78.49 162.62 26.22 Favored 'General case' 0 CA--C 1.523 -0.079 0 O-C-N 122.669 -0.312 . . . . 0.0 110.262 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.05 151.64 49.16 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -80.1 173.94 55.0 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -65.15 150.72 47.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.749 0.42 . . . . 0.0 109.901 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -61.04 142.91 48.62 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -160.24 156.34 26.33 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.495 0.318 . . . . 0.0 110.343 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.92 40.78 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.006 -1.997 . . . . 0.0 110.911 178.86 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 C5'-C4'-C3' 111.039 -2.974 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.402 0 N19-C1'-C2' 109.633 -2.354 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 N19-C1'-C2' 109.138 -2.664 . 0.833 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.696 0 C4'-C3'-C2' 100.11 -2.59 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 0 C5'-C4'-C3' 111.41 -2.727 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 111.131 2.931 . 0.932 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 111.139 2.939 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 O4'-C1'-N19 111.285 3.085 . 0.76 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 C5'-C4'-C3' 111.903 -2.398 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 0 C5'-C4'-C3' 111.271 -2.819 . 0.614 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.407 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 C5'-C4'-C3' 111.687 -2.542 . 0.596 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.407 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 110.428 -3.381 . 0.384 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 1 C5'-C4'-C3' 109.453 -4.031 . 0.277 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.3 1 O4'-C1'-N19 112.679 4.479 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.537 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.062 1 C5'-C4'-C3' 109.48 -4.013 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.638 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.423 -2.478 1 C3'-C2'-C1' 105.7 4.667 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.802 0 C5'-C4'-C3' 110.321 -3.453 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 1 C5'-C4'-C3' 109.29 -4.14 OUTLIER-DELTA 0.065 2h . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 C5'-C4'-C3' 110.087 -3.609 . 0.0 OUTLIER '7D dist 1c' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 N19-C1'-C2' 109.339 -2.538 . 0.64 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.58 0 N19-C1'-C2' 109.07 -2.706 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 C4'-C3'-C2' 100.365 -2.335 . 0.667 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 C4'-C3'-C2' 100.389 -2.311 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 110.924 2.724 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.553 0 O4'-C1'-N19 110.846 2.646 . 0.731 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.705 0 O4'-C1'-N19 110.827 2.627 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 O4'-C1'-N19 110.253 2.053 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.659 2.459 . 0.843 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.88 -175.66 46.09 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -70.62 176.89 3.81 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -65.73 -177.94 0.51 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.271 1.028 . . . . 0.0 110.713 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.587 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -65.13 -14.02 59.53 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -94.92 -5.65 44.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.052 0.387 . . . . 0.0 111.651 175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.05 11.74 78.15 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.321 170.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 68.03 -160.61 50.4 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 118.792 1.296 . . . . 0.0 110.82 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.54 21.8 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.871 3.048 . . . . 0.0 112.308 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 267' ' ' GLY . 63.1 ttm-85 -79.09 -33.36 44.54 Favored 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.677 -0.64 . . . . 0.0 110.377 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -110.05 9.3 24.2 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.074 0.55 . . . . 0.0 112.047 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -7.83 35.81 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 86.85 -104.57 2.95 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 86.5 p -77.21 18.32 0.4 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.66 ' H ' ' HD3' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -68.48 -3.04 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.304 0.502 . . . . 0.0 112.315 -175.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -96.97 -12.98 22.66 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.614 0.365 . . . . 0.0 111.32 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -125.25 5.35 7.78 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.7 t -154.75 158.48 39.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.62 -1.04 47.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.02 0.528 . . . . 0.0 110.248 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -87.04 -81.37 0.23 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.976 0.51 . . . . 0.0 110.125 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 48.62 15.68 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -156.7 167.7 29.66 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.249 0.477 . . . . 0.0 110.21 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 -36.11 0.08 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.285 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -93.76 8.11 42.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -127.76 47.07 2.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.188 0.595 . . . . 0.0 111.528 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -69.12 -1.79 8.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.228 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.8 m -99.42 147.8 24.89 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.3 pt -129.47 150.07 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 122.842 0.457 . . . . 0.0 110.115 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -105.02 149.44 25.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.0 t -134.16 148.82 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 123.219 0.607 . . . . 0.0 111.288 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -138.31 150.9 47.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.46 59.08 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 120.079 -0.289 . . . . 0.0 113.165 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.63 -55.84 28.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.14 0.576 . . . . 0.0 111.254 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.471 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.52 179.99 47.88 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.22 -11.42 59.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.74 0.816 . . . . 0.0 112.219 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.86 0.49 34.88 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.427 0.291 . . . . 0.0 111.323 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.59 155.24 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 112.666 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.4 168.16 28.14 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.7 mm -49.83 -39.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.294 1.037 . . . . 0.0 111.615 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -74.04 -28.47 61.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 121.254 -0.179 . . . . 0.0 111.011 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.6 t -75.44 -48.06 24.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.786 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.4 -53.58 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.43 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.89 -37.59 76.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.264 0.483 . . . . 0.0 110.898 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -76.41 -15.09 60.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.45 0.3 . . . . 0.0 111.219 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -95.09 -27.22 15.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -96.44 -20.32 18.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.9 pttt -65.56 -18.74 65.55 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.4 pt20 -64.56 -21.55 66.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.3 mm -88.32 -24.12 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.765 0.316 . . . . 0.0 110.28 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.27 169.42 27.8 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.85 135.76 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.516 0.327 . . . . 0.0 111.186 -172.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 322' ' ' ILE . 7.4 mm -77.03 137.27 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.417 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 36.9 ttmt -70.86 149.92 46.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.623 0.249 . . . . 0.0 110.485 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.2 m -127.22 135.4 50.59 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -73.15 158.53 35.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -86.16 -4.66 59.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -146.27 -5.29 0.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.0 p -86.06 -20.82 28.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.805 0.729 . . . . 0.0 112.87 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.94 16.7 78.29 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.21 159.73 48.16 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 117.367 0.583 . . . . 0.0 109.732 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.55 155.49 47.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.312 2.008 . . . . 0.0 109.51 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.417 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 36.9 mtp -77.16 77.64 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.614 0.366 . . . . 0.0 111.118 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.786 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -135.63 158.3 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.724 -178.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -156.69 131.7 9.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.5 mm? -92.28 122.12 34.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -84.37 158.89 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 29.1 p -134.79 151.96 51.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.471 0.653 . . . . 0.0 112.603 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.66 134.52 56.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.954 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -8.92 58.19 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.676 0.39 . . . . 0.0 111.374 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.24 -4.3 25.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.282 0.633 . . . . 0.0 112.572 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.0 t -150.85 -22.38 0.22 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.706 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.28 24.84 50.22 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.709 -0.495 . . . . 0.0 112.508 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -132.22 170.53 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.784 0.792 . . . . 0.0 110.266 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -45.43 121.35 2.94 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.77 0.828 . . . . 0.0 111.356 -173.274 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.526 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -81.17 -19.7 42.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.987 0.915 . . . . 0.0 109.418 174.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.66 -0.88 59.69 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.55 150.31 21.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.344 0.572 . . . . 0.0 110.927 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.59 165.75 33.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.12 0.568 . . . . 0.0 109.606 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 122.74 20.61 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.02 125.65 73.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.8 t -98.06 129.48 44.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.557 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -87.24 147.74 25.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.02 -18.66 60.3 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -126.37 131.91 24.12 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 110.539 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 34.8 Cg_endo -67.71 -32.16 30.88 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.737 2.292 . . . . 0.0 114.347 -175.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -75.29 -19.65 17.06 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 121.411 1.54 . . . . 0.0 110.833 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -76.39 -29.76 57.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.647 0.203 . . . . 0.0 110.556 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.94 72.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -63.64 -38.81 92.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.484 0.183 . . . . 0.0 110.864 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.88 81.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.296 0.239 . . . . 0.0 110.894 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.22 65.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.25 -56.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.77 -21.24 62.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -93.83 -59.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.72 -32.56 71.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -56.59 112.27 1.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.19 -16.0 30.18 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.008 -0.884 . . . . 0.0 113.114 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -95.01 -172.63 2.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.75 1.275 . . . . 0.0 109.813 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.26 174.37 6.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.882 0.372 . . . . 0.0 110.47 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.614 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.5 t80 -129.95 -38.64 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.162 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.9 t -143.3 13.46 1.8 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.07 0.462 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.61 -22.37 7.79 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.97 147.97 33.82 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.37 151.6 76.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.256 2.637 . . . . 0.0 110.522 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.614 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.61 168.83 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.001 0.52 . . . . 0.0 110.911 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -133.89 156.73 47.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.6 t -144.78 146.65 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 123.703 0.627 . . . . 0.0 109.983 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 68.5 m -155.36 175.13 14.26 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.0 108.858 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -59.14 160.35 6.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -128.58 137.58 51.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 14.2 m -140.74 135.69 31.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.734 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -48.03 118.16 2.24 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 123.247 0.342 . . . . 0.0 110.217 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.41 72.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.41 73.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.306 0.242 . . . . 0.0 111.136 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -66.66 -10.68 48.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.587 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.9 m-85 -102.4 -11.49 18.58 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.95 -40.84 0.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.3 -1.78 46.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.193 0.451 . . . . 0.0 112.012 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 86.15 14.94 65.67 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.74 -173.27 55.09 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -78.48 149.39 33.57 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -151.54 167.32 28.43 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.717 0.807 . . . . 0.0 110.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -172.46 170.53 43.58 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -76.75 168.45 20.07 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.918 0.487 . . . . 0.0 111.112 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -73.71 178.31 42.83 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -73.51 166.39 54.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -156.0 155.04 32.03 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.265 0.626 . . . . 0.0 109.428 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -68.78 159.33 52.53 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -60.84 125.94 25.56 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.648 0.779 . . . . 0.0 110.135 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.7 45.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 117.176 -1.902 . . . . 0.0 110.952 -178.073 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 C5'-C4'-C3' 110.812 -3.126 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 N19-C1'-C2' 109.249 -2.594 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 N19-C1'-C2' 109.336 -2.54 . 0.856 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 N19-C1'-C2' 109.177 -2.64 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 O4'-C1'-N19 111.044 2.844 . 0.84 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 O4'-C1'-N19 110.916 2.716 . 0.91 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.766 0 O4'-C1'-N19 111.026 2.826 . 0.783 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 O4'-C1'-N19 110.512 2.312 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.04 0 C5'-C4'-C3' 111.692 -2.539 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 110.908 -3.061 . 0.562 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.423 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.56 0 C5'-C4'-C3' 111.273 -2.818 . 0.435 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.423 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 C5'-C4'-C3' 110.369 -3.42 . 0.383 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C5'-C4'-C3' 109.642 -3.906 . 0.29 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.116 1 O4'-C1'-N19 112.763 4.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.526 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.855 -3.763 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.999 1 C3'-C2'-C1' 105.549 4.498 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 C5'-C4'-C3' 109.847 -3.769 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.328 0 C5'-C4'-C3' 110.47 -3.354 . 0.584 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.379 0 N19-C1'-C2' 109.631 -2.356 . 0.507 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 N19-C1'-C2' 109.183 -2.636 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.647 0 N19-C1'-C2' 109.178 -2.639 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 C4'-C3'-C2' 100.257 -2.443 . 0.706 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.528 0 C5'-C4'-C3' 112.061 -2.293 . 0.8 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 O4'-C1'-N19 110.698 2.498 . 0.766 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 110.752 2.552 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 O4'-C1'-N19 110.869 2.669 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 O4'-C1'-N19 110.374 2.174 . 0.834 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 110.644 2.444 . 0.843 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.46 -178.6 48.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.89 -53.51 53.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -157.49 -178.53 7.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.971 0.908 . . . . 0.0 108.652 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.581 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.6 -8.68 36.37 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.341 -0.224 . . . . 0.0 111.589 176.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -106.56 -4.31 19.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.428 0.156 . . . . 0.0 110.776 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 86.38 0.63 86.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.219 -0.767 . . . . 0.0 114.825 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 65.77 -163.67 40.11 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 119.332 1.566 . . . . 0.0 110.507 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.55 23.51 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.018 3.145 . . . . 0.0 112.388 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -75.07 -26.89 59.7 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.856 -0.528 . . . . 0.0 111.03 -173.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -137.45 21.53 2.94 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.018 0.527 . . . . 0.0 111.331 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -7.86 7.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.273 0.629 . . . . 0.0 112.51 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 93.44 -112.56 4.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 14.9 t -75.8 17.48 0.31 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.472 0.709 . . . . 0.0 112.815 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -5.33 18.16 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 121.65 -0.656 . . . . 0.0 112.259 -176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -86.25 -6.93 58.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.441 0.296 . . . . 0.0 111.144 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -150.72 25.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 46.2 t -152.44 148.5 27.51 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -91.13 4.86 51.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.074 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -102.59 -88.98 0.39 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.695 0.398 . . . . 0.0 110.512 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.8 p30 48.68 16.61 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.412 1.485 . . . . 0.0 114.639 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.39 160.7 43.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.6 t -157.09 -34.28 0.08 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.296 0.094 . . . . 0.0 110.949 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.33 5.27 35.46 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -124.08 154.94 39.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.681 0.792 . . . . 0.0 109.699 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -158.97 15.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.647 0.379 . . . . 0.0 110.548 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.7 m -131.51 151.14 51.83 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.577 0.351 . . . . 0.0 111.223 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.7 pt -126.6 148.82 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.063 0.545 . . . . 0.0 110.429 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -100.78 150.11 23.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.36 149.4 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.383 0.673 . . . . 0.0 111.042 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -139.75 150.22 44.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.97 58.28 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.954 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.4 ' HB3' HG21 ' A' ' 296' ' ' VAL . 5.0 mp -55.63 -54.07 48.69 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.504 0.652 . . . . 0.0 111.678 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.51 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.59 -176.26 44.54 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -171.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -85.67 -7.23 58.93 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.551 0.741 . . . . 0.0 112.537 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -79.29 -2.69 42.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.431 -0.168 . . . . 0.0 111.056 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 292' ' ' LEU . 1.6 t -97.74 158.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.769 0.828 . . . . 0.0 112.695 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.64 167.59 29.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.32 -39.73 17.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 124.344 1.057 . . . . 0.0 111.724 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.03 -29.07 63.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.248 -0.282 . . . . 0.0 111.094 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.6 -50.51 17.61 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 122.316 0.247 . . . . 0.0 110.479 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.805 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -60.86 -53.92 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.437 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -37.46 77.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 0.519 . . . . 0.0 110.921 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -75.9 -17.38 59.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 111.014 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -92.92 -26.77 17.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.4 m-85 -98.02 -20.08 17.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.5 pttt -66.11 -18.79 65.57 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.406 0.283 . . . . 0.0 111.649 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -64.41 -20.38 66.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -88.97 -26.06 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.759 0.254 . . . . 0.0 110.456 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.18 170.37 31.0 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.62 134.36 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 111.254 -172.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 322' ' ' ILE . 8.3 mm -74.5 138.77 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.75 151.61 46.94 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m -134.04 135.92 43.67 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -74.7 160.28 30.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -92.41 -0.27 57.38 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -147.13 -5.18 0.52 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.3 p -88.05 -21.6 24.66 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 74.44 16.29 80.03 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -143.28 160.35 52.17 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 117.388 0.594 . . . . 0.0 109.706 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.21 155.69 55.04 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.34 2.027 . . . . 0.0 109.812 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.9 mtp -77.62 75.93 4.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.044 0.538 . . . . 0.0 110.813 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.805 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.19 155.6 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.939 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -153.19 130.71 11.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.135 0.974 . . . . 0.0 109.017 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.6 mm? -93.73 118.33 31.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.1 157.32 24.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 31.5 p -130.25 156.87 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -72.48 127.87 33.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.35 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -73.32 -5.06 37.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.066 0.547 . . . . 0.0 111.284 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.51 -5.95 23.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.7 t -151.0 -23.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.23 0.468 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.78 50.1 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.984 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -127.85 171.13 12.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.883 0.841 . . . . 0.0 109.781 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 293' ' ' GLY . 4.8 mt -49.87 126.8 14.9 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.182 0.515 . . . . 0.0 110.991 -172.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.558 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.6 ttmm -76.69 -13.63 60.03 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.056 0.942 . . . . 0.0 109.577 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.84 -5.22 66.37 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.94 147.44 25.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.006 0.403 . . . . 0.0 111.072 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.05 165.81 34.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.0 m -137.28 122.13 18.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.277 0.231 . . . . 0.0 111.046 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 305' ' ' PHE . 95.5 t -115.64 120.7 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 29.9 t -91.78 136.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.903 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -95.11 145.78 24.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.12 -15.2 61.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.419 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 88.2 m-20 -129.38 135.18 27.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.686 0.794 . . . . 0.0 111.433 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 22.8 Cg_endo -66.74 -33.77 33.59 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.837 2.358 . . . . 0.0 114.414 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.3 Cg_endo -76.91 -18.32 14.86 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.517 1.478 . . . . 0.0 111.307 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.7 m -76.33 -29.88 57.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.66 85.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.403 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.5 tptm -64.13 -40.86 97.08 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.457 0.17 . . . . 0.0 110.827 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.12 85.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.48 0.312 . . . . 0.0 110.68 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.77 -25.2 64.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 348' ' ' LYS . 63.7 mt -72.95 -57.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.41 -20.59 60.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -95.23 -60.53 1.65 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -69.69 -32.16 70.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.93 113.14 1.74 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.28 -15.82 32.66 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.893 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -95.04 -172.56 2.72 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.709 1.255 . . . . 0.0 109.838 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -101.18 173.7 6.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.612 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.9 t80 -128.06 -39.08 1.77 Allowed 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.9 t -143.07 8.49 1.65 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.729 0.412 . . . . 0.0 110.117 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.48 -20.62 5.21 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -102.86 149.3 36.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.24 150.55 76.71 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.359 2.706 . . . . 0.0 110.595 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -136.33 168.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-O 121.068 0.461 . . . . 0.0 110.763 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -131.79 156.87 45.24 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 54.4 t -145.71 146.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 110.396 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.4 m -154.53 172.71 17.36 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.06 162.91 6.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.216 -0.302 . . . . 0.0 111.771 170.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.425 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -137.16 144.8 43.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.81 0.338 . . . . 0.0 111.054 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 26.4 m -146.08 140.45 26.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.085 0.954 . . . . 0.0 109.359 175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -47.36 120.2 3.08 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.605 0.362 . . . . 0.0 110.532 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -32.95 73.91 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.043 0.537 . . . . 0.0 109.663 -175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.01 -32.01 73.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.142 0.177 . . . . 0.0 111.073 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.09 -9.29 21.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.502 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.3 m-85 -105.93 -13.08 15.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.98 -41.41 0.09 Allowed 'General case' 0 C--N 1.341 0.196 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -79.74 -1.76 40.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.169 0.441 . . . . 0.0 111.934 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.67 75.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.25 -174.9 54.63 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -73.22 166.58 54.54 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -157.46 172.31 18.79 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 169.14 -172.53 43.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -146.29 161.63 39.88 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.565 0.746 . . . . 0.0 110.057 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.05 163.12 29.12 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -176.24 160.99 29.11 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -155.5 167.6 29.85 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 122.904 0.482 . . . . 0.0 110.159 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -77.82 157.08 45.01 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -69.99 134.09 47.94 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.83 0.452 . . . . 0.0 110.313 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -103.88 -10.6 34.54 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.115 -1.936 . . . . 0.0 110.807 179.776 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 C5'-C4'-C3' 110.645 -3.237 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.711 0 N19-C1'-C2' 109.429 -2.482 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 C4'-C3'-C2' 100.037 -2.663 . 0.83 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.608 0 N19-C1'-C2' 109.202 -2.624 . 0.833 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 C5'-C4'-C3' 111.437 -2.708 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 O4'-C1'-N19 111.147 2.947 . 0.894 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 O4'-C1'-N19 110.865 2.665 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.527 0 O4'-C1'-N19 111.324 3.124 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.854 0 O4'-C1'-N19 111.057 2.857 . 0.426 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 C5'-C4'-C3' 111.507 -2.662 . 0.663 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.655 0 C5'-C4'-C3' 111.358 -2.761 . 0.494 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.371 0 C5'-C4'-C3' 110.759 -3.161 . 0.394 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.772 1 C5'-C4'-C3' 109.083 -4.278 . 0.267 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.104 1 O4'-C1'-N19 112.621 4.421 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.558 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 C5'-C4'-C3' 109.731 -3.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.425 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.866 1 C3'-C2'-C1' 105.86 4.844 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.599 0 C5'-C4'-C3' 110.105 -3.597 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.379 0 C5'-C4'-C3' 110.225 -3.516 . 0.532 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 N19-C1'-C2' 109.162 -2.649 . 0.496 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 N19-C1'-C2' 109.528 -2.42 . 0.711 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 109.76 -2.275 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.255 0 N19-C1'-C2' 109.462 -2.461 . 0.722 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.487 -2.213 . 0.813 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 O4'-C1'-N19 110.916 2.716 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.748 2.548 . 0.677 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 O4'-C1'-N19 110.915 2.715 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 O4'-C1'-N19 110.578 2.378 . 0.813 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.841 0 O4'-C1'-N19 110.701 2.501 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.36 170.09 53.72 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -143.74 176.96 8.85 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.435 ' ND2' ' H22' ' B' ' 106' ' ' ' G' . 10.1 m-80 -68.74 -173.92 0.52 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.692 0.797 . . . . 0.0 110.598 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.643 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.628 0.371 . . . . 0.0 111.789 -176.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -95.19 -4.77 45.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.903 0.319 . . . . 0.0 110.609 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.08 9.44 85.21 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.185 -0.786 . . . . 0.0 115.05 169.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 66.67 -161.57 46.11 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 119.408 1.604 . . . . 0.0 111.053 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.24 19.6 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.382 2.721 . . . . 0.0 112.61 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.6 ttp180 -74.77 -41.6 59.73 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.89 -0.507 . . . . 0.0 110.355 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -105.73 11.61 31.9 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.122 0.569 . . . . 0.0 111.085 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -7.7 34.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 84.0 -112.74 3.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 74.8 m -74.17 18.98 0.13 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -3.35 12.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.799 0.727 . . . . 0.0 111.929 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -89.42 -15.12 33.93 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.854 0.297 . . . . 0.0 110.824 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -123.82 8.76 8.79 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 92.4 p -156.77 167.38 30.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.39 15.25 17.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.242 173.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -92.1 -83.2 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.1 p30 48.7 15.5 0.09 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -155.67 169.22 24.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 110.035 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.6 t -155.64 -34.31 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.458 0.303 . . . . 0.0 110.187 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -97.86 9.27 43.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.94 0.496 . . . . 0.0 112.268 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -126.72 48.28 2.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.168 0.587 . . . . 0.0 111.463 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -70.73 -0.39 8.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.829 0.452 . . . . 0.0 111.366 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.1 m -100.53 148.68 24.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.43 150.2 34.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.835 0.454 . . . . 0.0 109.945 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -106.26 148.85 27.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 t -133.73 148.28 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.105 0.562 . . . . 0.0 111.194 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -138.69 150.63 46.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.74 5.1 58.84 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.834 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.1 -57.22 12.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.322 0.649 . . . . 0.0 111.135 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.472 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.89 179.64 44.47 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.13 -10.64 59.53 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.907 0.883 . . . . 0.0 112.365 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.98 -0.85 45.97 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 111.556 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.03 155.78 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.16 168.24 27.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.0 mm -49.43 -40.18 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.362 1.065 . . . . 0.0 111.691 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.42 62.32 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.859 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -76.15 -48.89 18.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.379 0.272 . . . . 0.0 110.634 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.808 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.58 -53.68 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.439 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.01 -37.93 78.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.798 -0.563 . . . . 0.0 110.602 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.96 -15.84 60.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.721 0.237 . . . . 0.0 111.087 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.51 -26.78 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.4 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.9 m-85 -97.3 -20.19 18.03 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.9 pttt -66.16 -18.64 65.48 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.418 0.287 . . . . 0.0 111.697 -173.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 7.1 pt20 -65.21 -20.41 66.42 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.1 mm -88.62 -25.05 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.976 0.417 . . . . 0.0 110.156 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.64 169.08 27.74 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.06 136.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.713 -0.286 . . . . 0.0 111.256 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 322' ' ' ILE . 7.1 mm -77.54 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.456 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 37.0 ttmt -69.55 136.53 51.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m -97.76 138.63 34.84 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.9 139.55 53.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.62 -4.42 51.54 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -133.26 -35.46 1.03 Allowed 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.244 0.475 . . . . 0.0 111.848 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -90.5 -16.36 29.03 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 77.49 -19.57 3.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.328 0.489 . . . . 0.0 113.167 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.45 163.02 56.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 117.883 0.841 . . . . 0.0 109.429 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.71 152.23 75.43 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.895 1.73 . . . . 0.0 108.833 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.456 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.9 mtp -77.74 79.07 4.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.808 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.07 155.09 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.619 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.94 129.16 11.93 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -91.75 120.87 32.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.409 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 97.0 m-85 -85.23 159.48 20.08 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 40.4 p -132.83 157.19 45.65 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.492 0.663 . . . . 0.0 112.53 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.46 133.23 48.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.416 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -77.5 -9.11 58.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.625 0.37 . . . . 0.0 110.913 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -98.52 -6.15 30.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.7 t -150.55 -22.11 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.088 0.403 . . . . 0.0 111.008 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.56 22.78 52.84 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.683 -0.509 . . . . 0.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -130.27 172.97 11.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 117.931 0.865 . . . . 0.0 110.334 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -45.76 123.37 4.34 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 123.769 0.828 . . . . 0.0 111.629 -173.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.615 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -83.77 -19.53 34.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.737 173.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.472 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.04 0.63 59.96 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -90.56 150.29 21.81 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 117.425 0.612 . . . . 0.0 110.903 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.43 165.87 32.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.073 0.549 . . . . 0.0 109.58 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 m -136.78 122.64 20.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 305' ' ' PHE . 92.5 t -115.63 124.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -174.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.4 t -96.21 128.15 42.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.234 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.53 148.31 25.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -74.33 -21.42 59.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -124.11 131.49 24.22 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.496 0.718 . . . . 0.0 110.91 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.8 Cg_endo -65.98 -33.09 43.11 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.768 2.312 . . . . 0.0 114.161 -175.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.74 -19.22 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.189 1.46 . . . . 0.0 111.142 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.2 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.787 0.267 . . . . 0.0 110.385 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.6 79.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.398 0.142 . . . . 0.0 110.672 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -63.41 -39.97 95.94 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 122.35 0.26 . . . . 0.0 110.756 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.1 81.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.984 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.72 -26.35 66.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -72.15 -57.72 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -60.92 -21.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -92.38 -59.74 2.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -70.02 -31.92 69.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -56.78 112.36 1.28 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.19 31.25 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.061 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.7 -172.35 2.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.705 1.253 . . . . 0.0 109.941 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.21 175.03 5.72 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.454 0.302 . . . . 0.0 110.535 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.593 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.8 t80 -130.72 -38.76 1.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.2 t -143.04 20.31 1.94 Allowed 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 122.585 0.354 . . . . 0.0 110.345 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.36 -2.22 31.04 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -121.81 146.5 46.05 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 123.996 0.918 . . . . 0.0 109.473 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.85 149.73 72.84 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.48 2.787 . . . . 0.0 110.779 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.593 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.62 169.4 18.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.087 0.555 . . . . 0.0 110.697 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -134.67 156.37 48.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.828 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -144.21 147.34 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.119 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 70.8 m -154.04 174.64 14.42 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -58.27 160.65 4.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.414 ' HB1' " H1'" ' B' ' 106' ' ' ' G' . . . -130.93 138.16 49.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.6 m -141.12 137.04 32.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.309 0.643 . . . . 0.0 110.71 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 43.3 mtp85 -42.51 113.32 0.44 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.409 0.684 . . . . 0.0 110.509 -173.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -33.86 73.5 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.02 71.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.38 -11.65 44.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.48 -8.61 19.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.7 -40.0 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -84.09 3.35 35.15 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 80.69 9.09 86.8 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.64 0.54 89.94 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.788 -0.451 . . . . 0.0 112.304 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 77.96 163.45 21.47 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -150.49 172.75 14.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.717 0.807 . . . . 0.0 110.091 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -171.08 166.04 39.19 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -157.15 164.48 37.78 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.787 0.435 . . . . 0.0 110.194 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 156.57 -9.12 0.26 Allowed Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -66.1 160.37 45.77 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -157.68 169.44 24.64 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.957 0.503 . . . . 0.0 110.068 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -70.83 153.15 51.14 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -144.49 163.5 33.67 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.38 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 179.03 179.49 48.72 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 117.207 -1.885 . . . . 0.0 111.039 -179.612 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 111.024 -2.984 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 N19-C1'-C2' 109.288 -2.57 . 0.806 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 N19-C1'-C2' 109.098 -2.689 . 0.871 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 C4'-C3'-C2' 100.312 -2.388 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 O4'-C1'-N19 110.859 2.659 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.957 2.757 . 0.893 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 111.019 2.819 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 111.28 3.08 . 0.719 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.991 0 O4'-C1'-N19 110.691 2.491 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 111.427 -2.715 . 0.692 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.479 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.931 0 C5'-C4'-C3' 111.428 -2.714 . 0.59 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.479 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 C5'-C4'-C3' 110.631 -3.246 . 0.483 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 1 C5'-C4'-C3' 109.297 -4.135 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.128 1 O4'-C1'-N19 113.683 5.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.615 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.84 0 C5'-C4'-C3' 111.063 -2.958 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.435 ' H22' ' ND2' ' A' ' 263' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.778 1 C3'-C2'-C1' 105.348 4.275 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.506 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 C5'-C4'-C3' 109.663 -3.891 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . 0.506 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 P--O5' 1.619 2.637 0 C4'-C3'-C2' 100.257 -2.443 . 0.079 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 N19-C1'-C2' 108.784 -2.885 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 N19-C1'-C2' 108.924 -2.797 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.908 0 N19-C1'-C2' 109.098 -2.689 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.528 0 N19-C1'-C2' 109.655 -2.34 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 110.11 -2.056 . 0.771 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 O4'-C1'-N19 110.716 2.516 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 110.75 2.55 . 0.717 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.625 0 O4'-C1'-N19 110.785 2.585 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.498 2.298 . 0.836 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 O4'-C1'-N19 110.585 2.385 . 0.825 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.125 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.68 87.09 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -144.24 -179.88 6.8 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.415 ' CG ' ' H22' ' B' ' 106' ' ' ' G' . 38.8 m-80 -66.17 -178.44 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.778 0.831 . . . . 0.0 111.267 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -65.25 -14.09 59.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.78 0.432 . . . . 0.0 111.933 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -95.8 -3.92 44.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.972 0.351 . . . . 0.0 111.746 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.15 77.27 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.35 -0.695 . . . . 0.0 113.913 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 66.6 -156.33 51.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.696 1.248 . . . . 0.0 110.883 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.91 18.74 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.612 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -74.98 -38.84 61.56 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.728 -0.608 . . . . 0.0 110.725 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -105.56 10.17 33.17 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.866 0.467 . . . . 0.0 111.128 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -10.18 54.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.93 -105.95 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 85.9 p -74.01 13.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -0.48 7.39 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -93.71 -16.05 24.63 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.873 0.306 . . . . 0.0 111.144 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -126.59 7.45 6.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 48.4 t -152.21 154.06 35.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.681 0.393 . . . . 0.0 110.25 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.67 -1.0 55.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.092 0.557 . . . . 0.0 110.581 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -87.65 -82.01 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.161 0.584 . . . . 0.0 110.082 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 48.8 16.36 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -155.1 168.02 28.43 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.989 -0.445 . . . . 0.0 109.835 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.0 p -153.14 -32.79 0.12 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.551 0.34 . . . . 0.0 110.6 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -107.32 16.21 24.19 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.548 0.739 . . . . 0.0 112.198 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.75 48.87 2.37 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.119 0.568 . . . . 0.0 111.615 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -71.56 3.19 4.14 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.517 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -104.76 148.78 26.23 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.38 147.6 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.642 0.377 . . . . 0.0 110.441 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -102.73 149.01 24.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.9 t -134.12 148.24 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.298 0.639 . . . . 0.0 111.636 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -138.59 150.06 45.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.31 5.11 58.19 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.762 -0.466 . . . . 0.0 112.299 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.83 -56.06 23.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.541 0.67 . . . . 0.0 111.009 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.461 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.71 179.45 46.21 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -80.18 -7.22 58.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.738 0.815 . . . . 0.0 112.124 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -81.8 -1.6 47.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.374 0.27 . . . . 0.0 111.32 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.54 156.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.48 168.03 28.04 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.6 mm -48.57 -40.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.223 1.009 . . . . 0.0 111.762 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.4 -28.49 62.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.28 -0.263 . . . . 0.0 111.102 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.0 t -75.85 -48.84 19.86 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.823 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.64 45.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.436 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.6 -37.6 78.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.296 0.498 . . . . 0.0 110.783 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -75.81 -15.39 60.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -95.15 -26.78 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.404 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.2 m-85 -97.46 -20.62 17.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.5 pttt -65.13 -19.43 65.98 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -63.97 -21.49 66.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.2 mm -87.07 -27.19 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.8 170.6 31.89 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.7 mm -68.02 135.07 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.768 0.318 . . . . 0.0 111.047 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 322' ' ' ILE . 7.5 mm -76.42 136.97 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.423 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.1 ttmm -68.4 135.84 52.37 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.692 0.282 . . . . 0.0 110.628 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.7 m -94.1 139.88 30.43 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -66.95 149.95 49.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -70.84 -20.0 62.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -142.71 -19.59 0.67 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.5 p -86.87 -15.58 38.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.85 0.75 . . . . 0.0 112.88 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.77 -17.88 3.35 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.351 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -81.54 160.97 63.3 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 117.867 0.833 . . . . 0.0 109.812 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.98 151.96 82.97 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.089 1.86 . . . . 0.0 109.13 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.423 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 48.6 mtp -79.74 80.15 6.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.47 0.308 . . . . 0.0 111.235 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.823 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -132.14 154.98 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.0 120.6 7.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.269 0.628 . . . . 0.0 109.693 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -88.59 122.14 31.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.513 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 77.1 m-85 -80.27 164.43 23.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 70.0 p -137.13 155.73 49.24 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.246 0.546 . . . . 0.0 111.415 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -69.27 130.13 41.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.28 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -75.02 -6.94 52.1 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 122.66 0.384 . . . . 0.0 111.162 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.38 -7.11 26.65 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 4.9 t -150.04 -21.23 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.211 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.04 17.38 61.3 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.552 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -122.39 172.73 8.12 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 117.878 0.839 . . . . 0.0 110.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -45.67 123.81 4.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.884 0.874 . . . . 0.0 111.298 -175.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.6 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.5 ttmm -79.56 -17.99 52.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.648 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.461 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 93.48 15.51 50.11 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.57 154.09 34.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.403 0.601 . . . . 0.0 110.164 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.65 170.35 22.36 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.609 0.363 . . . . 0.0 110.287 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 32.3 m -134.51 127.56 31.63 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.865 0.466 . . . . 0.0 110.583 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.404 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.2 t -117.43 127.49 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.2 t -98.76 128.63 45.06 Favored 'General case' 0 C--N 1.337 0.05 0 O-C-N 121.962 -0.461 . . . . 0.0 110.324 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.65 147.64 25.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.61 -16.61 59.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -125.49 131.77 24.13 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 110.594 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.455 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.5 Cg_endo -66.46 -32.89 39.12 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.006 2.471 . . . . 0.0 114.446 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -76.9 -19.49 13.98 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 CA-C-N 121.208 1.467 . . . . 0.0 110.81 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -29.31 58.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.75 80.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -64.68 -38.45 91.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.462 -0.149 . . . . 0.0 110.635 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.89 -40.26 83.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.583 0.353 . . . . 0.0 110.943 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.6 -25.96 66.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 66.7 mt -72.62 -56.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.6 -20.87 61.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -94.51 -60.21 1.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.27 -32.47 71.68 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.91 110.42 0.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.16 -14.73 25.83 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.042 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -96.36 -171.01 2.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.872 1.336 . . . . 0.0 110.249 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.04 174.39 5.89 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 110.307 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.618 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.5 t80 -130.39 -39.32 1.32 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 109.941 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.39 -18.77 10.95 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.75 148.14 35.1 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 151.08 74.16 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.43 2.753 . . . . 0.0 110.508 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.618 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.02 168.64 21.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -134.35 155.69 49.81 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.803 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.95 146.76 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.047 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 m -154.4 174.64 14.58 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.754 0.822 . . . . 0.0 108.789 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -60.36 155.65 17.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.598 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -123.91 137.7 54.59 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 8.9 m -142.93 136.47 28.61 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.519 0.727 . . . . 0.0 110.28 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -45.27 112.16 0.41 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 122.979 0.511 . . . . 0.0 110.404 -170.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -29.5 66.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.856 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.83 -34.16 75.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 122.378 -0.201 . . . . 0.0 111.07 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -67.56 -6.77 21.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.473 0.309 . . . . 0.0 110.369 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.649 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 95.9 m-85 -108.41 -9.36 15.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -151.96 -41.81 0.11 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -81.32 -1.83 46.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.79 2.79 89.7 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 69.89 19.57 75.35 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -66.1 173.9 22.53 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.233 0.517 . . . . 0.0 111.898 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -141.97 153.17 44.11 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.867 0.467 . . . . 0.0 110.416 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -101.49 158.39 18.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -162.77 167.26 23.19 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.705 0.402 . . . . 0.0 110.586 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -178.34 20.2 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.587 -0.563 . . . . 0.0 112.569 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.48 178.69 34.67 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 117.802 0.801 . . . . 0.0 111.766 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -60.85 156.81 16.43 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.739 0.415 . . . . 0.0 111.284 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -94.26 -178.91 38.54 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -60.88 142.55 56.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.577 0.351 . . . . 0.0 110.347 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.98 34.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 CA-C-O 117.301 -1.833 . . . . 0.0 110.503 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 C5'-C4'-C3' 110.637 -3.242 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 109.231 -2.606 . 0.82 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 C4'-C3'-C2' 99.829 -2.871 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 C4'-C3'-C2' 100.276 -2.424 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 C5'-C4'-C3' 111.494 -2.671 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 O4'-C1'-N19 110.882 2.682 . 0.883 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 O4'-C1'-N19 110.825 2.625 . 0.815 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 O4'-C1'-N19 111.167 2.967 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 O4'-C1'-N19 110.793 2.593 . 0.639 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.003 0 C5'-C4'-C3' 110.972 -3.019 . 0.67 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.45 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.051 0 C5'-C4'-C3' 111.385 -2.743 . 0.811 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.45 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 C5'-C4'-C3' 110.88 -3.08 . 0.466 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 C5'-C4'-C3' 109.553 -3.965 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.138 1 O4'-C1'-N19 112.735 4.535 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.6 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.833 0 C5'-C4'-C3' 109.565 -3.956 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.598 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.749 1 C3'-C2'-C1' 105.625 4.583 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.56 " H3'" H5'' ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 109.687 -3.876 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . 0.56 H5'' " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.044 0 C4'-C3'-C2' 100.021 -2.679 . 0.079 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.546 0 C5'-C4'-C3' 111.067 -2.955 . 0.656 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 N19-C1'-C2' 109.607 -2.371 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.479 -2.45 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.466 -2.458 . 0.787 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C5'-C4'-C3' 112.257 -2.162 . 0.79 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.818 2.618 . 0.784 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 110.738 2.538 . 0.722 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 O4'-C1'-N19 110.879 2.679 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 O4'-C1'-N19 110.819 2.619 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.749 0 O4'-C1'-N19 110.638 2.438 . 0.847 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 74.95 -171.18 53.96 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -71.12 178.67 3.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -65.42 -178.7 0.54 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.105 0.962 . . . . 0.0 110.886 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.569 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -66.46 -14.61 62.45 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -93.81 -3.26 52.33 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.915 0.325 . . . . 0.0 110.91 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.36 77.33 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.293 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 67.71 -160.25 50.03 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.059 1.429 . . . . 0.0 110.829 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.95 36.25 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.863 3.042 . . . . 0.0 111.876 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -88.34 -42.51 12.16 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.174 -0.329 . . . . 0.0 110.401 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -109.1 16.21 22.71 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.233 0.613 . . . . 0.0 110.332 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -67.61 -22.28 65.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.856 0.462 . . . . 0.0 111.386 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 112.66 -129.6 9.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 9.1 t -79.46 20.88 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.439 0.696 . . . . 0.0 112.106 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -7.38 3.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.066 0.547 . . . . 0.0 112.382 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -83.07 -6.53 59.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.28 21.46 0.95 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 37.4 t -155.33 144.87 21.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.915 -0.491 . . . . 0.0 110.421 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -84.97 5.71 28.1 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.132 0.573 . . . . 0.0 110.256 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -103.13 -112.03 0.23 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . 0.256 8.7 m-20 52.67 17.78 0.88 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -148.12 162.27 39.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.9 p -155.52 -37.3 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -97.02 15.88 21.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.232 0.613 . . . . 0.0 112.28 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.83 41.89 3.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.464 0.706 . . . . 0.0 111.374 -176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -67.38 -4.8 12.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.866 0.466 . . . . 0.0 111.142 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.5 m -95.99 146.61 24.48 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.63 150.3 34.18 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 C-N-CA 122.729 0.411 . . . . 0.0 109.917 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -105.03 148.99 26.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.9 t -133.2 146.62 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 123.05 0.54 . . . . 0.0 111.376 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -137.33 148.54 46.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.71 57.3 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.974 -0.348 . . . . 0.0 112.597 173.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.05 -56.88 14.81 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.82 179.9 44.49 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.81 -10.0 59.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.671 0.789 . . . . 0.0 112.33 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -81.79 -2.29 50.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 117.562 0.165 . . . . 0.0 111.329 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -99.39 155.95 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.16 168.0 28.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.98 -39.73 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 124.403 1.081 . . . . 0.0 111.59 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.55 -29.09 63.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -75.35 -49.38 19.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.131 0.172 . . . . 0.0 110.643 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 322' ' ' ILE . 2.8 m -61.33 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.07 -37.52 77.27 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.193 0.452 . . . . 0.0 110.739 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.04 -15.78 60.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.984 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.72 -27.25 15.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -96.76 -20.37 18.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -66.16 -18.84 65.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.439 0.296 . . . . 0.0 111.763 -173.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -21.52 66.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 353' ' ' TRP . 12.4 mm -87.12 -27.33 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.308 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.86 170.26 31.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.27 134.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.629 0.252 . . . . 0.0 111.347 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 322' ' ' ILE . 7.2 mm -75.51 138.62 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.443 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 35.4 ttmt -68.46 144.58 54.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -123.71 135.51 53.91 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -75.19 140.89 43.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.19 -19.3 56.93 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.709 0.403 . . . . 0.0 111.654 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -115.62 0.25 13.22 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.6 p -125.09 -20.34 4.93 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.9 -17.46 3.68 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.383 0.516 . . . . 0.0 113.007 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -86.72 157.96 54.41 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.661 0.73 . . . . 0.0 109.673 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.6 153.13 76.9 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.255 1.97 . . . . 0.0 109.126 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.443 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 54.7 mtp -79.1 79.24 5.51 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.516 0.326 . . . . 0.0 110.985 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.812 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.11 155.81 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.345 -178.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.34 127.32 11.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.7 mm? -90.75 119.92 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.402 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 96.8 m-85 -81.25 160.67 24.2 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.7 p -136.46 146.96 46.92 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 111.753 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.35 131.69 50.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.412 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -73.86 -6.8 49.38 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.393 0.277 . . . . 0.0 111.643 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.31 -5.63 27.13 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.8 t -151.18 -23.32 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.499 0.59 . . . . 0.0 111.245 -176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.46 19.58 58.25 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.158 172.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -124.94 169.06 12.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.996 0.898 . . . . 0.0 110.1 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.46 117.94 1.79 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.46 0.704 . . . . 0.0 110.678 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.625 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 13.2 ptmm? -87.63 0.32 55.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.162 174.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 89.47 9.3 66.98 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.598 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -108.25 151.62 25.7 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.929 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.92 166.46 32.57 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.2 m -135.51 122.66 21.55 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.872 0.469 . . . . 0.0 111.508 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.06 124.62 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.4 t -96.23 128.64 43.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.215 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -86.29 148.22 25.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -73.94 -20.33 60.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 95.2 m-20 -127.73 133.35 25.01 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 123.855 0.862 . . . . 0.0 111.033 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.1 Cg_endo -66.14 -33.9 38.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.683 2.256 . . . . 0.0 114.195 -175.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.5 Cg_endo -74.94 -18.42 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.141 1.443 . . . . 0.0 110.822 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 71.0 m -76.7 -29.67 56.36 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.16 -46.42 80.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.947 0.154 . . . . 0.0 110.725 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -66.15 -37.3 85.33 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.38 -40.13 81.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.369 0.267 . . . . 0.0 110.854 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.48 -26.35 65.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.58 -56.95 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.41 -21.79 62.63 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.403 ' CD1' HD11 ' A' ' 308' ' ' ILE . 48.2 t-105 -93.62 -59.49 1.99 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.7 -32.78 70.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -57.03 112.48 1.36 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.68 31.9 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.008 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.66 -172.45 2.75 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.477 1.138 . . . . 0.0 109.924 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -101.64 173.27 6.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.557 0.343 . . . . 0.0 110.457 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.6 t80 -128.51 -38.54 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.682 0.393 . . . . 0.0 110.262 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.1 t -144.54 17.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.981 0.512 . . . . 0.0 109.959 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.23 -20.2 16.65 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -96.12 140.49 22.28 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.98 151.4 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.997 2.464 . . . . 0.0 110.369 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.4 pt -138.12 168.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 122.608 0.363 . . . . 0.0 111.223 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -134.54 155.25 50.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.15 0.58 . . . . 0.0 110.765 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.63 146.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.998 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 37.4 m -155.44 172.99 17.3 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -57.02 156.84 6.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -124.44 139.53 53.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.0 m -144.36 137.23 26.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.759 0.824 . . . . 0.0 109.879 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -49.0 119.76 3.44 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.798 -171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -34.03 75.22 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.35 71.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.036 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -67.14 -10.06 46.3 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.568 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.1 m-85 -102.67 -10.76 18.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.44 -39.98 0.08 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -83.39 1.79 39.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.056 0.389 . . . . 0.0 111.798 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.0 7.18 85.83 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.56 0.34 83.78 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.75 -168.26 54.13 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -154.34 158.23 39.79 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.605 0.362 . . . . 0.0 110.531 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -87.67 -177.27 48.2 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -144.45 155.98 43.99 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.225 0.61 . . . . 0.0 109.488 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -82.05 151.59 30.36 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -83.31 166.66 44.24 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -65.78 155.03 37.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -62.58 154.44 42.34 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -156.19 165.02 37.62 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.019 0.528 . . . . 0.0 110.204 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 167.63 -6.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.184 -1.898 . . . . 0.0 110.815 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 C5'-C4'-C3' 111.066 -2.956 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 N19-C1'-C2' 109.345 -2.535 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 C4'-C3'-C2' 99.795 -2.905 . 0.839 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C4'-C3'-C2' 100.101 -2.599 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.534 0 O4'-C1'-N19 110.879 2.679 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 111.079 2.879 . 0.891 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.744 0 O4'-C1'-N19 111.002 2.802 . 0.782 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 O4'-C1'-N19 111.21 3.01 . 0.759 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 C5'-C4'-C3' 111.551 -2.633 . 0.613 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 0 C5'-C4'-C3' 111.269 -2.821 . 0.65 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.434 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.882 0 C5'-C4'-C3' 110.968 -3.022 . 0.561 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.434 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 C5'-C4'-C3' 110.667 -3.222 . 0.562 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 C5'-C4'-C3' 110.78 -3.147 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . 0.402 " H1'" " O4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 P--O5' 1.616 2.287 1 O4'-C1'-N19 113.369 5.169 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.625 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.041 0 C5'-C4'-C3' 110.138 -3.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.068 1 C3'-C2'-C1' 105.775 4.75 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.484 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 C5'-C4'-C3' 109.872 -3.752 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . 0.484 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C4'-C3'-C2' 100.043 -2.657 . 0.111 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 110.898 2.698 . 0.713 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 O4'-C1'-N19 110.645 2.445 . 0.592 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C5'-C4'-C3' 111.796 -2.469 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 C5'-C4'-C3' 112.325 -2.117 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 C5'-C4'-C3' 112.075 -2.283 . 0.771 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 O4'-C1'-N19 110.697 2.497 . 0.746 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 O4'-C1'-N19 111.012 2.812 . 0.706 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.564 0 O4'-C1'-N19 110.641 2.441 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.355 0 O4'-C1'-N19 110.484 2.284 . 0.858 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.731 2.531 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.04 179.41 48.91 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -70.34 174.88 5.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -66.95 -173.87 0.28 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.611 0.764 . . . . 0.0 110.635 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.06 -15.1 58.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -95.49 -6.06 41.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.123 0.42 . . . . 0.0 110.878 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.0 10.12 84.37 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.224 -0.764 . . . . 0.0 114.724 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.77 -162.41 48.17 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.817 1.309 . . . . 0.0 110.911 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.91 22.57 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.757 2.971 . . . . 0.0 112.587 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 267' ' ' GLY . 16.1 tpt180 -79.18 -33.62 43.78 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.811 -0.555 . . . . 0.0 110.708 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -110.6 10.49 22.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.228 0.611 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -7.74 34.64 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 82.89 -108.35 2.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 82.0 p -72.37 13.05 0.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.86 -3.81 17.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.496 0.589 . . . . 0.0 112.468 -174.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -88.03 -6.33 58.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.467 0.307 . . . . 0.0 111.405 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -151.05 24.06 0.74 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.9 t -156.01 154.23 30.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.76 -0.16 51.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 0.0 110.213 174.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -91.43 -85.12 0.24 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.007 0.523 . . . . 0.0 110.183 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 49.1 16.43 0.13 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.95 168.79 25.79 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.779 -0.575 . . . . 0.0 110.075 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.7 p -153.75 -32.07 0.12 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.29 0.236 . . . . 0.0 111.018 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -108.55 13.24 25.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.359 0.664 . . . . 0.0 112.304 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -126.56 46.43 2.47 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.069 0.548 . . . . 0.0 111.245 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -70.0 -0.62 7.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.39 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.2 m -100.01 147.7 25.32 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.5 pt -128.82 149.92 33.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -104.92 149.49 25.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.74 148.76 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.264 0.625 . . . . 0.0 110.752 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -139.3 150.18 45.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.27 57.95 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.86 -0.411 . . . . 0.0 112.659 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.2 mp -54.72 -54.45 41.72 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 117.55 0.675 . . . . 0.0 111.614 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.481 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.42 -175.86 44.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -171.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -86.86 -7.8 57.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.534 0.734 . . . . 0.0 112.286 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.84 -3.55 42.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.238 0.215 . . . . 0.0 110.954 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.38 158.98 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.739 0.816 . . . . 0.0 112.804 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.43 168.05 25.99 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.75 -39.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.019 0.928 . . . . 0.0 111.65 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -73.15 -28.89 62.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.318 -0.239 . . . . 0.0 111.064 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.9 t -75.12 -49.44 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.193 0.197 . . . . 0.0 110.797 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.11 -53.65 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.441 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.39 -37.33 77.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.719 -0.613 . . . . 0.0 110.78 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -76.9 -15.29 59.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.189 -0.32 . . . . 0.0 111.201 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.47 -27.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.4 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.0 m-85 -96.47 -20.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.8 pttt -65.08 -19.29 65.92 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.36 -20.85 66.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.52 -25.02 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 165.06 168.79 27.76 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.97 136.0 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.706 0.289 . . . . 0.0 111.081 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 322' ' ' ILE . 6.5 mm -76.72 136.45 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -68.93 142.8 54.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -108.62 136.2 48.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.33 132.6 43.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -74.46 -20.68 59.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.91 0.484 . . . . 0.0 111.364 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.53 -8.39 18.06 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.1 p -131.91 -15.96 2.95 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.28 -15.3 5.65 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.394 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -84.23 162.19 52.33 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 118.204 1.002 . . . . 0.0 109.333 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.15 152.02 81.79 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.653 1.569 . . . . 0.0 108.877 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 41.9 mtp -77.71 79.12 4.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.709 0.404 . . . . 0.0 110.955 -174.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.815 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.9 154.96 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 123.703 0.627 . . . . 0.0 110.849 -179.104 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.62 130.12 13.0 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 324' ' ' LEU . 1.8 mm? -92.99 117.08 29.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.463 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 97.3 m-85 -81.39 156.5 25.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 79.4 p -130.88 158.15 41.0 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.822 0.82 . . . . 0.0 112.083 -170.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -68.88 119.96 14.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.183 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -70.11 -6.53 34.63 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 122.237 0.215 . . . . 0.0 111.454 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 329' ' ' GLU . 12.5 pt-20 -88.96 -13.9 37.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 14.9 t -155.59 -20.01 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.36 9.73 60.08 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.507 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -91.82 164.09 13.81 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.461 1.131 . . . . 0.0 109.633 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.2 mt -56.43 123.66 15.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.59 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.9 ttmm -74.23 -13.94 60.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.454 0.702 . . . . 0.0 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.481 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.97 -4.76 63.18 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.52 145.49 26.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.143 0.471 . . . . 0.0 110.807 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.23 165.12 35.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.1 m -136.39 120.75 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.475 0.31 . . . . 0.0 111.829 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 305' ' ' PHE . 94.8 t -114.96 124.17 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.2 t -95.78 128.12 42.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.268 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -85.1 147.07 26.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 172.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.76 -16.77 59.39 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -125.21 131.27 24.04 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.837 0.855 . . . . 0.0 110.688 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.454 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.7 Cg_endo -66.62 -32.69 38.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.67 2.247 . . . . 0.0 114.332 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.4 Cg_endo -76.26 -19.63 15.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-N 121.508 1.574 . . . . 0.0 110.85 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -75.51 -29.69 59.56 Favored 'General case' 0 CA--C 1.524 -0.041 0 O-C-N 122.391 -0.193 . . . . 0.0 110.547 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.55 -48.21 75.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 351' ' ' ILE . 17.0 tptm -64.07 -38.68 91.95 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.6 82.92 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.484 0.314 . . . . 0.0 110.705 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.24 65.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 348' ' ' LYS . 66.5 mt -72.04 -57.32 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.43 -21.91 62.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -93.11 -60.38 1.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.62 -32.44 71.15 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.43 112.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.01 -15.35 31.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.091 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -94.67 -172.81 2.84 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.605 1.203 . . . . 0.0 109.946 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -102.65 170.77 7.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.477 0.311 . . . . 0.0 110.171 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.9 t80 -125.38 -38.54 2.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.371 0.268 . . . . 0.0 110.601 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t -143.84 8.04 1.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.329 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.08 -21.11 4.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -103.83 148.87 36.5 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.94 152.86 76.56 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.395 2.73 . . . . 0.0 110.581 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -139.12 169.14 17.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.96 0.409 . . . . 0.0 110.538 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -133.68 155.61 49.4 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.748 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -143.89 146.39 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 50.0 m -153.76 174.76 14.12 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.65 163.68 4.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.079 -0.388 . . . . 0.0 111.914 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -132.59 137.16 46.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.0 m -140.7 134.12 29.89 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.676 0.79 . . . . 0.0 110.469 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -48.97 118.09 2.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -26.95 63.58 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.8 74.36 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.424 -0.173 . . . . 0.0 110.843 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.56 -8.73 15.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.438 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 98.8 m-85 -107.67 -10.0 15.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.92 -40.33 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -79.29 -8.76 59.3 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.847 0.294 . . . . 0.0 111.66 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.56 14.8 69.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 86.24 -178.59 49.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.98 160.26 52.6 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -148.85 169.94 19.37 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.399 0.68 . . . . 0.0 110.496 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -170.49 168.15 41.22 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -73.48 168.04 20.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.875 0.47 . . . . 0.0 110.199 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -74.21 149.93 41.49 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.24 83.71 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 60.0 ttm-85 -153.68 149.6 27.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.242 0.521 . . . . 0.0 109.719 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -73.15 172.61 49.64 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ARG . . . . . 0.477 ' HG2' ' H ' ' A' ' 390' ' ' GLY . 21.1 ttt180 -152.62 149.83 28.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.998 0.519 . . . . 0.0 109.718 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -80.4 8.65 52.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 122.999 0.333 . . . . 0.0 112.274 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLY . . . . . 0.477 ' H ' ' HG2' ' A' ' 388' ' ' ARG . . . . . . . . 0 C--O 1.251 1.2 0 CA-C-O 117.407 -1.774 . . . . 0.0 110.702 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.403 0 C5'-C4'-C3' 111.007 -2.995 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 N19-C1'-C2' 109.212 -2.618 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C4'-C3'-C2' 99.94 -2.76 . 0.859 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 N19-C1'-C2' 109.414 -2.491 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 O4'-C1'-N19 110.94 2.74 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 0 O4'-C1'-N19 111.211 3.011 . 0.839 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.706 0 O4'-C1'-N19 111.103 2.903 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 O4'-C1'-N19 111.09 2.89 . 0.694 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 C5'-C4'-C3' 111.512 -2.659 . 0.71 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.812 0 C5'-C4'-C3' 111.237 -2.842 . 0.723 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 C5'-C4'-C3' 111.386 -2.742 . 0.631 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 C5'-C4'-C3' 110.586 -3.276 . 0.383 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 C5'-C4'-C3' 109.064 -4.291 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.168 1 O4'-C1'-N19 113.032 4.832 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.59 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 C5'-C4'-C3' 110.641 -3.239 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.828 1 C3'-C2'-C1' 105.859 4.843 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.904 0 C5'-C4'-C3' 110.122 -3.585 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 0 C5'-C4'-C3' 110.927 -3.049 . 0.66 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.326 0 N19-C1'-C2' 109.284 -2.572 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 N19-C1'-C2' 108.893 -2.817 . 0.761 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.455 0 N19-C1'-C2' 109.279 -2.576 . 0.72 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 N19-C1'-C2' 109.461 -2.462 . 0.753 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.575 0 C4'-C3'-C2' 100.483 -2.217 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.878 0 O4'-C1'-N19 110.541 2.341 . 0.722 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.624 2.424 . 0.694 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O4'-C1'-N19 110.614 2.414 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.058 0 C5'-C4'-C3' 112.031 -2.312 . 0.794 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.89 0 O4'-C1'-N19 110.771 2.571 . 0.815 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 179.77 -177.95 48.36 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -69.98 176.4 3.77 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.429 ' ND2' ' H22' ' B' ' 106' ' ' ' G' . 12.4 m-80 -68.93 -174.4 0.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.622 0.769 . . . . 0.0 110.469 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.648 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -63.81 -16.59 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.617 0.367 . . . . 0.0 111.775 -177.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -95.96 -3.75 44.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.933 0.333 . . . . 0.0 111.021 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.15 85.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.885 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.63 -158.84 51.04 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.373 1.586 . . . . 0.0 110.496 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.99 15.62 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.732 2.955 . . . . 0.0 112.496 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 267' ' ' GLY . 72.5 ttt-85 -75.81 -40.55 54.79 Favored 'General case' 0 C--N 1.334 -0.075 0 O-C-N 122.051 -0.406 . . . . 0.0 110.122 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -95.97 3.54 53.42 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.749 0.419 . . . . 0.0 111.709 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.32 168.07 13.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.914 0.486 . . . . 0.0 111.104 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -77.49 -115.59 0.17 Allowed Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.146 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.3 t -77.12 30.76 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.751 0.82 . . . . 0.0 112.552 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -5.56 9.77 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.545 -0.722 . . . . 0.0 111.774 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -89.32 -19.66 25.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.835 0.454 . . . . 0.0 111.194 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -128.47 6.34 5.73 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 39.0 t -154.98 160.85 41.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.112 0.565 . . . . 0.0 109.697 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -108.94 14.0 24.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.879 0.471 . . . . 0.0 110.375 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -89.05 -82.67 0.24 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.57 13.87 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.004 1.721 . . . . 0.0 115.105 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -149.98 160.35 43.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.879 -0.513 . . . . 0.0 109.949 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.1 t -147.27 0.91 0.72 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.512 0.196 . . . . 0.0 111.144 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -151.04 24.14 0.74 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -136.21 44.83 2.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.113 0.565 . . . . 0.0 110.919 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -69.7 -1.2 8.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.946 0.499 . . . . 0.0 111.185 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -99.26 147.57 25.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.99 150.24 34.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.867 0.467 . . . . 0.0 109.897 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -105.38 149.68 25.89 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.14 148.7 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.251 0.621 . . . . 0.0 111.238 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -138.55 150.59 46.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.08 5.79 59.37 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.74 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -55.36 -56.69 17.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 117.45 0.625 . . . . 0.0 111.29 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.46 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 90.15 -179.66 43.89 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.79 -11.57 59.85 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.786 0.835 . . . . 0.0 112.106 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.69 0.39 39.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.416 0.286 . . . . 0.0 111.275 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.33 154.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -157.58 168.38 27.46 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 32.5 mm -49.87 -40.16 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.406 1.082 . . . . 0.0 111.776 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.37 -28.74 63.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.55 -0.094 . . . . 0.0 111.059 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.3 t -75.23 -49.46 19.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.159 0.184 . . . . 0.0 110.817 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.38 -54.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.436 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.81 -37.72 77.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.375 0.534 . . . . 0.0 110.699 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -76.17 -15.76 60.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.41 -27.42 16.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -96.5 -20.58 18.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.1 pttt -65.67 -18.72 65.53 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.341 0.257 . . . . 0.0 111.68 -172.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.2 pt20 -64.39 -21.9 66.78 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.3 mm -87.01 -27.99 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 168.28 170.44 32.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.73 135.74 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.879 0.34 . . . . 0.0 111.261 -172.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -76.98 137.84 21.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -69.61 149.37 48.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m -128.32 132.65 48.62 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -72.34 150.14 43.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -81.51 -6.58 59.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -139.97 -5.22 1.32 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.0 p -91.09 -20.95 21.49 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.57 15.99 79.12 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -141.09 158.77 63.84 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 117.415 0.608 . . . . 0.0 109.707 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.99 154.38 62.28 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.264 1.976 . . . . 0.0 109.47 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.6 mtp -77.14 76.94 3.68 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.63 0.372 . . . . 0.0 111.159 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.63 154.25 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.389 0.675 . . . . 0.0 110.747 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -150.99 130.33 12.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.684 0.794 . . . . 0.0 108.939 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -90.87 122.31 33.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.489 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 97.1 m-85 -86.22 160.16 19.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 48.8 p -134.81 161.35 35.44 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.346 0.593 . . . . 0.0 111.661 -170.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -71.86 117.8 13.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.985 170.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -73.64 -4.86 36.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.438 -0.164 . . . . 0.0 111.195 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -94.39 -6.77 43.4 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.265 0.626 . . . . 0.0 112.533 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.9 t -150.02 -23.0 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.44 0.564 . . . . 0.0 111.14 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.13 32.59 16.81 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.962 171.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -135.55 166.18 23.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 117.852 0.826 . . . . 0.0 110.756 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -47.77 122.87 5.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.74 0.816 . . . . 0.0 111.262 -174.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.653 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.3 ttmm -83.64 -20.86 32.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.3 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 99.87 0.37 56.3 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -90.58 151.04 21.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.628 0.714 . . . . 0.0 110.902 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.36 166.21 31.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.316 0.646 . . . . 0.0 109.355 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.3 m -136.84 122.68 20.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.634 0.374 . . . . 0.0 111.603 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.22 125.09 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.2 t -96.83 128.35 43.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.573 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -85.59 147.82 26.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -76.1 -17.24 59.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -125.39 132.24 24.26 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.453 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.4 Cg_endo -66.88 -32.2 36.63 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.782 2.321 . . . . 0.0 114.562 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 92.5 Cg_endo -77.5 -18.79 13.54 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 121.135 1.441 . . . . 0.0 111.146 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.6 m -75.76 -29.27 58.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.24 -0.288 . . . . 0.0 110.478 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.99 -47.69 76.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.71 -39.81 95.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.484 0.314 . . . . 0.0 110.53 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.92 81.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 0.0 110.59 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.12 -26.14 65.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.62 -58.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -60.64 -21.3 62.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -92.99 -59.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -70.37 -32.34 69.97 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.24 112.01 1.12 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -15.59 30.61 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.063 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -94.76 -172.35 2.7 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.646 1.223 . . . . 0.0 110.03 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.5 174.07 6.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.708 0.29 . . . . 0.0 110.459 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.609 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.6 t80 -129.27 -37.78 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.518 0.327 . . . . 0.0 110.654 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.2 t -144.87 20.31 1.63 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.687 0.395 . . . . 0.0 110.043 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.07 0.01 31.56 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -125.32 146.6 54.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 123.801 0.84 . . . . 0.0 109.773 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.79 149.22 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.575 2.85 . . . . 0.0 110.93 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.46 169.21 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.067 0.547 . . . . 0.0 110.636 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -133.5 157.17 46.31 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.004 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 44.7 t -143.95 147.3 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.039 0.536 . . . . 0.0 110.223 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.9 m -154.73 172.86 17.24 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.64 159.11 6.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.44 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -127.77 134.93 49.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.5 m -138.99 136.3 35.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.628 0.771 . . . . 0.0 110.002 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -47.39 112.49 0.55 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.022 0.529 . . . . 0.0 110.105 -170.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -28.42 64.9 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.83 74.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.47 -0.144 . . . . 0.0 110.786 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.56 -9.51 19.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.405 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.8 m-85 -106.87 -7.94 16.9 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.71 -40.88 0.07 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -84.12 2.57 38.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.211 0.46 . . . . 0.0 112.023 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.04 81.69 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 88.75 1.77 79.76 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 76.29 177.98 44.34 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.347 0.574 . . . . 0.0 111.871 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -158.54 162.12 37.37 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 172.05 141.89 3.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -146.9 162.02 39.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.13 0.465 . . . . 0.0 110.847 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -157.07 176.08 34.39 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 161.48 25.71 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 CA-C-N 117.333 0.567 . . . . 0.0 112.671 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -60.36 144.34 50.96 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.777 0.788 . . . . 0.0 110.003 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -71.88 165.71 53.72 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -153.73 146.77 24.54 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.323 0.649 . . . . 0.0 109.925 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.01 85.15 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.224 -1.876 . . . . 0.0 110.888 179.658 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 N19-C1'-C2' 109.785 -2.26 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 N19-C1'-C2' 109.464 -2.46 . 0.88 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C4'-C3'-C2' 99.951 -2.749 . 0.885 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 N19-C1'-C2' 109.073 -2.704 . 0.836 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.361 -2.759 . 0.821 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.689 0 C4'-C3'-C2' 100.345 -2.355 . 0.9 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.499 0 C4'-C3'-C2' 100.068 -2.632 . 0.833 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.66 0 O4'-C1'-N19 111.51 3.31 . 0.766 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 C5'-C4'-C3' 111.742 -2.505 . 0.676 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.876 0 C5'-C4'-C3' 111.138 -2.908 . 0.647 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.418 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 C5'-C4'-C3' 111.2 -2.866 . 0.794 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.418 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 C5'-C4'-C3' 110.268 -3.488 . 0.414 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 C5'-C4'-C3' 109.939 -3.707 . 0.205 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . 0.424 " H1'" " O4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.427 -2.188 1 O4'-C1'-N19 112.505 4.305 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.653 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.723 1 C5'-C4'-C3' 109.216 -4.189 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.44 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.416 -3.042 1 C3'-C2'-C1' 105.64 4.6 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 C5'-C4'-C3' 109.777 -3.815 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 110.291 -3.473 . 0.496 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 C5'-C4'-C3' 110.633 -3.245 . 0.153 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 N19-C1'-C2' 109.601 -2.375 . 0.724 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.54 0 N19-C1'-C2' 109.541 -2.412 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 N19-C1'-C2' 109.45 -2.468 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 C5'-C4'-C3' 111.997 -2.335 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 O4'-C1'-N19 110.968 2.768 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 C4'-C3'-C2' 100.012 -2.688 . 0.697 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.794 0 O4'-C1'-N19 110.669 2.469 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 O4'-C1'-N19 110.706 2.506 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.863 0 N19-C1'-C2' 109.628 -2.357 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.106 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.94 -174.85 54.21 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.52 -53.22 51.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -157.35 -178.02 7.04 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 108.884 -173.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.566 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -68.64 -7.02 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 176.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -109.1 -2.98 17.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.76 88.75 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.03 -0.872 . . . . 0.0 114.811 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 66.24 -156.5 50.25 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.405 1.603 . . . . 0.0 110.118 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.08 17.88 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.766 2.978 . . . . 0.0 112.246 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -77.17 -40.48 45.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 122.26 -0.275 . . . . 0.0 110.267 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.1 3.48 53.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.798 0.439 . . . . 0.0 111.356 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.09 170.16 12.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.706 0.402 . . . . 0.0 111.271 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -79.18 -118.69 0.27 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.776 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.7 t -77.5 23.34 0.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.106 0.963 . . . . 0.0 111.831 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -7.01 4.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -86.6 -5.99 58.99 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.277 0.631 . . . . 0.0 111.156 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.9 22.3 0.88 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 39.1 t -158.45 150.66 21.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -96.57 14.9 23.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.077 0.551 . . . . 0.0 110.026 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.95 -113.03 0.26 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.327 0.651 . . . . 0.0 109.372 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.22 24.68 2.11 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.78 162.88 40.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 78.6 p -155.04 -29.94 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.077 0.151 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -108.14 18.2 21.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.257 0.623 . . . . 0.0 112.274 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -134.04 48.79 2.31 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.328 0.651 . . . . 0.0 111.233 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -67.24 -12.62 60.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.6 m -87.26 144.42 26.82 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -177.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.8 pt -129.05 147.4 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -101.78 147.8 26.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.54 146.86 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 122.983 0.513 . . . . 0.0 111.062 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -137.51 149.88 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.19 58.24 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.8 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.36 -54.74 42.03 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.281 0.632 . . . . 0.0 111.022 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.497 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.54 179.6 46.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -78.33 -9.05 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.818 0.847 . . . . 0.0 111.989 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -82.64 0.06 44.85 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.31 0.244 . . . . 0.0 111.461 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.98 155.76 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.71 168.24 27.8 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.26 -40.25 13.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 124.385 1.074 . . . . 0.0 111.948 -174.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.54 -29.14 63.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.487 -0.085 . . . . 0.0 111.198 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.5 t -74.9 -49.47 20.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.194 0.197 . . . . 0.0 110.57 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.8 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.72 -54.18 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.445 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.84 -38.27 78.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.29 0.496 . . . . 0.0 110.915 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -75.73 -15.15 60.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.788 0.327 . . . . 0.0 111.217 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -95.47 -26.79 15.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -97.27 -20.43 17.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.8 pttt -65.92 -18.98 65.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -64.11 -21.37 66.51 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.84 -25.74 5.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.32 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.15 170.03 30.53 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.54 136.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 122.674 -0.309 . . . . 0.0 111.167 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 322' ' ' ILE . 6.7 mm -77.66 137.66 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.46 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.0 ttmm -68.84 148.46 50.23 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m -119.21 139.82 51.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -70.84 144.95 50.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.76 -0.12 46.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -144.45 5.63 1.24 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.8 p -124.73 -18.27 5.66 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.49 -17.22 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.404 0.526 . . . . 0.0 113.028 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -85.06 158.94 57.96 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.864 0.832 . . . . 0.0 109.524 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.07 153.61 75.14 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.131 1.887 . . . . 0.0 109.264 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.46 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.7 mtp -79.46 79.57 5.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.8 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.84 156.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.49 0.716 . . . . 0.0 110.412 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -152.56 127.97 9.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.633 0.773 . . . . 0.0 109.199 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -92.84 121.67 34.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -84.45 158.58 21.0 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 26.2 p -135.43 145.18 46.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -57.78 139.4 54.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -77.89 -13.21 59.96 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -94.12 -5.24 47.69 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.1 t -150.81 -23.08 0.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.942 0.337 . . . . 0.0 110.849 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 82.14 19.69 64.37 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.561 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -126.4 168.15 14.58 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.23 118.72 1.38 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.769 0.828 . . . . 0.0 111.109 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.605 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 10.2 ptpt -88.0 -2.22 58.48 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.06 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.497 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.11 4.84 68.42 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.406 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 151.09 21.74 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 117.906 0.853 . . . . 0.0 111.059 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.52 167.4 29.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.12 0.568 . . . . 0.0 109.713 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.7 m -138.19 123.81 19.73 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.763 0.425 . . . . 0.0 111.228 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 99.5 t -116.36 125.23 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.431 0.692 . . . . 0.0 109.233 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.4 t -96.78 125.53 41.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.084 -0.385 . . . . 0.0 110.466 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -82.4 150.1 27.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.37 -15.69 58.43 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 86.7 m-20 -129.55 136.1 28.58 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.447 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 17.9 Cg_endo -65.48 -36.67 33.3 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.774 2.316 . . . . 0.0 114.31 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 85.8 Cg_endo -75.8 -18.66 16.9 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 120.935 1.37 . . . . 0.0 111.122 -175.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.0 m -75.9 -30.09 58.68 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.0 71.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.141 0.177 . . . . 0.0 110.871 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -64.12 -38.27 90.47 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.455 0.169 . . . . 0.0 110.643 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.5 83.02 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.555 0.342 . . . . 0.0 110.834 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -25.72 65.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.9 mt -72.71 -56.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -60.31 -20.95 61.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -94.99 -59.65 1.86 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.83 -31.5 69.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -57.76 112.81 1.58 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.49 -15.46 32.32 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.908 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.52 -172.14 2.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.742 1.271 . . . . 0.0 109.86 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -102.61 174.38 5.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.837 0.351 . . . . 0.0 110.347 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.589 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.1 t80 -130.02 -39.39 1.38 Allowed 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.3 t -143.34 18.18 1.89 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.993 0.517 . . . . 0.0 109.7 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.75 -18.81 24.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -175.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -97.11 140.2 21.94 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.27 151.27 81.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.997 2.465 . . . . 0.0 110.486 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.589 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.5 pt -136.88 168.93 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.153 0.502 . . . . 0.0 111.041 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.82 155.64 49.47 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.901 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.43 146.79 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 122.939 0.495 . . . . 0.0 110.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.4 m -155.11 173.1 17.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.3 160.7 4.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.416 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -130.8 139.23 50.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 17.3 m -141.05 135.97 31.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.957 0.903 . . . . 0.0 109.866 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -48.1 123.13 5.87 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.444 0.297 . . . . 0.0 110.666 -170.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -29.72 68.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.981 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -64.25 -8.77 13.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.542 ' CD1' ' HE3' ' A' ' 264' ' ' LYS . 90.2 m-85 -112.19 -8.88 13.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.51 -41.39 0.1 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -82.22 -0.33 44.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.048 0.385 . . . . 0.0 111.846 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 81.6 6.7 88.93 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.77 -4.91 72.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.266 0.46 . . . . 0.0 112.291 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.69 177.07 34.53 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.712 0.756 . . . . 0.0 111.401 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -146.45 152.48 39.09 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.981 0.513 . . . . 0.0 110.571 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -94.6 -171.29 37.61 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.415 ' HD2' " H1'" ' B' ' 100' ' ' ' C' . 10.2 ptp85 -158.07 163.43 37.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.728 0.411 . . . . 0.0 109.93 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -73.81 147.89 39.06 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.76 154.55 29.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -76.51 163.25 27.1 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 122.743 0.417 . . . . 0.0 110.182 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -74.9 174.01 51.83 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -153.09 152.53 31.42 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.282 0.633 . . . . 0.0 109.712 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -163.61 -173.48 32.36 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.377 -1.791 . . . . 0.0 110.767 179.38 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 C5'-C4'-C3' 110.859 -3.094 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.366 -2.521 . 0.772 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 C4'-C3'-C2' 100.13 -2.57 . 0.85 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.697 0 N19-C1'-C2' 109.097 -2.69 . 0.821 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.451 0 O4'-C1'-N19 110.858 2.658 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 110.927 2.727 . 0.9 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 O4'-C1'-N19 110.922 2.722 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 110.921 2.721 . 0.81 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.203 0 C5'-C4'-C3' 111.297 -2.802 . 0.68 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . 0.415 " H1'" ' HD2' ' A' ' 383' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 C5'-C4'-C3' 111.052 -2.965 . 0.632 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.426 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 111.145 -2.903 . 0.708 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.426 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 C5'-C4'-C3' 110.241 -3.506 . 0.491 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . 0.402 H5'' ' C8 ' ' B' ' 103' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.304 0 C5'-C4'-C3' 109.632 -3.912 OUTLIER-DELTA 0.0 OUTLIER '7D dist 4s' 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.235 1 O4'-C1'-N19 113.536 5.336 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.605 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 110.151 -3.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.416 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C3'-C2'-C1' 105.718 4.687 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.457 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.57 0 C5'-C4'-C3' 109.962 -3.692 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . 0.457 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.646 0 C5'-C4'-C3' 112.467 -2.022 . 0.207 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C5'-C4'-C3' 110.716 -3.189 . 0.615 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 110.49 2.29 . 0.688 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 109.566 -2.396 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 N19-C1'-C2' 109.449 -2.47 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 0 C4'-C3'-C2' 100.646 -2.054 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 C4'-C3'-C2' 100.275 -2.425 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 O4'-C1'-N19 110.796 2.596 . 0.71 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.57 0 C4'-C3'-C2' 100.232 -2.468 . 0.711 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.868 0 O4'-C1'-N19 110.536 2.336 . 0.817 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.69 0 N19-C1'-C2' 109.573 -2.392 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.113 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 74.94 -172.84 52.98 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.28 178.19 3.49 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.19 -177.12 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.02 0.928 . . . . 0.0 110.542 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.574 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -65.61 -12.54 54.13 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -96.9 -8.95 29.51 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.132 0.423 . . . . 0.0 110.667 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 88.93 7.78 70.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 64.31 -167.22 28.17 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.478 1.639 . . . . 0.0 111.0 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.59 21.43 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.642 2.894 . . . . 0.0 112.198 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 267' ' ' GLY . 78.4 ttt-85 -76.16 -24.56 54.82 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 122.16 -0.337 . . . . 0.0 110.978 -172.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.0 p30 -137.54 21.38 2.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.155 0.582 . . . . 0.0 111.211 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.95 -7.1 7.31 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.328 0.651 . . . . 0.0 112.461 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.73 -115.43 4.86 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 62.5 m -76.05 22.02 0.16 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -3.94 10.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.617 0.644 . . . . 0.0 112.244 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -92.4 -13.41 30.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.528 0.331 . . . . 0.0 111.219 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -127.33 6.23 6.37 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 41.6 t -152.05 150.1 29.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -87.96 -0.02 56.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.026 0.531 . . . . 0.0 110.542 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -91.4 -83.42 0.28 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.582 0.353 . . . . 0.0 110.077 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p30 49.03 15.73 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.727 1.611 . . . . 0.0 114.582 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -151.81 164.59 36.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -155.92 -34.43 0.09 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.484 0.183 . . . . 0.0 111.087 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.41 6.68 42.26 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -123.7 142.14 51.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.822 0.449 . . . . 0.0 110.025 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -145.17 15.41 1.5 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.733 0.813 . . . . 0.0 110.124 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.4 m -133.63 150.33 51.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.88 146.22 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.756 0.422 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -100.47 146.53 26.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.59 147.08 32.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 122.766 0.426 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -137.78 150.41 47.21 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.13 5.96 58.01 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.556 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.45 -57.32 12.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.499 0.72 . . . . 0.0 111.176 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.473 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.74 -179.1 45.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.02 -10.88 59.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.569 0.748 . . . . 0.0 112.405 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.8 -0.63 35.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.549 0.34 . . . . 0.0 111.355 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.58 155.58 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.95 168.4 27.25 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -48.67 -39.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.264 1.026 . . . . 0.0 111.825 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.89 -28.59 61.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.251 -0.281 . . . . 0.0 111.248 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -75.75 -48.33 22.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.89 -53.97 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.434 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.28 -37.55 77.97 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.045 -0.409 . . . . 0.0 110.843 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.67 -15.6 59.76 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.241 -0.287 . . . . 0.0 111.105 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -94.46 -27.13 16.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 339' ' ' VAL . 45.5 m-85 -97.03 -19.85 18.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.2 pttt -65.79 -18.91 65.67 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.3 pt20 -64.05 -21.8 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.8 mm -87.39 -27.26 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 167.89 169.89 31.96 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.03 135.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.577 -0.366 . . . . 0.0 111.064 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.496 HG21 HD11 ' A' ' 322' ' ' ILE . 8.1 mm -75.41 138.6 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.12 153.64 43.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.82 137.76 50.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -76.13 137.46 40.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.19 -19.58 56.55 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.94 -48.43 4.89 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.705 0.23 . . . . 0.0 110.7 -176.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.8 p -85.13 -21.52 29.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.36 -16.5 4.78 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.528 -0.596 . . . . 0.0 113.141 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.31 160.45 65.16 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 118.178 0.989 . . . . 0.0 109.803 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.15 153.46 69.4 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.963 1.775 . . . . 0.0 109.541 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.7 mtp -78.95 76.04 5.45 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.199 0.6 . . . . 0.0 111.128 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -130.89 159.63 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.143 0.577 . . . . 0.0 110.617 -178.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -156.24 125.23 6.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.84 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -90.05 121.73 32.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.546 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 65.3 m-85 -76.0 163.75 26.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.1 p -137.77 156.61 47.79 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.484 0.659 . . . . 0.0 111.106 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.44 131.9 44.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.31 1.044 . . . . 0.0 112.081 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 62.8 mtt-85 -79.34 -7.74 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.605 0.362 . . . . 0.0 111.718 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.64 -5.7 34.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.8 t -151.62 -25.27 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.964 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.33 51.88 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.041 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 174.64 6.41 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.907 0.854 . . . . 0.0 110.452 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -50.36 122.54 7.12 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.215 0.606 . . . . 0.0 111.132 -176.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.509 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -76.52 -16.49 59.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.488 0.715 . . . . 0.0 109.691 174.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.473 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.79 16.01 50.18 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -123.08 155.91 35.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.44 0.62 . . . . 0.0 110.388 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.68 173.39 16.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.906 0.482 . . . . 0.0 109.918 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.2 m -139.56 129.26 24.58 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 305' ' ' PHE . 89.6 t -119.24 127.18 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 39.5 t -98.36 132.89 43.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.724 -0.39 . . . . 0.0 109.971 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.24 145.11 24.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.175 0.99 . . . . 0.0 113.201 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -72.08 -16.41 62.02 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 99.5 m-20 -125.61 134.09 25.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.785 0.834 . . . . 0.0 110.835 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 22.3 Cg_endo -66.14 -33.93 38.7 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.702 2.268 . . . . 0.0 114.055 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 93.9 Cg_endo -77.69 -19.03 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.499 1.466 . . . . 0.0 111.522 -177.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.7 m -74.35 -29.14 61.46 Favored 'General case' 0 C--N 1.335 -0.05 0 CA-C-N 117.774 0.261 . . . . 0.0 110.35 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.64 79.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.3 tptm -62.51 -40.11 95.68 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.402 -0.187 . . . . 0.0 111.111 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.361 0.265 . . . . 0.0 110.92 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.54 -24.96 64.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 348' ' ' LYS . 65.8 mt -73.9 -55.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -60.76 -20.86 62.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -95.36 -60.27 1.7 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.76 -32.4 70.9 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.33 111.8 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.7 -17.11 25.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.287 -0.729 . . . . 0.0 112.806 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -94.43 -171.73 2.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.53 1.165 . . . . 0.0 109.94 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -102.7 174.25 5.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.582 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.3 t80 -129.38 -38.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.565 0.346 . . . . 0.0 110.078 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.8 t -144.49 17.33 1.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.016 0.526 . . . . 0.0 109.738 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.89 16.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -94.71 140.29 22.54 Favored Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.96 151.38 82.23 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.102 2.534 . . . . 0.0 110.326 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.582 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.2 pt -138.51 168.32 19.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 121.168 0.509 . . . . 0.0 111.092 -177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -133.81 155.64 49.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.268 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 56.9 t -144.63 147.43 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 O-C-N 123.412 0.445 . . . . 0.0 110.093 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.3 m -154.36 171.85 18.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.99 155.63 7.89 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.593 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -124.71 135.18 52.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.0 m -135.28 132.76 38.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.282 0.633 . . . . 0.0 109.698 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -46.7 113.97 0.74 Allowed 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.067 0.547 . . . . 0.0 110.355 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.86 74.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.53 71.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.049 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -66.01 -10.25 37.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.574 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.3 m-85 -104.29 -9.7 18.37 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.68 -42.11 0.09 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.56 -9.15 59.57 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.38 13.82 72.68 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.62 177.29 50.38 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.6 163.29 54.34 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -160.83 174.53 13.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.113 0.565 . . . . 0.0 110.563 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -163.95 174.88 40.13 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -78.49 171.2 15.45 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.895 0.478 . . . . 0.0 110.435 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -74.98 162.08 53.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -79.56 -173.58 45.04 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -149.52 148.76 29.77 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 123.187 0.595 . . . . 0.0 109.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -74.46 162.47 54.1 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.76 162.04 38.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.927 0.491 . . . . 0.0 109.988 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 178.15 177.48 46.91 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 117.296 -1.835 . . . . 0.0 110.93 179.824 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 N19-C1'-C2' 109.847 -2.22 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 C4'-C3'-C2' 100.12 -2.58 . 0.873 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 N19-C1'-C2' 109.267 -2.583 . 0.837 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.759 0 N19-C1'-C2' 109.165 -2.647 . 0.779 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 O4'-C1'-N19 111.003 2.803 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.971 2.771 . 0.868 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 O4'-C1'-N19 110.935 2.735 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 0 O4'-C1'-N19 110.898 2.698 . 0.753 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.782 0 C5'-C4'-C3' 111.723 -2.518 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.964 0 C5'-C4'-C3' 111.129 -2.914 . 0.647 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.525 0 C5'-C4'-C3' 111.431 -2.713 . 0.577 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 110.647 -3.236 . 0.367 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 C5'-C4'-C3' 109.462 -4.025 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . 0.405 " H1'" " H4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.26 1 O4'-C1'-N19 112.782 4.582 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.546 " H1'" ' CD2' ' A' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.866 0 C5'-C4'-C3' 110.456 -3.363 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.593 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 C3'-C2'-C1' 105.805 4.783 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 O4'-C1'-N19 110.926 2.726 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 C5'-C4'-C3' 110.744 -3.17 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 0 C5'-C4'-C3' 109.902 -3.732 . 0.41 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 N19-C1'-C2' 109.348 -2.532 . 0.688 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 N19-C1'-C2' 109.089 -2.694 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 N19-C1'-C2' 109.362 -2.524 . 0.641 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.29 -2.41 . 0.759 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 110.793 2.593 . 0.746 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.858 2.658 . 0.708 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 O4'-C1'-N19 110.702 2.502 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.521 2.321 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.684 2.484 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.239 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.19 174.78 44.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -62.65 -51.41 67.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -157.3 -178.23 7.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.106 0.962 . . . . 0.0 108.986 -173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.554 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.95 -8.4 36.69 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.435 -0.165 . . . . 0.0 111.301 176.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -107.7 -5.13 17.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.003 0.365 . . . . 0.0 110.326 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 87.55 2.13 82.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.002 -0.888 . . . . 0.0 115.215 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 64.95 -157.31 46.3 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 119.549 1.675 . . . . 0.0 110.739 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 271' ' ' GLN . 57.2 Cg_endo -73.59 42.27 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.883 3.056 . . . . 0.0 111.834 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -91.02 -24.92 19.92 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 122.152 -0.342 . . . . 0.0 111.028 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -142.31 22.39 2.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.251 0.621 . . . . 0.0 110.683 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 268' ' ' PRO . 30.3 tp60 -63.51 -21.43 66.32 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.308 0.643 . . . . 0.0 111.204 -175.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.51 -133.38 10.03 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.2 t -78.61 20.36 0.44 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.679 0.791 . . . . 0.0 111.541 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -7.52 3.54 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.942 0.497 . . . . 0.0 112.263 -174.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -85.07 -19.52 31.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.78 0.432 . . . . 0.0 110.822 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.19 0.95 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 58.4 m -144.95 150.65 37.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.97 0.508 . . . . 0.0 110.585 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -88.57 2.12 53.66 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -98.51 -110.09 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 54.27 15.27 0.91 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -149.24 160.23 43.56 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 41.0 t -157.24 -33.91 0.08 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -91.27 5.14 50.35 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.82 0.848 . . . . 0.0 112.92 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.44 44.51 2.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.198 0.599 . . . . 0.0 111.088 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.42 3.98 2.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.197 0.599 . . . . 0.0 111.694 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 m -105.75 147.83 28.14 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 15.6 pt -128.45 149.91 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.035 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -104.75 149.76 25.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.11 147.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.485 0.714 . . . . 0.0 111.12 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -139.38 150.13 44.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.05 57.83 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.995 -0.336 . . . . 0.0 112.801 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.64 -56.31 21.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.516 0.727 . . . . 0.0 111.288 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.72 -179.43 45.87 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.19 -10.41 59.39 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.704 0.802 . . . . 0.0 112.251 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -81.56 -0.69 43.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.242 0.217 . . . . 0.0 111.319 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.87 155.95 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.54 168.39 27.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -50.3 -40.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.324 1.05 . . . . 0.0 111.572 -174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -72.36 -28.83 63.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.405 -0.184 . . . . 0.0 111.102 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.5 -50.26 18.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.272 0.229 . . . . 0.0 110.456 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.25 -53.55 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.428 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.59 -37.39 78.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.531 0.605 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -76.12 -15.81 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 111.109 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -94.52 -27.52 15.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -96.71 -20.68 18.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.6 pttt -65.31 -19.09 65.8 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.45 -20.76 66.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.0 mm -88.59 -24.65 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-O 120.665 0.269 . . . . 0.0 110.342 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.53 168.79 27.18 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.37 136.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.614 -0.345 . . . . 0.0 111.002 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -78.22 137.58 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.419 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.8 ttmm -71.89 145.92 48.21 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 110.578 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.22 142.65 38.17 Favored 'General case' 0 N--CA 1.458 -0.075 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -74.53 -14.55 60.82 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 58.94 7.66 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -134.73 -30.46 1.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.928 0.785 . . . . 0.0 112.007 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 74.6 p -95.81 -9.98 30.19 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.467 0.307 . . . . 0.0 110.658 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.11 79.76 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.4 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 3.4 pt20 -140.05 161.28 56.57 Favored Pre-proline 0 C--O 1.231 0.096 0 CA-C-N 117.449 0.625 . . . . 0.0 109.687 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 319' ' ' GLN . 20.9 Cg_endo -61.25 155.73 49.83 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.476 2.117 . . . . 0.0 109.856 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 59.2 mtp -76.79 76.64 3.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.956 0.502 . . . . 0.0 110.997 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.799 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.75 158.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -157.37 133.1 9.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.5 mm? -93.37 120.12 33.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.92 159.73 22.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 57.4 p -133.8 157.11 46.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.298 0.57 . . . . 0.0 111.77 -171.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.57 127.89 34.55 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.184 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 328' ' ' ARG . 35.0 mtp85 -76.24 -6.86 53.3 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.33 0.252 . . . . 0.0 111.132 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -98.74 -5.56 31.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.6 t -149.93 -23.0 0.26 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.742 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.71 25.76 40.86 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.717 -0.491 . . . . 0.0 112.992 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -131.46 170.65 14.4 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 117.646 0.723 . . . . 0.0 110.414 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 333' ' ' LEU . 0.2 OUTLIER -47.57 122.87 5.16 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.901 0.881 . . . . 0.0 111.269 -173.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.561 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.7 ttmm -81.65 -18.76 43.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.983 0.913 . . . . 0.0 109.782 174.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.62 2.13 61.69 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.77 150.97 19.64 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.455 0.627 . . . . 0.0 111.119 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.47 33.68 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.003 0.521 . . . . 0.0 109.723 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.4 m -135.74 123.14 21.95 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.2 123.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 32.8 t -95.73 127.54 41.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.712 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.48 147.65 26.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -75.71 -17.5 59.92 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 90.5 m-20 -128.27 133.28 24.98 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.048 0.939 . . . . 0.0 110.834 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -67.12 -32.65 33.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.669 2.246 . . . . 0.0 114.6 -175.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 95.8 Cg_endo -75.17 -19.35 17.58 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 121.175 1.456 . . . . 0.0 110.753 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.5 m -76.98 -29.32 55.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.74 -47.56 74.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -64.92 -37.39 87.49 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.92 80.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.31 0.244 . . . . 0.0 110.483 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -25.27 65.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.7 mt -73.27 -56.07 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.93 -21.88 63.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -93.54 -60.78 1.69 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -69.22 -32.1 71.12 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.24 112.17 1.3 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.95 -16.06 30.78 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.945 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.76 -172.3 2.69 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.753 1.276 . . . . 0.0 109.969 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.91 174.22 6.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.588 0.355 . . . . 0.0 110.457 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.619 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -129.78 -38.37 1.49 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 15.57 1.74 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.698 0.399 . . . . 0.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 120.07 -18.7 9.63 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -104.22 148.77 36.47 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.02 151.11 73.31 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.483 2.789 . . . . 0.0 110.624 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.62 168.76 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.016 0.527 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -134.1 155.39 50.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.139 0.576 . . . . 0.0 111.101 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.1 t -144.34 146.27 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 122.899 0.48 . . . . 0.0 110.221 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.3 m -154.23 172.91 16.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.69 160.01 6.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.894 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -130.96 137.54 49.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 12.7 m -140.21 135.6 32.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 109.932 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -47.52 120.47 3.3 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.285 0.366 . . . . 0.0 110.936 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -69.16 -28.74 66.7 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.27 75.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.904 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.28 -7.92 28.06 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.509 ' CD2' ' HE3' ' A' ' 264' ' ' LYS . 93.8 m-85 -108.08 -9.2 15.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.93 -40.45 0.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -83.22 -2.8 56.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.802 0.274 . . . . 0.0 111.718 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.2 4.36 88.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.39 63.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 117.413 0.607 . . . . 0.0 112.263 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -80.72 160.99 43.82 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 117.618 0.709 . . . . 0.0 111.483 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -150.17 169.12 22.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.486 0.715 . . . . 0.0 110.361 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -75.17 167.47 54.88 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -154.52 -177.49 6.51 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.176 0.512 . . . . 0.0 110.604 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.518 ' H ' ' H21' ' B' ' 109' ' ' ' G' . . . -173.8 -161.04 23.23 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 159.78 -1.9 0.09 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 46.9 ttm105 -150.67 148.87 29.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -58.52 148.23 38.35 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -67.55 148.3 51.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.656 0.383 . . . . 0.0 110.236 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 178.56 -179.33 48.72 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 117.334 -1.815 . . . . 0.0 110.978 -179.579 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C5'-C4'-C3' 110.767 -3.156 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.373 -2.517 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 N19-C1'-C2' 109.107 -2.683 . 0.848 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 N19-C1'-C2' 109.333 -2.542 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 110.907 2.707 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 O4'-C1'-N19 110.724 2.524 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.85 0 O4'-C1'-N19 110.83 2.63 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.82 0 C5'-C4'-C3' 111.542 -2.639 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.871 0 C5'-C4'-C3' 111.739 -2.507 . 0.762 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.923 0 C5'-C4'-C3' 110.563 -3.291 . 0.676 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.458 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.051 0 C5'-C4'-C3' 111.575 -2.617 . 0.529 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.458 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.427 -2.175 0 C5'-C4'-C3' 110.707 -3.195 . 0.445 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 C5'-C4'-C3' 109.411 -4.059 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 1 O4'-C1'-N19 112.994 4.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.561 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 C5'-C4'-C3' 109.73 -3.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 1 C3'-C2'-C1' 105.621 4.579 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . 0.486 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.746 0 C5'-C4'-C3' 109.969 -3.688 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . 0.486 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 C4'-C3'-C2' 100.309 -2.391 . 0.132 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . 0.518 ' H21' ' H ' ' A' ' 384' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C4'-C3'-C2' 100.0 -2.7 . 0.721 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 O4'-C1'-N19 110.777 2.577 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 N19-C1'-C2' 109.154 -2.654 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 C4'-C3'-C2' 100.267 -2.433 . 0.733 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 C5'-C4'-C3' 112.202 -2.199 . 0.794 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 O4'-C1'-N19 110.66 2.46 . 0.777 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 110.648 2.448 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 O4'-C1'-N19 110.707 2.507 . 0.799 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 O4'-C1'-N19 110.591 2.391 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.83 0 O4'-C1'-N19 110.764 2.564 . 0.848 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.45 -171.53 54.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -72.16 178.56 3.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.447 ' CG ' ' H22' ' B' ' 106' ' ' ' G' . 23.8 m-80 -67.0 -176.45 0.52 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.529 0.731 . . . . 0.0 110.656 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.486 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -62.36 -19.11 63.04 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.613 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -95.3 -4.45 45.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.702 0.228 . . . . 0.0 110.865 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.44 10.24 77.54 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.464 169.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 68.12 -161.37 49.99 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.972 1.386 . . . . 0.0 110.572 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 271' ' ' GLN . 55.6 Cg_endo -71.11 35.56 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.914 3.076 . . . . 0.0 111.873 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -89.42 -39.05 13.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.928 -0.482 . . . . 0.0 110.527 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -112.58 16.26 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.988 0.515 . . . . 0.0 110.343 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 268' ' ' PRO . 23.2 tp60 -67.61 -23.81 65.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.842 0.457 . . . . 0.0 111.529 -172.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 114.35 -130.43 9.27 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 9.8 t -78.2 20.71 0.38 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.644 0.777 . . . . 0.0 112.117 -174.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -5.43 3.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.029 0.531 . . . . 0.0 112.307 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -86.93 -19.81 28.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.559 0.344 . . . . 0.0 111.09 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -123.38 2.34 9.08 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 57.8 m -151.72 156.83 41.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 109.08 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -104.42 16.81 25.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.42 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -100.09 -108.76 0.21 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 54.84 13.73 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -146.82 151.6 37.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.2 t -156.09 -33.73 0.09 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.556 0.162 . . . . 0.0 110.75 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.81 7.38 8.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.648 0.261 . . . . 0.0 111.523 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.62 147.88 52.56 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.934 0.894 . . . . 0.0 109.499 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -154.75 27.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.2 m -135.22 149.5 49.9 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -172.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.1 pt -131.95 146.95 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.582 0.353 . . . . 0.0 110.309 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.25 150.19 22.8 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.2 t -134.13 147.23 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.866 0.466 . . . . 0.0 111.783 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -136.74 149.85 48.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.72 6.15 58.4 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 120.005 -0.33 . . . . 0.0 112.361 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.76 -56.1 24.55 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.467 0.707 . . . . 0.0 110.857 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.469 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.82 -179.89 45.85 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -78.95 -10.35 59.79 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.873 0.869 . . . . 0.0 112.26 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.83 -1.63 43.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.352 0.261 . . . . 0.0 111.348 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.68 156.19 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -158.7 168.51 26.66 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.2 mm -49.32 -40.27 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.421 1.088 . . . . 0.0 111.728 -174.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.71 -29.14 63.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.348 -0.22 . . . . 0.0 111.209 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.68 -50.14 18.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.235 0.214 . . . . 0.0 110.594 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.837 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.18 -53.57 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.435 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.68 -38.15 80.75 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.975 -0.453 . . . . 0.0 110.565 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -75.94 -15.46 60.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 111.028 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -94.39 -27.02 16.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.8 m-85 -97.66 -20.13 17.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.3 pttt -66.08 -18.9 65.64 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -173.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -63.77 -21.59 66.49 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -87.35 -24.06 6.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.968 0.349 . . . . 0.0 110.2 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 161.19 172.72 28.91 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 40.2 mm -66.41 137.39 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 322' ' ' ILE . 7.1 mm -78.38 133.82 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 342' ' ' ASP . 12.6 tppt? -64.55 133.01 51.47 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.8 m -89.96 141.38 28.72 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.7 152.48 45.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -72.16 -23.21 61.25 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -146.35 -13.51 0.46 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.4 p -87.16 -14.56 40.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.746 0.703 . . . . 0.0 112.508 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.15 -19.62 2.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.649 0.642 . . . . 0.0 113.395 171.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -80.78 161.99 61.77 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 117.761 0.78 . . . . 0.0 110.039 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.88 152.04 82.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.04 1.827 . . . . 0.0 109.047 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 71.1 mtp -78.27 80.69 4.67 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.579 0.352 . . . . 0.0 111.196 -175.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.837 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -133.78 154.6 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -150.36 121.3 7.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.227 0.611 . . . . 0.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -88.41 121.83 31.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.516 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 77.6 m-85 -79.26 162.21 25.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.108 0.48 . . . . 0.0 112.092 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.9 p -137.42 153.57 50.12 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.503 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -63.28 135.53 57.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.607 0.763 . . . . 0.0 112.305 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.12 -13.11 59.99 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.286 -0.259 . . . . 0.0 110.405 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -93.44 -5.72 48.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.0 t -150.2 -23.81 0.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.025 0.375 . . . . 0.0 110.588 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.64 17.58 63.57 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.808 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -119.94 169.67 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.967 0.884 . . . . 0.0 110.299 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.4 OUTLIER -45.98 122.55 3.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.534 0.733 . . . . 0.0 111.469 -174.439 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.517 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.2 ttmm -80.62 -21.43 41.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.596 174.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.96 16.88 31.78 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -119.81 154.96 33.49 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 117.398 0.599 . . . . 0.0 110.405 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.81 171.02 20.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.878 0.471 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 42.0 m -134.78 128.18 32.32 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.739 0.416 . . . . 0.0 110.262 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.411 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.1 t -118.23 128.39 75.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 321' ' ' MET . 43.7 t -98.92 132.91 43.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.73 176.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -90.86 148.28 22.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HA ' ' CE ' ' A' ' 312' ' ' LYS . 47.4 t0 -70.96 -22.78 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.44 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.8 m-20 -124.82 135.82 27.2 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.318 0.647 . . . . 0.0 111.693 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 19.2 Cg_endo -64.05 -36.67 47.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.799 2.333 . . . . 0.0 113.925 -175.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 94.5 Cg_endo -76.89 -16.42 16.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.579 1.519 . . . . 0.0 111.172 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.4 m -77.44 -29.53 52.9 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.87 81.58 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -64.52 -39.47 93.83 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 122.175 0.19 . . . . 0.0 110.742 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.37 83.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.565 0.346 . . . . 0.0 110.908 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -24.97 65.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.56 -57.72 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.85 -21.44 63.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -92.8 -59.15 2.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.76 -33.45 70.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.43 112.11 1.17 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.37 -16.46 29.45 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.188 -0.785 . . . . 0.0 113.046 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -93.83 -171.92 2.72 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.7 1.25 . . . . 0.0 109.695 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -102.8 172.21 6.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.696 0.284 . . . . 0.0 110.421 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.6 t80 -126.34 -38.92 2.08 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 26.4 t -142.59 6.29 1.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.834 0.454 . . . . 0.0 110.477 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.38 -22.27 3.97 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -101.76 149.37 36.4 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.73 152.29 77.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.474 2.782 . . . . 0.0 110.296 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.66 166.29 24.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 122.747 0.419 . . . . 0.0 110.792 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -131.46 156.1 46.23 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.155 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 45.3 t -144.86 147.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.453 0.471 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -156.53 173.21 17.25 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.809 0.843 . . . . 0.0 108.801 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -60.23 152.89 23.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.623 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -123.95 137.16 54.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 7.4 m -142.71 139.52 31.16 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -44.13 109.57 0.16 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.117 0.567 . . . . 0.0 110.533 -173.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -31.03 67.89 Favored 'General case' 0 C--N 1.337 0.054 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.84 -32.0 73.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.131 0.172 . . . . 0.0 110.803 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.8 -8.81 11.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.78 -7.54 15.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.25 -41.84 0.11 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -80.71 -9.13 59.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.178 0.445 . . . . 0.0 111.569 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.69 72.08 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.48 47.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -71.72 163.36 54.33 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.71 169.42 24.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.967 0.507 . . . . 0.0 110.618 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -170.35 164.18 37.46 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -78.14 159.12 28.81 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 122.687 0.395 . . . . 0.0 110.498 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -68.1 139.49 34.37 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -95.81 171.27 28.65 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -64.76 137.94 58.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -81.79 132.06 10.88 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -79.04 151.13 31.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -72.94 -165.64 9.18 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.532 -1.705 . . . . 0.0 110.938 178.319 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 N19-C1'-C2' 109.689 -2.32 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C4'-C3'-C2' 100.174 -2.526 . 0.882 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 N19-C1'-C2' 109.177 -2.639 . 0.867 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 N19-C1'-C2' 109.034 -2.729 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.56 0 C5'-C4'-C3' 111.713 -2.524 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.951 0 O4'-C1'-N19 110.911 2.711 . 0.89 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 110.831 2.631 . 0.799 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.903 2.703 . 0.799 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 O4'-C1'-N19 110.917 2.717 . 0.662 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 C5'-C4'-C3' 111.426 -2.716 . 0.627 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.527 0 C5'-C4'-C3' 111.014 -2.991 . 0.396 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C5'-C4'-C3' 110.507 -3.329 . 0.361 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.888 0 C5'-C4'-C3' 109.663 -3.891 . 0.255 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.615 2.211 1 O4'-C1'-N19 113.249 5.049 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.517 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 C5'-C4'-C3' 110.513 -3.325 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.623 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.601 1 C3'-C2'-C1' 105.647 4.608 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.868 -3.755 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.564 0 C5'-C4'-C3' 110.305 -3.464 . 0.454 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C4'-C3'-C2' 100.071 -2.629 . 0.378 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 N19-C1'-C2' 109.147 -2.658 . 0.749 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 N19-C1'-C2' 109.106 -2.684 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.416 0 N19-C1'-C2' 109.696 -2.315 . 0.752 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 C5'-C4'-C3' 112.428 -2.048 . 0.774 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.029 2.829 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 111.181 2.981 . 0.674 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 110.956 2.756 . 0.718 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.962 0 O4'-C1'-N19 110.994 2.794 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 O4'-C1'-N19 110.734 2.534 . 0.841 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.06 172.09 51.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -69.72 108.0 3.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 58.55 -167.21 0.15 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.163 0.585 . . . . 0.0 110.783 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.609 ' HD3' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -78.63 -1.62 35.1 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 -175.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -116.48 -8.79 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.069 0.395 . . . . 0.0 109.967 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.85 87.03 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.962 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 65.36 -149.29 51.63 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.95 1.375 . . . . 0.0 110.56 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.77 16.05 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.999 3.132 . . . . 0.0 112.593 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 267' ' ' GLY . 49.6 tpt85 -82.69 -24.73 33.53 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.217 -0.302 . . . . 0.0 110.58 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -108.96 3.64 22.45 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.16 167.3 19.64 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.745 0.418 . . . . 0.0 110.863 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -79.27 -113.54 0.23 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.759 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 74.5 m -75.54 29.28 0.1 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.808 0.843 . . . . 0.0 113.139 -174.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.56 -6.12 10.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.237 0.471 . . . . 0.0 112.036 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -89.54 -17.9 27.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.791 0.436 . . . . 0.0 111.068 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -129.52 -0.03 4.99 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.4 m -144.46 155.05 43.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.82 0.73 56.41 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.315 0.646 . . . . 0.0 111.207 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -89.43 -82.65 0.25 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.442 0.297 . . . . 0.0 110.355 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p30 49.62 15.03 0.13 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.142 1.777 . . . . 0.0 114.853 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -152.7 158.43 42.33 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 34.1 t -149.46 2.35 0.54 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 110.632 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -140.46 10.15 2.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.765 0.826 . . . . 0.0 112.425 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -133.2 56.18 1.86 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.296 0.639 . . . . 0.0 110.854 -172.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.4 -12.48 60.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.608 0.363 . . . . 0.0 110.39 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 m -92.57 147.33 22.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.26 147.89 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 122.939 0.496 . . . . 0.0 109.883 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -101.78 148.38 25.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.27 148.7 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.133 0.573 . . . . 0.0 111.125 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.33 149.35 45.54 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.23 5.6 58.06 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.943 -0.365 . . . . 0.0 112.849 172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.39 -53.86 51.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.655 0.727 . . . . 0.0 111.412 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.509 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.51 -176.61 44.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -170.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -86.87 -7.51 58.14 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.669 0.788 . . . . 0.0 112.519 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.01 -5.69 52.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 110.887 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.23 159.62 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.661 0.785 . . . . 0.0 112.303 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.05 168.03 26.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.07 -39.87 12.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.2 1.0 . . . . 0.0 111.712 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.47 -28.52 61.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.368 -0.208 . . . . 0.0 110.905 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.2 t -75.09 -49.5 19.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.104 0.161 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.808 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -60.98 -53.86 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.447 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.84 -38.07 77.89 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.053 0.388 . . . . 0.0 110.751 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -75.89 -15.67 60.17 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.129 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.58 -27.49 15.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -96.98 -20.42 18.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.9 pttt -65.39 -19.04 65.77 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -173.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.6 pt20 -64.57 -21.19 66.63 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.5 mm -88.11 -24.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.312 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.2 169.31 27.56 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.17 137.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 122.645 -0.327 . . . . 0.0 111.093 -172.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.451 HG21 HD11 ' A' ' 322' ' ' ILE . 6.7 mm -78.95 137.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 22.3 ttmm -69.42 149.7 48.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -125.04 138.46 54.2 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -71.1 141.04 50.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -77.08 -18.43 58.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -112.88 -38.55 4.5 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.151 0.432 . . . . 0.0 111.904 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.8 p -85.1 -20.27 30.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.81 -15.49 4.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.3 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -83.95 158.56 61.68 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 117.837 0.818 . . . . 0.0 109.52 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.34 154.02 70.75 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.368 2.045 . . . . 0.0 109.193 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.453 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 65.8 mtp -79.35 79.67 5.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.696 0.399 . . . . 0.0 110.928 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.808 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -135.15 155.53 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.668 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.98 129.53 13.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -92.08 119.83 32.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.434 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 97.4 m-85 -83.94 157.33 21.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.429 HG22 HD23 ' A' ' 333' ' ' LEU . 18.9 p -132.33 155.17 48.86 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -69.64 122.61 19.44 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.19 170.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -74.03 -5.22 40.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.522 0.201 . . . . 0.0 110.728 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.36 -6.78 36.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.475 0.71 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.5 t -149.01 -23.72 0.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.533 0.606 . . . . 0.0 110.81 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.97 41.33 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.796 -0.446 . . . . 0.0 112.816 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -129.29 166.4 19.52 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.756 0.778 . . . . 0.0 109.845 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.429 HD23 HG22 ' A' ' 326' ' ' THR . 4.9 mt -50.23 126.24 14.33 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.522 0.201 . . . . 0.0 110.783 -173.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.714 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 0.1 OUTLIER -85.02 1.81 45.98 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.094 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.13 -2.31 75.05 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.37 146.62 24.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.786 0.793 . . . . 0.0 111.136 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.77 166.64 32.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 10.3 m -138.56 121.32 16.42 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 122.556 0.342 . . . . 0.0 111.457 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.68 126.07 72.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.4 t -97.31 127.69 43.5 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.309 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.439 ' O ' ' HE2' ' A' ' 312' ' ' LYS . 42.2 m-85 -84.29 147.71 27.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.6 -18.66 59.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -126.06 133.79 25.29 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 110.685 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 27.5 Cg_endo -66.31 -33.68 37.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 114.405 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 84.8 Cg_endo -75.81 -20.1 15.61 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 121.2 1.464 . . . . 0.0 111.122 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 52.6 m -74.82 -29.61 61.13 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.8 78.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.13 0.172 . . . . 0.0 110.742 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -63.04 -39.75 95.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.404 0.282 . . . . 0.0 110.622 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.68 81.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.53 0.332 . . . . 0.0 110.842 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.04 65.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.4 -57.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -59.78 -21.93 61.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -93.82 -60.0 1.86 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.44 -31.94 70.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.43 111.73 1.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.45 -14.97 30.1 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.052 -0.86 . . . . 0.0 113.07 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -95.25 -171.99 2.55 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.748 1.274 . . . . 0.0 109.851 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.51 175.5 5.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.303 0.241 . . . . 0.0 110.606 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.606 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -131.08 -38.4 1.23 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -143.23 16.49 1.89 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.157 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.89 12.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.93 148.51 35.43 Favored Pre-proline 0 C--O 1.233 0.187 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.06 152.1 73.0 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.707 2.938 . . . . 0.0 110.722 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.36 168.3 20.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 122.821 0.448 . . . . 0.0 110.953 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.7 156.32 47.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.0 146.11 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.089 0.555 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 m -154.64 171.82 18.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -58.47 159.45 6.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.412 ' HB1' " H1'" ' B' ' 106' ' ' ' G' . . . -130.36 138.24 50.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 4.1 m -141.8 136.69 30.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -48.09 109.34 0.22 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 122.895 0.478 . . . . 0.0 110.413 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -31.26 66.53 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.002 0.521 . . . . 0.0 109.923 -173.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.47 71.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.447 -0.158 . . . . 0.0 110.807 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -67.21 -11.56 57.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.457 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 96.5 m-85 -97.09 -13.08 22.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.09 -40.48 0.08 Allowed 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 37.9 mmm-85 -82.9 -2.13 54.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.37 12.09 73.82 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.8 -158.41 35.14 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -73.25 -170.76 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -150.02 169.57 20.9 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.921 0.488 . . . . 0.0 109.707 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -175.25 169.2 42.0 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -135.88 164.23 28.41 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.189 0.596 . . . . 0.0 109.462 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.28 133.81 26.35 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -92.37 175.5 37.73 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -68.89 141.18 55.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -79.79 172.07 54.76 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -67.79 147.22 52.88 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -72.07 174.34 43.94 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 117.158 -1.912 . . . . 0.0 110.818 -179.78 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.41 0 C5'-C4'-C3' 110.849 -3.101 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.699 0 C4'-C3'-C2' 100.235 -2.465 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 C4'-C3'-C2' 100.102 -2.598 . 0.837 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 O4'-C1'-N19 110.848 2.648 . 0.783 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.708 2.508 . 0.846 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 O4'-C1'-N19 110.795 2.595 . 0.867 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O4'-C1'-N19 111.216 3.016 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 0 O4'-C1'-N19 111.2 3.0 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.906 0 O4'-C1'-N19 110.58 2.38 . 0.773 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C5'-C4'-C3' 111.007 -2.995 . 0.574 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ' C' . . . . . 0.426 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.913 0 C5'-C4'-C3' 111.343 -2.771 . 0.774 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' ' A' . . . . . 0.426 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C5'-C4'-C3' 110.503 -3.331 . 0.404 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.563 0 C5'-C4'-C3' 109.626 -3.916 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.886 1 O4'-C1'-N19 112.64 4.44 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ' U' . . . . . 0.714 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.737 1 C5'-C4'-C3' 109.399 -4.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ' G' . . . . . 0.412 " H1'" ' HB1' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.8 1 C3'-C2'-C1' 105.795 4.772 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 109.929 -3.714 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 C5'-C4'-C3' 110.928 -3.048 . 0.353 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.393 0 N19-C1'-C2' 109.059 -2.713 . 0.718 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 N19-C1'-C2' 109.29 -2.569 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.584 0 N19-C1'-C2' 109.24 -2.6 . 0.783 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 N19-C1'-C2' 108.999 -2.75 . 0.697 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 C5'-C4'-C3' 112.095 -2.27 . 0.746 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O4'-C1'-N19 110.786 2.586 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.508 0 O4'-C1'-N19 110.715 2.515 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 110.383 2.183 . 0.701 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.787 0 C4'-C3'-C2' 100.445 -2.255 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.678 0 N19-C1'-C2' 109.627 -2.358 . 0.818 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.824 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 C-N-CA 124.009 3.139 . . . . 0.0 111.932 178.005 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.8 m -101.83 147.85 26.01 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.6 pt -128.84 149.22 33.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.006 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -103.68 149.77 24.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.3 147.96 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 123.105 0.562 . . . . 0.0 111.163 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -139.54 149.07 43.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.95 4.81 57.65 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.718 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.18 -54.46 43.09 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.339 0.57 . . . . 0.0 111.159 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.466 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.28 -179.23 48.08 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.12 -9.65 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.596 0.758 . . . . 0.0 112.299 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -81.59 -1.53 46.77 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.446 0.298 . . . . 0.0 111.44 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.34 156.77 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.45 168.18 27.65 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.83 -39.34 14.9 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.313 1.045 . . . . 0.0 111.71 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -73.92 -28.54 61.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.434 -0.166 . . . . 0.0 110.89 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.63 -49.84 20.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.266 0.226 . . . . 0.0 110.539 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.53 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.431 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -38.32 79.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.187 0.449 . . . . 0.0 110.583 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -75.23 -15.7 60.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 111.272 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -95.03 -26.58 16.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -97.88 -20.0 17.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.6 pttt -66.22 -19.13 65.74 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.8 pt20 -64.05 -21.07 66.37 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.4 mm -87.8 -28.34 5.55 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.444 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 168.49 170.05 32.68 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.8 mm -68.04 134.85 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 122.519 -0.401 . . . . 0.0 111.247 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 322' ' ' ILE . 6.2 mm -76.97 137.09 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.429 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.7 ttmm -69.68 139.33 53.45 Favored 'General case' 0 C--O 1.23 0.041 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.106 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.67 153.42 75.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.798 1.665 . . . . 0.0 109.027 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.5 mtp -78.69 79.35 5.11 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.786 0.434 . . . . 0.0 111.175 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.803 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.37 159.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.697 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -156.42 130.62 8.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -91.97 119.61 31.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -82.79 158.36 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.38 0.61 . . . . 0.0 112.085 -170.733 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.22 1.71 58.1 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -94.32 150.9 19.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.331 0.566 . . . . 0.0 110.916 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.27 165.77 32.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.072 0.549 . . . . 0.0 109.59 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 7.1 m -136.47 122.55 20.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 96.2 t -114.99 124.01 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.7 t -96.29 126.6 41.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.253 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -84.09 148.32 26.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.84 -17.65 59.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 92.4 m-20 -128.13 134.08 25.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 110.687 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.8 Cg_endo -67.2 -32.94 32.45 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.689 2.259 . . . . 0.0 114.659 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.4 Cg_endo -75.13 -18.94 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 121.11 1.432 . . . . 0.0 110.831 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.8 m -77.19 -29.81 54.54 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.01 78.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -66.0 -37.03 84.89 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.397 -0.189 . . . . 0.0 110.629 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.48 -40.31 81.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.459 0.304 . . . . 0.0 110.969 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.17 -25.92 65.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.26 -56.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.13 -21.68 63.97 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -94.04 -58.67 2.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -70.92 -32.34 69.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.07 112.37 1.33 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.02 -16.48 30.33 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.837 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -94.26 -172.29 2.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.788 1.294 . . . . 0.0 110.07 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -101.73 173.7 6.29 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.622 0.369 . . . . 0.0 110.302 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.608 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.5 t80 -127.96 -38.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.3 t -141.73 4.8 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.05 -22.58 4.0 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.61 148.45 34.75 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 151.91 78.25 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.291 2.661 . . . . 0.0 110.74 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.34 169.36 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.629 0.371 . . . . 0.0 110.862 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -134.17 155.88 49.31 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.922 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.74 146.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.956 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.3 m -154.92 173.86 15.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 108.881 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -57.98 159.77 5.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 169.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.676 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 123.996 3.131 . . . . 0.0 112.343 177.087 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -98.43 147.16 25.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.44 149.88 34.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.018 0.527 . . . . 0.0 110.139 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -105.12 149.08 26.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.14 148.19 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 123.181 0.592 . . . . 0.0 111.056 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -138.45 149.55 45.57 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.58 57.61 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.848 -0.418 . . . . 0.0 112.599 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.06 -54.53 38.01 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.404 0.682 . . . . 0.0 111.639 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.51 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.68 -176.81 43.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -170.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -85.44 -9.17 57.86 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.773 0.829 . . . . 0.0 112.265 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -78.77 -5.2 52.67 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.184 -0.322 . . . . 0.0 111.209 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.51 158.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.547 0.739 . . . . 0.0 112.678 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.66 167.16 29.07 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.9 mm -49.32 -39.35 13.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.359 1.064 . . . . 0.0 111.731 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.14 -28.41 62.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.35 -0.219 . . . . 0.0 111.15 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.1 t -75.73 -48.73 20.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.303 0.241 . . . . 0.0 110.765 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.792 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.44 -53.62 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.425 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.22 -37.55 77.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.36 0.527 . . . . 0.0 110.52 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -75.96 -16.02 60.07 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.217 -0.302 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.98 -27.48 16.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -97.02 -19.86 18.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -65.27 -18.95 65.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.5 pt20 -64.6 -21.59 66.75 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.5 mm -87.67 -25.76 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.047 0 CA-C-O 120.818 0.342 . . . . 0.0 110.313 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 165.81 169.81 29.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.52 135.86 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 O-C-N 122.646 -0.326 . . . . 0.0 110.993 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.482 HG21 HD11 ' A' ' 322' ' ' ILE . 7.2 mm -76.54 137.99 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.402 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.2 ttmm -69.97 147.51 50.07 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.821 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 C--O 1.232 0.184 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.82 155.06 56.77 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.316 2.011 . . . . 0.0 109.413 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.402 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 49.3 mtp -76.9 76.99 3.48 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.723 0.409 . . . . 0.0 111.154 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.792 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -136.03 154.55 33.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.065 0 C-N-CA 123.283 0.633 . . . . 0.0 110.792 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -151.9 131.9 13.43 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -93.02 118.06 30.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -80.5 158.44 25.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 CA--C 1.513 -0.462 0 CA-C-O 121.413 0.625 . . . . 0.0 112.59 -173.093 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.27 1.5 72.07 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.415 0.531 . . . . 0.0 111.911 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.17 148.5 24.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 117.808 0.804 . . . . 0.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.2 165.84 33.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.388 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 5.0 m -135.22 121.22 19.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.976 0.51 . . . . 0.0 111.943 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.08 125.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 33.3 t -96.66 129.68 44.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.49 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.48 147.27 26.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -76.72 -17.35 59.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -124.84 131.25 24.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.069 0.948 . . . . 0.0 110.525 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.9 Cg_endo -66.17 -33.3 40.53 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.798 2.332 . . . . 0.0 114.382 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 93.0 Cg_endo -75.53 -20.27 16.0 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 CA-C-N 121.372 1.526 . . . . 0.0 111.016 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -74.72 -29.81 61.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.52 -47.98 76.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.411 ' HA ' HD12 ' A' ' 351' ' ' ILE . 17.3 tptm -64.62 -38.15 90.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.346 0.117 . . . . 0.0 110.71 -177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.59 82.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.471 0.308 . . . . 0.0 110.808 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.91 -25.81 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 348' ' ' LYS . 66.4 mt -72.54 -57.92 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -59.67 -22.32 61.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -92.65 -60.35 1.84 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.72 -32.03 70.36 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.58 112.45 1.28 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.89 -15.81 31.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.149 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.47 -171.91 2.5 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.719 1.26 . . . . 0.0 109.861 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -101.12 174.68 5.89 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.427 0.291 . . . . 0.0 110.455 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.602 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.1 t80 -130.66 -37.38 1.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.617 0.367 . . . . 0.0 110.404 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.3 t -144.37 15.59 1.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.86 10.79 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.82 148.0 34.44 Favored Pre-proline 0 CA--C 1.53 0.175 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.26 151.22 76.77 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.485 2.79 . . . . 0.0 110.646 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.602 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.07 169.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 122.858 0.463 . . . . 0.0 110.705 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 156.27 49.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.698 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.06 147.87 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.068 0.547 . . . . 0.0 110.307 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 175.88 13.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.126 0.971 . . . . 0.0 108.809 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.23 163.84 3.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.206 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 N--CA 1.456 -0.684 0 C-N-CA 123.787 2.991 . . . . 0.0 112.603 177.304 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.4 m -98.49 148.7 23.47 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.3 pt -128.98 149.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.335 0.654 . . . . 0.0 109.854 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -103.0 149.09 24.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.2 t -133.94 148.34 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.319 0.647 . . . . 0.0 110.892 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -139.14 151.09 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.1 5.34 59.56 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 120.013 -0.326 . . . . 0.0 112.797 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.5 mp -55.09 -55.22 33.51 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.428 0.614 . . . . 0.0 111.292 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.507 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.86 -176.99 44.62 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.03 -7.22 58.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.087 0.955 . . . . 0.0 112.368 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.29 -6.7 55.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.677 0.275 . . . . 0.0 110.805 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.73 159.76 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 163.63 39.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 44.3 mm -50.7 -37.1 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.009 0.924 . . . . 0.0 111.805 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -73.86 -28.59 61.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.251 -0.281 . . . . 0.0 110.991 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.6 t -74.0 -48.52 29.73 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 122.258 0.223 . . . . 0.0 110.548 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.825 HG21 HG21 ' A' ' 322' ' ' ILE . 2.3 m -61.71 -53.45 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.434 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -38.45 79.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.182 0.446 . . . . 0.0 110.884 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -75.33 -16.22 60.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 111.088 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -93.94 -27.56 16.29 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -96.85 -20.08 18.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.2 pttt -65.99 -19.09 65.74 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -173.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.4 pt20 -64.31 -21.24 66.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.2 mm -87.99 -23.66 6.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 162.2 169.74 25.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.06 138.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 122.535 -0.391 . . . . 0.0 111.178 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.462 HG21 HD11 ' A' ' 322' ' ' ILE . 7.3 mm -78.9 135.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.455 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 15.5 ttpp -70.04 139.18 52.64 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -176.442 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.64 152.39 80.62 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.927 1.752 . . . . 0.0 108.913 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.2 mtp -78.09 79.8 4.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.004 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.825 HG21 HG21 ' A' ' 301' ' ' VAL . 0.5 OUTLIER -132.67 152.16 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.328 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -146.42 126.44 13.69 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 36.0 mt -96.07 113.46 25.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -79.25 156.09 28.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 CA--C 1.514 -0.415 0 CA-C-O 121.736 0.779 . . . . 0.0 112.855 -170.08 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.03 -5.69 61.58 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -87.23 144.98 26.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.76 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.83 166.49 33.23 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.7 m -138.64 119.24 13.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.705 0.402 . . . . 0.0 111.353 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.65 125.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.9 t -96.94 132.91 42.26 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.06 -0.4 . . . . 0.0 110.301 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.89 147.28 23.26 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -73.69 -20.49 60.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -124.5 133.16 24.51 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 123.671 0.788 . . . . 0.0 110.706 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 26.2 Cg_endo -66.69 -33.78 34.07 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.724 2.283 . . . . 0.0 114.031 -175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 85.5 Cg_endo -76.84 -18.93 14.55 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 CA-C-N 121.214 1.469 . . . . 0.0 111.032 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 56.2 m -75.49 -29.72 59.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.38 -48.03 79.58 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -64.64 -39.04 93.01 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-O 120.595 0.236 . . . . 0.0 110.714 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.72 -39.32 84.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.392 0.277 . . . . 0.0 110.642 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.1 -26.15 65.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -72.79 -57.25 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.68 -22.27 61.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -93.13 -60.37 1.81 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.77 -31.55 69.55 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -56.75 113.24 1.56 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.005 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.33 37.68 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.169 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -96.5 -172.48 2.52 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.545 1.173 . . . . 0.0 110.027 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.96 175.6 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.843 0.354 . . . . 0.0 110.559 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.4 t80 -131.45 -39.41 1.14 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 17.0 t -141.53 19.69 2.2 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.798 0.439 . . . . 0.0 110.101 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.79 -8.29 34.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -111.49 146.77 35.32 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 123.881 0.872 . . . . 0.0 109.587 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.49 149.42 68.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.563 2.842 . . . . 0.0 110.846 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.75 169.72 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.924 0.49 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -135.83 156.5 48.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.127 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.4 t -144.7 147.55 19.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.09 0.556 . . . . 0.0 110.153 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 71.0 m -155.23 175.41 13.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.054 0.941 . . . . 0.0 108.833 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -59.8 163.81 4.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.887 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 C-N-CA 123.81 3.007 . . . . 0.0 112.377 178.23 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 26.7 m -132.71 150.79 52.11 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.662 0.385 . . . . 0.0 111.146 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.1 pt -128.42 148.84 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.876 0.47 . . . . 0.0 110.271 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -101.15 149.82 23.58 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.4 148.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.362 0.665 . . . . 0.0 110.902 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -138.77 149.53 45.11 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.47 5.59 57.83 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.971 -0.349 . . . . 0.0 112.869 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.91 -56.67 17.82 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 117.479 0.639 . . . . 0.0 111.408 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.452 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.86 -179.61 44.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.84 -10.0 59.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.626 0.77 . . . . 0.0 112.281 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -82.17 2.48 31.34 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.386 0.274 . . . . 0.0 111.553 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.91 155.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -158.49 168.91 25.65 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.7 mm -49.62 -40.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.391 1.077 . . . . 0.0 111.645 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.59 -28.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.449 -0.157 . . . . 0.0 110.876 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.7 t -75.08 -49.84 18.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.221 0.208 . . . . 0.0 110.611 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 322' ' ' ILE . 2.8 m -61.09 -53.71 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.441 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.04 -38.1 78.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.212 0.46 . . . . 0.0 110.718 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -76.07 -15.81 60.04 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -94.14 -27.63 16.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 339' ' ' VAL . 45.4 m-85 -97.23 -19.99 18.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -65.65 -19.05 65.75 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.27 -21.02 66.45 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -88.34 -26.04 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.732 0.301 . . . . 0.0 110.474 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.34 170.7 31.58 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 52.1 mm -68.4 134.63 29.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 O-C-N 122.662 -0.316 . . . . 0.0 111.348 -172.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 322' ' ' ILE . 6.8 mm -76.19 137.34 22.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.431 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.8 ttmm -67.78 147.37 52.68 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.7 153.87 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.173 1.915 . . . . 0.0 109.102 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.431 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.9 mtp -79.65 78.52 6.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 122.476 0.31 . . . . 0.0 111.001 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.809 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.6 156.86 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.36 0.664 . . . . 0.0 110.71 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -152.76 130.57 11.66 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.918 0.887 . . . . 0.0 109.455 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -94.07 119.49 33.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -84.03 160.09 21.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 C--N 1.339 0.147 0 CA-C-O 121.763 0.792 . . . . 0.0 110.357 -171.198 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.52 0.22 59.46 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.81 149.44 21.98 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.396 0.598 . . . . 0.0 110.927 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.13 165.83 32.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.378 0.671 . . . . 0.0 109.75 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.0 m -136.9 121.74 18.73 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 305' ' ' PHE . 98.2 t -114.16 121.45 66.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.8 t -92.72 126.42 37.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.17 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -84.46 147.39 27.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.05 -14.81 59.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 94.0 m-20 -127.64 135.75 27.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 111.221 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.457 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 24.1 Cg_endo -65.82 -35.37 36.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.025 2.484 . . . . 0.0 114.422 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.8 Cg_endo -76.46 -20.34 14.16 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.719 1.613 . . . . 0.0 111.358 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -74.19 -30.67 62.33 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 122.297 -0.252 . . . . 0.0 110.431 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.73 93.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -65.07 -41.15 95.35 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 120.547 0.213 . . . . 0.0 110.834 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.98 86.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.354 0.262 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -25.08 64.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.6 mt -73.4 -56.59 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -60.36 -21.63 62.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -94.06 -59.92 1.86 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -70.78 -32.52 69.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.46 113.74 1.92 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.16 -17.09 32.14 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.949 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -93.76 -172.88 3.0 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.648 1.224 . . . . 0.0 109.808 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -100.33 173.72 6.46 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.34 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.613 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -127.31 -38.7 1.94 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.437 0.295 . . . . 0.0 110.277 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.6 t -143.2 6.61 1.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 110.363 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.48 -22.27 4.18 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.41 149.25 35.92 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 109.463 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.65 151.95 74.7 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.538 2.825 . . . . 0.0 110.388 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.62 168.28 21.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.076 0.55 . . . . 0.0 110.851 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 156.17 47.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.917 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 51.4 t -145.2 146.77 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 123.636 0.585 . . . . 0.0 110.224 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.0 m -155.26 171.65 19.48 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -59.01 162.24 4.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.228 177.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 C-N-CA 123.913 3.075 . . . . 0.0 112.003 178.534 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -98.79 148.44 23.89 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 11.1 pt -131.39 146.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.697 0.399 . . . . 0.0 110.575 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -100.78 149.6 23.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.87 147.32 30.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.111 0.564 . . . . 0.0 111.817 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.73 151.03 48.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 109.811 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.28 5.89 59.06 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 120.025 -0.319 . . . . 0.0 112.699 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.61 -57.68 10.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.397 0.679 . . . . 0.0 111.1 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.464 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.28 -178.57 44.71 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -77.89 -10.87 59.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.974 0.909 . . . . 0.0 112.109 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.02 0.2 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.25 0.22 . . . . 0.0 111.484 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.95 155.59 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.41 168.49 26.81 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.52 -39.73 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.897 0.879 . . . . 0.0 111.878 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.61 62.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.526 -0.109 . . . . 0.0 111.158 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.25 -49.52 19.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.729 -0.1 . . . . 0.0 110.729 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.821 HG21 HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.56 -53.88 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.36 -37.44 77.92 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.249 0.477 . . . . 0.0 110.804 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -76.07 -15.83 60.04 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 111.099 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.56 -26.96 16.18 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.6 m-85 -97.17 -20.22 18.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -65.68 -18.85 65.63 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.6 pt20 -64.44 -21.16 66.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.6 mm -87.96 -25.47 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 110.161 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.92 170.28 29.67 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.91 135.24 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 O-C-N 122.478 -0.425 . . . . 0.0 111.135 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.477 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -76.01 138.08 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -69.15 148.97 49.16 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.091 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.706 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.9 151.96 81.57 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.845 1.697 . . . . 0.0 109.005 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.9 mtp -77.91 78.69 4.4 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.77 0.428 . . . . 0.0 111.206 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.821 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.25 155.3 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 0.0 110.527 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -150.24 121.89 8.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.524 0.73 . . . . 0.0 109.326 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -88.14 121.67 30.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -77.64 162.83 26.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.61 16.62 36.11 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.37 156.83 31.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.783 0.791 . . . . 0.0 110.23 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.74 171.2 19.96 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.802 0.441 . . . . 0.0 110.262 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 70.8 m -136.33 129.07 30.82 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.8 t -118.67 127.89 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.5 t -98.98 127.91 45.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.997 0.362 . . . . 0.0 110.513 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.18 147.95 26.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -75.85 -17.26 59.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 91.2 m-20 -127.54 133.89 25.59 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.979 0.912 . . . . 0.0 110.987 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.465 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -66.64 -33.79 34.54 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.646 2.231 . . . . 0.0 114.463 -175.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 88.7 Cg_endo -74.81 -19.79 18.0 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 CA-C-N 121.052 1.412 . . . . 0.0 110.843 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.9 m -75.89 -29.45 58.47 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.32 -0.237 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.47 73.34 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -65.33 -36.99 85.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.425 0.155 . . . . 0.0 110.593 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.38 82.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.493 0.317 . . . . 0.0 110.943 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.55 65.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.81 -56.09 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.69 -22.08 63.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -93.92 -59.99 1.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.82 -32.76 71.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.03 110.74 0.87 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.41 -16.09 24.57 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.035 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.6 -171.52 2.39 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.824 1.312 . . . . 0.0 109.902 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.53 173.94 6.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.664 0.269 . . . . 0.0 110.322 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.6 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.1 t80 -128.44 -37.44 1.81 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.608 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -145.0 11.05 1.35 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.682 0.393 . . . . 0.0 109.988 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.47 -20.3 6.18 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -103.12 148.64 35.94 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 151.97 75.13 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.388 2.725 . . . . 0.0 110.451 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.18 167.74 21.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.873 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.15 156.47 46.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.803 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.68 146.48 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.047 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 47.1 m -155.05 174.23 15.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.19 150.66 29.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.643 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 C-N-CA 123.486 2.791 . . . . 0.0 112.775 177.423 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.6 m -101.74 150.2 23.38 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.89 147.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 122.545 0.338 . . . . 0.0 110.101 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -102.57 147.94 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.28 147.53 31.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.076 0.551 . . . . 0.0 112.079 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -138.71 151.3 47.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.84 59.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.84 -57.08 13.54 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.359 0.664 . . . . 0.0 111.033 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.457 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.43 -178.05 45.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.62 -10.65 59.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.849 0.86 . . . . 0.0 112.178 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -80.54 -0.55 38.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.321 -0.237 . . . . 0.0 111.234 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.29 156.28 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.06 168.39 26.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.3 mm -48.67 -39.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 124.421 1.088 . . . . 0.0 111.861 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.92 -29.75 63.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.345 -0.222 . . . . 0.0 111.217 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.05 -48.61 23.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.154 0.182 . . . . 0.0 110.679 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.57 -54.22 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.446 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.44 -37.8 79.04 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.969 -0.457 . . . . 0.0 110.875 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.95 -15.82 60.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.252 -0.28 . . . . 0.0 110.932 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -94.32 -27.54 16.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.426 ' CD2' HG21 ' A' ' 339' ' ' VAL . 44.3 m-85 -96.59 -19.91 18.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.2 pttt -66.35 -18.63 65.47 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -173.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.404 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.74 -20.82 66.56 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.7 mm -87.93 -26.28 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.14 170.48 31.11 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.05 134.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 122.58 -0.365 . . . . 0.0 111.299 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.468 HG21 HD11 ' A' ' 322' ' ' ILE . 7.7 mm -76.3 138.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.438 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.7 ttmm -69.08 148.58 49.81 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.1 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 155.03 61.98 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.518 2.145 . . . . 0.0 109.935 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.7 mtp -79.28 77.44 5.81 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 122.791 0.436 . . . . 0.0 110.81 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.816 HG21 HG21 ' A' ' 301' ' ' VAL . 0.5 OUTLIER -130.91 159.26 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.428 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -155.93 124.73 6.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.787 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -90.13 120.96 31.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -73.36 162.68 29.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.518 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.656 0.741 . . . . 0.0 109.33 -178.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.457 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.0 18.86 28.12 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.7 156.08 38.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.417 0.609 . . . . 0.0 110.553 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.96 173.48 16.42 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.71 0.404 . . . . 0.0 110.288 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.0 m -139.92 128.14 22.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 122.658 0.383 . . . . 0.0 109.969 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 305' ' ' PHE . 94.6 t -118.11 127.12 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 124.024 0.93 . . . . 0.0 109.064 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.6 t -97.68 128.01 44.05 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.89 -0.506 . . . . 0.0 110.207 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -85.64 147.26 26.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -76.24 -18.2 59.13 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -124.88 133.36 24.73 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 123.704 0.802 . . . . 0.0 110.72 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.4 Cg_endo -66.24 -34.31 36.51 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.818 2.346 . . . . 0.0 114.215 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.79 -19.54 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 121.168 1.453 . . . . 0.0 111.104 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 41.9 m -75.55 -30.52 59.75 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.26 78.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.58 -0.075 . . . . 0.0 110.799 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -64.28 -38.88 92.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.553 0.216 . . . . 0.0 110.954 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.68 83.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.372 0.269 . . . . 0.0 110.611 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.66 66.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.19 -57.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.26 -21.19 61.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -94.31 -60.3 1.76 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.85 -31.76 69.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -57.26 111.05 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.7 25.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.127 -0.818 . . . . 0.0 113.106 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.5 -171.8 2.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.674 1.237 . . . . 0.0 109.908 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.75 171.26 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.595 0.358 . . . . 0.0 110.447 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.606 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.4 t80 -127.19 -38.28 1.99 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.382 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.7 t -144.33 15.28 1.65 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.648 0.379 . . . . 0.0 110.098 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.64 -19.43 8.48 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.54 148.69 36.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.01 151.73 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 0.0 110.677 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.1 pt -138.32 168.11 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 121.267 0.556 . . . . 0.0 110.66 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -133.62 155.45 49.64 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.17 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.8 t -144.35 147.04 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 122.867 0.467 . . . . 0.0 110.417 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.4 m -153.6 174.43 14.46 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -60.61 159.08 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.679 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.043 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.454 -0.847 0 C-N-CA 123.871 3.048 . . . . 0.0 112.308 176.805 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 111.228 0.084 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.8 m -99.42 147.8 24.89 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.3 pt -129.47 150.07 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 122.842 0.457 . . . . 0.0 110.115 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -105.02 149.44 25.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.0 t -134.16 148.82 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 123.219 0.607 . . . . 0.0 111.288 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -138.31 150.9 47.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.46 59.08 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 120.079 -0.289 . . . . 0.0 113.165 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.63 -55.84 28.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.14 0.576 . . . . 0.0 111.254 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.471 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.52 179.99 47.88 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.22 -11.42 59.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.74 0.816 . . . . 0.0 112.219 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.86 0.49 34.88 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.427 0.291 . . . . 0.0 111.323 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.59 155.24 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 112.666 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.4 168.16 28.14 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.7 mm -49.83 -39.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.294 1.037 . . . . 0.0 111.615 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -74.04 -28.47 61.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 121.254 -0.179 . . . . 0.0 111.011 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.6 t -75.44 -48.06 24.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.786 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.4 -53.58 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.43 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.89 -37.59 76.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.264 0.483 . . . . 0.0 110.898 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -76.41 -15.09 60.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.45 0.3 . . . . 0.0 111.219 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -95.09 -27.22 15.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -96.44 -20.32 18.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.9 pttt -65.56 -18.74 65.55 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.4 pt20 -64.56 -21.55 66.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.3 mm -88.32 -24.12 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.765 0.316 . . . . 0.0 110.28 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.27 169.42 27.8 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.85 135.76 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.516 0.327 . . . . 0.0 111.186 -172.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 322' ' ' ILE . 7.4 mm -77.03 137.27 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.417 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 36.9 ttmt -70.86 149.92 46.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.623 0.249 . . . . 0.0 110.485 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.231 0.124 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.331 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.55 155.49 47.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.312 2.008 . . . . 0.0 109.51 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.417 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 36.9 mtp -77.16 77.64 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.614 0.366 . . . . 0.0 111.118 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.786 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -135.63 158.3 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.724 -178.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -156.69 131.7 9.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.5 mm? -92.28 122.12 34.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -84.37 158.89 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 121.471 0.653 . . . . 0.0 112.603 -172.069 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.66 -0.88 59.69 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.55 150.31 21.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.344 0.572 . . . . 0.0 110.927 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.59 165.75 33.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.12 0.568 . . . . 0.0 109.606 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 122.74 20.61 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.02 125.65 73.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.8 t -98.06 129.48 44.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.557 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -87.24 147.74 25.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.02 -18.66 60.3 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -126.37 131.91 24.12 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 110.539 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 34.8 Cg_endo -67.71 -32.16 30.88 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.737 2.292 . . . . 0.0 114.347 -175.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -75.29 -19.65 17.06 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 121.411 1.54 . . . . 0.0 110.833 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -76.39 -29.76 57.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.647 0.203 . . . . 0.0 110.556 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.94 72.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -63.64 -38.81 92.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.484 0.183 . . . . 0.0 110.864 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.88 81.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.296 0.239 . . . . 0.0 110.894 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.22 65.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.25 -56.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.77 -21.24 62.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -93.83 -59.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.72 -32.56 71.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -56.59 112.27 1.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.19 -16.0 30.18 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.008 -0.884 . . . . 0.0 113.114 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -95.01 -172.63 2.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.75 1.275 . . . . 0.0 109.813 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.26 174.37 6.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.882 0.372 . . . . 0.0 110.47 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.614 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.5 t80 -129.95 -38.64 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.162 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.9 t -143.3 13.46 1.8 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.07 0.462 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.61 -22.37 7.79 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.97 147.97 33.82 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.37 151.6 76.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.256 2.637 . . . . 0.0 110.522 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.614 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.61 168.83 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.001 0.52 . . . . 0.0 110.911 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -133.89 156.73 47.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.6 t -144.78 146.65 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 123.703 0.627 . . . . 0.0 109.983 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 68.5 m -155.36 175.13 14.26 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.0 108.858 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -59.14 160.35 6.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.816 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 124.018 3.145 . . . . 0.0 112.388 178.426 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.7 m -131.51 151.14 51.83 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.577 0.351 . . . . 0.0 111.223 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.7 pt -126.6 148.82 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.063 0.545 . . . . 0.0 110.429 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -100.78 150.11 23.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.36 149.4 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.383 0.673 . . . . 0.0 111.042 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -139.75 150.22 44.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.97 58.28 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.954 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.4 ' HB3' HG21 ' A' ' 296' ' ' VAL . 5.0 mp -55.63 -54.07 48.69 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.504 0.652 . . . . 0.0 111.678 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.51 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.59 -176.26 44.54 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -171.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -85.67 -7.23 58.93 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.551 0.741 . . . . 0.0 112.537 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -79.29 -2.69 42.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.431 -0.168 . . . . 0.0 111.056 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 292' ' ' LEU . 1.6 t -97.74 158.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.769 0.828 . . . . 0.0 112.695 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.64 167.59 29.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.32 -39.73 17.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 124.344 1.057 . . . . 0.0 111.724 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.03 -29.07 63.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.248 -0.282 . . . . 0.0 111.094 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.6 -50.51 17.61 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 122.316 0.247 . . . . 0.0 110.479 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.805 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -60.86 -53.92 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.437 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -37.46 77.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 0.519 . . . . 0.0 110.921 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -75.9 -17.38 59.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 111.014 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -92.92 -26.77 17.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.4 m-85 -98.02 -20.08 17.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.5 pttt -66.11 -18.79 65.57 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.406 0.283 . . . . 0.0 111.649 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -64.41 -20.38 66.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -88.97 -26.06 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.759 0.254 . . . . 0.0 110.456 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.18 170.37 31.0 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.62 134.36 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 111.254 -172.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 322' ' ' ILE . 8.3 mm -74.5 138.77 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.75 151.61 46.94 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.594 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.21 155.69 55.04 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.34 2.027 . . . . 0.0 109.812 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.9 mtp -77.62 75.93 4.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.044 0.538 . . . . 0.0 110.813 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.805 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.19 155.6 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.939 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -153.19 130.71 11.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.135 0.974 . . . . 0.0 109.017 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -93.73 118.33 31.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.1 157.32 24.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 CA--C 1.515 -0.397 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.57 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm . . . . . 0 CA--C 1.527 0.077 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.84 -5.22 66.37 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.94 147.44 25.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.006 0.403 . . . . 0.0 111.072 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.05 165.81 34.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.0 m -137.28 122.13 18.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.277 0.231 . . . . 0.0 111.046 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 305' ' ' PHE . 95.5 t -115.64 120.7 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 29.9 t -91.78 136.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.903 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -95.11 145.78 24.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.12 -15.2 61.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.419 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 88.2 m-20 -129.38 135.18 27.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.686 0.794 . . . . 0.0 111.433 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 22.8 Cg_endo -66.74 -33.77 33.59 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.837 2.358 . . . . 0.0 114.414 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.3 Cg_endo -76.91 -18.32 14.86 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.517 1.478 . . . . 0.0 111.307 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.7 m -76.33 -29.88 57.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.66 85.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.403 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.5 tptm -64.13 -40.86 97.08 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.457 0.17 . . . . 0.0 110.827 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.12 85.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.48 0.312 . . . . 0.0 110.68 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.77 -25.2 64.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 348' ' ' LYS . 63.7 mt -72.95 -57.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.41 -20.59 60.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -95.23 -60.53 1.65 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -69.69 -32.16 70.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.93 113.14 1.74 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.28 -15.82 32.66 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.893 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -95.04 -172.56 2.72 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.709 1.255 . . . . 0.0 109.838 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -101.18 173.7 6.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.612 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.9 t80 -128.06 -39.08 1.77 Allowed 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.9 t -143.07 8.49 1.65 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.729 0.412 . . . . 0.0 110.117 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.48 -20.62 5.21 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -102.86 149.3 36.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.24 150.55 76.71 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.359 2.706 . . . . 0.0 110.595 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -136.33 168.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-O 121.068 0.461 . . . . 0.0 110.763 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -131.79 156.87 45.24 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 54.4 t -145.71 146.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 110.396 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.4 m -154.53 172.71 17.36 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.06 162.91 6.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.216 -0.302 . . . . 0.0 111.771 170.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.81 0.338 . . . . 0.0 111.054 177.611 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.026 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 N--CA 1.456 -0.683 0 C-N-CA 123.382 2.721 . . . . 0.0 112.61 176.809 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 111.366 0.135 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.1 m -100.53 148.68 24.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.43 150.2 34.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.835 0.454 . . . . 0.0 109.945 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -106.26 148.85 27.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 t -133.73 148.28 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.105 0.562 . . . . 0.0 111.194 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -138.69 150.63 46.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.74 5.1 58.84 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.834 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.1 -57.22 12.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.322 0.649 . . . . 0.0 111.135 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.472 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.89 179.64 44.47 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.13 -10.64 59.53 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.907 0.883 . . . . 0.0 112.365 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.98 -0.85 45.97 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 111.556 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.03 155.78 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.16 168.24 27.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.0 mm -49.43 -40.18 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.362 1.065 . . . . 0.0 111.691 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.42 62.32 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.859 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -76.15 -48.89 18.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.379 0.272 . . . . 0.0 110.634 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.808 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.58 -53.68 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.439 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.01 -37.93 78.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.798 -0.563 . . . . 0.0 110.602 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.96 -15.84 60.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.721 0.237 . . . . 0.0 111.087 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.51 -26.78 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.4 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.9 m-85 -97.3 -20.19 18.03 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.9 pttt -66.16 -18.64 65.48 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.418 0.287 . . . . 0.0 111.697 -173.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 7.1 pt20 -65.21 -20.41 66.42 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.1 mm -88.62 -25.05 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.976 0.417 . . . . 0.0 110.156 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.64 169.08 27.74 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.06 136.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.713 -0.286 . . . . 0.0 111.256 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 322' ' ' ILE . 7.1 mm -77.54 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.456 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 37.0 ttmt -69.55 136.53 51.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.142 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.71 152.23 75.43 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.895 1.73 . . . . 0.0 108.833 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.456 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.9 mtp -77.74 79.07 4.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.808 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.07 155.09 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.619 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.94 129.16 11.93 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -91.75 120.87 32.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.23 159.48 20.08 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 121.492 0.663 . . . . 0.0 112.53 -171.264 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.472 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.04 0.63 59.96 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -90.56 150.29 21.81 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 117.425 0.612 . . . . 0.0 110.903 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.43 165.87 32.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.073 0.549 . . . . 0.0 109.58 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 m -136.78 122.64 20.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 305' ' ' PHE . 92.5 t -115.63 124.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -174.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.4 t -96.21 128.15 42.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.234 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.53 148.31 25.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -74.33 -21.42 59.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -124.11 131.49 24.22 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.496 0.718 . . . . 0.0 110.91 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.8 Cg_endo -65.98 -33.09 43.11 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.768 2.312 . . . . 0.0 114.161 -175.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.74 -19.22 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.189 1.46 . . . . 0.0 111.142 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.2 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.787 0.267 . . . . 0.0 110.385 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.6 79.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.398 0.142 . . . . 0.0 110.672 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -63.41 -39.97 95.94 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 122.35 0.26 . . . . 0.0 110.756 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.1 81.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.984 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.72 -26.35 66.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -72.15 -57.72 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -60.92 -21.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -92.38 -59.74 2.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -70.02 -31.92 69.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -56.78 112.36 1.28 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.19 31.25 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.061 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.7 -172.35 2.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.705 1.253 . . . . 0.0 109.941 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.21 175.03 5.72 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.454 0.302 . . . . 0.0 110.535 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.593 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.8 t80 -130.72 -38.76 1.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.2 t -143.04 20.31 1.94 Allowed 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 122.585 0.354 . . . . 0.0 110.345 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.36 -2.22 31.04 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -121.81 146.5 46.05 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 123.996 0.918 . . . . 0.0 109.473 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.85 149.73 72.84 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.48 2.787 . . . . 0.0 110.779 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.593 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.62 169.4 18.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.087 0.555 . . . . 0.0 110.697 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -134.67 156.37 48.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.828 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -144.21 147.34 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.119 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 70.8 m -154.04 174.64 14.42 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -58.27 160.65 4.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.756 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 N--CA 1.457 -0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.612 178.285 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -104.76 148.78 26.23 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.38 147.6 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.642 0.377 . . . . 0.0 110.441 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -102.73 149.01 24.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.9 t -134.12 148.24 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.298 0.639 . . . . 0.0 111.636 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -138.59 150.06 45.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.31 5.11 58.19 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.762 -0.466 . . . . 0.0 112.299 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.83 -56.06 23.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.541 0.67 . . . . 0.0 111.009 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.461 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.71 179.45 46.21 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -80.18 -7.22 58.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.738 0.815 . . . . 0.0 112.124 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -81.8 -1.6 47.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.374 0.27 . . . . 0.0 111.32 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.54 156.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.48 168.03 28.04 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.6 mm -48.57 -40.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.223 1.009 . . . . 0.0 111.762 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.4 -28.49 62.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.28 -0.263 . . . . 0.0 111.102 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.0 t -75.85 -48.84 19.86 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.823 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.64 45.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.436 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.6 -37.6 78.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.296 0.498 . . . . 0.0 110.783 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -75.81 -15.39 60.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -95.15 -26.78 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.404 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.2 m-85 -97.46 -20.62 17.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.5 pttt -65.13 -19.43 65.98 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -63.97 -21.49 66.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.2 mm -87.07 -27.19 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.8 170.6 31.89 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.7 mm -68.02 135.07 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.768 0.318 . . . . 0.0 111.047 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 322' ' ' ILE . 7.5 mm -76.42 136.97 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.423 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.1 ttmm -68.4 135.84 52.37 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.692 0.282 . . . . 0.0 110.628 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.332 -0.178 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.769 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.98 151.96 82.97 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.089 1.86 . . . . 0.0 109.13 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.423 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 48.6 mtp -79.74 80.15 6.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.47 0.308 . . . . 0.0 111.235 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.823 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -132.14 154.98 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.0 120.6 7.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.269 0.628 . . . . 0.0 109.693 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -88.59 122.14 31.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -80.27 164.43 23.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 121.246 0.546 . . . . 0.0 111.415 -177.073 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.461 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 93.48 15.51 50.11 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.57 154.09 34.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.403 0.601 . . . . 0.0 110.164 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.65 170.35 22.36 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.609 0.363 . . . . 0.0 110.287 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 32.3 m -134.51 127.56 31.63 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.865 0.466 . . . . 0.0 110.583 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.404 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.2 t -117.43 127.49 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.2 t -98.76 128.63 45.06 Favored 'General case' 0 C--N 1.337 0.05 0 O-C-N 121.962 -0.461 . . . . 0.0 110.324 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.65 147.64 25.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.61 -16.61 59.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -125.49 131.77 24.13 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 110.594 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.455 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.5 Cg_endo -66.46 -32.89 39.12 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.006 2.471 . . . . 0.0 114.446 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -76.9 -19.49 13.98 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 CA-C-N 121.208 1.467 . . . . 0.0 110.81 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -29.31 58.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.75 80.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -64.68 -38.45 91.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.462 -0.149 . . . . 0.0 110.635 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.89 -40.26 83.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.583 0.353 . . . . 0.0 110.943 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.6 -25.96 66.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 66.7 mt -72.62 -56.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.6 -20.87 61.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -94.51 -60.21 1.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.27 -32.47 71.68 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.91 110.42 0.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.16 -14.73 25.83 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.042 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -96.36 -171.01 2.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.872 1.336 . . . . 0.0 110.249 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.04 174.39 5.89 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 110.307 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.618 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.5 t80 -130.39 -39.32 1.32 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 109.941 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.39 -18.77 10.95 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.75 148.14 35.1 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 151.08 74.16 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.43 2.753 . . . . 0.0 110.508 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.618 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.02 168.64 21.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -134.35 155.69 49.81 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.803 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.95 146.76 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.047 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 m -154.4 174.64 14.58 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.754 0.822 . . . . 0.0 108.789 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -60.36 155.65 17.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 N--CA 1.453 -0.858 0 C-N-CA 123.863 3.042 . . . . 0.0 111.876 176.076 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.5 m -95.99 146.61 24.48 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.63 150.3 34.18 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 C-N-CA 122.729 0.411 . . . . 0.0 109.917 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -105.03 148.99 26.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.9 t -133.2 146.62 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 123.05 0.54 . . . . 0.0 111.376 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -137.33 148.54 46.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.71 57.3 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.974 -0.348 . . . . 0.0 112.597 173.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.05 -56.88 14.81 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.82 179.9 44.49 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.81 -10.0 59.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.671 0.789 . . . . 0.0 112.33 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -81.79 -2.29 50.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 117.562 0.165 . . . . 0.0 111.329 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -99.39 155.95 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.16 168.0 28.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.98 -39.73 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 124.403 1.081 . . . . 0.0 111.59 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.55 -29.09 63.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -75.35 -49.38 19.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.131 0.172 . . . . 0.0 110.643 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 322' ' ' ILE . 2.8 m -61.33 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.07 -37.52 77.27 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.193 0.452 . . . . 0.0 110.739 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.04 -15.78 60.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.984 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.72 -27.25 15.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -96.76 -20.37 18.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -66.16 -18.84 65.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.439 0.296 . . . . 0.0 111.763 -173.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -21.52 66.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 353' ' ' TRP . 12.4 mm -87.12 -27.33 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.308 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.86 170.26 31.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.27 134.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.629 0.252 . . . . 0.0 111.347 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 322' ' ' ILE . 7.2 mm -75.51 138.62 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.443 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 35.4 ttmt -68.46 144.58 54.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.331 -0.2 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.029 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.6 153.13 76.9 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.255 1.97 . . . . 0.0 109.126 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.443 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 54.7 mtp -79.1 79.24 5.51 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.516 0.326 . . . . 0.0 110.985 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.812 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.11 155.81 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.345 -178.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.34 127.32 11.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -90.75 119.92 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -81.25 160.67 24.2 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 111.753 -175.964 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 89.47 9.3 66.98 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.598 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -108.25 151.62 25.7 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.929 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.92 166.46 32.57 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.2 m -135.51 122.66 21.55 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.872 0.469 . . . . 0.0 111.508 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.06 124.62 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.4 t -96.23 128.64 43.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.215 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -86.29 148.22 25.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -73.94 -20.33 60.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 95.2 m-20 -127.73 133.35 25.01 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 123.855 0.862 . . . . 0.0 111.033 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.1 Cg_endo -66.14 -33.9 38.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.683 2.256 . . . . 0.0 114.195 -175.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.5 Cg_endo -74.94 -18.42 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.141 1.443 . . . . 0.0 110.822 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 71.0 m -76.7 -29.67 56.36 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.16 -46.42 80.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.947 0.154 . . . . 0.0 110.725 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -66.15 -37.3 85.33 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.38 -40.13 81.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.369 0.267 . . . . 0.0 110.854 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.48 -26.35 65.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.58 -56.95 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.41 -21.79 62.63 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.403 ' CD1' HD11 ' A' ' 308' ' ' ILE . 48.2 t-105 -93.62 -59.49 1.99 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.7 -32.78 70.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -57.03 112.48 1.36 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.68 31.9 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.008 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.66 -172.45 2.75 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.477 1.138 . . . . 0.0 109.924 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -101.64 173.27 6.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.557 0.343 . . . . 0.0 110.457 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.6 t80 -128.51 -38.54 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.682 0.393 . . . . 0.0 110.262 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.1 t -144.54 17.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.981 0.512 . . . . 0.0 109.959 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.23 -20.2 16.65 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -96.12 140.49 22.28 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.98 151.4 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.997 2.464 . . . . 0.0 110.369 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.4 pt -138.12 168.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 122.608 0.363 . . . . 0.0 111.223 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -134.54 155.25 50.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.15 0.58 . . . . 0.0 110.765 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.63 146.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.998 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 37.4 m -155.44 172.99 17.3 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -57.02 156.84 6.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 C-N-CA 123.757 2.971 . . . . 0.0 112.587 177.069 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.2 m -100.01 147.7 25.32 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.5 pt -128.82 149.92 33.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -104.92 149.49 25.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.74 148.76 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.264 0.625 . . . . 0.0 110.752 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -139.3 150.18 45.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.27 57.95 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.86 -0.411 . . . . 0.0 112.659 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.2 mp -54.72 -54.45 41.72 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 117.55 0.675 . . . . 0.0 111.614 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.481 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.42 -175.86 44.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -171.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -86.86 -7.8 57.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.534 0.734 . . . . 0.0 112.286 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.84 -3.55 42.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.238 0.215 . . . . 0.0 110.954 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.38 158.98 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.739 0.816 . . . . 0.0 112.804 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.43 168.05 25.99 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.75 -39.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.019 0.928 . . . . 0.0 111.65 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -73.15 -28.89 62.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.318 -0.239 . . . . 0.0 111.064 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.9 t -75.12 -49.44 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.193 0.197 . . . . 0.0 110.797 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.11 -53.65 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.441 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.39 -37.33 77.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.719 -0.613 . . . . 0.0 110.78 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -76.9 -15.29 59.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.189 -0.32 . . . . 0.0 111.201 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.47 -27.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.4 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.0 m-85 -96.47 -20.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.8 pttt -65.08 -19.29 65.92 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.36 -20.85 66.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.52 -25.02 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 165.06 168.79 27.76 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.97 136.0 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.706 0.289 . . . . 0.0 111.081 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 322' ' ' ILE . 6.5 mm -76.72 136.45 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -68.93 142.8 54.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.673 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.15 152.02 81.79 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.653 1.569 . . . . 0.0 108.877 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 41.9 mtp -77.71 79.12 4.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.709 0.404 . . . . 0.0 110.955 -174.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.815 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.9 154.96 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 123.703 0.627 . . . . 0.0 110.849 -179.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.62 130.12 13.0 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -92.99 117.08 29.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.39 156.5 25.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 79.4 p . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.822 0.82 . . . . 0.0 112.083 -170.767 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.481 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.97 -4.76 63.18 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.52 145.49 26.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.143 0.471 . . . . 0.0 110.807 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.23 165.12 35.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.1 m -136.39 120.75 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.475 0.31 . . . . 0.0 111.829 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 305' ' ' PHE . 94.8 t -114.96 124.17 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.2 t -95.78 128.12 42.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.268 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -85.1 147.07 26.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 172.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.76 -16.77 59.39 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -125.21 131.27 24.04 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.837 0.855 . . . . 0.0 110.688 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.454 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.7 Cg_endo -66.62 -32.69 38.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.67 2.247 . . . . 0.0 114.332 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.4 Cg_endo -76.26 -19.63 15.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-N 121.508 1.574 . . . . 0.0 110.85 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -75.51 -29.69 59.56 Favored 'General case' 0 CA--C 1.524 -0.041 0 O-C-N 122.391 -0.193 . . . . 0.0 110.547 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.55 -48.21 75.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 351' ' ' ILE . 17.0 tptm -64.07 -38.68 91.95 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.6 82.92 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.484 0.314 . . . . 0.0 110.705 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.24 65.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 348' ' ' LYS . 66.5 mt -72.04 -57.32 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.43 -21.91 62.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -93.11 -60.38 1.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.62 -32.44 71.15 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.43 112.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.01 -15.35 31.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.091 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -94.67 -172.81 2.84 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.605 1.203 . . . . 0.0 109.946 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -102.65 170.77 7.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.477 0.311 . . . . 0.0 110.171 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.9 t80 -125.38 -38.54 2.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.371 0.268 . . . . 0.0 110.601 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t -143.84 8.04 1.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.329 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.08 -21.11 4.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -103.83 148.87 36.5 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.94 152.86 76.56 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.395 2.73 . . . . 0.0 110.581 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -139.12 169.14 17.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.96 0.409 . . . . 0.0 110.538 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -133.68 155.61 49.4 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.748 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -143.89 146.39 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 50.0 m -153.76 174.76 14.12 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.65 163.68 4.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.079 -0.388 . . . . 0.0 111.914 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.244 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.271 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 N--CA 1.455 -0.737 0 C-N-CA 123.732 2.955 . . . . 0.0 112.496 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.185 0.069 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -99.26 147.57 25.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.99 150.24 34.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.867 0.467 . . . . 0.0 109.897 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -105.38 149.68 25.89 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.14 148.7 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.251 0.621 . . . . 0.0 111.238 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -138.55 150.59 46.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.08 5.79 59.37 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.74 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -55.36 -56.69 17.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 117.45 0.625 . . . . 0.0 111.29 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.46 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 90.15 -179.66 43.89 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.79 -11.57 59.85 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.786 0.835 . . . . 0.0 112.106 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.69 0.39 39.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.416 0.286 . . . . 0.0 111.275 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.33 154.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -157.58 168.38 27.46 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 32.5 mm -49.87 -40.16 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.406 1.082 . . . . 0.0 111.776 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.37 -28.74 63.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.55 -0.094 . . . . 0.0 111.059 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.3 t -75.23 -49.46 19.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.159 0.184 . . . . 0.0 110.817 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.38 -54.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.436 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.81 -37.72 77.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.375 0.534 . . . . 0.0 110.699 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -76.17 -15.76 60.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.41 -27.42 16.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -96.5 -20.58 18.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.1 pttt -65.67 -18.72 65.53 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.341 0.257 . . . . 0.0 111.68 -172.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.2 pt20 -64.39 -21.9 66.78 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.3 mm -87.01 -27.99 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 168.28 170.44 32.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.73 135.74 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.879 0.34 . . . . 0.0 111.261 -172.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -76.98 137.84 21.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -69.61 149.37 48.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.835 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.99 154.38 62.28 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.264 1.976 . . . . 0.0 109.47 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.6 mtp -77.14 76.94 3.68 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.63 0.372 . . . . 0.0 111.159 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.63 154.25 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.389 0.675 . . . . 0.0 110.747 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -150.99 130.33 12.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.684 0.794 . . . . 0.0 108.939 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -90.87 122.31 33.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.22 160.16 19.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.346 0.593 . . . . 0.0 111.661 -170.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 99.87 0.37 56.3 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -90.58 151.04 21.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.628 0.714 . . . . 0.0 110.902 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.36 166.21 31.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.316 0.646 . . . . 0.0 109.355 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.3 m -136.84 122.68 20.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.634 0.374 . . . . 0.0 111.603 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.22 125.09 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.2 t -96.83 128.35 43.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.573 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -85.59 147.82 26.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -76.1 -17.24 59.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -125.39 132.24 24.26 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.453 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.4 Cg_endo -66.88 -32.2 36.63 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.782 2.321 . . . . 0.0 114.562 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 92.5 Cg_endo -77.5 -18.79 13.54 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 121.135 1.441 . . . . 0.0 111.146 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.6 m -75.76 -29.27 58.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.24 -0.288 . . . . 0.0 110.478 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.99 -47.69 76.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.71 -39.81 95.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.484 0.314 . . . . 0.0 110.53 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.92 81.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 0.0 110.59 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.12 -26.14 65.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.62 -58.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -60.64 -21.3 62.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -92.99 -59.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -70.37 -32.34 69.97 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.24 112.01 1.12 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -15.59 30.61 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.063 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -94.76 -172.35 2.7 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.646 1.223 . . . . 0.0 110.03 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.5 174.07 6.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.708 0.29 . . . . 0.0 110.459 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.609 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.6 t80 -129.27 -37.78 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.518 0.327 . . . . 0.0 110.654 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.2 t -144.87 20.31 1.63 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.687 0.395 . . . . 0.0 110.043 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.07 0.01 31.56 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -125.32 146.6 54.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 123.801 0.84 . . . . 0.0 109.773 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.79 149.22 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.575 2.85 . . . . 0.0 110.93 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.46 169.21 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.067 0.547 . . . . 0.0 110.636 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -133.5 157.17 46.31 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.004 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 44.7 t -143.95 147.3 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.039 0.536 . . . . 0.0 110.223 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.9 m -154.73 172.86 17.24 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.64 159.11 6.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.038 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.008 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 N--CA 1.453 -0.871 0 C-N-CA 123.766 2.978 . . . . 0.0 112.246 177.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.6 m -87.26 144.42 26.82 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -177.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.8 pt -129.05 147.4 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -101.78 147.8 26.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.54 146.86 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 122.983 0.513 . . . . 0.0 111.062 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -137.51 149.88 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.19 58.24 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.8 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.36 -54.74 42.03 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.281 0.632 . . . . 0.0 111.022 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.497 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.54 179.6 46.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -78.33 -9.05 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.818 0.847 . . . . 0.0 111.989 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -82.64 0.06 44.85 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.31 0.244 . . . . 0.0 111.461 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.98 155.76 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.71 168.24 27.8 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.26 -40.25 13.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 124.385 1.074 . . . . 0.0 111.948 -174.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.54 -29.14 63.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.487 -0.085 . . . . 0.0 111.198 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.5 t -74.9 -49.47 20.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.194 0.197 . . . . 0.0 110.57 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.8 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.72 -54.18 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.445 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.84 -38.27 78.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.29 0.496 . . . . 0.0 110.915 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -75.73 -15.15 60.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.788 0.327 . . . . 0.0 111.217 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -95.47 -26.79 15.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -97.27 -20.43 17.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.8 pttt -65.92 -18.98 65.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -64.11 -21.37 66.51 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.84 -25.74 5.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.32 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.15 170.03 30.53 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.54 136.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 122.674 -0.309 . . . . 0.0 111.167 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 322' ' ' ILE . 6.7 mm -77.66 137.66 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.46 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.0 ttmm -68.84 148.46 50.23 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.521 -0.138 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.07 153.61 75.14 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.131 1.887 . . . . 0.0 109.264 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.46 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.7 mtp -79.46 79.57 5.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.8 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.84 156.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.49 0.716 . . . . 0.0 110.412 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -152.56 127.97 9.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.633 0.773 . . . . 0.0 109.199 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -92.84 121.67 34.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -84.45 158.58 21.0 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 26.2 p . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.279 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.497 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.11 4.84 68.42 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.406 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 151.09 21.74 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 117.906 0.853 . . . . 0.0 111.059 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.52 167.4 29.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.12 0.568 . . . . 0.0 109.713 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.7 m -138.19 123.81 19.73 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.763 0.425 . . . . 0.0 111.228 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 99.5 t -116.36 125.23 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.431 0.692 . . . . 0.0 109.233 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.4 t -96.78 125.53 41.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.084 -0.385 . . . . 0.0 110.466 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -82.4 150.1 27.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.37 -15.69 58.43 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 86.7 m-20 -129.55 136.1 28.58 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.447 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 17.9 Cg_endo -65.48 -36.67 33.3 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.774 2.316 . . . . 0.0 114.31 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 85.8 Cg_endo -75.8 -18.66 16.9 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 120.935 1.37 . . . . 0.0 111.122 -175.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.0 m -75.9 -30.09 58.68 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.0 71.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.141 0.177 . . . . 0.0 110.871 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -64.12 -38.27 90.47 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.455 0.169 . . . . 0.0 110.643 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.5 83.02 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.555 0.342 . . . . 0.0 110.834 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -25.72 65.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.9 mt -72.71 -56.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -60.31 -20.95 61.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -94.99 -59.65 1.86 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.83 -31.5 69.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -57.76 112.81 1.58 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.49 -15.46 32.32 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.908 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.52 -172.14 2.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.742 1.271 . . . . 0.0 109.86 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -102.61 174.38 5.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.837 0.351 . . . . 0.0 110.347 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.589 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.1 t80 -130.02 -39.39 1.38 Allowed 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.3 t -143.34 18.18 1.89 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.993 0.517 . . . . 0.0 109.7 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.75 -18.81 24.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -175.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -97.11 140.2 21.94 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.27 151.27 81.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.997 2.465 . . . . 0.0 110.486 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.589 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.5 pt -136.88 168.93 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.153 0.502 . . . . 0.0 111.041 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.82 155.64 49.47 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.901 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.43 146.79 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 122.939 0.495 . . . . 0.0 110.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.4 m -155.11 173.1 17.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.3 160.7 4.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.133 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 C-N-CA 123.642 2.894 . . . . 0.0 112.198 176.357 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.4 m -133.63 150.33 51.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.88 146.22 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.756 0.422 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -100.47 146.53 26.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.59 147.08 32.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 122.766 0.426 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.78 150.41 47.21 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.13 5.96 58.01 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.556 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.45 -57.32 12.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.499 0.72 . . . . 0.0 111.176 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.473 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.74 -179.1 45.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.02 -10.88 59.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.569 0.748 . . . . 0.0 112.405 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.8 -0.63 35.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.549 0.34 . . . . 0.0 111.355 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.58 155.58 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.95 168.4 27.25 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -48.67 -39.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.264 1.026 . . . . 0.0 111.825 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.89 -28.59 61.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.251 -0.281 . . . . 0.0 111.248 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -75.75 -48.33 22.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.89 -53.97 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.434 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.28 -37.55 77.97 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.045 -0.409 . . . . 0.0 110.843 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.67 -15.6 59.76 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.241 -0.287 . . . . 0.0 111.105 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -94.46 -27.13 16.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 339' ' ' VAL . 45.5 m-85 -97.03 -19.85 18.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.2 pttt -65.79 -18.91 65.67 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.3 pt20 -64.05 -21.8 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.8 mm -87.39 -27.26 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 167.89 169.89 31.96 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.03 135.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.577 -0.366 . . . . 0.0 111.064 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.496 HG21 HD11 ' A' ' 322' ' ' ILE . 8.1 mm -75.41 138.6 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.12 153.64 43.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.15 153.46 69.4 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.963 1.775 . . . . 0.0 109.541 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.7 mtp -78.95 76.04 5.45 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.199 0.6 . . . . 0.0 111.128 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -130.89 159.63 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.143 0.577 . . . . 0.0 110.617 -178.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -156.24 125.23 6.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.84 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -90.05 121.73 32.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -76.0 163.75 26.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.484 0.659 . . . . 0.0 111.106 -179.509 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.473 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.79 16.01 50.18 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -123.08 155.91 35.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.44 0.62 . . . . 0.0 110.388 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.68 173.39 16.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.906 0.482 . . . . 0.0 109.918 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.2 m -139.56 129.26 24.58 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 305' ' ' PHE . 89.6 t -119.24 127.18 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 39.5 t -98.36 132.89 43.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.724 -0.39 . . . . 0.0 109.971 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.24 145.11 24.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.175 0.99 . . . . 0.0 113.201 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -72.08 -16.41 62.02 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 99.5 m-20 -125.61 134.09 25.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.785 0.834 . . . . 0.0 110.835 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 22.3 Cg_endo -66.14 -33.93 38.7 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.702 2.268 . . . . 0.0 114.055 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 93.9 Cg_endo -77.69 -19.03 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.499 1.466 . . . . 0.0 111.522 -177.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.7 m -74.35 -29.14 61.46 Favored 'General case' 0 C--N 1.335 -0.05 0 CA-C-N 117.774 0.261 . . . . 0.0 110.35 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.64 79.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.3 tptm -62.51 -40.11 95.68 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.402 -0.187 . . . . 0.0 111.111 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.361 0.265 . . . . 0.0 110.92 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.54 -24.96 64.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 348' ' ' LYS . 65.8 mt -73.9 -55.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -60.76 -20.86 62.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -95.36 -60.27 1.7 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.76 -32.4 70.9 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.33 111.8 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.7 -17.11 25.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.287 -0.729 . . . . 0.0 112.806 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -94.43 -171.73 2.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.53 1.165 . . . . 0.0 109.94 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -102.7 174.25 5.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.582 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.3 t80 -129.38 -38.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.565 0.346 . . . . 0.0 110.078 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.8 t -144.49 17.33 1.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.016 0.526 . . . . 0.0 109.738 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.89 16.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -94.71 140.29 22.54 Favored Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.96 151.38 82.23 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.102 2.534 . . . . 0.0 110.326 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.582 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.2 pt -138.51 168.32 19.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 121.168 0.509 . . . . 0.0 111.092 -177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -133.81 155.64 49.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.268 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 56.9 t -144.63 147.43 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 O-C-N 123.412 0.445 . . . . 0.0 110.093 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.3 m -154.36 171.85 18.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.99 155.63 7.89 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.513 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.161 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 123.883 3.056 . . . . 0.0 111.834 176.83 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 m -105.75 147.83 28.14 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 15.6 pt -128.45 149.91 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.035 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -104.75 149.76 25.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.11 147.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.485 0.714 . . . . 0.0 111.12 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -139.38 150.13 44.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.05 57.83 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.995 -0.336 . . . . 0.0 112.801 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.64 -56.31 21.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.516 0.727 . . . . 0.0 111.288 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.72 -179.43 45.87 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.19 -10.41 59.39 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.704 0.802 . . . . 0.0 112.251 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -81.56 -0.69 43.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.242 0.217 . . . . 0.0 111.319 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.87 155.95 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.54 168.39 27.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -50.3 -40.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.324 1.05 . . . . 0.0 111.572 -174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -72.36 -28.83 63.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.405 -0.184 . . . . 0.0 111.102 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.5 -50.26 18.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.272 0.229 . . . . 0.0 110.456 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.25 -53.55 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.428 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.59 -37.39 78.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.531 0.605 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -76.12 -15.81 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 111.109 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -94.52 -27.52 15.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -96.71 -20.68 18.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.6 pttt -65.31 -19.09 65.8 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.45 -20.76 66.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.0 mm -88.59 -24.65 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-O 120.665 0.269 . . . . 0.0 110.342 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.53 168.79 27.18 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.37 136.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.614 -0.345 . . . . 0.0 111.002 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -78.22 137.58 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.419 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.8 ttmm -71.89 145.92 48.21 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 110.578 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.4 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 3.4 pt20 . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 319' ' ' GLN . 20.9 Cg_endo -61.25 155.73 49.83 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.476 2.117 . . . . 0.0 109.856 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 59.2 mtp -76.79 76.64 3.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.956 0.502 . . . . 0.0 110.997 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.799 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.75 158.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -157.37 133.1 9.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.5 mm? -93.37 120.12 33.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.92 159.73 22.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 121.298 0.57 . . . . 0.0 111.77 -171.172 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.62 2.13 61.69 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.77 150.97 19.64 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.455 0.627 . . . . 0.0 111.119 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.47 33.68 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.003 0.521 . . . . 0.0 109.723 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.4 m -135.74 123.14 21.95 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.2 123.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 32.8 t -95.73 127.54 41.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.712 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.48 147.65 26.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -75.71 -17.5 59.92 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 90.5 m-20 -128.27 133.28 24.98 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.048 0.939 . . . . 0.0 110.834 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -67.12 -32.65 33.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.669 2.246 . . . . 0.0 114.6 -175.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 95.8 Cg_endo -75.17 -19.35 17.58 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 121.175 1.456 . . . . 0.0 110.753 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.5 m -76.98 -29.32 55.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.74 -47.56 74.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -64.92 -37.39 87.49 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.92 80.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.31 0.244 . . . . 0.0 110.483 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -25.27 65.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.7 mt -73.27 -56.07 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.93 -21.88 63.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -93.54 -60.78 1.69 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -69.22 -32.1 71.12 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.24 112.17 1.3 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.95 -16.06 30.78 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.945 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.76 -172.3 2.69 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.753 1.276 . . . . 0.0 109.969 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.91 174.22 6.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.588 0.355 . . . . 0.0 110.457 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.619 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -129.78 -38.37 1.49 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 15.57 1.74 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.698 0.399 . . . . 0.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 120.07 -18.7 9.63 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -104.22 148.77 36.47 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.02 151.11 73.31 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.483 2.789 . . . . 0.0 110.624 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.62 168.76 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.016 0.527 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -134.1 155.39 50.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.139 0.576 . . . . 0.0 111.101 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.1 t -144.34 146.27 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 122.899 0.48 . . . . 0.0 110.221 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.3 m -154.23 172.91 16.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.69 160.01 6.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.894 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.241 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.939 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.452 -0.955 0 C-N-CA 123.914 3.076 . . . . 0.0 111.873 176.16 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.2 m -135.22 149.5 49.9 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -172.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.1 pt -131.95 146.95 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.582 0.353 . . . . 0.0 110.309 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.25 150.19 22.8 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.2 t -134.13 147.23 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.866 0.466 . . . . 0.0 111.783 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -136.74 149.85 48.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.72 6.15 58.4 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 120.005 -0.33 . . . . 0.0 112.361 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.76 -56.1 24.55 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.467 0.707 . . . . 0.0 110.857 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.469 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.82 -179.89 45.85 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -78.95 -10.35 59.79 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.873 0.869 . . . . 0.0 112.26 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.83 -1.63 43.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.352 0.261 . . . . 0.0 111.348 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.68 156.19 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -158.7 168.51 26.66 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.2 mm -49.32 -40.27 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.421 1.088 . . . . 0.0 111.728 -174.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.71 -29.14 63.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.348 -0.22 . . . . 0.0 111.209 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.68 -50.14 18.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.235 0.214 . . . . 0.0 110.594 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.837 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.18 -53.57 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.435 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.68 -38.15 80.75 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.975 -0.453 . . . . 0.0 110.565 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -75.94 -15.46 60.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 111.028 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -94.39 -27.02 16.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.8 m-85 -97.66 -20.13 17.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.3 pttt -66.08 -18.9 65.64 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -173.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -63.77 -21.59 66.49 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -87.35 -24.06 6.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.968 0.349 . . . . 0.0 110.2 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 161.19 172.72 28.91 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 40.2 mm -66.41 137.39 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 322' ' ' ILE . 7.1 mm -78.38 133.82 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 342' ' ' ASP . 12.6 tppt? -64.55 133.01 51.47 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.333 -0.145 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 175.26 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.88 152.04 82.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.04 1.827 . . . . 0.0 109.047 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 71.1 mtp -78.27 80.69 4.67 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.579 0.352 . . . . 0.0 111.196 -175.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.837 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -133.78 154.6 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -150.36 121.3 7.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.227 0.611 . . . . 0.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -88.41 121.83 31.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -79.26 162.21 25.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.108 0.48 . . . . 0.0 112.092 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.9 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.503 -178.117 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.96 16.88 31.78 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -119.81 154.96 33.49 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 117.398 0.599 . . . . 0.0 110.405 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.81 171.02 20.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.878 0.471 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 42.0 m -134.78 128.18 32.32 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.739 0.416 . . . . 0.0 110.262 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.411 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.1 t -118.23 128.39 75.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 321' ' ' MET . 43.7 t -98.92 132.91 43.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.73 176.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -90.86 148.28 22.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HA ' ' CE ' ' A' ' 312' ' ' LYS . 47.4 t0 -70.96 -22.78 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.44 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.8 m-20 -124.82 135.82 27.2 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.318 0.647 . . . . 0.0 111.693 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 19.2 Cg_endo -64.05 -36.67 47.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.799 2.333 . . . . 0.0 113.925 -175.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 94.5 Cg_endo -76.89 -16.42 16.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.579 1.519 . . . . 0.0 111.172 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.4 m -77.44 -29.53 52.9 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.87 81.58 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -64.52 -39.47 93.83 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 122.175 0.19 . . . . 0.0 110.742 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.37 83.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.565 0.346 . . . . 0.0 110.908 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -24.97 65.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.56 -57.72 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.85 -21.44 63.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -92.8 -59.15 2.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.76 -33.45 70.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.43 112.11 1.17 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.37 -16.46 29.45 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.188 -0.785 . . . . 0.0 113.046 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -93.83 -171.92 2.72 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.7 1.25 . . . . 0.0 109.695 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -102.8 172.21 6.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.696 0.284 . . . . 0.0 110.421 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.6 t80 -126.34 -38.92 2.08 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 26.4 t -142.59 6.29 1.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.834 0.454 . . . . 0.0 110.477 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.38 -22.27 3.97 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -101.76 149.37 36.4 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.73 152.29 77.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.474 2.782 . . . . 0.0 110.296 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.66 166.29 24.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 122.747 0.419 . . . . 0.0 110.792 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -131.46 156.1 46.23 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.155 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 45.3 t -144.86 147.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.453 0.471 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -156.53 173.21 17.25 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.809 0.843 . . . . 0.0 108.801 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -60.23 152.89 23.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.65 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 C-N-CA 123.999 3.132 . . . . 0.0 112.593 -179.898 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 m -92.57 147.33 22.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.26 147.89 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 122.939 0.496 . . . . 0.0 109.883 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -101.78 148.38 25.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.27 148.7 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.133 0.573 . . . . 0.0 111.125 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.33 149.35 45.54 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.23 5.6 58.06 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.943 -0.365 . . . . 0.0 112.849 172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.39 -53.86 51.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.655 0.727 . . . . 0.0 111.412 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.509 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.51 -176.61 44.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -170.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -86.87 -7.51 58.14 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.669 0.788 . . . . 0.0 112.519 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.01 -5.69 52.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 110.887 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.23 159.62 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.661 0.785 . . . . 0.0 112.303 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.05 168.03 26.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.07 -39.87 12.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.2 1.0 . . . . 0.0 111.712 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.47 -28.52 61.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.368 -0.208 . . . . 0.0 110.905 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.2 t -75.09 -49.5 19.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.104 0.161 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.808 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -60.98 -53.86 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.447 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.84 -38.07 77.89 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.053 0.388 . . . . 0.0 110.751 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -75.89 -15.67 60.17 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.129 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.58 -27.49 15.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -96.98 -20.42 18.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.9 pttt -65.39 -19.04 65.77 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -173.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.6 pt20 -64.57 -21.19 66.63 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.5 mm -88.11 -24.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.312 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.2 169.31 27.56 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.17 137.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 122.645 -0.327 . . . . 0.0 111.093 -172.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.451 HG21 HD11 ' A' ' 322' ' ' ILE . 6.7 mm -78.95 137.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 22.3 ttmm -69.42 149.7 48.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.299 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.34 154.02 70.75 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.368 2.045 . . . . 0.0 109.193 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.453 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 65.8 mtp -79.35 79.67 5.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.696 0.399 . . . . 0.0 110.928 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.808 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -135.15 155.53 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.668 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.98 129.53 13.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -92.08 119.83 32.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -83.94 157.33 21.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.532 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.13 -2.31 75.05 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.37 146.62 24.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.786 0.793 . . . . 0.0 111.136 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.77 166.64 32.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 10.3 m -138.56 121.32 16.42 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 122.556 0.342 . . . . 0.0 111.457 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.68 126.07 72.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.4 t -97.31 127.69 43.5 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.309 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.439 ' O ' ' HE2' ' A' ' 312' ' ' LYS . 42.2 m-85 -84.29 147.71 27.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.6 -18.66 59.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -126.06 133.79 25.29 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 110.685 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 27.5 Cg_endo -66.31 -33.68 37.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 114.405 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 84.8 Cg_endo -75.81 -20.1 15.61 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 121.2 1.464 . . . . 0.0 111.122 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 52.6 m -74.82 -29.61 61.13 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.8 78.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.13 0.172 . . . . 0.0 110.742 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -63.04 -39.75 95.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.404 0.282 . . . . 0.0 110.622 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.68 81.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.53 0.332 . . . . 0.0 110.842 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.04 65.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.4 -57.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -59.78 -21.93 61.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -93.82 -60.0 1.86 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.44 -31.94 70.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.43 111.73 1.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.45 -14.97 30.1 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.052 -0.86 . . . . 0.0 113.07 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -95.25 -171.99 2.55 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.748 1.274 . . . . 0.0 109.851 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.51 175.5 5.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.303 0.241 . . . . 0.0 110.606 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.606 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -131.08 -38.4 1.23 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -143.23 16.49 1.89 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.157 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.89 12.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.93 148.51 35.43 Favored Pre-proline 0 C--O 1.233 0.187 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.06 152.1 73.0 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.707 2.938 . . . . 0.0 110.722 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.36 168.3 20.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 122.821 0.448 . . . . 0.0 110.953 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.7 156.32 47.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.0 146.11 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.089 0.555 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 m -154.64 171.82 18.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -58.47 159.45 6.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.184 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 72.29 -171.49 48.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -64.27 -54.4 33.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -156.98 -178.51 7.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.937 0.895 . . . . 0.0 109.124 -174.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.541 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.68 -7.47 27.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -108.8 -3.24 17.88 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.805 0.275 . . . . 0.0 110.972 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.19 3.6 87.18 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.332 -0.704 . . . . 0.0 114.467 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 66.92 -158.18 50.48 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.015 1.408 . . . . 0.0 110.496 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.81 25.16 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.009 3.139 . . . . 0.0 111.932 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -78.27 -40.94 35.51 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.802 -0.561 . . . . 0.0 110.704 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -105.45 8.23 33.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.832 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -15.94 61.36 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 96.13 -118.05 5.86 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.606 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.1 t -79.53 16.79 0.98 Allowed 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -170.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.42 -5.78 5.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -86.82 -19.24 29.29 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.423 0.289 . . . . 0.0 111.211 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -125.73 4.15 7.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 75.1 m -148.65 147.75 29.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 109.639 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.66 9.23 33.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.971 0.508 . . . . 0.0 111.322 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -101.72 -109.15 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.79 22.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -153.59 161.79 41.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 43.3 t -156.18 -35.53 0.08 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.068 0.147 . . . . 0.0 110.7 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -93.4 13.46 21.51 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -132.62 45.2 2.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.335 0.654 . . . . 0.0 111.61 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -69.53 -0.75 7.13 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.506 0.322 . . . . 0.0 111.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.8 m -101.83 147.85 26.01 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.6 pt -128.84 149.22 33.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 122.969 0.508 . . . . 0.0 110.006 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -103.68 149.77 24.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.3 147.96 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 123.105 0.562 . . . . 0.0 111.163 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -139.54 149.07 43.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.95 4.81 57.65 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 120.141 -0.255 . . . . 0.0 112.718 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.18 -54.46 43.09 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.339 0.57 . . . . 0.0 111.159 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.466 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.28 -179.23 48.08 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -173.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.12 -9.65 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.596 0.758 . . . . 0.0 112.299 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -81.59 -1.53 46.77 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.446 0.298 . . . . 0.0 111.44 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.34 156.77 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.45 168.18 27.65 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.83 -39.34 14.9 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.313 1.045 . . . . 0.0 111.71 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -73.92 -28.54 61.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.434 -0.166 . . . . 0.0 110.89 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.63 -49.84 20.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.266 0.226 . . . . 0.0 110.539 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.53 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.431 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -38.32 79.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.187 0.449 . . . . 0.0 110.583 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -75.23 -15.7 60.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 111.272 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -95.03 -26.58 16.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -97.88 -20.0 17.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.6 pttt -66.22 -19.13 65.74 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.8 pt20 -64.05 -21.07 66.37 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.4 mm -87.8 -28.34 5.55 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.444 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 168.49 170.05 32.68 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.8 mm -68.04 134.85 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 O-C-N 122.519 -0.401 . . . . 0.0 111.247 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 322' ' ' ILE . 6.2 mm -76.97 137.09 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.429 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.7 ttmm -69.68 139.33 53.45 Favored 'General case' 0 C--O 1.23 0.041 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m -99.28 141.43 32.07 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -69.44 148.56 49.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.659 0.384 . . . . 0.0 110.186 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -81.8 -1.49 47.55 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -147.03 -24.24 0.4 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.02 0.827 . . . . 0.0 112.952 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 10.0 p -89.81 -16.43 30.18 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.25 -17.87 3.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.269 0.461 . . . . 0.0 112.881 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -81.47 161.82 60.59 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 117.865 0.833 . . . . 0.0 109.619 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.67 153.42 75.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.798 1.665 . . . . 0.0 109.027 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.5 mtp -78.69 79.35 5.11 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.786 0.434 . . . . 0.0 111.175 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.803 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.37 159.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.697 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -156.42 130.62 8.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -91.97 119.61 31.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -82.79 158.36 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 43.2 p -133.19 157.05 46.35 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.38 0.61 . . . . 0.0 112.085 -170.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -68.97 127.01 31.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.208 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -76.41 -7.41 54.98 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 122.469 0.307 . . . . 0.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.76 -7.73 36.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 4.1 t -149.67 -22.6 0.27 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.187 0.449 . . . . 0.0 110.922 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.41 27.07 33.98 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.126 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -132.6 169.82 16.08 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.986 0.893 . . . . 0.0 110.429 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 333' ' ' LEU . 0.2 OUTLIER -45.34 123.94 4.45 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.664 0.786 . . . . 0.0 111.598 -174.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.545 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -84.04 -19.43 34.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.976 0.911 . . . . 0.0 109.71 174.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.22 1.71 58.1 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -94.32 150.9 19.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.331 0.566 . . . . 0.0 110.916 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.27 165.77 32.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.072 0.549 . . . . 0.0 109.59 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 7.1 m -136.47 122.55 20.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 96.2 t -114.99 124.01 71.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.7 t -96.29 126.6 41.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.253 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -84.09 148.32 26.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.84 -17.65 59.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 92.4 m-20 -128.13 134.08 25.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 110.687 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.8 Cg_endo -67.2 -32.94 32.45 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.689 2.259 . . . . 0.0 114.659 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.4 Cg_endo -75.13 -18.94 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 CA-C-N 121.11 1.432 . . . . 0.0 110.831 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.8 m -77.19 -29.81 54.54 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.01 78.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -66.0 -37.03 84.89 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.397 -0.189 . . . . 0.0 110.629 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.48 -40.31 81.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.459 0.304 . . . . 0.0 110.969 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.17 -25.92 65.5 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.26 -56.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -61.13 -21.68 63.97 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -94.04 -58.67 2.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -70.92 -32.34 69.23 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.07 112.37 1.33 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.02 -16.48 30.33 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.837 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -94.26 -172.29 2.76 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.788 1.294 . . . . 0.0 110.07 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -101.73 173.7 6.29 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.622 0.369 . . . . 0.0 110.302 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.608 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.5 t80 -127.96 -38.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.3 t -141.73 4.8 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.05 -22.58 4.0 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.61 148.45 34.75 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.75 151.91 78.25 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.291 2.661 . . . . 0.0 110.74 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.34 169.36 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.629 0.371 . . . . 0.0 110.862 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -134.17 155.88 49.31 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.922 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.74 146.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.956 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.3 m -154.92 173.86 15.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 108.881 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -57.98 159.77 5.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 169.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.403 ' HB1' " H1'" ' B' ' 106' ' ' ' G' . . . -128.83 140.33 51.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 13.8 m -142.56 135.09 27.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.554 0.741 . . . . 0.0 110.174 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -49.15 119.12 3.05 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 122.668 0.387 . . . . 0.0 110.783 -169.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -30.73 70.16 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.62 75.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.665 -0.207 . . . . 0.0 110.934 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -66.99 -9.33 37.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.519 ' CD2' ' HE3' ' A' ' 264' ' ' LYS . 94.7 m-85 -106.26 -9.8 16.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.13 -41.8 0.09 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -81.16 -1.53 44.9 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.78 11.07 77.82 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.45 -168.71 53.98 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -76.9 172.29 55.03 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -145.28 155.94 43.52 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.058 0.543 . . . . 0.0 110.415 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -80.61 169.34 52.28 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -144.42 167.13 23.22 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.561 0.744 . . . . 0.0 110.722 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.2 170.55 47.52 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 163.86 -153.9 24.52 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -62.76 163.36 9.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.031 0.415 . . . . 0.0 110.587 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -138.79 172.36 23.12 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -60.54 142.93 54.75 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 122.604 0.362 . . . . 0.0 110.632 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.74 64.59 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.637 -1.646 . . . . 0.0 111.38 178.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 110.885 -3.077 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 N19-C1'-C2' 109.277 -2.577 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C4'-C3'-C2' 100.063 -2.637 . 0.848 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 C4'-C3'-C2' 100.117 -2.583 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 110.789 2.589 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 O4'-C1'-N19 111.278 3.078 . 0.844 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.655 0 O4'-C1'-N19 110.978 2.778 . 0.752 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 111.381 -2.746 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.856 0 C5'-C4'-C3' 110.999 -3.001 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.785 0 C5'-C4'-C3' 110.974 -3.017 . 0.67 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.435 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.089 0 C5'-C4'-C3' 111.489 -2.674 . 0.687 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.435 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.445 0 C5'-C4'-C3' 110.217 -3.522 . 0.409 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 1 C5'-C4'-C3' 109.492 -4.005 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.349 1 O4'-C1'-N19 113.116 4.916 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.545 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 110.04 -3.64 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.403 " H1'" ' HB1' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.922 1 C3'-C2'-C1' 105.693 4.659 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.457 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.387 0 C5'-C4'-C3' 110.093 -3.604 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . 0.457 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.975 0 C4'-C3'-C2' 100.71 -1.99 . 0.212 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C5'-C4'-C3' 110.745 -3.17 . 0.425 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 N19-C1'-C2' 109.303 -2.56 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 N19-C1'-C2' 108.979 -2.763 . 0.761 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 C4'-C3'-C2' 100.279 -2.421 . 0.681 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 112.154 -2.23 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . 0.41 " H2'" ' C6 ' ' B' ' 115' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 110.881 2.681 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . 0.41 ' C6 ' " H2'" ' B' ' 114' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 O4'-C1'-N19 110.671 2.471 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.241 -2.459 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.711 0 O4'-C1'-N19 110.634 2.434 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.717 0 O4'-C1'-N19 110.737 2.537 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.182 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.63 -177.54 47.92 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.98 176.25 2.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -68.2 -173.99 0.45 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.478 0.711 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.64 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.02 -14.28 53.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.183 0.593 . . . . 0.0 112.366 -178.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -97.02 -6.89 34.29 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.066 0.394 . . . . 0.0 110.901 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.17 8.69 83.38 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.067 -0.852 . . . . 0.0 114.785 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 69.01 -161.64 51.89 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.454 1.627 . . . . 0.0 110.888 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.551 ' HA ' HE21 ' A' ' 271' ' ' GLN . 58.7 Cg_endo -70.19 27.9 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.996 3.131 . . . . 0.0 112.343 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 267' ' ' GLY . 77.0 ttt-85 -84.14 -19.55 33.98 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.664 0.386 . . . . 0.0 110.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -146.82 27.57 1.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 268' ' ' PRO . 3.7 tp-100 -67.12 -13.87 62.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.797 0.439 . . . . 0.0 111.253 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 105.49 -119.42 6.12 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 79.7 p -73.37 18.22 0.12 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -2.98 9.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.864 0.757 . . . . 0.0 112.549 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -93.26 -15.61 25.66 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.395 0.278 . . . . 0.0 111.061 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -127.75 6.78 6.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 42.0 t -156.74 158.76 37.48 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.071 0.548 . . . . 0.0 109.593 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -99.88 2.01 43.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.055 0.542 . . . . 0.0 110.639 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -85.97 -80.51 0.23 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.08 0.552 . . . . 0.0 109.798 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 49.63 14.25 0.11 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -156.2 167.3 30.86 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.733 -0.604 . . . . 0.0 110.235 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.1 t -155.64 -35.84 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -95.94 7.4 46.45 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -125.38 45.23 2.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.184 0.593 . . . . 0.0 111.715 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -69.46 -1.18 7.83 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.245 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -98.43 147.16 25.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.44 149.88 34.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.018 0.527 . . . . 0.0 110.139 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -105.12 149.08 26.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.14 148.19 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 123.181 0.592 . . . . 0.0 111.056 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -138.45 149.55 45.57 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.58 57.61 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.848 -0.418 . . . . 0.0 112.599 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.06 -54.53 38.01 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.404 0.682 . . . . 0.0 111.639 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.51 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.68 -176.81 43.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -170.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -85.44 -9.17 57.86 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.773 0.829 . . . . 0.0 112.265 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -78.77 -5.2 52.67 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.184 -0.322 . . . . 0.0 111.209 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.51 158.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.547 0.739 . . . . 0.0 112.678 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.66 167.16 29.07 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.9 mm -49.32 -39.35 13.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.359 1.064 . . . . 0.0 111.731 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.14 -28.41 62.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.35 -0.219 . . . . 0.0 111.15 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.1 t -75.73 -48.73 20.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.303 0.241 . . . . 0.0 110.765 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.792 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.44 -53.62 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.425 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.22 -37.55 77.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.36 0.527 . . . . 0.0 110.52 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -75.96 -16.02 60.07 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.217 -0.302 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -93.98 -27.48 16.31 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -97.02 -19.86 18.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -65.27 -18.95 65.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.5 pt20 -64.6 -21.59 66.75 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.5 mm -87.67 -25.76 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.047 0 CA-C-O 120.818 0.342 . . . . 0.0 110.313 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 165.81 169.81 29.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -67.52 135.86 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 O-C-N 122.646 -0.326 . . . . 0.0 110.993 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.482 HG21 HD11 ' A' ' 322' ' ' ILE . 7.2 mm -76.54 137.99 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.402 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.2 ttmm -69.97 147.51 50.07 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.9 m -127.78 131.94 49.56 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.35 149.5 42.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -81.87 -6.09 58.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 -1.41 1.32 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -90.09 -22.82 21.61 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.9 79.32 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -145.24 159.32 49.42 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 117.454 0.627 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.82 155.06 56.77 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.316 2.011 . . . . 0.0 109.413 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.402 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 49.3 mtp -76.9 76.99 3.48 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.723 0.409 . . . . 0.0 111.154 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.792 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -136.03 154.55 33.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.065 0 C-N-CA 123.283 0.633 . . . . 0.0 110.792 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -151.9 131.9 13.43 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -93.02 118.06 30.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -80.5 158.44 25.85 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 333' ' ' LEU . 19.6 p -133.3 148.4 51.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.413 0.625 . . . . 0.0 112.59 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.61 128.33 35.83 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.822 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 328' ' ' ARG . 41.3 mtp85 -72.01 -4.82 30.82 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -100.65 -6.21 25.51 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.8 t -150.18 -24.34 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.498 0.59 . . . . 0.0 110.957 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.13 20.06 58.01 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.105 172.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -124.88 169.01 12.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.948 0.874 . . . . 0.0 109.547 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 293' ' ' GLY . 3.6 mt -50.81 121.38 5.84 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 120.538 0.209 . . . . 0.0 110.771 -173.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.664 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 12.9 ptmm? -83.43 2.38 36.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.021 0.529 . . . . 0.0 109.579 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.27 1.5 72.07 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.415 0.531 . . . . 0.0 111.911 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.17 148.5 24.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 117.808 0.804 . . . . 0.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.2 165.84 33.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.388 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 5.0 m -135.22 121.22 19.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 122.976 0.51 . . . . 0.0 111.943 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.08 125.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 33.3 t -96.66 129.68 44.02 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.49 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.48 147.27 26.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -76.72 -17.35 59.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -124.84 131.25 24.09 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.069 0.948 . . . . 0.0 110.525 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 29.9 Cg_endo -66.17 -33.3 40.53 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.798 2.332 . . . . 0.0 114.382 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 93.0 Cg_endo -75.53 -20.27 16.0 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 CA-C-N 121.372 1.526 . . . . 0.0 111.016 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -74.72 -29.81 61.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.52 -47.98 76.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.411 ' HA ' HD12 ' A' ' 351' ' ' ILE . 17.3 tptm -64.62 -38.15 90.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.346 0.117 . . . . 0.0 110.71 -177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.59 82.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.471 0.308 . . . . 0.0 110.808 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.91 -25.81 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 348' ' ' LYS . 66.4 mt -72.54 -57.92 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -59.67 -22.32 61.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -92.65 -60.35 1.84 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.72 -32.03 70.36 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.58 112.45 1.28 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.89 -15.81 31.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.149 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.47 -171.91 2.5 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.719 1.26 . . . . 0.0 109.861 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -101.12 174.68 5.89 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.427 0.291 . . . . 0.0 110.455 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.602 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.1 t80 -130.66 -37.38 1.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.617 0.367 . . . . 0.0 110.404 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.3 t -144.37 15.59 1.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.13 -19.86 10.79 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.82 148.0 34.44 Favored Pre-proline 0 CA--C 1.53 0.175 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.26 151.22 76.77 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.485 2.79 . . . . 0.0 110.646 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.602 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.07 169.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 122.858 0.463 . . . . 0.0 110.705 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 156.27 49.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.698 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.8 t -144.06 147.87 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.068 0.547 . . . . 0.0 110.307 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 175.88 13.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.126 0.971 . . . . 0.0 108.809 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.23 163.84 3.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -131.98 137.58 47.95 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 10.3 m -141.64 134.37 28.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.7 0.8 . . . . 0.0 110.203 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -47.42 115.98 1.28 Allowed 'General case' 0 C--N 1.34 0.159 0 O-C-N 123.236 0.335 . . . . 0.0 110.448 -170.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -24.0 61.02 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.16 76.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.166 -0.334 . . . . 0.0 110.44 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.37 -9.83 13.95 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.445 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 97.7 m-85 -107.43 -9.63 15.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.42 -41.68 0.09 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -82.14 -1.55 49.21 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 80.48 12.55 82.88 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 88.59 170.43 45.55 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.26 154.45 53.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -157.94 171.5 20.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 110.421 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.06 162.49 36.02 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -74.86 165.11 25.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.842 0.353 . . . . 0.0 110.374 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.77 139.7 29.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -89.65 175.28 42.05 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -66.9 135.39 53.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -101.1 -178.57 29.0 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -140.2 166.44 24.67 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.311 0.644 . . . . 0.0 110.43 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 75.15 -174.67 51.67 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.102 -1.944 . . . . 0.0 110.61 -179.47 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 C5'-C4'-C3' 110.59 -3.274 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 N19-C1'-C2' 109.298 -2.564 . 0.772 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.369 0 N19-C1'-C2' 108.945 -2.784 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 N19-C1'-C2' 109.324 -2.547 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 C5'-C4'-C3' 111.44 -2.707 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.729 2.529 . 0.907 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 O4'-C1'-N19 110.877 2.677 . 0.832 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.465 0 O4'-C1'-N19 111.316 3.116 . 0.652 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 O4'-C1'-N19 111.207 3.007 . 0.719 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.878 0 C5'-C4'-C3' 111.383 -2.745 . 0.671 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 C5'-C4'-C3' 111.272 -2.819 . 0.478 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.428 0 C5'-C4'-C3' 110.608 -3.261 . 0.278 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 109.785 -3.81 . 0.26 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 1 O4'-C1'-N19 112.694 4.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.664 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 C5'-C4'-C3' 109.929 -3.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.996 1 C3'-C2'-C1' 106.055 5.062 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.809 0 C5'-C4'-C3' 109.869 -3.754 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 0 C5'-C4'-C3' 110.846 -3.103 . 0.619 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 N19-C1'-C2' 109.125 -2.672 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 N19-C1'-C2' 109.653 -2.342 . 0.762 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 N19-C1'-C2' 109.358 -2.526 . 0.774 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 109.797 -2.252 . 0.699 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 C5'-C4'-C3' 111.798 -2.468 . 0.802 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 O4'-C1'-N19 110.86 2.66 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 O4'-C1'-N19 110.845 2.645 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.884 0 O4'-C1'-N19 110.837 2.637 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.705 2.505 . 0.793 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.501 2.301 . 0.827 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.022 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.33 -8.37 87.02 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -143.07 175.83 9.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -68.67 -174.29 0.55 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.648 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.02 -15.88 60.4 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.997 0.519 . . . . 0.0 112.097 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -94.87 -5.18 45.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.192 0.451 . . . . 0.0 111.304 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.64 10.09 83.76 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.135 -0.814 . . . . 0.0 114.098 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.92 -160.64 50.16 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 119.024 1.412 . . . . 0.0 110.788 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.67 20.96 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.787 2.991 . . . . 0.0 112.603 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.8 ttp180 -74.88 -41.96 58.78 Favored 'General case' 0 CA--C 1.527 0.07 0 O-C-N 121.815 -0.553 . . . . 0.0 110.188 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -105.45 11.36 32.69 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.133 0.573 . . . . 0.0 111.029 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -8.48 41.7 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.59 -107.98 2.99 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 81.0 p -72.43 12.37 0.47 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -3.52 14.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -87.73 -6.72 58.06 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.777 0.262 . . . . 0.0 111.411 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -150.19 22.82 0.84 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 48.5 t -155.79 154.47 31.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.919 -0.488 . . . . 0.0 110.138 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.69 -0.67 48.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.243 0.617 . . . . 0.0 110.155 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -90.13 -84.53 0.23 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.218 0.607 . . . . 0.0 110.082 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 48.96 17.35 0.15 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -155.47 168.63 26.5 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.5 t -149.53 -30.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.53 -11.04 14.51 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -92.11 54.41 2.37 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.937 0.495 . . . . 0.0 111.556 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -68.43 -10.74 57.3 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.56 0.344 . . . . 0.0 110.747 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.4 m -98.49 148.7 23.47 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.3 pt -128.98 149.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.335 0.654 . . . . 0.0 109.854 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -103.0 149.09 24.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.2 t -133.94 148.34 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.319 0.647 . . . . 0.0 110.892 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -139.14 151.09 46.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.1 5.34 59.56 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 120.013 -0.326 . . . . 0.0 112.797 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.5 mp -55.09 -55.22 33.51 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.428 0.614 . . . . 0.0 111.292 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.507 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.86 -176.99 44.62 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -171.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.03 -7.22 58.32 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.087 0.955 . . . . 0.0 112.368 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.29 -6.7 55.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.677 0.275 . . . . 0.0 110.805 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.73 159.76 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 112.282 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 163.63 39.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 44.3 mm -50.7 -37.1 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.009 0.924 . . . . 0.0 111.805 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -73.86 -28.59 61.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.251 -0.281 . . . . 0.0 110.991 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.6 t -74.0 -48.52 29.73 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 122.258 0.223 . . . . 0.0 110.548 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.825 HG21 HG21 ' A' ' 322' ' ' ILE . 2.3 m -61.71 -53.45 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.434 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -38.45 79.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.182 0.446 . . . . 0.0 110.884 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -75.33 -16.22 60.42 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.849 0.357 . . . . 0.0 111.088 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -93.94 -27.56 16.29 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -96.85 -20.08 18.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.2 pttt -65.99 -19.09 65.74 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -173.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.4 pt20 -64.31 -21.24 66.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.2 mm -87.99 -23.66 6.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 162.2 169.74 25.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 51.3 mm -66.06 138.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 122.535 -0.391 . . . . 0.0 111.178 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.462 HG21 HD11 ' A' ' 322' ' ' ILE . 7.3 mm -78.9 135.14 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.455 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 15.5 ttpp -70.04 139.18 52.64 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m -107.32 143.23 35.89 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -70.69 143.2 51.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.75 -13.2 59.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HA ' ' HE2' ' A' ' 316' ' ' LYS . 6.8 mmpt? -125.46 -36.35 2.47 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.12 0.418 . . . . 0.0 111.839 -174.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.4 p -85.84 -18.17 33.61 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.43 -16.49 3.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.468 0.556 . . . . 0.0 113.421 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -80.83 160.02 67.46 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 117.984 0.892 . . . . 0.0 109.813 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.64 152.39 80.62 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.927 1.752 . . . . 0.0 108.913 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.2 mtp -78.09 79.8 4.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 111.004 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.825 HG21 HG21 ' A' ' 301' ' ' VAL . 0.5 OUTLIER -132.67 152.16 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.328 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -146.42 126.44 13.69 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 36.0 mt -96.07 113.46 25.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -79.25 156.09 28.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 35.7 p -130.47 156.25 45.09 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.736 0.779 . . . . 0.0 112.855 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 122.73 20.15 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.577 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.23 -4.0 30.28 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.372 0.269 . . . . 0.0 111.164 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.82 -6.17 29.7 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.494 0.717 . . . . 0.0 112.742 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.9 t -150.68 -24.29 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.272 0.487 . . . . 0.0 111.247 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 88.37 19.61 51.83 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.6 -0.556 . . . . 0.0 113.05 172.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -122.61 169.5 10.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.965 0.883 . . . . 0.0 110.228 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.5 mt -50.61 126.43 15.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.031 0.443 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.584 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.9 ttmm -76.61 -14.6 59.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.067 0.947 . . . . 0.0 109.173 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 98.03 -5.69 61.58 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -87.23 144.98 26.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.882 0.372 . . . . 0.0 110.76 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.83 166.49 33.23 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 8.7 m -138.64 119.24 13.96 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.705 0.402 . . . . 0.0 111.353 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.8 t -113.65 125.99 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.9 t -96.94 132.91 42.26 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.06 -0.4 . . . . 0.0 110.301 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.89 147.28 23.26 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -73.69 -20.49 60.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -124.5 133.16 24.51 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 123.671 0.788 . . . . 0.0 110.706 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 26.2 Cg_endo -66.69 -33.78 34.07 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.724 2.283 . . . . 0.0 114.031 -175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 85.5 Cg_endo -76.84 -18.93 14.55 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 CA-C-N 121.214 1.469 . . . . 0.0 111.032 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 56.2 m -75.49 -29.72 59.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.38 -48.03 79.58 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -64.64 -39.04 93.01 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-O 120.595 0.236 . . . . 0.0 110.714 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.72 -39.32 84.33 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.392 0.277 . . . . 0.0 110.642 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.1 -26.15 65.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -72.79 -57.25 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.68 -22.27 61.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -93.13 -60.37 1.81 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -69.77 -31.55 69.55 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -56.75 113.24 1.56 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.005 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.33 37.68 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.257 -0.746 . . . . 0.0 113.169 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -96.5 -172.48 2.52 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.545 1.173 . . . . 0.0 110.027 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.96 175.6 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.843 0.354 . . . . 0.0 110.559 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.4 t80 -131.45 -39.41 1.14 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 17.0 t -141.53 19.69 2.2 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.798 0.439 . . . . 0.0 110.101 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.79 -8.29 34.01 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -111.49 146.77 35.32 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 123.881 0.872 . . . . 0.0 109.587 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.49 149.42 68.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.563 2.842 . . . . 0.0 110.846 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.62 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.75 169.72 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.924 0.49 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -135.83 156.5 48.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.127 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.4 t -144.7 147.55 19.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.09 0.556 . . . . 0.0 110.153 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 71.0 m -155.23 175.41 13.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.054 0.941 . . . . 0.0 108.833 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -59.8 163.81 4.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.412 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -136.04 141.73 44.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.3 m -144.94 139.04 27.29 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.838 0.855 . . . . 0.0 110.383 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -46.73 114.08 0.77 Allowed 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -72.8 -26.54 61.55 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.81 -30.85 71.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.446 -0.159 . . . . 0.0 110.607 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -64.77 -8.27 14.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.48 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 96.6 m-85 -106.2 -11.66 15.99 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.05 -41.37 0.07 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -81.09 -3.14 50.98 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 72.73 45.07 36.49 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -59.86 -9.87 11.77 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.877 0.751 . . . . 0.0 112.969 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -75.6 -8.87 84.61 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 117.87 0.835 . . . . 0.0 111.814 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -70.52 169.52 14.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.284 0.634 . . . . 0.0 111.23 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -167.15 -166.74 26.76 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -142.57 159.37 42.37 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.974 0.51 . . . . 0.0 110.753 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -82.41 -177.11 51.74 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -174.11 155.35 21.43 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -70.95 119.84 15.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -79.74 151.14 33.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -71.18 150.85 44.95 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 71.54 1.39 44.43 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 CA-C-O 117.165 -1.908 . . . . 0.0 110.694 -179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 C4'-C3'-C2' 100.58 -2.12 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 N19-C1'-C2' 109.276 -2.577 . 0.865 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 C4'-C3'-C2' 100.116 -2.584 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C4'-C3'-C2' 100.13 -2.57 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 O4'-C1'-N19 110.635 2.435 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 O4'-C1'-N19 111.015 2.815 . 0.865 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 O4'-C1'-N19 110.971 2.771 . 0.735 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 C5'-C4'-C3' 111.755 -2.497 . 0.82 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.96 0 C5'-C4'-C3' 111.725 -2.517 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C5'-C4'-C3' 111.267 -2.822 . 0.611 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.46 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.963 0 C5'-C4'-C3' 111.473 -2.685 . 0.555 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.46 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 C5'-C4'-C3' 110.814 -3.124 . 0.425 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 C5'-C4'-C3' 109.998 -3.668 . 0.306 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . 0.4 " H1'" " O4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.253 1 O4'-C1'-N19 112.835 4.635 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.584 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 C5'-C4'-C3' 109.871 -3.752 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.412 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 C3'-C2'-C1' 105.637 4.597 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C5'-C4'-C3' 109.968 -3.688 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 C5'-C4'-C3' 109.565 -3.957 . 0.508 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.579 0 N19-C1'-C2' 109.651 -2.343 . 0.339 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 N19-C1'-C2' 109.646 -2.346 . 0.658 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 N19-C1'-C2' 109.668 -2.333 . 0.713 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 0 N19-C1'-C2' 109.954 -2.154 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 C5'-C4'-C3' 112.331 -2.112 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 O4'-C1'-N19 110.657 2.457 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 C4'-C3'-C2' 100.282 -2.418 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 O4'-C1'-N19 110.647 2.447 . 0.728 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 O4'-C1'-N19 110.425 2.225 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.66 0 O4'-C1'-N19 110.707 2.507 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 73.19 -171.69 50.81 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -64.18 -53.85 42.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -157.31 -178.96 7.74 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.128 0.971 . . . . 0.0 109.267 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.566 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.28 -7.54 25.09 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 119.774 -0.155 . . . . 0.0 111.323 176.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.31 -3.58 18.24 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.7 0.227 . . . . 0.0 111.152 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.96 5.7 89.07 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.18 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.74 -160.3 50.04 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 118.926 1.363 . . . . 0.0 110.404 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.44 19.84 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.81 3.007 . . . . 0.0 112.377 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 267' ' ' GLY . 59.5 ttt85 -78.05 -31.89 50.59 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.76 -0.588 . . . . 0.0 110.535 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -113.87 11.05 17.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.397 0.679 . . . . 0.0 111.84 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -11.46 58.22 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 84.93 -105.09 2.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 88.5 p -73.57 14.17 0.39 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -170.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -0.21 7.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.581 0.628 . . . . 0.0 112.644 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -95.19 -14.55 24.0 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.824 0.284 . . . . 0.0 110.989 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -126.57 6.16 6.85 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 43.1 t -152.65 152.76 32.15 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.644 0.259 . . . . 0.0 110.92 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -90.67 0.29 57.45 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.048 0.539 . . . . 0.0 110.613 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -90.89 -81.84 0.3 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.92 0.488 . . . . 0.0 110.284 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p30 47.95 15.47 0.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.572 1.549 . . . . 0.0 115.144 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -151.71 162.6 40.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.9 t -156.75 -32.55 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.372 0.13 . . . . 0.0 111.331 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -88.88 -0.53 57.45 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.56 153.52 32.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.485 0.714 . . . . 0.0 109.925 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -158.66 17.99 0.2 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.019 0.528 . . . . 0.0 110.525 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 26.7 m -132.71 150.79 52.11 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.662 0.385 . . . . 0.0 111.146 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.1 pt -128.42 148.84 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.876 0.47 . . . . 0.0 110.271 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -101.15 149.82 23.58 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.4 148.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.362 0.665 . . . . 0.0 110.902 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -138.77 149.53 45.11 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.47 5.59 57.83 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.971 -0.349 . . . . 0.0 112.869 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.91 -56.67 17.82 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 117.479 0.639 . . . . 0.0 111.408 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.452 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.86 -179.61 44.28 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.84 -10.0 59.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.626 0.77 . . . . 0.0 112.281 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -82.17 2.48 31.34 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.386 0.274 . . . . 0.0 111.553 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.91 155.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -158.49 168.91 25.65 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.7 mm -49.62 -40.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 124.391 1.077 . . . . 0.0 111.645 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.59 -28.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.449 -0.157 . . . . 0.0 110.876 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.7 t -75.08 -49.84 18.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.221 0.208 . . . . 0.0 110.611 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 322' ' ' ILE . 2.8 m -61.09 -53.71 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.441 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.04 -38.1 78.54 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.212 0.46 . . . . 0.0 110.718 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -76.07 -15.81 60.04 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -94.14 -27.63 16.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 339' ' ' VAL . 45.4 m-85 -97.23 -19.99 18.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -65.65 -19.05 65.75 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.27 -21.02 66.45 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -88.34 -26.04 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.732 0.301 . . . . 0.0 110.474 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.34 170.7 31.58 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 52.1 mm -68.4 134.63 29.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 O-C-N 122.662 -0.316 . . . . 0.0 111.348 -172.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.464 HG21 HD11 ' A' ' 322' ' ' ILE . 6.8 mm -76.19 137.34 22.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.431 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.8 ttmm -67.78 147.37 52.68 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -121.96 138.05 54.56 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -71.59 145.78 48.81 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -81.29 -2.37 48.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -142.29 4.7 1.62 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.8 p -124.2 -18.25 5.91 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.31 -17.12 3.3 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.778 -0.457 . . . . 0.0 112.895 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -87.32 158.31 52.22 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 117.797 0.798 . . . . 0.0 109.862 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.7 153.87 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.173 1.915 . . . . 0.0 109.102 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.431 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.9 mtp -79.65 78.52 6.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 122.476 0.31 . . . . 0.0 111.001 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.809 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.6 156.86 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.36 0.664 . . . . 0.0 110.71 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -152.76 130.57 11.66 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.918 0.887 . . . . 0.0 109.455 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -94.07 119.49 33.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -84.03 160.09 21.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 42.7 p -135.76 159.07 42.77 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 121.763 0.792 . . . . 0.0 110.357 -171.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.27 124.59 23.54 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.588 172.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -72.27 -8.24 53.77 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.411 0.285 . . . . 0.0 111.681 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.96 -13.76 43.68 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.2 t -157.2 -18.93 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.7 10.97 61.1 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.19 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -91.1 162.83 14.52 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.237 1.019 . . . . 0.0 110.549 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -55.33 118.74 4.68 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.55 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -78.18 -19.51 53.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.526 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.52 0.22 59.46 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -90.81 149.44 21.98 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.396 0.598 . . . . 0.0 110.927 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.13 165.83 32.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.378 0.671 . . . . 0.0 109.75 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.0 m -136.9 121.74 18.73 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 305' ' ' PHE . 98.2 t -114.16 121.45 66.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 31.8 t -92.72 126.42 37.79 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.17 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -84.46 147.39 27.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.05 -14.81 59.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 94.0 m-20 -127.64 135.75 27.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 111.221 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.457 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 24.1 Cg_endo -65.82 -35.37 36.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.025 2.484 . . . . 0.0 114.422 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.8 Cg_endo -76.46 -20.34 14.16 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 121.719 1.613 . . . . 0.0 111.358 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -74.19 -30.67 62.33 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 122.297 -0.252 . . . . 0.0 110.431 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.73 93.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -65.07 -41.15 95.35 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-O 120.547 0.213 . . . . 0.0 110.834 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.98 86.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.354 0.262 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -25.08 64.26 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.6 mt -73.4 -56.59 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -60.36 -21.63 62.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -94.06 -59.92 1.86 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -70.78 -32.52 69.66 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.46 113.74 1.92 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.16 -17.09 32.14 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.949 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -93.76 -172.88 3.0 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.648 1.224 . . . . 0.0 109.808 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -100.33 173.72 6.46 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.34 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.613 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -127.31 -38.7 1.94 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.437 0.295 . . . . 0.0 110.277 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.6 t -143.2 6.61 1.53 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 110.363 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 132.48 -22.27 4.18 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.41 149.25 35.92 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 109.463 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.65 151.95 74.7 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.538 2.825 . . . . 0.0 110.388 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.62 168.28 21.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.076 0.55 . . . . 0.0 110.851 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 156.17 47.11 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.917 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 51.4 t -145.2 146.77 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 123.636 0.585 . . . . 0.0 110.224 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.0 m -155.26 171.65 19.48 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -59.01 162.24 4.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -138.29 144.59 40.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.228 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 10.7 m -148.38 139.88 23.55 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.404 1.082 . . . . 0.0 109.67 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -43.52 121.36 2.26 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.371 0.669 . . . . 0.0 110.806 -172.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -68.35 -32.94 73.4 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -175.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.16 -31.93 73.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.977 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -64.57 -10.53 26.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.564 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.5 m-85 -104.56 -13.73 15.9 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.94 -41.64 0.09 Allowed 'General case' 0 C--N 1.34 0.188 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -78.88 -0.29 30.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.69 11.57 79.41 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.93 52.78 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -72.9 165.4 54.75 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -158.17 172.28 18.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.07 -167.85 27.33 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -136.58 163.83 29.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.149 0.58 . . . . 0.0 109.99 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.02 149.72 46.49 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.75 42.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -73.9 170.7 14.84 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.606 0.362 . . . . 0.0 110.565 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -63.81 162.45 34.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -69.69 161.13 30.34 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.575 0.35 . . . . 0.0 110.647 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.71 86.66 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.917 -2.046 . . . . 0.0 110.368 179.503 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 C5'-C4'-C3' 110.854 -3.097 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 N19-C1'-C2' 109.523 -2.423 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.488 0 N19-C1'-C2' 109.156 -2.653 . 0.867 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 N19-C1'-C2' 109.263 -2.586 . 0.834 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.973 2.773 . 0.872 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 O4'-C1'-N19 110.927 2.727 . 0.874 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.764 0 O4'-C1'-N19 111.016 2.816 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 111.272 3.072 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C5'-C4'-C3' 111.792 -2.472 . 0.698 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.888 0 C5'-C4'-C3' 111.592 -2.605 . 0.643 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 C5'-C4'-C3' 111.074 -2.95 . 0.349 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 C5'-C4'-C3' 110.613 -3.258 . 0.248 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.448 1 C5'-C4'-C3' 109.349 -4.101 . 0.293 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.102 1 O4'-C1'-N19 112.611 4.411 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.55 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 C5'-C4'-C3' 110.109 -3.594 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.823 1 C3'-C2'-C1' 105.374 4.304 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.463 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 110.362 -3.425 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . 0.463 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 C5'-C4'-C3' 112.291 -2.14 . 0.168 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.26 0 C5'-C4'-C3' 110.8 -3.133 . 0.319 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 N19-C1'-C2' 109.001 -2.749 . 0.794 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.239 -2.6 . 0.79 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 N19-C1'-C2' 109.479 -2.451 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 C4'-C3'-C2' 100.41 -2.29 . 0.804 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 O4'-C1'-N19 110.548 2.348 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 C4'-C3'-C2' 100.192 -2.508 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.859 0 O4'-C1'-N19 110.826 2.626 . 0.757 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.521 2.321 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 110.779 2.579 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -72.76 174.11 46.45 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -60.93 -52.78 63.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -156.35 -179.73 8.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.048 0.939 . . . . 0.0 108.923 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.66 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -66.52 -10.33 43.78 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.752 -0.166 . . . . 0.0 111.214 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.59 -4.26 21.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.756 0.253 . . . . 0.0 111.245 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.34 5.68 84.9 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.495 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 68.08 -156.35 52.87 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.24 1.52 . . . . 0.0 110.088 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.17 22.6 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.913 3.075 . . . . 0.0 112.003 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -76.65 -41.22 46.5 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.852 -0.53 . . . . 0.0 110.908 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -104.5 8.3 35.52 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.732 0.413 . . . . 0.0 111.198 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -15.29 61.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.96 -117.47 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -79.05 17.1 0.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -6.53 6.94 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -85.48 -7.22 59.02 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.468 0.307 . . . . 0.0 111.021 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -146.1 20.7 1.41 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 36.7 t -154.81 143.17 20.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.51 0.324 . . . . 0.0 110.197 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.75 6.29 21.72 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.17 0.588 . . . . 0.0 110.211 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -103.34 -111.5 0.24 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . 0.25 2.9 m-20 50.17 23.87 1.28 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -152.42 161.25 42.87 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.2 p -154.27 -36.62 0.1 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 122.431 0.292 . . . . 0.0 110.522 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -98.39 14.09 29.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.106 0.562 . . . . 0.0 112.152 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -132.4 44.65 2.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.413 0.685 . . . . 0.0 111.346 -175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.69 -0.6 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.764 0.426 . . . . 0.0 111.361 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -98.79 148.44 23.89 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 11.1 pt -131.39 146.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.697 0.399 . . . . 0.0 110.575 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -100.78 149.6 23.66 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.87 147.32 30.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.111 0.564 . . . . 0.0 111.817 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.73 151.03 48.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 109.811 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.28 5.89 59.06 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 120.025 -0.319 . . . . 0.0 112.699 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.61 -57.68 10.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.397 0.679 . . . . 0.0 111.1 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.464 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.28 -178.57 44.71 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -77.89 -10.87 59.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.974 0.909 . . . . 0.0 112.109 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.02 0.2 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.25 0.22 . . . . 0.0 111.484 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.95 155.59 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.41 168.49 26.81 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.2 mm -49.52 -39.73 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.897 0.879 . . . . 0.0 111.878 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.61 62.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.526 -0.109 . . . . 0.0 111.158 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.25 -49.52 19.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.729 -0.1 . . . . 0.0 110.729 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.821 HG21 HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.56 -53.88 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.36 -37.44 77.92 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.249 0.477 . . . . 0.0 110.804 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -76.07 -15.83 60.04 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.182 -0.324 . . . . 0.0 111.099 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.56 -26.96 16.18 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.6 m-85 -97.17 -20.22 18.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -65.68 -18.85 65.63 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.6 pt20 -64.44 -21.16 66.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.6 mm -87.96 -25.47 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 110.161 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 164.92 170.28 29.67 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.91 135.24 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 O-C-N 122.478 -0.425 . . . . 0.0 111.135 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.477 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -76.01 138.08 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -69.15 148.97 49.16 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m -122.57 134.51 54.53 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -74.09 134.74 42.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.47 -22.23 59.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.592 0.357 . . . . 0.0 111.173 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -101.34 -9.06 21.51 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 p -130.13 -17.6 3.43 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.03 -15.69 5.05 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.273 0.463 . . . . 0.0 113.557 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.19 159.71 56.11 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 117.968 0.884 . . . . 0.0 109.619 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.9 151.96 81.57 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.845 1.697 . . . . 0.0 109.005 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.9 mtp -77.91 78.69 4.4 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.77 0.428 . . . . 0.0 111.206 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.821 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.25 155.3 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 0.0 110.527 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -150.24 121.89 8.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.524 0.73 . . . . 0.0 109.326 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -88.14 121.67 30.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.632 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 73.9 m-85 -77.64 162.83 26.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.8 p -140.18 157.3 45.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -67.22 117.39 9.17 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.206 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -68.4 -7.75 34.38 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.77 -14.37 51.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 13.8 t -156.22 -20.44 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 94.73 10.87 57.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.26 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -91.89 162.08 14.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 118.492 1.146 . . . . 0.0 110.56 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -54.66 120.44 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.615 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -77.47 -18.86 56.73 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.087 0.555 . . . . 0.0 109.783 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.61 16.62 36.11 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.37 156.83 31.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.783 0.791 . . . . 0.0 110.23 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.74 171.2 19.96 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.802 0.441 . . . . 0.0 110.262 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 70.8 m -136.33 129.07 30.82 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.8 t -118.67 127.89 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.5 t -98.98 127.91 45.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.997 0.362 . . . . 0.0 110.513 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.18 147.95 26.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -75.85 -17.26 59.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 91.2 m-20 -127.54 133.89 25.59 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.979 0.912 . . . . 0.0 110.987 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.465 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -66.64 -33.79 34.54 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.646 2.231 . . . . 0.0 114.463 -175.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 88.7 Cg_endo -74.81 -19.79 18.0 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 CA-C-N 121.052 1.412 . . . . 0.0 110.843 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.9 m -75.89 -29.45 58.47 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.32 -0.237 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.47 73.34 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -65.33 -36.99 85.7 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.425 0.155 . . . . 0.0 110.593 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.38 82.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.493 0.317 . . . . 0.0 110.943 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.55 65.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.81 -56.09 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.69 -22.08 63.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -93.92 -59.99 1.85 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -69.82 -32.76 71.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.03 110.74 0.87 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.41 -16.09 24.57 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.109 -0.828 . . . . 0.0 113.035 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.6 -171.52 2.39 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.824 1.312 . . . . 0.0 109.902 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.53 173.94 6.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.664 0.269 . . . . 0.0 110.322 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.6 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.1 t80 -128.44 -37.44 1.81 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.608 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -145.0 11.05 1.35 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.682 0.393 . . . . 0.0 109.988 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.47 -20.3 6.18 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -103.12 148.64 35.94 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 151.97 75.13 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.388 2.725 . . . . 0.0 110.451 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.18 167.74 21.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.873 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.15 156.47 46.34 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.803 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.68 146.48 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.047 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 47.1 m -155.05 174.23 15.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.19 150.66 29.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.528 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -120.63 137.31 54.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 7.6 m -141.95 134.17 27.74 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.255 0.622 . . . . 0.0 110.599 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -46.29 110.33 0.26 Allowed 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.358 0.663 . . . . 0.0 110.489 -170.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.435 HH21 ' P ' ' B' ' 105' ' ' ' U' . 0.6 OUTLIER -70.17 -29.35 66.21 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.155 -174.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.31 -31.66 72.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 110.743 -0.095 . . . . 0.0 110.743 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -65.44 -10.45 34.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.56 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.5 m-85 -104.04 -10.52 17.99 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.45 -43.55 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -77.31 -5.14 48.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.273 0.488 . . . . 0.0 111.909 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.46 12.13 76.26 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.34 -176.22 53.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.63 168.92 54.5 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.48 170.8 20.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -162.52 166.58 36.68 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -77.07 173.58 11.66 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 122.745 0.418 . . . . 0.0 110.238 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -78.73 151.87 36.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.65 162.2 37.5 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -77.64 159.97 28.82 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.302 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -77.37 179.54 50.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -134.59 164.18 28.06 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.205 0.602 . . . . 0.0 110.04 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 179.98 179.0 48.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 117.371 -1.794 . . . . 0.0 110.584 179.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 110.867 -3.089 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 109.22 -2.613 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 N19-C1'-C2' 109.119 -2.676 . 0.863 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 N19-C1'-C2' 109.41 -2.494 . 0.842 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 O4'-C1'-N19 110.861 2.661 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 0 O4'-C1'-N19 110.905 2.705 . 0.826 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 O4'-C1'-N19 110.702 2.502 . 0.801 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.992 0 O4'-C1'-N19 111.129 2.929 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 111.358 -2.761 . 0.755 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.678 0 C5'-C4'-C3' 111.116 -2.923 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 C5'-C4'-C3' 110.877 -3.082 . 0.302 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C5'-C4'-C3' 110.066 -3.623 . 0.242 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.706 -3.863 . 0.254 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . 0.405 " H1'" " O4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.427 -2.174 1 O4'-C1'-N19 112.995 4.795 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.632 " H1'" ' CD1' ' A' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.413 -3.332 1 C5'-C4'-C3' 109.288 -4.141 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.528 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.593 1 C3'-C2'-C1' 105.886 4.874 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 109.924 -3.718 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C5'-C4'-C3' 109.965 -3.69 . 0.431 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 C5'-C4'-C3' 110.479 -3.347 . 0.063 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 N19-C1'-C2' 109.301 -2.562 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 N19-C1'-C2' 109.251 -2.593 . 0.773 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C4'-C3'-C2' 100.405 -2.295 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 C5'-C4'-C3' 111.96 -2.36 . 0.759 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 110.581 2.381 . 0.76 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 110.81 2.61 . 0.686 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 O4'-C1'-N19 110.98 2.78 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 O4'-C1'-N19 110.803 2.603 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 O4'-C1'-N19 110.762 2.562 . 0.813 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.01 -177.68 48.4 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -70.11 176.29 3.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -68.18 -174.97 0.55 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.41 0.684 . . . . 0.0 110.655 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.637 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -63.64 -14.8 55.24 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.273 0.629 . . . . 0.0 112.156 -178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -96.93 -5.82 37.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.217 0.462 . . . . 0.0 111.262 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.03 79.49 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.06 -0.856 . . . . 0.0 114.509 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.66 -159.49 50.57 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.242 1.521 . . . . 0.0 110.818 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.97 18.85 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.486 2.791 . . . . 0.0 112.775 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.1 ttp180 -74.47 -41.36 60.91 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.846 -0.534 . . . . 0.0 110.254 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -106.2 11.84 30.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.178 0.591 . . . . 0.0 110.89 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -9.68 53.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.84 -106.1 2.82 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.8 p -73.62 13.13 0.52 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -1.76 10.02 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -91.05 -15.81 28.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.739 0.245 . . . . 0.0 110.969 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -127.98 7.69 6.12 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.0 t -152.55 155.51 37.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.488 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -95.87 1.73 53.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.09 0.556 . . . . 0.0 110.309 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -89.89 -83.01 0.25 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 49.22 15.99 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -156.46 170.83 21.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 83.7 p -149.39 -33.7 0.2 Allowed 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.515 -0.116 . . . . 0.0 111.229 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -113.94 1.35 14.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.25 0.62 . . . . 0.0 112.194 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.72 35.15 1.4 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.303 0.641 . . . . 0.0 109.715 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -68.27 -0.03 4.31 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.923 -174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.6 m -101.74 150.2 23.38 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.7 pt -129.89 147.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 C-N-CA 122.545 0.338 . . . . 0.0 110.101 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -102.57 147.94 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.28 147.53 31.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.076 0.551 . . . . 0.0 112.079 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -138.71 151.3 47.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.84 59.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.84 -57.08 13.54 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.359 0.664 . . . . 0.0 111.033 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.457 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.43 -178.05 45.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -78.62 -10.65 59.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.849 0.86 . . . . 0.0 112.178 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -80.54 -0.55 38.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.321 -0.237 . . . . 0.0 111.234 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.29 156.28 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.06 168.39 26.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.3 mm -48.67 -39.9 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 124.421 1.088 . . . . 0.0 111.861 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.92 -29.75 63.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.345 -0.222 . . . . 0.0 111.217 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.8 t -75.05 -48.61 23.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.154 0.182 . . . . 0.0 110.679 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 322' ' ' ILE . 2.5 m -61.57 -54.22 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.446 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.44 -37.8 79.04 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.969 -0.457 . . . . 0.0 110.875 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.95 -15.82 60.11 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.252 -0.28 . . . . 0.0 110.932 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -94.32 -27.54 16.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.426 ' CD2' HG21 ' A' ' 339' ' ' VAL . 44.3 m-85 -96.59 -19.91 18.71 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.2 pttt -66.35 -18.63 65.47 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -173.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.404 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.74 -20.82 66.56 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.7 mm -87.93 -26.28 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.14 170.48 31.11 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.05 134.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 122.58 -0.365 . . . . 0.0 111.299 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.468 HG21 HD11 ' A' ' 322' ' ' ILE . 7.7 mm -76.3 138.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.438 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.7 ttmm -69.08 148.58 49.81 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 134.51 42.68 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -76.27 150.66 36.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -79.73 -18.05 52.1 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.39 -34.09 5.06 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 4.2 p -73.94 -22.0 59.83 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 70.96 17.05 75.16 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -139.4 158.47 68.67 Favored Pre-proline 0 C--O 1.232 0.154 0 CA-C-N 117.35 0.575 . . . . 0.0 109.695 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 155.03 61.98 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.518 2.145 . . . . 0.0 109.935 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.438 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 51.7 mtp -79.28 77.44 5.81 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 122.791 0.436 . . . . 0.0 110.81 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.816 HG21 HG21 ' A' ' 301' ' ' VAL . 0.5 OUTLIER -130.91 159.26 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.428 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -155.93 124.73 6.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.787 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -90.13 120.96 31.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.473 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 70.1 m-85 -73.36 162.68 29.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.518 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 39.5 p -140.79 155.78 46.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.656 0.741 . . . . 0.0 109.33 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -64.57 123.86 20.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.887 172.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.38 -6.76 45.7 Favored 'General case' 0 N--CA 1.458 -0.045 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.13 -15.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.2 t -156.24 -17.78 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 92.07 10.69 60.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.944 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -90.72 163.66 14.41 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 118.17 0.985 . . . . 0.0 110.171 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 333' ' ' LEU . 0.3 OUTLIER -54.65 120.83 7.29 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.537 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.4 ttmm -77.7 -19.43 55.3 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.708 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.457 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.0 18.86 28.12 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.7 156.08 38.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.417 0.609 . . . . 0.0 110.553 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.96 173.48 16.42 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.71 0.404 . . . . 0.0 110.288 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.0 m -139.92 128.14 22.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 122.658 0.383 . . . . 0.0 109.969 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 305' ' ' PHE . 94.6 t -118.11 127.12 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 124.024 0.93 . . . . 0.0 109.064 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.6 t -97.68 128.01 44.05 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.89 -0.506 . . . . 0.0 110.207 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -85.64 147.26 26.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -76.24 -18.2 59.13 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -124.88 133.36 24.73 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 123.704 0.802 . . . . 0.0 110.72 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.4 Cg_endo -66.24 -34.31 36.51 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.818 2.346 . . . . 0.0 114.215 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.79 -19.54 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 121.168 1.453 . . . . 0.0 111.104 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 41.9 m -75.55 -30.52 59.75 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.26 78.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.58 -0.075 . . . . 0.0 110.799 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -64.28 -38.88 92.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.553 0.216 . . . . 0.0 110.954 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.98 -39.68 83.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.372 0.269 . . . . 0.0 110.611 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.66 66.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.19 -57.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.26 -21.19 61.58 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -94.31 -60.3 1.76 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -69.85 -31.76 69.79 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -57.26 111.05 0.96 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.7 25.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.127 -0.818 . . . . 0.0 113.106 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -95.5 -171.8 2.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.674 1.237 . . . . 0.0 109.908 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.75 171.26 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.595 0.358 . . . . 0.0 110.447 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.606 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.4 t80 -127.19 -38.28 1.99 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.382 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 24.7 t -144.33 15.28 1.65 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.648 0.379 . . . . 0.0 110.098 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.64 -19.43 8.48 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -104.54 148.69 36.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.01 151.73 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.349 2.699 . . . . 0.0 110.677 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.1 pt -138.32 168.11 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 121.267 0.556 . . . . 0.0 110.66 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -133.62 155.45 49.64 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.17 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.8 t -144.35 147.04 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 122.867 0.467 . . . . 0.0 110.417 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.4 m -153.6 174.43 14.46 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -60.61 159.08 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.638 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -132.11 138.19 48.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 4.3 m -143.73 137.81 28.39 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.414 0.686 . . . . 0.0 109.893 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -43.81 109.71 0.16 Allowed 'General case' 0 C--N 1.338 0.074 0 C-N-CA 122.635 0.374 . . . . 0.0 110.977 -171.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -25.39 59.44 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.44 -30.1 70.39 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 122.441 -0.162 . . . . 0.0 110.676 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -67.22 -11.47 57.5 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.545 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 95.8 m-85 -98.92 -10.53 22.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.23 -40.97 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -81.78 1.86 32.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.262 0.483 . . . . 0.0 112.074 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 86.06 8.14 79.31 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 80.98 7.3 88.74 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 117.496 0.648 . . . . 0.0 112.035 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 83.92 165.76 39.34 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 117.497 0.649 . . . . 0.0 111.64 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.74 177.67 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 0.0 110.11 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -163.59 156.53 28.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -78.49 162.62 26.22 Favored 'General case' 0 CA--C 1.523 -0.079 0 O-C-N 122.669 -0.312 . . . . 0.0 110.262 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -71.05 151.64 49.16 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -80.1 173.94 55.0 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -65.15 150.72 47.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.749 0.42 . . . . 0.0 109.901 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -61.04 142.91 48.62 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -160.24 156.34 26.33 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.495 0.318 . . . . 0.0 110.343 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.92 40.78 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.006 -1.997 . . . . 0.0 110.911 178.86 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 C5'-C4'-C3' 111.039 -2.974 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.402 0 N19-C1'-C2' 109.633 -2.354 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 N19-C1'-C2' 109.138 -2.664 . 0.833 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.696 0 C4'-C3'-C2' 100.11 -2.59 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 0 C5'-C4'-C3' 111.41 -2.727 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 O4'-C1'-N19 111.131 2.931 . 0.932 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 111.139 2.939 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 O4'-C1'-N19 111.285 3.085 . 0.76 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 C5'-C4'-C3' 111.903 -2.398 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 0 C5'-C4'-C3' 111.271 -2.819 . 0.614 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.407 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 C5'-C4'-C3' 111.687 -2.542 . 0.596 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.407 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 110.428 -3.381 . 0.384 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 1 C5'-C4'-C3' 109.453 -4.031 . 0.277 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.3 1 O4'-C1'-N19 112.679 4.479 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.537 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.062 1 C5'-C4'-C3' 109.48 -4.013 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.638 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.423 -2.478 1 C3'-C2'-C1' 105.7 4.667 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.802 0 C5'-C4'-C3' 110.321 -3.453 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 1 C5'-C4'-C3' 109.29 -4.14 OUTLIER-DELTA 0.065 2h . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 C5'-C4'-C3' 110.087 -3.609 . 0.0 OUTLIER '7D dist 1c' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 N19-C1'-C2' 109.339 -2.538 . 0.64 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.58 0 N19-C1'-C2' 109.07 -2.706 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 C4'-C3'-C2' 100.365 -2.335 . 0.667 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 C4'-C3'-C2' 100.389 -2.311 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 110.924 2.724 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.553 0 O4'-C1'-N19 110.846 2.646 . 0.731 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.705 0 O4'-C1'-N19 110.827 2.627 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 O4'-C1'-N19 110.253 2.053 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.659 2.459 . 0.843 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -178.88 -175.66 46.09 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -70.62 176.89 3.81 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -65.73 -177.94 0.51 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.271 1.028 . . . . 0.0 110.713 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.587 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -65.13 -14.02 59.53 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -94.92 -5.65 44.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.052 0.387 . . . . 0.0 111.651 175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.05 11.74 78.15 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.321 170.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 68.03 -160.61 50.4 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 118.792 1.296 . . . . 0.0 110.82 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.54 21.8 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.871 3.048 . . . . 0.0 112.308 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 267' ' ' GLY . 63.1 ttm-85 -79.09 -33.36 44.54 Favored 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.677 -0.64 . . . . 0.0 110.377 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -110.05 9.3 24.2 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.074 0.55 . . . . 0.0 112.047 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -7.83 35.81 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 86.85 -104.57 2.95 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 86.5 p -77.21 18.32 0.4 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.66 ' H ' ' HD3' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -68.48 -3.04 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.304 0.502 . . . . 0.0 112.315 -175.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -96.97 -12.98 22.66 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.614 0.365 . . . . 0.0 111.32 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -125.25 5.35 7.78 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.7 t -154.75 158.48 39.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.62 -1.04 47.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.02 0.528 . . . . 0.0 110.248 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -87.04 -81.37 0.23 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.976 0.51 . . . . 0.0 110.125 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 48.62 15.68 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -156.7 167.7 29.66 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.249 0.477 . . . . 0.0 110.21 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 -36.11 0.08 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.285 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -93.76 8.11 42.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -127.76 47.07 2.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.188 0.595 . . . . 0.0 111.528 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -69.12 -1.79 8.64 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.228 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.8 m -99.42 147.8 24.89 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.3 pt -129.47 150.07 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 122.842 0.457 . . . . 0.0 110.115 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -105.02 149.44 25.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.0 t -134.16 148.82 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 123.219 0.607 . . . . 0.0 111.288 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -138.31 150.9 47.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.46 59.08 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 120.079 -0.289 . . . . 0.0 113.165 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.63 -55.84 28.93 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.14 0.576 . . . . 0.0 111.254 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.471 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 87.52 179.99 47.88 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.22 -11.42 59.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.74 0.816 . . . . 0.0 112.219 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.86 0.49 34.88 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.427 0.291 . . . . 0.0 111.323 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.59 155.24 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 112.666 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.4 168.16 28.14 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.7 mm -49.83 -39.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.294 1.037 . . . . 0.0 111.615 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -74.04 -28.47 61.43 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 121.254 -0.179 . . . . 0.0 111.011 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.6 t -75.44 -48.06 24.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.599 -0.148 . . . . 0.0 110.599 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.786 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -62.4 -53.58 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.43 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.89 -37.59 76.94 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.264 0.483 . . . . 0.0 110.898 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -76.41 -15.09 60.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.45 0.3 . . . . 0.0 111.219 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -95.09 -27.22 15.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -96.44 -20.32 18.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.9 pttt -65.56 -18.74 65.55 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.4 pt20 -64.56 -21.55 66.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.3 mm -88.32 -24.12 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.765 0.316 . . . . 0.0 110.28 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.27 169.42 27.8 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.85 135.76 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.516 0.327 . . . . 0.0 111.186 -172.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 322' ' ' ILE . 7.4 mm -77.03 137.27 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.417 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 36.9 ttmt -70.86 149.92 46.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.623 0.249 . . . . 0.0 110.485 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.2 m -127.22 135.4 50.59 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -73.15 158.53 35.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -86.16 -4.66 59.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -146.27 -5.29 0.59 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.0 p -86.06 -20.82 28.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.805 0.729 . . . . 0.0 112.87 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.94 16.7 78.29 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.21 159.73 48.16 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 117.367 0.583 . . . . 0.0 109.732 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.55 155.49 47.38 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.312 2.008 . . . . 0.0 109.51 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.417 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 36.9 mtp -77.16 77.64 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.614 0.366 . . . . 0.0 111.118 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.786 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -135.63 158.3 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.724 -178.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -156.69 131.7 9.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.5 mm? -92.28 122.12 34.44 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -84.37 158.89 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 29.1 p -134.79 151.96 51.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.471 0.653 . . . . 0.0 112.603 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.66 134.52 56.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.954 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -8.92 58.19 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.676 0.39 . . . . 0.0 111.374 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.24 -4.3 25.93 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.282 0.633 . . . . 0.0 112.572 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.0 t -150.85 -22.38 0.22 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.706 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.28 24.84 50.22 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.709 -0.495 . . . . 0.0 112.508 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -132.22 170.53 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.784 0.792 . . . . 0.0 110.266 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 333' ' ' LEU . 0.2 OUTLIER -45.43 121.35 2.94 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.77 0.828 . . . . 0.0 111.356 -173.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.526 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -81.17 -19.7 42.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.987 0.915 . . . . 0.0 109.418 174.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.66 -0.88 59.69 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.55 150.31 21.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.344 0.572 . . . . 0.0 110.927 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.59 165.75 33.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.12 0.568 . . . . 0.0 109.606 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.0 m -136.4 122.74 20.61 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.02 125.65 73.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.8 t -98.06 129.48 44.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.557 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -87.24 147.74 25.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.02 -18.66 60.3 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -126.37 131.91 24.12 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 110.539 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 34.8 Cg_endo -67.71 -32.16 30.88 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.737 2.292 . . . . 0.0 114.347 -175.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -75.29 -19.65 17.06 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 121.411 1.54 . . . . 0.0 110.833 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.6 m -76.39 -29.76 57.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.647 0.203 . . . . 0.0 110.556 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.73 -48.94 72.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -63.64 -38.81 92.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.484 0.183 . . . . 0.0 110.864 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.88 81.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.296 0.239 . . . . 0.0 110.894 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.43 -26.22 65.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.25 -56.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.77 -21.24 62.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -93.83 -59.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.72 -32.56 71.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -56.59 112.27 1.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.19 -16.0 30.18 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.008 -0.884 . . . . 0.0 113.114 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -95.01 -172.63 2.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.75 1.275 . . . . 0.0 109.813 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.26 174.37 6.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.882 0.372 . . . . 0.0 110.47 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.614 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.5 t80 -129.95 -38.64 1.44 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.162 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.9 t -143.3 13.46 1.8 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.07 0.462 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 121.61 -22.37 7.79 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.97 147.97 33.82 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.37 151.6 76.01 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.256 2.637 . . . . 0.0 110.522 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.614 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.61 168.83 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.001 0.52 . . . . 0.0 110.911 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -133.89 156.73 47.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.6 t -144.78 146.65 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 123.703 0.627 . . . . 0.0 109.983 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 68.5 m -155.36 175.13 14.26 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.0 108.858 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -59.14 160.35 6.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -128.58 137.58 51.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 14.2 m -140.74 135.69 31.79 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.734 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -48.03 118.16 2.24 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 123.247 0.342 . . . . 0.0 110.217 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.41 72.13 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.41 73.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.306 0.242 . . . . 0.0 111.136 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -66.66 -10.68 48.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.587 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.9 m-85 -102.4 -11.49 18.58 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.95 -40.84 0.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -81.3 -1.78 46.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.193 0.451 . . . . 0.0 112.012 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 86.15 14.94 65.67 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.74 -173.27 55.09 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -78.48 149.39 33.57 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -151.54 167.32 28.43 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.717 0.807 . . . . 0.0 110.248 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -172.46 170.53 43.58 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -76.75 168.45 20.07 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.918 0.487 . . . . 0.0 111.112 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -73.71 178.31 42.83 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -73.51 166.39 54.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -156.0 155.04 32.03 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.265 0.626 . . . . 0.0 109.428 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -68.78 159.33 52.53 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -60.84 125.94 25.56 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.648 0.779 . . . . 0.0 110.135 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.7 45.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 117.176 -1.902 . . . . 0.0 110.952 -178.073 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 C5'-C4'-C3' 110.812 -3.126 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 N19-C1'-C2' 109.249 -2.594 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 N19-C1'-C2' 109.336 -2.54 . 0.856 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 N19-C1'-C2' 109.177 -2.64 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 O4'-C1'-N19 111.044 2.844 . 0.84 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 O4'-C1'-N19 110.916 2.716 . 0.91 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.766 0 O4'-C1'-N19 111.026 2.826 . 0.783 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 O4'-C1'-N19 110.512 2.312 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.04 0 C5'-C4'-C3' 111.692 -2.539 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 110.908 -3.061 . 0.562 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.423 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.56 0 C5'-C4'-C3' 111.273 -2.818 . 0.435 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.423 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 C5'-C4'-C3' 110.369 -3.42 . 0.383 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C5'-C4'-C3' 109.642 -3.906 . 0.29 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.116 1 O4'-C1'-N19 112.763 4.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.526 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.855 -3.763 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.999 1 C3'-C2'-C1' 105.549 4.498 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 C5'-C4'-C3' 109.847 -3.769 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.328 0 C5'-C4'-C3' 110.47 -3.354 . 0.584 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.379 0 N19-C1'-C2' 109.631 -2.356 . 0.507 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 N19-C1'-C2' 109.183 -2.636 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.647 0 N19-C1'-C2' 109.178 -2.639 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 C4'-C3'-C2' 100.257 -2.443 . 0.706 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.528 0 C5'-C4'-C3' 112.061 -2.293 . 0.8 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 O4'-C1'-N19 110.698 2.498 . 0.766 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 110.752 2.552 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 O4'-C1'-N19 110.869 2.669 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 O4'-C1'-N19 110.374 2.174 . 0.834 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 110.644 2.444 . 0.843 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.46 -178.6 48.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.89 -53.51 53.07 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -157.49 -178.53 7.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.971 0.908 . . . . 0.0 108.652 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.581 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.6 -8.68 36.37 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.341 -0.224 . . . . 0.0 111.589 176.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -106.56 -4.31 19.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.428 0.156 . . . . 0.0 110.776 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 86.38 0.63 86.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.219 -0.767 . . . . 0.0 114.825 169.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 65.77 -163.67 40.11 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-N 119.332 1.566 . . . . 0.0 110.507 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.55 23.51 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.018 3.145 . . . . 0.0 112.388 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -75.07 -26.89 59.7 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.856 -0.528 . . . . 0.0 111.03 -173.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -137.45 21.53 2.94 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.018 0.527 . . . . 0.0 111.331 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -7.86 7.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.273 0.629 . . . . 0.0 112.51 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 93.44 -112.56 4.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 14.9 t -75.8 17.48 0.31 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.472 0.709 . . . . 0.0 112.815 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.33 -5.33 18.16 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 121.65 -0.656 . . . . 0.0 112.259 -176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -86.25 -6.93 58.87 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.441 0.296 . . . . 0.0 111.144 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -150.72 25.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 46.2 t -152.44 148.5 27.51 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -91.13 4.86 51.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.074 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -102.59 -88.98 0.39 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.695 0.398 . . . . 0.0 110.512 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.8 p30 48.68 16.61 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.412 1.485 . . . . 0.0 114.639 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.39 160.7 43.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.6 t -157.09 -34.28 0.08 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.296 0.094 . . . . 0.0 110.949 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.33 5.27 35.46 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -124.08 154.94 39.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.681 0.792 . . . . 0.0 109.699 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -158.97 15.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.647 0.379 . . . . 0.0 110.548 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.7 m -131.51 151.14 51.83 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.577 0.351 . . . . 0.0 111.223 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.7 pt -126.6 148.82 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.063 0.545 . . . . 0.0 110.429 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -100.78 150.11 23.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.36 149.4 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.383 0.673 . . . . 0.0 111.042 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -139.75 150.22 44.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.97 58.28 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.954 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.4 ' HB3' HG21 ' A' ' 296' ' ' VAL . 5.0 mp -55.63 -54.07 48.69 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.504 0.652 . . . . 0.0 111.678 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.51 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.59 -176.26 44.54 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -171.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -85.67 -7.23 58.93 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.551 0.741 . . . . 0.0 112.537 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -79.29 -2.69 42.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.431 -0.168 . . . . 0.0 111.056 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 292' ' ' LEU . 1.6 t -97.74 158.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.769 0.828 . . . . 0.0 112.695 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.64 167.59 29.15 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.8 mm -50.32 -39.73 17.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 124.344 1.057 . . . . 0.0 111.724 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.03 -29.07 63.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.248 -0.282 . . . . 0.0 111.094 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.6 -50.51 17.61 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 122.316 0.247 . . . . 0.0 110.479 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.805 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -60.86 -53.92 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.437 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.06 -37.46 77.1 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 0.519 . . . . 0.0 110.921 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -75.9 -17.38 59.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 111.014 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -92.92 -26.77 17.44 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.4 m-85 -98.02 -20.08 17.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.5 pttt -66.11 -18.79 65.57 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.406 0.283 . . . . 0.0 111.649 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -64.41 -20.38 66.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -88.97 -26.06 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.759 0.254 . . . . 0.0 110.456 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.18 170.37 31.0 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.62 134.36 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 111.254 -172.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 322' ' ' ILE . 8.3 mm -74.5 138.77 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.75 151.61 46.94 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.3 m -134.04 135.92 43.67 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -74.7 160.28 30.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -92.41 -0.27 57.38 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -147.13 -5.18 0.52 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.3 p -88.05 -21.6 24.66 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 74.44 16.29 80.03 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -143.28 160.35 52.17 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 117.388 0.594 . . . . 0.0 109.706 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.21 155.69 55.04 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.34 2.027 . . . . 0.0 109.812 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.9 mtp -77.62 75.93 4.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.044 0.538 . . . . 0.0 110.813 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.805 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.19 155.6 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.939 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -153.19 130.71 11.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.135 0.974 . . . . 0.0 109.017 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -93.73 118.33 31.27 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -82.1 157.32 24.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 31.5 p -130.25 156.87 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -72.48 127.87 33.86 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.35 172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -73.32 -5.06 37.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.066 0.547 . . . . 0.0 111.284 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.51 -5.95 23.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.7 t -151.0 -23.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.23 0.468 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.78 50.1 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.984 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -127.85 171.13 12.05 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.883 0.841 . . . . 0.0 109.781 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 293' ' ' GLY . 4.8 mt -49.87 126.8 14.9 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.182 0.515 . . . . 0.0 110.991 -172.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.558 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.6 ttmm -76.69 -13.63 60.03 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.056 0.942 . . . . 0.0 109.577 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.84 -5.22 66.37 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -87.94 147.44 25.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.006 0.403 . . . . 0.0 111.072 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.05 165.81 34.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.0 m -137.28 122.13 18.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 122.277 0.231 . . . . 0.0 111.046 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 305' ' ' PHE . 95.5 t -115.64 120.7 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 29.9 t -91.78 136.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.903 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -95.11 145.78 24.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.12 -15.2 61.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.419 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 88.2 m-20 -129.38 135.18 27.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.686 0.794 . . . . 0.0 111.433 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 22.8 Cg_endo -66.74 -33.77 33.59 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.837 2.358 . . . . 0.0 114.414 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.3 Cg_endo -76.91 -18.32 14.86 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.517 1.478 . . . . 0.0 111.307 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.7 m -76.33 -29.88 57.45 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.66 85.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.403 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.5 tptm -64.13 -40.86 97.08 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.457 0.17 . . . . 0.0 110.827 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.12 85.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.48 0.312 . . . . 0.0 110.68 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.77 -25.2 64.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 348' ' ' LYS . 63.7 mt -72.95 -57.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.41 -20.59 60.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -95.23 -60.53 1.65 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -69.69 -32.16 70.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.93 113.14 1.74 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.28 -15.82 32.66 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.192 -0.782 . . . . 0.0 112.893 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -95.04 -172.56 2.72 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.709 1.255 . . . . 0.0 109.838 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -101.18 173.7 6.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.612 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.9 t80 -128.06 -39.08 1.77 Allowed 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.9 t -143.07 8.49 1.65 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.729 0.412 . . . . 0.0 110.117 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.48 -20.62 5.21 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -102.86 149.3 36.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.24 150.55 76.71 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.359 2.706 . . . . 0.0 110.595 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -136.33 168.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-O 121.068 0.461 . . . . 0.0 110.763 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -131.79 156.87 45.24 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 54.4 t -145.71 146.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 110.396 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.4 m -154.53 172.71 17.36 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.06 162.91 6.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.216 -0.302 . . . . 0.0 111.771 170.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.425 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -137.16 144.8 43.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.81 0.338 . . . . 0.0 111.054 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 26.4 m -146.08 140.45 26.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.085 0.954 . . . . 0.0 109.359 175.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -47.36 120.2 3.08 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.605 0.362 . . . . 0.0 110.532 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -32.95 73.91 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.043 0.537 . . . . 0.0 109.663 -175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.01 -32.01 73.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.142 0.177 . . . . 0.0 111.073 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.09 -9.29 21.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.502 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.3 m-85 -105.93 -13.08 15.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.98 -41.41 0.09 Allowed 'General case' 0 C--N 1.341 0.196 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -79.74 -1.76 40.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.169 0.441 . . . . 0.0 111.934 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.67 75.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.25 -174.9 54.63 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -73.22 166.58 54.54 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -157.46 172.31 18.79 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 169.14 -172.53 43.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -146.29 161.63 39.88 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.565 0.746 . . . . 0.0 110.057 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 178.05 163.12 29.12 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -176.24 160.99 29.11 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -155.5 167.6 29.85 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 122.904 0.482 . . . . 0.0 110.159 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -77.82 157.08 45.01 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -69.99 134.09 47.94 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.83 0.452 . . . . 0.0 110.313 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -103.88 -10.6 34.54 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.115 -1.936 . . . . 0.0 110.807 179.776 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 C5'-C4'-C3' 110.645 -3.237 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.711 0 N19-C1'-C2' 109.429 -2.482 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 C4'-C3'-C2' 100.037 -2.663 . 0.83 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.608 0 N19-C1'-C2' 109.202 -2.624 . 0.833 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 C5'-C4'-C3' 111.437 -2.708 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 O4'-C1'-N19 111.147 2.947 . 0.894 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 O4'-C1'-N19 110.865 2.665 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.527 0 O4'-C1'-N19 111.324 3.124 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.854 0 O4'-C1'-N19 111.057 2.857 . 0.426 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 C5'-C4'-C3' 111.507 -2.662 . 0.663 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.655 0 C5'-C4'-C3' 111.358 -2.761 . 0.494 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.371 0 C5'-C4'-C3' 110.759 -3.161 . 0.394 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.772 1 C5'-C4'-C3' 109.083 -4.278 . 0.267 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.104 1 O4'-C1'-N19 112.621 4.421 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.558 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 C5'-C4'-C3' 109.731 -3.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.425 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.866 1 C3'-C2'-C1' 105.86 4.844 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.599 0 C5'-C4'-C3' 110.105 -3.597 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.379 0 C5'-C4'-C3' 110.225 -3.516 . 0.532 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 N19-C1'-C2' 109.162 -2.649 . 0.496 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 N19-C1'-C2' 109.528 -2.42 . 0.711 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 109.76 -2.275 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.255 0 N19-C1'-C2' 109.462 -2.461 . 0.722 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.487 -2.213 . 0.813 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 O4'-C1'-N19 110.916 2.716 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.748 2.548 . 0.677 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 O4'-C1'-N19 110.915 2.715 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 O4'-C1'-N19 110.578 2.378 . 0.813 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.841 0 O4'-C1'-N19 110.701 2.501 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.36 170.09 53.72 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -143.74 176.96 8.85 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.435 ' ND2' ' H22' ' B' ' 106' ' ' ' G' . 10.1 m-80 -68.74 -173.92 0.52 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.692 0.797 . . . . 0.0 110.598 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.643 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.628 0.371 . . . . 0.0 111.789 -176.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -95.19 -4.77 45.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.903 0.319 . . . . 0.0 110.609 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.08 9.44 85.21 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.185 -0.786 . . . . 0.0 115.05 169.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 66.67 -161.57 46.11 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 119.408 1.604 . . . . 0.0 111.053 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.24 19.6 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.382 2.721 . . . . 0.0 112.61 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 267' ' ' GLY . 50.6 ttp180 -74.77 -41.6 59.73 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.89 -0.507 . . . . 0.0 110.355 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -105.73 11.61 31.9 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.122 0.569 . . . . 0.0 111.085 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -7.7 34.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 84.0 -112.74 3.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 74.8 m -74.17 18.98 0.13 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -3.35 12.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.799 0.727 . . . . 0.0 111.929 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -89.42 -15.12 33.93 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.854 0.297 . . . . 0.0 110.824 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -123.82 8.76 8.79 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 92.4 p -156.77 167.38 30.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.39 15.25 17.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.242 173.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -92.1 -83.2 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.1 p30 48.7 15.5 0.09 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -155.67 169.22 24.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 110.035 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.6 t -155.64 -34.31 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.458 0.303 . . . . 0.0 110.187 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -97.86 9.27 43.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.94 0.496 . . . . 0.0 112.268 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -126.72 48.28 2.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.168 0.587 . . . . 0.0 111.463 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -70.73 -0.39 8.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.829 0.452 . . . . 0.0 111.366 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.1 m -100.53 148.68 24.52 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.43 150.2 34.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.835 0.454 . . . . 0.0 109.945 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -106.26 148.85 27.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 t -133.73 148.28 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.105 0.562 . . . . 0.0 111.194 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -138.69 150.63 46.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.74 5.1 58.84 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.834 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.1 -57.22 12.61 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.322 0.649 . . . . 0.0 111.135 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.472 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.89 179.64 44.47 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.13 -10.64 59.53 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.907 0.883 . . . . 0.0 112.365 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.98 -0.85 45.97 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 111.556 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.03 155.78 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.16 168.24 27.61 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.0 mm -49.43 -40.18 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.362 1.065 . . . . 0.0 111.691 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -73.05 -28.42 62.32 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.859 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -76.15 -48.89 18.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.379 0.272 . . . . 0.0 110.634 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.808 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.58 -53.68 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.439 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.01 -37.93 78.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.798 -0.563 . . . . 0.0 110.602 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.96 -15.84 60.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.721 0.237 . . . . 0.0 111.087 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.51 -26.78 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.4 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.9 m-85 -97.3 -20.19 18.03 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.9 pttt -66.16 -18.64 65.48 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.418 0.287 . . . . 0.0 111.697 -173.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 7.1 pt20 -65.21 -20.41 66.42 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.1 mm -88.62 -25.05 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 120.976 0.417 . . . . 0.0 110.156 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.64 169.08 27.74 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.06 136.34 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.713 -0.286 . . . . 0.0 111.256 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 322' ' ' ILE . 7.1 mm -77.54 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.456 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 37.0 ttmt -69.55 136.53 51.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m -97.76 138.63 34.84 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.9 139.55 53.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.62 -4.42 51.54 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -133.26 -35.46 1.03 Allowed 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.244 0.475 . . . . 0.0 111.848 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -90.5 -16.36 29.03 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 77.49 -19.57 3.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.328 0.489 . . . . 0.0 113.167 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.45 163.02 56.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 117.883 0.841 . . . . 0.0 109.429 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.71 152.23 75.43 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.895 1.73 . . . . 0.0 108.833 171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.456 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 57.9 mtp -77.74 79.07 4.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 111.216 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.808 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.07 155.09 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.619 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.94 129.16 11.93 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -91.75 120.87 32.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.409 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 97.0 m-85 -85.23 159.48 20.08 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 40.4 p -132.83 157.19 45.65 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.492 0.663 . . . . 0.0 112.53 -171.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -68.46 133.23 48.31 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.416 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -77.5 -9.11 58.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.625 0.37 . . . . 0.0 110.913 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -98.52 -6.15 30.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.7 t -150.55 -22.11 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.088 0.403 . . . . 0.0 111.008 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.56 22.78 52.84 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.683 -0.509 . . . . 0.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -130.27 172.97 11.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 117.931 0.865 . . . . 0.0 110.334 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -45.76 123.37 4.34 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 123.769 0.828 . . . . 0.0 111.629 -173.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.615 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -83.77 -19.53 34.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.737 173.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.472 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.04 0.63 59.96 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -90.56 150.29 21.81 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 117.425 0.612 . . . . 0.0 110.903 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.43 165.87 32.23 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.073 0.549 . . . . 0.0 109.58 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.8 m -136.78 122.64 20.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 305' ' ' PHE . 92.5 t -115.63 124.83 72.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -174.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.4 t -96.21 128.15 42.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.234 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.53 148.31 25.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -74.33 -21.42 59.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -124.11 131.49 24.22 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.496 0.718 . . . . 0.0 110.91 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.8 Cg_endo -65.98 -33.09 43.11 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.768 2.312 . . . . 0.0 114.161 -175.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.5 Cg_endo -75.74 -19.22 16.54 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.189 1.46 . . . . 0.0 111.142 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.2 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.787 0.267 . . . . 0.0 110.385 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.6 79.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.398 0.142 . . . . 0.0 110.672 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -63.41 -39.97 95.94 Favored 'General case' 0 C--O 1.23 0.052 0 C-N-CA 122.35 0.26 . . . . 0.0 110.756 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.1 81.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.984 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.72 -26.35 66.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -72.15 -57.72 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -60.92 -21.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -92.38 -59.74 2.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -70.02 -31.92 69.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -56.78 112.36 1.28 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.19 31.25 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.061 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.7 -172.35 2.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.705 1.253 . . . . 0.0 109.941 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.21 175.03 5.72 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 122.454 0.302 . . . . 0.0 110.535 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.593 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.8 t80 -130.72 -38.76 1.28 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 21.2 t -143.04 20.31 1.94 Allowed 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 122.585 0.354 . . . . 0.0 110.345 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.36 -2.22 31.04 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -121.81 146.5 46.05 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 123.996 0.918 . . . . 0.0 109.473 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.85 149.73 72.84 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.48 2.787 . . . . 0.0 110.779 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.593 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.62 169.4 18.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.087 0.555 . . . . 0.0 110.697 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -134.67 156.37 48.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.828 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -144.21 147.34 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.119 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 70.8 m -154.04 174.64 14.42 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -58.27 160.65 4.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.414 ' HB1' " H1'" ' B' ' 106' ' ' ' G' . . . -130.93 138.16 49.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.6 m -141.12 137.04 32.5 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.309 0.643 . . . . 0.0 110.71 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 43.3 mtp85 -42.51 113.32 0.44 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.409 0.684 . . . . 0.0 110.509 -173.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -33.86 73.5 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.02 71.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.996 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.38 -11.65 44.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.48 -8.61 19.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.7 -40.0 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -84.09 3.35 35.15 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 80.69 9.09 86.8 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.64 0.54 89.94 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.788 -0.451 . . . . 0.0 112.304 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 77.96 163.45 21.47 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -150.49 172.75 14.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.717 0.807 . . . . 0.0 110.091 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -171.08 166.04 39.19 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -157.15 164.48 37.78 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.787 0.435 . . . . 0.0 110.194 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 156.57 -9.12 0.26 Allowed Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -66.1 160.37 45.77 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -157.68 169.44 24.64 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.957 0.503 . . . . 0.0 110.068 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -70.83 153.15 51.14 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -144.49 163.5 33.67 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.08 0.552 . . . . 0.0 110.38 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 179.03 179.49 48.72 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 117.207 -1.885 . . . . 0.0 111.039 -179.612 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 111.024 -2.984 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 N19-C1'-C2' 109.288 -2.57 . 0.806 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 N19-C1'-C2' 109.098 -2.689 . 0.871 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 C4'-C3'-C2' 100.312 -2.388 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 O4'-C1'-N19 110.859 2.659 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.957 2.757 . 0.893 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 111.019 2.819 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 111.28 3.08 . 0.719 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.991 0 O4'-C1'-N19 110.691 2.491 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 C5'-C4'-C3' 111.427 -2.715 . 0.692 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.479 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.931 0 C5'-C4'-C3' 111.428 -2.714 . 0.59 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.479 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 C5'-C4'-C3' 110.631 -3.246 . 0.483 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 1 C5'-C4'-C3' 109.297 -4.135 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.128 1 O4'-C1'-N19 113.683 5.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.615 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.84 0 C5'-C4'-C3' 111.063 -2.958 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.435 ' H22' ' ND2' ' A' ' 263' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.778 1 C3'-C2'-C1' 105.348 4.275 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.506 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 C5'-C4'-C3' 109.663 -3.891 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . 0.506 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 P--O5' 1.619 2.637 0 C4'-C3'-C2' 100.257 -2.443 . 0.079 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 N19-C1'-C2' 108.784 -2.885 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 N19-C1'-C2' 108.924 -2.797 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.908 0 N19-C1'-C2' 109.098 -2.689 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.528 0 N19-C1'-C2' 109.655 -2.34 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 110.11 -2.056 . 0.771 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 O4'-C1'-N19 110.716 2.516 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 110.75 2.55 . 0.717 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.625 0 O4'-C1'-N19 110.785 2.585 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.498 2.298 . 0.836 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 O4'-C1'-N19 110.585 2.385 . 0.825 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.125 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.68 87.09 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -144.24 -179.88 6.8 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.415 ' CG ' ' H22' ' B' ' 106' ' ' ' G' . 38.8 m-80 -66.17 -178.44 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.778 0.831 . . . . 0.0 111.267 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.655 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -65.25 -14.09 59.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.78 0.432 . . . . 0.0 111.933 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -95.8 -3.92 44.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.972 0.351 . . . . 0.0 111.746 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.15 77.27 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.35 -0.695 . . . . 0.0 113.913 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 66.6 -156.33 51.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 118.696 1.248 . . . . 0.0 110.883 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.91 18.74 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.612 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -74.98 -38.84 61.56 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.728 -0.608 . . . . 0.0 110.725 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -105.56 10.17 33.17 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.866 0.467 . . . . 0.0 111.128 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.64 -10.18 54.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 83.93 -105.95 2.81 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 85.9 p -74.01 13.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -0.48 7.39 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -93.71 -16.05 24.63 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.873 0.306 . . . . 0.0 111.144 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -126.59 7.45 6.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 48.4 t -152.21 154.06 35.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.681 0.393 . . . . 0.0 110.25 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.67 -1.0 55.82 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.092 0.557 . . . . 0.0 110.581 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -87.65 -82.01 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.161 0.584 . . . . 0.0 110.082 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 48.8 16.36 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -155.1 168.02 28.43 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.989 -0.445 . . . . 0.0 109.835 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.0 p -153.14 -32.79 0.12 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.551 0.34 . . . . 0.0 110.6 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -107.32 16.21 24.19 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.548 0.739 . . . . 0.0 112.198 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.75 48.87 2.37 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.119 0.568 . . . . 0.0 111.615 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -71.56 3.19 4.14 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.517 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.0 m -104.76 148.78 26.23 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.38 147.6 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.642 0.377 . . . . 0.0 110.441 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -102.73 149.01 24.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.9 t -134.12 148.24 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.298 0.639 . . . . 0.0 111.636 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -138.59 150.06 45.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.31 5.11 58.19 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.762 -0.466 . . . . 0.0 112.299 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -54.83 -56.06 23.49 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 117.541 0.67 . . . . 0.0 111.009 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.461 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.71 179.45 46.21 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -80.18 -7.22 58.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.738 0.815 . . . . 0.0 112.124 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -81.8 -1.6 47.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.374 0.27 . . . . 0.0 111.32 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.54 156.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -158.48 168.03 28.04 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.6 mm -48.57 -40.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.223 1.009 . . . . 0.0 111.762 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.4 -28.49 62.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.28 -0.263 . . . . 0.0 111.102 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.0 t -75.85 -48.84 19.86 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.823 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.59 -53.64 45.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.436 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.6 -37.6 78.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.296 0.498 . . . . 0.0 110.783 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -75.81 -15.39 60.25 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -95.15 -26.78 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.404 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.2 m-85 -97.46 -20.62 17.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.5 pttt -65.13 -19.43 65.98 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -63.97 -21.49 66.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.2 mm -87.07 -27.19 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.8 170.6 31.89 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.7 mm -68.02 135.07 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.768 0.318 . . . . 0.0 111.047 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 322' ' ' ILE . 7.5 mm -76.42 136.97 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.423 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.1 ttmm -68.4 135.84 52.37 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.692 0.282 . . . . 0.0 110.628 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.7 m -94.1 139.88 30.43 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -66.95 149.95 49.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -70.84 -20.0 62.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -142.71 -19.59 0.67 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.5 p -86.87 -15.58 38.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.85 0.75 . . . . 0.0 112.88 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.77 -17.88 3.35 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.351 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -81.54 160.97 63.3 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 117.867 0.833 . . . . 0.0 109.812 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.98 151.96 82.97 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.089 1.86 . . . . 0.0 109.13 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.423 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 48.6 mtp -79.74 80.15 6.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.47 0.308 . . . . 0.0 111.235 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.823 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -132.14 154.98 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.3 0.64 . . . . 0.0 110.498 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.0 120.6 7.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.269 0.628 . . . . 0.0 109.693 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -88.59 122.14 31.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.513 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 77.1 m-85 -80.27 164.43 23.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 70.0 p -137.13 155.73 49.24 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.246 0.546 . . . . 0.0 111.415 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -69.27 130.13 41.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.28 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -75.02 -6.94 52.1 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 122.66 0.384 . . . . 0.0 111.162 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.38 -7.11 26.65 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 4.9 t -150.04 -21.23 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.211 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.04 17.38 61.3 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.569 -0.573 . . . . 0.0 112.552 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -122.39 172.73 8.12 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 117.878 0.839 . . . . 0.0 110.353 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 333' ' ' LEU . 0.3 OUTLIER -45.67 123.81 4.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.884 0.874 . . . . 0.0 111.298 -175.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.6 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.5 ttmm -79.56 -17.99 52.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.648 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.461 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 93.48 15.51 50.11 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.57 154.09 34.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.403 0.601 . . . . 0.0 110.164 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.65 170.35 22.36 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.609 0.363 . . . . 0.0 110.287 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 32.3 m -134.51 127.56 31.63 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.865 0.466 . . . . 0.0 110.583 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.404 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.2 t -117.43 127.49 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 36.2 t -98.76 128.63 45.06 Favored 'General case' 0 C--N 1.337 0.05 0 O-C-N 121.962 -0.461 . . . . 0.0 110.324 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -86.65 147.64 25.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.61 -16.61 59.53 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -125.49 131.77 24.13 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 110.594 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.455 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.5 Cg_endo -66.46 -32.89 39.12 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.006 2.471 . . . . 0.0 114.446 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 87.6 Cg_endo -76.9 -19.49 13.98 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 CA-C-N 121.208 1.467 . . . . 0.0 110.81 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -29.31 58.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.75 80.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -64.68 -38.45 91.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.462 -0.149 . . . . 0.0 110.635 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.89 -40.26 83.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.583 0.353 . . . . 0.0 110.943 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.6 -25.96 66.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 66.7 mt -72.62 -56.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.6 -20.87 61.81 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -94.51 -60.21 1.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.27 -32.47 71.68 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -56.91 110.42 0.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 112.16 -14.73 25.83 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.042 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -96.36 -171.01 2.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.872 1.336 . . . . 0.0 110.249 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.04 174.39 5.89 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 110.307 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.618 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.5 t80 -130.39 -39.32 1.32 Allowed 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 109.941 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.39 -18.77 10.95 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.75 148.14 35.1 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.85 151.08 74.16 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.43 2.753 . . . . 0.0 110.508 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.618 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.02 168.64 21.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -134.35 155.69 49.81 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.803 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.95 146.76 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.047 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 m -154.4 174.64 14.58 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.754 0.822 . . . . 0.0 108.789 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -60.36 155.65 17.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.598 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -123.91 137.7 54.59 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 8.9 m -142.93 136.47 28.61 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.519 0.727 . . . . 0.0 110.28 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -45.27 112.16 0.41 Allowed 'General case' 0 C--N 1.34 0.155 0 C-N-CA 122.979 0.511 . . . . 0.0 110.404 -170.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -29.5 66.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.856 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.83 -34.16 75.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 122.378 -0.201 . . . . 0.0 111.07 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -67.56 -6.77 21.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.473 0.309 . . . . 0.0 110.369 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.649 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 95.9 m-85 -108.41 -9.36 15.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -151.96 -41.81 0.11 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -81.32 -1.83 46.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.79 2.79 89.7 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 69.89 19.57 75.35 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -66.1 173.9 22.53 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.233 0.517 . . . . 0.0 111.898 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -141.97 153.17 44.11 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.867 0.467 . . . . 0.0 110.416 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -101.49 158.39 18.72 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -162.77 167.26 23.19 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.705 0.402 . . . . 0.0 110.586 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -178.34 20.2 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.587 -0.563 . . . . 0.0 112.569 176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.48 178.69 34.67 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 117.802 0.801 . . . . 0.0 111.766 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -60.85 156.81 16.43 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.739 0.415 . . . . 0.0 111.284 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -94.26 -178.91 38.54 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -60.88 142.55 56.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.577 0.351 . . . . 0.0 110.347 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 165.7 173.98 34.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 CA-C-O 117.301 -1.833 . . . . 0.0 110.503 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 C5'-C4'-C3' 110.637 -3.242 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 109.231 -2.606 . 0.82 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 C4'-C3'-C2' 99.829 -2.871 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 C4'-C3'-C2' 100.276 -2.424 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 C5'-C4'-C3' 111.494 -2.671 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 O4'-C1'-N19 110.882 2.682 . 0.883 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 O4'-C1'-N19 110.825 2.625 . 0.815 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 O4'-C1'-N19 111.167 2.967 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 O4'-C1'-N19 110.793 2.593 . 0.639 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.003 0 C5'-C4'-C3' 110.972 -3.019 . 0.67 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.45 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.051 0 C5'-C4'-C3' 111.385 -2.743 . 0.811 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.45 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 C5'-C4'-C3' 110.88 -3.08 . 0.466 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 C5'-C4'-C3' 109.553 -3.965 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.138 1 O4'-C1'-N19 112.735 4.535 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.6 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.833 0 C5'-C4'-C3' 109.565 -3.956 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.598 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.749 1 C3'-C2'-C1' 105.625 4.583 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.56 " H3'" H5'' ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 109.687 -3.876 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . 0.56 H5'' " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.044 0 C4'-C3'-C2' 100.021 -2.679 . 0.079 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.546 0 C5'-C4'-C3' 111.067 -2.955 . 0.656 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 N19-C1'-C2' 109.607 -2.371 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.479 -2.45 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.466 -2.458 . 0.787 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C5'-C4'-C3' 112.257 -2.162 . 0.79 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.818 2.618 . 0.784 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 110.738 2.538 . 0.722 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 O4'-C1'-N19 110.879 2.679 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 O4'-C1'-N19 110.819 2.619 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.749 0 O4'-C1'-N19 110.638 2.438 . 0.847 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 74.95 -171.18 53.96 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -71.12 178.67 3.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -65.42 -178.7 0.54 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.105 0.962 . . . . 0.0 110.886 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.569 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -66.46 -14.61 62.45 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -93.81 -3.26 52.33 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.915 0.325 . . . . 0.0 110.91 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.36 77.33 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.194 -0.781 . . . . 0.0 114.293 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 67.71 -160.25 50.03 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.059 1.429 . . . . 0.0 110.829 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.523 ' HA ' HE21 ' A' ' 271' ' ' GLN . 58.5 Cg_endo -71.95 36.25 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.863 3.042 . . . . 0.0 111.876 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -88.34 -42.51 12.16 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.174 -0.329 . . . . 0.0 110.401 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -109.1 16.21 22.71 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.233 0.613 . . . . 0.0 110.332 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.523 HE21 ' HA ' ' A' ' 268' ' ' PRO . 4.3 tp-100 -67.61 -22.28 65.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.856 0.462 . . . . 0.0 111.386 -173.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 112.66 -129.6 9.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 9.1 t -79.46 20.88 0.52 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.439 0.696 . . . . 0.0 112.106 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -7.38 3.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.066 0.547 . . . . 0.0 112.382 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -83.07 -6.53 59.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.28 21.46 0.95 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 37.4 t -155.33 144.87 21.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.915 -0.491 . . . . 0.0 110.421 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -84.97 5.71 28.1 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.132 0.573 . . . . 0.0 110.256 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -103.13 -112.03 0.23 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . 0.256 8.7 m-20 52.67 17.78 0.88 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -148.12 162.27 39.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.9 p -155.52 -37.3 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -97.02 15.88 21.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.232 0.613 . . . . 0.0 112.28 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.83 41.89 3.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.464 0.706 . . . . 0.0 111.374 -176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -67.38 -4.8 12.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.866 0.466 . . . . 0.0 111.142 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.5 m -95.99 146.61 24.48 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.6 pt -128.63 150.3 34.18 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 C-N-CA 122.729 0.411 . . . . 0.0 109.917 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -105.03 148.99 26.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.9 t -133.2 146.62 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 123.05 0.54 . . . . 0.0 111.376 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -137.33 148.54 46.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.71 57.3 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.974 -0.348 . . . . 0.0 112.597 173.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.0 mp -55.05 -56.88 14.81 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 123.363 0.665 . . . . 0.0 111.263 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 89.82 179.9 44.49 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.81 -10.0 59.32 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.671 0.789 . . . . 0.0 112.33 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -81.79 -2.29 50.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 117.562 0.165 . . . . 0.0 111.329 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -99.39 155.95 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -173.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.16 168.0 28.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.98 -39.73 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 124.403 1.081 . . . . 0.0 111.59 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -72.55 -29.09 63.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.949 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -75.35 -49.38 19.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.131 0.172 . . . . 0.0 110.643 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 322' ' ' ILE . 2.8 m -61.33 -54.38 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.07 -37.52 77.27 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.193 0.452 . . . . 0.0 110.739 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.04 -15.78 60.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.984 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.72 -27.25 15.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -96.76 -20.37 18.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -66.16 -18.84 65.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.439 0.296 . . . . 0.0 111.763 -173.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -21.52 66.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 353' ' ' TRP . 12.4 mm -87.12 -27.33 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.308 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 166.86 170.26 31.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.27 134.94 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.629 0.252 . . . . 0.0 111.347 -171.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 322' ' ' ILE . 7.2 mm -75.51 138.62 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.443 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 35.4 ttmt -68.46 144.58 54.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -123.71 135.51 53.91 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -75.19 140.89 43.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.19 -19.3 56.93 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.709 0.403 . . . . 0.0 111.654 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -115.62 0.25 13.22 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.6 p -125.09 -20.34 4.93 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.9 -17.46 3.68 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.383 0.516 . . . . 0.0 113.007 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -86.72 157.96 54.41 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.661 0.73 . . . . 0.0 109.673 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.6 153.13 76.9 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.255 1.97 . . . . 0.0 109.126 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.443 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 54.7 mtp -79.1 79.24 5.51 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.516 0.326 . . . . 0.0 110.985 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.812 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.11 155.81 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.345 -178.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -150.34 127.32 11.13 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -90.75 119.92 31.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.402 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 96.8 m-85 -81.25 160.67 24.2 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.7 p -136.46 146.96 46.92 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 111.753 -175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.35 131.69 50.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.412 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -73.86 -6.8 49.38 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.393 0.277 . . . . 0.0 111.643 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.31 -5.63 27.13 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.8 t -151.18 -23.32 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.499 0.59 . . . . 0.0 111.245 -176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 85.46 19.58 58.25 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.158 172.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -124.94 169.06 12.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.996 0.898 . . . . 0.0 110.1 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.46 117.94 1.79 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.46 0.704 . . . . 0.0 110.678 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.625 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 13.2 ptmm? -87.63 0.32 55.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.162 174.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 89.47 9.3 66.98 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.598 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -108.25 151.62 25.7 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.929 . . . . 0.0 112.023 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.92 166.46 32.57 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.2 m -135.51 122.66 21.55 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.872 0.469 . . . . 0.0 111.508 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 92.7 t -115.06 124.62 71.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.4 t -96.23 128.64 43.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.215 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -86.29 148.22 25.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -73.94 -20.33 60.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 95.2 m-20 -127.73 133.35 25.01 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 123.855 0.862 . . . . 0.0 111.033 -177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 28.1 Cg_endo -66.14 -33.9 38.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.683 2.256 . . . . 0.0 114.195 -175.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 89.5 Cg_endo -74.94 -18.42 18.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.141 1.443 . . . . 0.0 110.822 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 71.0 m -76.7 -29.67 56.36 Favored 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.16 -46.42 80.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.947 0.154 . . . . 0.0 110.725 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -66.15 -37.3 85.33 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.38 -40.13 81.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.369 0.267 . . . . 0.0 110.854 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.48 -26.35 65.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.58 -56.95 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -60.41 -21.79 62.63 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.403 ' CD1' HD11 ' A' ' 308' ' ' ILE . 48.2 t-105 -93.62 -59.49 1.99 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.7 -32.78 70.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -57.03 112.48 1.36 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.61 -15.68 31.9 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.008 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.66 -172.45 2.75 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.477 1.138 . . . . 0.0 109.924 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -101.64 173.27 6.5 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.557 0.343 . . . . 0.0 110.457 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.6 t80 -128.51 -38.54 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.682 0.393 . . . . 0.0 110.262 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.1 t -144.54 17.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.981 0.512 . . . . 0.0 109.959 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.23 -20.2 16.65 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -96.12 140.49 22.28 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.98 151.4 82.14 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.997 2.464 . . . . 0.0 110.369 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.4 pt -138.12 168.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 122.608 0.363 . . . . 0.0 111.223 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -134.54 155.25 50.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.15 0.58 . . . . 0.0 110.765 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 58.6 t -144.63 146.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.998 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 37.4 m -155.44 172.99 17.3 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -57.02 156.84 6.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -124.44 139.53 53.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 15.0 m -144.36 137.23 26.96 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.759 0.824 . . . . 0.0 109.879 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -49.0 119.76 3.44 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 120.698 0.285 . . . . 0.0 110.798 -171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -34.03 75.22 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.35 71.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.036 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -67.14 -10.06 46.3 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.568 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.1 m-85 -102.67 -10.76 18.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.44 -39.98 0.08 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -83.39 1.79 39.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.056 0.389 . . . . 0.0 111.798 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.0 7.18 85.83 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.56 0.34 83.78 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.75 -168.26 54.13 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -154.34 158.23 39.79 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.605 0.362 . . . . 0.0 110.531 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -87.67 -177.27 48.2 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -144.45 155.98 43.99 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.225 0.61 . . . . 0.0 109.488 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -82.05 151.59 30.36 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -83.31 166.66 44.24 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -65.78 155.03 37.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -62.58 154.44 42.34 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -156.19 165.02 37.62 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.019 0.528 . . . . 0.0 110.204 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 167.63 -6.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.184 -1.898 . . . . 0.0 110.815 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 C5'-C4'-C3' 111.066 -2.956 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.677 0 N19-C1'-C2' 109.345 -2.535 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 C4'-C3'-C2' 99.795 -2.905 . 0.839 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C4'-C3'-C2' 100.101 -2.599 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.534 0 O4'-C1'-N19 110.879 2.679 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 111.079 2.879 . 0.891 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.744 0 O4'-C1'-N19 111.002 2.802 . 0.782 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 O4'-C1'-N19 111.21 3.01 . 0.759 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 C5'-C4'-C3' 111.551 -2.633 . 0.613 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 0 C5'-C4'-C3' 111.269 -2.821 . 0.65 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.434 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.882 0 C5'-C4'-C3' 110.968 -3.022 . 0.561 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.434 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 C5'-C4'-C3' 110.667 -3.222 . 0.562 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 C5'-C4'-C3' 110.78 -3.147 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . 0.402 " H1'" " O4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 P--O5' 1.616 2.287 1 O4'-C1'-N19 113.369 5.169 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.625 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.041 0 C5'-C4'-C3' 110.138 -3.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.068 1 C3'-C2'-C1' 105.775 4.75 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.484 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 C5'-C4'-C3' 109.872 -3.752 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . 0.484 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C4'-C3'-C2' 100.043 -2.657 . 0.111 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 110.898 2.698 . 0.713 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 O4'-C1'-N19 110.645 2.445 . 0.592 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C5'-C4'-C3' 111.796 -2.469 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 C5'-C4'-C3' 112.325 -2.117 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 C5'-C4'-C3' 112.075 -2.283 . 0.771 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 O4'-C1'-N19 110.697 2.497 . 0.746 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.602 0 O4'-C1'-N19 111.012 2.812 . 0.706 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.564 0 O4'-C1'-N19 110.641 2.441 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.355 0 O4'-C1'-N19 110.484 2.284 . 0.858 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.731 2.531 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -179.04 179.41 48.91 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -70.34 174.88 5.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -66.95 -173.87 0.28 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.611 0.764 . . . . 0.0 110.635 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.636 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -64.06 -15.1 58.76 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -95.49 -6.06 41.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.123 0.42 . . . . 0.0 110.878 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 82.0 10.12 84.37 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.224 -0.764 . . . . 0.0 114.724 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.77 -162.41 48.17 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.817 1.309 . . . . 0.0 110.911 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.91 22.57 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.757 2.971 . . . . 0.0 112.587 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 267' ' ' GLY . 16.1 tpt180 -79.18 -33.62 43.78 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.811 -0.555 . . . . 0.0 110.708 -177.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -110.6 10.49 22.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.228 0.611 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -7.74 34.64 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 82.89 -108.35 2.97 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 82.0 p -72.37 13.05 0.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.86 -3.81 17.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.496 0.589 . . . . 0.0 112.468 -174.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -88.03 -6.33 58.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.467 0.307 . . . . 0.0 111.405 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -151.05 24.06 0.74 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 47.9 t -156.01 154.23 30.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.76 -0.16 51.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 0.0 110.213 174.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -91.43 -85.12 0.24 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.007 0.523 . . . . 0.0 110.183 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 49.1 16.43 0.13 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.95 168.79 25.79 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.779 -0.575 . . . . 0.0 110.075 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.7 p -153.75 -32.07 0.12 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.29 0.236 . . . . 0.0 111.018 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -108.55 13.24 25.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.359 0.664 . . . . 0.0 112.304 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -126.56 46.43 2.47 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.069 0.548 . . . . 0.0 111.245 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -70.0 -0.62 7.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.39 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.2 m -100.01 147.7 25.32 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.5 pt -128.82 149.92 33.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -104.92 149.49 25.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.74 148.76 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 123.264 0.625 . . . . 0.0 110.752 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -139.3 150.18 45.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.27 57.95 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.86 -0.411 . . . . 0.0 112.659 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.2 mp -54.72 -54.45 41.72 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 117.55 0.675 . . . . 0.0 111.614 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.481 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.42 -175.86 44.54 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -171.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -86.86 -7.8 57.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.534 0.734 . . . . 0.0 112.286 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.84 -3.55 42.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.238 0.215 . . . . 0.0 110.954 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.38 158.98 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 123.739 0.816 . . . . 0.0 112.804 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.43 168.05 25.99 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.75 -39.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.019 0.928 . . . . 0.0 111.65 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -73.15 -28.89 62.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.318 -0.239 . . . . 0.0 111.064 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.9 t -75.12 -49.44 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.193 0.197 . . . . 0.0 110.797 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.11 -53.65 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.441 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.39 -37.33 77.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.719 -0.613 . . . . 0.0 110.78 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -76.9 -15.29 59.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.189 -0.32 . . . . 0.0 111.201 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -94.47 -27.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.4 ' CD1' HG21 ' A' ' 339' ' ' VAL . 45.0 m-85 -96.47 -20.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.8 pttt -65.08 -19.29 65.92 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.7 pt20 -64.36 -20.85 66.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.52 -25.02 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 165.06 168.79 27.76 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.0 mm -66.97 136.0 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.706 0.289 . . . . 0.0 111.081 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 322' ' ' ILE . 6.5 mm -76.72 136.45 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -68.93 142.8 54.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -108.62 136.2 48.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.33 132.6 43.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -74.46 -20.68 59.92 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.91 0.484 . . . . 0.0 111.364 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.53 -8.39 18.06 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.1 p -131.91 -15.96 2.95 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.28 -15.3 5.65 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.394 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -84.23 162.19 52.33 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 118.204 1.002 . . . . 0.0 109.333 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.15 152.02 81.79 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.653 1.569 . . . . 0.0 108.877 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 41.9 mtp -77.71 79.12 4.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.709 0.404 . . . . 0.0 110.955 -174.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.815 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -134.9 154.96 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 123.703 0.627 . . . . 0.0 110.849 -179.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -150.62 130.12 13.0 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -92.99 117.08 29.67 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.463 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 97.3 m-85 -81.39 156.5 25.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 79.4 p -130.88 158.15 41.0 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.822 0.82 . . . . 0.0 112.083 -170.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -68.88 119.96 14.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.183 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -70.11 -6.53 34.63 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 122.237 0.215 . . . . 0.0 111.454 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 329' ' ' GLU . 12.5 pt-20 -88.96 -13.9 37.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 14.9 t -155.59 -20.01 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.36 9.73 60.08 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.507 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -91.82 164.09 13.81 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.461 1.131 . . . . 0.0 109.633 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.2 mt -56.43 123.66 15.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.59 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 23.9 ttmm -74.23 -13.94 60.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.454 0.702 . . . . 0.0 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.481 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 96.97 -4.76 63.18 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.52 145.49 26.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.143 0.471 . . . . 0.0 110.807 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.23 165.12 35.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 6.1 m -136.39 120.75 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.475 0.31 . . . . 0.0 111.829 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 305' ' ' PHE . 94.8 t -114.96 124.17 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.049 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 34.2 t -95.78 128.12 42.39 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.268 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -85.1 147.07 26.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 172.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.76 -16.77 59.39 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -125.21 131.27 24.04 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.837 0.855 . . . . 0.0 110.688 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.454 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.7 Cg_endo -66.62 -32.69 38.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.67 2.247 . . . . 0.0 114.332 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 83.4 Cg_endo -76.26 -19.63 15.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-N 121.508 1.574 . . . . 0.0 110.85 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 48.8 m -75.51 -29.69 59.56 Favored 'General case' 0 CA--C 1.524 -0.041 0 O-C-N 122.391 -0.193 . . . . 0.0 110.547 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.55 -48.21 75.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 351' ' ' ILE . 17.0 tptm -64.07 -38.68 91.95 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.6 82.92 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.484 0.314 . . . . 0.0 110.705 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.24 65.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 348' ' ' LYS . 66.5 mt -72.04 -57.32 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.43 -21.91 62.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -93.11 -60.38 1.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.62 -32.44 71.15 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.43 112.39 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.01 -15.35 31.03 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.091 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -94.67 -172.81 2.84 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.605 1.203 . . . . 0.0 109.946 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -102.65 170.77 7.82 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.477 0.311 . . . . 0.0 110.171 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.9 t80 -125.38 -38.54 2.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.371 0.268 . . . . 0.0 110.601 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t -143.84 8.04 1.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.329 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 131.08 -21.11 4.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -103.83 148.87 36.5 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.94 152.86 76.56 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.395 2.73 . . . . 0.0 110.581 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -139.12 169.14 17.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.96 0.409 . . . . 0.0 110.538 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -133.68 155.61 49.4 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.748 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 49.1 t -143.89 146.39 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 50.0 m -153.76 174.76 14.12 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.65 163.68 4.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.079 -0.388 . . . . 0.0 111.914 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -132.59 137.16 46.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 5.0 m -140.7 134.12 29.89 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.676 0.79 . . . . 0.0 110.469 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -48.97 118.09 2.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -26.95 63.58 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.8 74.36 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.424 -0.173 . . . . 0.0 110.843 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.56 -8.73 15.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.438 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 98.8 m-85 -107.67 -10.0 15.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.92 -40.33 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -79.29 -8.76 59.3 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.847 0.294 . . . . 0.0 111.66 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.56 14.8 69.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 86.24 -178.59 49.35 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.98 160.26 52.6 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -148.85 169.94 19.37 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.399 0.68 . . . . 0.0 110.496 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -170.49 168.15 41.22 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -73.48 168.04 20.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.875 0.47 . . . . 0.0 110.199 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -74.21 149.93 41.49 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.24 83.71 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 60.0 ttm-85 -153.68 149.6 27.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.242 0.521 . . . . 0.0 109.719 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -73.15 172.61 49.64 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . 0.477 ' HG2' ' H ' ' A' ' 390' ' ' GLY . 21.1 ttt180 -152.62 149.83 28.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.998 0.519 . . . . 0.0 109.718 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -80.4 8.65 52.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 122.999 0.333 . . . . 0.0 112.274 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . 0.477 ' H ' ' HG2' ' A' ' 388' ' ' ARG . . . . . . . . 0 C--O 1.251 1.2 0 CA-C-O 117.407 -1.774 . . . . 0.0 110.702 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.403 0 C5'-C4'-C3' 111.007 -2.995 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 N19-C1'-C2' 109.212 -2.618 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C4'-C3'-C2' 99.94 -2.76 . 0.859 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 N19-C1'-C2' 109.414 -2.491 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 O4'-C1'-N19 110.94 2.74 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 0 O4'-C1'-N19 111.211 3.011 . 0.839 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.706 0 O4'-C1'-N19 111.103 2.903 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 O4'-C1'-N19 111.09 2.89 . 0.694 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 C5'-C4'-C3' 111.512 -2.659 . 0.71 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.812 0 C5'-C4'-C3' 111.237 -2.842 . 0.723 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 C5'-C4'-C3' 111.386 -2.742 . 0.631 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 C5'-C4'-C3' 110.586 -3.276 . 0.383 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 C5'-C4'-C3' 109.064 -4.291 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.168 1 O4'-C1'-N19 113.032 4.832 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.59 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 C5'-C4'-C3' 110.641 -3.239 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.828 1 C3'-C2'-C1' 105.859 4.843 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.904 0 C5'-C4'-C3' 110.122 -3.585 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 0 C5'-C4'-C3' 110.927 -3.049 . 0.66 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.326 0 N19-C1'-C2' 109.284 -2.572 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 N19-C1'-C2' 108.893 -2.817 . 0.761 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.455 0 N19-C1'-C2' 109.279 -2.576 . 0.72 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 N19-C1'-C2' 109.461 -2.462 . 0.753 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.575 0 C4'-C3'-C2' 100.483 -2.217 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.878 0 O4'-C1'-N19 110.541 2.341 . 0.722 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.624 2.424 . 0.694 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O4'-C1'-N19 110.614 2.414 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.058 0 C5'-C4'-C3' 112.031 -2.312 . 0.794 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.89 0 O4'-C1'-N19 110.771 2.571 . 0.815 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 179.77 -177.95 48.36 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -69.98 176.4 3.77 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.429 ' ND2' ' H22' ' B' ' 106' ' ' ' G' . 12.4 m-80 -68.93 -174.4 0.59 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.622 0.769 . . . . 0.0 110.469 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.648 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -63.81 -16.59 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.617 0.367 . . . . 0.0 111.775 -177.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -95.96 -3.75 44.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.933 0.333 . . . . 0.0 111.021 177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 81.93 9.15 85.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.885 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 67.63 -158.84 51.04 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.373 1.586 . . . . 0.0 110.496 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.99 15.62 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.732 2.955 . . . . 0.0 112.496 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 267' ' ' GLY . 72.5 ttt-85 -75.81 -40.55 54.79 Favored 'General case' 0 C--N 1.334 -0.075 0 O-C-N 122.051 -0.406 . . . . 0.0 110.122 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -95.97 3.54 53.42 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.749 0.419 . . . . 0.0 111.709 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.32 168.07 13.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.914 0.486 . . . . 0.0 111.104 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -77.49 -115.59 0.17 Allowed Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.146 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.3 t -77.12 30.76 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.751 0.82 . . . . 0.0 112.552 -173.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -5.56 9.77 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.545 -0.722 . . . . 0.0 111.774 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' A' ' 275' ' ' HIS . 21.1 p80 -89.32 -19.66 25.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.835 0.454 . . . . 0.0 111.194 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -128.47 6.34 5.73 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 39.0 t -154.98 160.85 41.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.112 0.565 . . . . 0.0 109.697 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -108.94 14.0 24.4 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.879 0.471 . . . . 0.0 110.375 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -89.05 -82.67 0.24 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.57 13.87 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.004 1.721 . . . . 0.0 115.105 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -149.98 160.35 43.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.879 -0.513 . . . . 0.0 109.949 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.1 t -147.27 0.91 0.72 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.512 0.196 . . . . 0.0 111.144 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -151.04 24.14 0.74 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -136.21 44.83 2.4 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.113 0.565 . . . . 0.0 110.919 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -69.7 -1.2 8.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.946 0.499 . . . . 0.0 111.185 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.6 m -99.26 147.57 25.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.99 150.24 34.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.867 0.467 . . . . 0.0 109.897 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -105.38 149.68 25.89 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.14 148.7 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.251 0.621 . . . . 0.0 111.238 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -138.55 150.59 46.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.08 5.79 59.37 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.74 171.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.3 mp -55.36 -56.69 17.15 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 117.45 0.625 . . . . 0.0 111.29 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.46 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 90.15 -179.66 43.89 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -76.79 -11.57 59.85 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.786 0.835 . . . . 0.0 112.106 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.69 0.39 39.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.416 0.286 . . . . 0.0 111.275 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.33 154.75 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.4 t -157.58 168.38 27.46 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 32.5 mm -49.87 -40.16 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.406 1.082 . . . . 0.0 111.776 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.37 -28.74 63.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.55 -0.094 . . . . 0.0 111.059 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.3 t -75.23 -49.46 19.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.159 0.184 . . . . 0.0 110.817 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.38 -54.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.436 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.81 -37.72 77.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.375 0.534 . . . . 0.0 110.699 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -76.17 -15.76 60.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -94.41 -27.42 16.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -96.5 -20.58 18.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.1 pttt -65.67 -18.72 65.53 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.341 0.257 . . . . 0.0 111.68 -172.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.2 pt20 -64.39 -21.9 66.78 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 13.3 mm -87.01 -27.99 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 168.28 170.44 32.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 50.4 mm -67.73 135.74 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.879 0.34 . . . . 0.0 111.261 -172.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -76.98 137.84 21.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -69.61 149.37 48.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.6 m -128.32 132.65 48.62 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -72.34 150.14 43.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -81.51 -6.58 59.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -139.97 -5.22 1.32 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.0 p -91.09 -20.95 21.49 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.57 15.99 79.12 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -141.09 158.77 63.84 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 117.415 0.608 . . . . 0.0 109.707 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.99 154.38 62.28 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.264 1.976 . . . . 0.0 109.47 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 39.6 mtp -77.14 76.94 3.68 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.63 0.372 . . . . 0.0 111.159 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.63 154.25 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.389 0.675 . . . . 0.0 110.747 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -150.99 130.33 12.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.684 0.794 . . . . 0.0 108.939 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.8 mm? -90.87 122.31 33.47 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.489 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 97.1 m-85 -86.22 160.16 19.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 48.8 p -134.81 161.35 35.44 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.346 0.593 . . . . 0.0 111.661 -170.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -71.86 117.8 13.91 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.985 170.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -73.64 -4.86 36.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.438 -0.164 . . . . 0.0 111.195 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -94.39 -6.77 43.4 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.265 0.626 . . . . 0.0 112.533 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.9 t -150.02 -23.0 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.44 0.564 . . . . 0.0 111.14 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.13 32.59 16.81 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.962 171.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -135.55 166.18 23.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 117.852 0.826 . . . . 0.0 110.756 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.3 OUTLIER -47.77 122.87 5.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.74 0.816 . . . . 0.0 111.262 -174.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.653 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.3 ttmm -83.64 -20.86 32.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.3 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 99.87 0.37 56.3 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -90.58 151.04 21.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.628 0.714 . . . . 0.0 110.902 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.36 166.21 31.61 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.316 0.646 . . . . 0.0 109.355 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 9.3 m -136.84 122.68 20.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.634 0.374 . . . . 0.0 111.603 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.22 125.09 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 35.2 t -96.83 128.35 43.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.573 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -85.59 147.82 26.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -76.1 -17.24 59.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -125.39 132.24 24.26 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.453 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.4 Cg_endo -66.88 -32.2 36.63 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.782 2.321 . . . . 0.0 114.562 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 92.5 Cg_endo -77.5 -18.79 13.54 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 121.135 1.441 . . . . 0.0 111.146 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 66.6 m -75.76 -29.27 58.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.24 -0.288 . . . . 0.0 110.478 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.99 -47.69 76.61 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.71 -39.81 95.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.484 0.314 . . . . 0.0 110.53 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.46 -39.92 81.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 0.0 110.59 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.12 -26.14 65.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.62 -58.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -60.64 -21.3 62.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -92.99 -59.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -70.37 -32.34 69.97 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.24 112.01 1.12 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -15.59 30.61 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.063 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -94.76 -172.35 2.7 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.646 1.223 . . . . 0.0 110.03 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -101.5 174.07 6.14 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.708 0.29 . . . . 0.0 110.459 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.609 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.6 t80 -129.27 -37.78 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.518 0.327 . . . . 0.0 110.654 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.2 t -144.87 20.31 1.63 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.687 0.395 . . . . 0.0 110.043 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 109.07 0.01 31.56 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -125.32 146.6 54.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 123.801 0.84 . . . . 0.0 109.773 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.79 149.22 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.575 2.85 . . . . 0.0 110.93 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.46 169.21 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.067 0.547 . . . . 0.0 110.636 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -133.5 157.17 46.31 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.004 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 44.7 t -143.95 147.3 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.039 0.536 . . . . 0.0 110.223 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.9 m -154.73 172.86 17.24 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.64 159.11 6.95 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.44 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -127.77 134.93 49.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.5 m -138.99 136.3 35.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.628 0.771 . . . . 0.0 110.002 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -47.39 112.49 0.55 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.022 0.529 . . . . 0.0 110.105 -170.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.55 -28.42 64.9 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.83 74.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.47 -0.144 . . . . 0.0 110.786 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.56 -9.51 19.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.405 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 98.8 m-85 -106.87 -7.94 16.9 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.71 -40.88 0.07 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -84.12 2.57 38.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.211 0.46 . . . . 0.0 112.023 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.04 81.69 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 88.75 1.77 79.76 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 76.29 177.98 44.34 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 117.347 0.574 . . . . 0.0 111.871 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -158.54 162.12 37.37 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 172.05 141.89 3.55 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -146.9 162.02 39.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.13 0.465 . . . . 0.0 110.847 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -157.07 176.08 34.39 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 161.48 25.71 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 CA-C-N 117.333 0.567 . . . . 0.0 112.671 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -60.36 144.34 50.96 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 117.777 0.788 . . . . 0.0 110.003 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -71.88 165.71 53.72 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -153.73 146.77 24.54 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.323 0.649 . . . . 0.0 109.925 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.01 85.15 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.224 -1.876 . . . . 0.0 110.888 179.658 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 N19-C1'-C2' 109.785 -2.26 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 N19-C1'-C2' 109.464 -2.46 . 0.88 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C4'-C3'-C2' 99.951 -2.749 . 0.885 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 N19-C1'-C2' 109.073 -2.704 . 0.836 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.361 -2.759 . 0.821 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.689 0 C4'-C3'-C2' 100.345 -2.355 . 0.9 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.499 0 C4'-C3'-C2' 100.068 -2.632 . 0.833 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.66 0 O4'-C1'-N19 111.51 3.31 . 0.766 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.886 0 C5'-C4'-C3' 111.742 -2.505 . 0.676 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.876 0 C5'-C4'-C3' 111.138 -2.908 . 0.647 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.418 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 C5'-C4'-C3' 111.2 -2.866 . 0.794 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.418 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 C5'-C4'-C3' 110.268 -3.488 . 0.414 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.846 0 C5'-C4'-C3' 109.939 -3.707 . 0.205 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . 0.424 " H1'" " O4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.427 -2.188 1 O4'-C1'-N19 112.505 4.305 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.653 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.723 1 C5'-C4'-C3' 109.216 -4.189 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.44 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.416 -3.042 1 C3'-C2'-C1' 105.64 4.6 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 C5'-C4'-C3' 109.777 -3.815 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 110.291 -3.473 . 0.496 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 C5'-C4'-C3' 110.633 -3.245 . 0.153 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 N19-C1'-C2' 109.601 -2.375 . 0.724 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.54 0 N19-C1'-C2' 109.541 -2.412 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 N19-C1'-C2' 109.45 -2.468 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 C5'-C4'-C3' 111.997 -2.335 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 O4'-C1'-N19 110.968 2.768 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 C4'-C3'-C2' 100.012 -2.688 . 0.697 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.794 0 O4'-C1'-N19 110.669 2.469 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 O4'-C1'-N19 110.706 2.506 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.863 0 N19-C1'-C2' 109.628 -2.357 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.106 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.94 -174.85 54.21 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.52 -53.22 51.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -157.35 -178.02 7.04 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 108.884 -173.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.566 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -68.64 -7.02 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 176.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -109.1 -2.98 17.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 84.9 1.76 88.75 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.03 -0.872 . . . . 0.0 114.811 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 66.24 -156.5 50.25 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.405 1.603 . . . . 0.0 110.118 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.08 17.88 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.766 2.978 . . . . 0.0 112.246 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -77.17 -40.48 45.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 122.26 -0.275 . . . . 0.0 110.267 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.1 3.48 53.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.798 0.439 . . . . 0.0 111.356 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.09 170.16 12.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.706 0.402 . . . . 0.0 111.271 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -79.18 -118.69 0.27 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.776 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.7 t -77.5 23.34 0.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.106 0.963 . . . . 0.0 111.831 -174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -7.01 4.56 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -86.6 -5.99 58.99 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.277 0.631 . . . . 0.0 111.156 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.9 22.3 0.88 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 39.1 t -158.45 150.66 21.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -96.57 14.9 23.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.077 0.551 . . . . 0.0 110.026 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -105.95 -113.03 0.26 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.327 0.651 . . . . 0.0 109.372 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 51.22 24.68 2.11 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.78 162.88 40.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 78.6 p -155.04 -29.94 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.077 0.151 . . . . 0.0 111.251 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -108.14 18.2 21.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.257 0.623 . . . . 0.0 112.274 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -134.04 48.79 2.31 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.328 0.651 . . . . 0.0 111.233 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -67.24 -12.62 60.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.6 m -87.26 144.42 26.82 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -177.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 12.8 pt -129.05 147.4 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -101.78 147.8 26.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.54 146.86 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 122.983 0.513 . . . . 0.0 111.062 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -137.51 149.88 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.19 58.24 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.8 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.36 -54.74 42.03 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.281 0.632 . . . . 0.0 111.022 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.497 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.54 179.6 46.42 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -78.33 -9.05 59.09 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.818 0.847 . . . . 0.0 111.989 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -82.64 0.06 44.85 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.31 0.244 . . . . 0.0 111.461 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.98 155.76 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.71 168.24 27.8 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.3 mm -49.26 -40.25 13.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 124.385 1.074 . . . . 0.0 111.948 -174.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.54 -29.14 63.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.487 -0.085 . . . . 0.0 111.198 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.5 t -74.9 -49.47 20.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.194 0.197 . . . . 0.0 110.57 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.8 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.72 -54.18 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.445 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.84 -38.27 78.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.29 0.496 . . . . 0.0 110.915 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -75.73 -15.15 60.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.788 0.327 . . . . 0.0 111.217 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -95.47 -26.79 15.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -97.27 -20.43 17.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 51.8 pttt -65.92 -18.98 65.7 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -64.11 -21.37 66.51 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.84 -25.74 5.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.32 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 166.15 170.03 30.53 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.54 136.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 122.674 -0.309 . . . . 0.0 111.167 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 322' ' ' ILE . 6.7 mm -77.66 137.66 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.46 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 24.0 ttmm -68.84 148.46 50.23 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.7 m -119.21 139.82 51.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -70.84 144.95 50.57 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.76 -0.12 46.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -144.45 5.63 1.24 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.8 p -124.73 -18.27 5.66 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.49 -17.22 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.404 0.526 . . . . 0.0 113.028 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -85.06 158.94 57.96 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 117.864 0.832 . . . . 0.0 109.524 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.07 153.61 75.14 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.131 1.887 . . . . 0.0 109.264 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.46 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 64.7 mtp -79.46 79.57 5.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.8 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -133.84 156.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.49 0.716 . . . . 0.0 110.412 -179.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -152.56 127.97 9.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.633 0.773 . . . . 0.0 109.199 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -92.84 121.67 34.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -84.45 158.58 21.0 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 26.2 p -135.43 145.18 46.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -57.78 139.4 54.09 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -77.89 -13.21 59.96 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -94.12 -5.24 47.69 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.1 t -150.81 -23.08 0.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.942 0.337 . . . . 0.0 110.849 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 82.14 19.69 64.37 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.561 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -126.4 168.15 14.58 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.903 0.852 . . . . 0.0 110.232 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.23 118.72 1.38 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.769 0.828 . . . . 0.0 111.109 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.605 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 10.2 ptpt -88.0 -2.22 58.48 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.06 172.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.497 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 91.11 4.84 68.42 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.406 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 151.09 21.74 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 117.906 0.853 . . . . 0.0 111.059 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.52 167.4 29.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.12 0.568 . . . . 0.0 109.713 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.7 m -138.19 123.81 19.73 Favored 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.763 0.425 . . . . 0.0 111.228 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 99.5 t -116.36 125.23 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.431 0.692 . . . . 0.0 109.233 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 41.4 t -96.78 125.53 41.3 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.084 -0.385 . . . . 0.0 110.466 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -82.4 150.1 27.3 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.37 -15.69 58.43 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 86.7 m-20 -129.55 136.1 28.58 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.0 111.23 -177.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.447 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 17.9 Cg_endo -65.48 -36.67 33.3 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.774 2.316 . . . . 0.0 114.31 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 85.8 Cg_endo -75.8 -18.66 16.9 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 120.935 1.37 . . . . 0.0 111.122 -175.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.0 m -75.9 -30.09 58.68 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.0 71.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.141 0.177 . . . . 0.0 110.871 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -64.12 -38.27 90.47 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.455 0.169 . . . . 0.0 110.643 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.5 83.02 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.555 0.342 . . . . 0.0 110.834 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -25.72 65.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.9 mt -72.71 -56.95 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -60.31 -20.95 61.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -94.99 -59.65 1.86 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.83 -31.5 69.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -57.76 112.81 1.58 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.49 -15.46 32.32 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.908 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.52 -172.14 2.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.742 1.271 . . . . 0.0 109.86 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -102.61 174.38 5.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.837 0.351 . . . . 0.0 110.347 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.589 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.1 t80 -130.02 -39.39 1.38 Allowed 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 15.3 t -143.34 18.18 1.89 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.993 0.517 . . . . 0.0 109.7 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.75 -18.81 24.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -175.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -97.11 140.2 21.94 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.27 151.27 81.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.997 2.465 . . . . 0.0 110.486 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.589 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.5 pt -136.88 168.93 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.153 0.502 . . . . 0.0 111.041 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.82 155.64 49.47 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.901 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.7 t -144.43 146.79 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 122.939 0.495 . . . . 0.0 110.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 19.4 m -155.11 173.1 17.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -58.3 160.7 4.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.416 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -130.8 139.23 50.18 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 17.3 m -141.05 135.97 31.56 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.957 0.903 . . . . 0.0 109.866 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -48.1 123.13 5.87 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.444 0.297 . . . . 0.0 110.666 -170.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -29.72 68.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.981 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -64.25 -8.77 13.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.542 ' CD1' ' HE3' ' A' ' 264' ' ' LYS . 90.2 m-85 -112.19 -8.88 13.96 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.51 -41.39 0.1 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -82.22 -0.33 44.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.048 0.385 . . . . 0.0 111.846 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 81.6 6.7 88.93 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.77 -4.91 72.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.266 0.46 . . . . 0.0 112.291 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.69 177.07 34.53 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 117.712 0.756 . . . . 0.0 111.401 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -146.45 152.48 39.09 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.981 0.513 . . . . 0.0 110.571 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -94.6 -171.29 37.61 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.415 ' HD2' " H1'" ' B' ' 100' ' ' ' C' . 10.2 ptp85 -158.07 163.43 37.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.728 0.411 . . . . 0.0 109.93 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -73.81 147.89 39.06 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -84.76 154.55 29.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -76.51 163.25 27.1 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 122.743 0.417 . . . . 0.0 110.182 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -74.9 174.01 51.83 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -153.09 152.53 31.42 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.282 0.633 . . . . 0.0 109.712 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -163.61 -173.48 32.36 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.377 -1.791 . . . . 0.0 110.767 179.38 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 C5'-C4'-C3' 110.859 -3.094 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.366 -2.521 . 0.772 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 C4'-C3'-C2' 100.13 -2.57 . 0.85 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.697 0 N19-C1'-C2' 109.097 -2.69 . 0.821 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.451 0 O4'-C1'-N19 110.858 2.658 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 110.927 2.727 . 0.9 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 O4'-C1'-N19 110.922 2.722 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 110.921 2.721 . 0.81 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.203 0 C5'-C4'-C3' 111.297 -2.802 . 0.68 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . 0.415 " H1'" ' HD2' ' A' ' 383' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.865 0 C5'-C4'-C3' 111.052 -2.965 . 0.632 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.426 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 111.145 -2.903 . 0.708 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.426 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 C5'-C4'-C3' 110.241 -3.506 . 0.491 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . 0.402 H5'' ' C8 ' ' B' ' 103' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.304 0 C5'-C4'-C3' 109.632 -3.912 OUTLIER-DELTA 0.0 OUTLIER '7D dist 4s' 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.235 1 O4'-C1'-N19 113.536 5.336 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.605 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C5'-C4'-C3' 110.151 -3.566 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.416 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C3'-C2'-C1' 105.718 4.687 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.457 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.57 0 C5'-C4'-C3' 109.962 -3.692 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . 0.457 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.646 0 C5'-C4'-C3' 112.467 -2.022 . 0.207 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C5'-C4'-C3' 110.716 -3.189 . 0.615 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 110.49 2.29 . 0.688 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 109.566 -2.396 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 N19-C1'-C2' 109.449 -2.47 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 0 C4'-C3'-C2' 100.646 -2.054 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 C4'-C3'-C2' 100.275 -2.425 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 O4'-C1'-N19 110.796 2.596 . 0.71 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.57 0 C4'-C3'-C2' 100.232 -2.468 . 0.711 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.868 0 O4'-C1'-N19 110.536 2.336 . 0.817 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.69 0 N19-C1'-C2' 109.573 -2.392 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.113 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 74.94 -172.84 52.98 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.28 178.19 3.49 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -66.19 -177.12 0.48 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.02 0.928 . . . . 0.0 110.542 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.574 ' HE3' ' CG ' ' A' ' 375' ' ' PHE . 0.0 OUTLIER -65.61 -12.54 54.13 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -96.9 -8.95 29.51 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.132 0.423 . . . . 0.0 110.667 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 88.93 7.78 70.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 64.31 -167.22 28.17 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.478 1.639 . . . . 0.0 111.0 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.59 21.43 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.642 2.894 . . . . 0.0 112.198 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 267' ' ' GLY . 78.4 ttt-85 -76.16 -24.56 54.82 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 122.16 -0.337 . . . . 0.0 110.978 -172.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 37.0 p30 -137.54 21.38 2.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.155 0.582 . . . . 0.0 111.211 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.95 -7.1 7.31 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.328 0.651 . . . . 0.0 112.461 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.73 -115.43 4.86 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 62.5 m -76.05 22.02 0.16 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -3.94 10.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.617 0.644 . . . . 0.0 112.244 -177.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -92.4 -13.41 30.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.528 0.331 . . . . 0.0 111.219 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -127.33 6.23 6.37 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 41.6 t -152.05 150.1 29.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -87.96 -0.02 56.48 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.026 0.531 . . . . 0.0 110.542 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -91.4 -83.42 0.28 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.582 0.353 . . . . 0.0 110.077 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p30 49.03 15.73 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.727 1.611 . . . . 0.0 114.582 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -151.81 164.59 36.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -155.92 -34.43 0.09 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.484 0.183 . . . . 0.0 111.087 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.41 6.68 42.26 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -123.7 142.14 51.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.822 0.449 . . . . 0.0 110.025 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -145.17 15.41 1.5 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.733 0.813 . . . . 0.0 110.124 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.4 m -133.63 150.33 51.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.88 146.22 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.756 0.422 . . . . 0.0 110.01 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -100.47 146.53 26.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.59 147.08 32.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 122.766 0.426 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -137.78 150.41 47.21 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.13 5.96 58.01 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.556 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.45 -57.32 12.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.499 0.72 . . . . 0.0 111.176 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.473 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.74 -179.1 45.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.02 -10.88 59.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.569 0.748 . . . . 0.0 112.405 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.8 -0.63 35.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.549 0.34 . . . . 0.0 111.355 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.58 155.58 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.1 t -157.95 168.4 27.25 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -48.67 -39.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.264 1.026 . . . . 0.0 111.825 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.89 -28.59 61.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.251 -0.281 . . . . 0.0 111.248 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.1 t -75.75 -48.33 22.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 322' ' ' ILE . 2.6 m -61.89 -53.97 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.434 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.28 -37.55 77.97 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.045 -0.409 . . . . 0.0 110.843 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.67 -15.6 59.76 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.241 -0.287 . . . . 0.0 111.105 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -94.46 -27.13 16.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 339' ' ' VAL . 45.5 m-85 -97.03 -19.85 18.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 53.2 pttt -65.79 -18.91 65.67 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -173.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.3 pt20 -64.05 -21.8 66.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.8 mm -87.39 -27.26 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 167.89 169.89 31.96 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.03 135.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.577 -0.366 . . . . 0.0 111.064 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.496 HG21 HD11 ' A' ' 322' ' ' ILE . 8.1 mm -75.41 138.6 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.12 153.64 43.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.82 137.76 50.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -76.13 137.46 40.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.19 -19.58 56.55 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.94 -48.43 4.89 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.705 0.23 . . . . 0.0 110.7 -176.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.8 p -85.13 -21.52 29.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.36 -16.5 4.78 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.528 -0.596 . . . . 0.0 113.141 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.31 160.45 65.16 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 118.178 0.989 . . . . 0.0 109.803 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.15 153.46 69.4 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.963 1.775 . . . . 0.0 109.541 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.7 mtp -78.95 76.04 5.45 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 123.199 0.6 . . . . 0.0 111.128 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -130.89 159.63 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.143 0.577 . . . . 0.0 110.617 -178.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -156.24 125.23 6.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.84 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -90.05 121.73 32.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.546 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 65.3 m-85 -76.0 163.75 26.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.1 p -137.77 156.61 47.79 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.484 0.659 . . . . 0.0 111.106 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.44 131.9 44.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.31 1.044 . . . . 0.0 112.081 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 62.8 mtt-85 -79.34 -7.74 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.605 0.362 . . . . 0.0 111.718 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -97.64 -5.7 34.81 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.8 t -151.62 -25.27 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.964 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.33 51.88 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.514 -0.603 . . . . 0.0 113.041 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 174.64 6.41 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.907 0.854 . . . . 0.0 110.452 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -50.36 122.54 7.12 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.215 0.606 . . . . 0.0 111.132 -176.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.509 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.8 ttmm -76.52 -16.49 59.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.488 0.715 . . . . 0.0 109.691 174.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.473 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.79 16.01 50.18 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -123.08 155.91 35.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.44 0.62 . . . . 0.0 110.388 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.68 173.39 16.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.906 0.482 . . . . 0.0 109.918 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 88.2 m -139.56 129.26 24.58 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 305' ' ' PHE . 89.6 t -119.24 127.18 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 39.5 t -98.36 132.89 43.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.724 -0.39 . . . . 0.0 109.971 176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.24 145.11 24.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.175 0.99 . . . . 0.0 113.201 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -72.08 -16.41 62.02 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.408 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 99.5 m-20 -125.61 134.09 25.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.785 0.834 . . . . 0.0 110.835 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 22.3 Cg_endo -66.14 -33.93 38.7 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.702 2.268 . . . . 0.0 114.055 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 93.9 Cg_endo -77.69 -19.03 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.499 1.466 . . . . 0.0 111.522 -177.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 51.7 m -74.35 -29.14 61.46 Favored 'General case' 0 C--N 1.335 -0.05 0 CA-C-N 117.774 0.261 . . . . 0.0 110.35 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.64 79.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 351' ' ' ILE . 15.3 tptm -62.51 -40.11 95.68 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.402 -0.187 . . . . 0.0 111.111 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.361 0.265 . . . . 0.0 110.92 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.54 -24.96 64.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 348' ' ' LYS . 65.8 mt -73.9 -55.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -60.76 -20.86 62.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -95.36 -60.27 1.7 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.76 -32.4 70.9 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.33 111.8 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.7 -17.11 25.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.287 -0.729 . . . . 0.0 112.806 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -94.43 -171.73 2.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.53 1.165 . . . . 0.0 109.94 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -102.7 174.25 5.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.582 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.3 t80 -129.38 -38.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.565 0.346 . . . . 0.0 110.078 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.8 t -144.49 17.33 1.67 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.016 0.526 . . . . 0.0 109.738 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.84 -20.89 16.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -94.71 140.29 22.54 Favored Pre-proline 0 N--CA 1.45 -0.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.96 151.38 82.23 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.102 2.534 . . . . 0.0 110.326 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.582 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.2 pt -138.51 168.32 19.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-O 121.168 0.509 . . . . 0.0 111.092 -177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -133.81 155.64 49.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.268 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 56.9 t -144.63 147.43 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 O-C-N 123.412 0.445 . . . . 0.0 110.093 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 21.3 m -154.36 171.85 18.64 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.99 155.63 7.89 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.593 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -124.71 135.18 52.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 18.0 m -135.28 132.76 38.15 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.282 0.633 . . . . 0.0 109.698 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -46.7 113.97 0.74 Allowed 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.067 0.547 . . . . 0.0 110.355 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.86 74.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.53 71.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.049 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -66.01 -10.25 37.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.574 ' CG ' ' HE3' ' A' ' 264' ' ' LYS . 99.3 m-85 -104.29 -9.7 18.37 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.68 -42.11 0.09 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.56 -9.15 59.57 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.38 13.82 72.68 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.62 177.29 50.38 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -74.6 163.29 54.34 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -160.83 174.53 13.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.113 0.565 . . . . 0.0 110.563 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -163.95 174.88 40.13 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -78.49 171.2 15.45 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.895 0.478 . . . . 0.0 110.435 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -74.98 162.08 53.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -79.56 -173.58 45.04 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -149.52 148.76 29.77 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 123.187 0.595 . . . . 0.0 109.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -74.46 162.47 54.1 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.76 162.04 38.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.927 0.491 . . . . 0.0 109.988 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 178.15 177.48 46.91 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 117.296 -1.835 . . . . 0.0 110.93 179.824 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 N19-C1'-C2' 109.847 -2.22 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 C4'-C3'-C2' 100.12 -2.58 . 0.873 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 N19-C1'-C2' 109.267 -2.583 . 0.837 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.759 0 N19-C1'-C2' 109.165 -2.647 . 0.779 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 O4'-C1'-N19 111.003 2.803 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.971 2.771 . 0.868 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 O4'-C1'-N19 110.935 2.735 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 0 O4'-C1'-N19 110.898 2.698 . 0.753 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.782 0 C5'-C4'-C3' 111.723 -2.518 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.964 0 C5'-C4'-C3' 111.129 -2.914 . 0.647 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.525 0 C5'-C4'-C3' 111.431 -2.713 . 0.577 &a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 110.647 -3.236 . 0.367 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 C5'-C4'-C3' 109.462 -4.025 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . 0.405 " H1'" " H4'" ' B' ' 105' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.26 1 O4'-C1'-N19 112.782 4.582 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.546 " H1'" ' CD2' ' A' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.866 0 C5'-C4'-C3' 110.456 -3.363 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.593 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 C3'-C2'-C1' 105.805 4.783 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 0 O4'-C1'-N19 110.926 2.726 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 C5'-C4'-C3' 110.744 -3.17 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 0 C5'-C4'-C3' 109.902 -3.732 . 0.41 1c . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 N19-C1'-C2' 109.348 -2.532 . 0.688 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 N19-C1'-C2' 109.089 -2.694 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.486 0 N19-C1'-C2' 109.362 -2.524 . 0.641 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C4'-C3'-C2' 100.29 -2.41 . 0.759 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 110.793 2.593 . 0.746 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.858 2.658 . 0.708 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 O4'-C1'-N19 110.702 2.502 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.521 2.321 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.684 2.484 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.239 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.19 174.78 44.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -62.65 -51.41 67.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -157.3 -178.23 7.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.106 0.962 . . . . 0.0 108.986 -173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.554 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -67.95 -8.4 36.69 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.435 -0.165 . . . . 0.0 111.301 176.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -107.7 -5.13 17.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.003 0.365 . . . . 0.0 110.326 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 87.55 2.13 82.59 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.002 -0.888 . . . . 0.0 115.215 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 64.95 -157.31 46.3 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 119.549 1.675 . . . . 0.0 110.739 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 271' ' ' GLN . 57.2 Cg_endo -73.59 42.27 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.883 3.056 . . . . 0.0 111.834 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -91.02 -24.92 19.92 Favored 'General case' 0 N--CA 1.462 0.162 0 O-C-N 122.152 -0.342 . . . . 0.0 111.028 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -142.31 22.39 2.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.251 0.621 . . . . 0.0 110.683 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 268' ' ' PRO . 5.4 tp-100 -63.51 -21.43 66.32 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.308 0.643 . . . . 0.0 111.204 -175.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.51 -133.38 10.03 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.2 t -78.61 20.36 0.44 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.679 0.791 . . . . 0.0 111.541 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -7.52 3.54 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.942 0.497 . . . . 0.0 112.263 -174.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -85.07 -19.52 31.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.78 0.432 . . . . 0.0 110.822 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.19 0.95 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 58.4 m -144.95 150.65 37.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.97 0.508 . . . . 0.0 110.585 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -88.57 2.12 53.66 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -98.51 -110.09 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 54.27 15.27 0.91 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -149.24 160.23 43.56 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 41.0 t -157.24 -33.91 0.08 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -91.27 5.14 50.35 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.82 0.848 . . . . 0.0 112.92 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.44 44.51 2.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.198 0.599 . . . . 0.0 111.088 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.42 3.98 2.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.197 0.599 . . . . 0.0 111.694 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 m -105.75 147.83 28.14 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 15.6 pt -128.45 149.91 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.035 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -104.75 149.76 25.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.11 147.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.485 0.714 . . . . 0.0 111.12 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -139.38 150.13 44.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.7 5.05 57.83 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.995 -0.336 . . . . 0.0 112.801 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.64 -56.31 21.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.516 0.727 . . . . 0.0 111.288 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.475 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.72 -179.43 45.87 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.19 -10.41 59.39 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.704 0.802 . . . . 0.0 112.251 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -81.56 -0.69 43.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.242 0.217 . . . . 0.0 111.319 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.87 155.95 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 t -157.54 168.39 27.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mm -50.3 -40.0 17.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.324 1.05 . . . . 0.0 111.572 -174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -72.36 -28.83 63.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.405 -0.184 . . . . 0.0 111.102 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.3 t -74.5 -50.26 18.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.272 0.229 . . . . 0.0 110.456 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.25 -53.55 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.428 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.59 -37.39 78.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.531 0.605 . . . . 0.0 110.664 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -76.12 -15.81 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 111.109 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -94.52 -27.52 15.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -96.71 -20.68 18.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.6 pttt -65.31 -19.09 65.8 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.45 -20.76 66.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.0 mm -88.59 -24.65 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-O 120.665 0.269 . . . . 0.0 110.342 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.53 168.79 27.18 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 49.3 mm -67.37 136.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 122.614 -0.345 . . . . 0.0 111.002 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 322' ' ' ILE . 6.9 mm -78.22 137.58 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.419 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 23.8 ttmm -71.89 145.92 48.21 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 110.578 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.22 142.65 38.17 Favored 'General case' 0 N--CA 1.458 -0.075 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -74.53 -14.55 60.82 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 58.94 7.66 0.84 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -134.73 -30.46 1.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 118.928 0.785 . . . . 0.0 112.007 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 74.6 p -95.81 -9.98 30.19 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 122.467 0.307 . . . . 0.0 110.658 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.11 79.76 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.4 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 3.4 pt20 -140.05 161.28 56.57 Favored Pre-proline 0 C--O 1.231 0.096 0 CA-C-N 117.449 0.625 . . . . 0.0 109.687 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 319' ' ' GLN . 20.9 Cg_endo -61.25 155.73 49.83 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.476 2.117 . . . . 0.0 109.856 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 59.2 mtp -76.79 76.64 3.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.956 0.502 . . . . 0.0 110.997 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.799 HG21 HG21 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -134.75 158.47 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -157.37 133.1 9.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.5 mm? -93.37 120.12 33.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -82.92 159.73 22.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 57.4 p -133.8 157.11 46.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.298 0.57 . . . . 0.0 111.77 -171.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.57 127.89 34.55 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.184 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 328' ' ' ARG . 35.0 mtp85 -76.24 -6.86 53.3 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.33 0.252 . . . . 0.0 111.132 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -98.74 -5.56 31.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.6 t -149.93 -23.0 0.26 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.742 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.71 25.76 40.86 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.717 -0.491 . . . . 0.0 112.992 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -131.46 170.65 14.4 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 117.646 0.723 . . . . 0.0 110.414 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 333' ' ' LEU . 0.2 OUTLIER -47.57 122.87 5.16 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.901 0.881 . . . . 0.0 111.269 -173.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.561 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.7 ttmm -81.65 -18.76 43.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.983 0.913 . . . . 0.0 109.782 174.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 95.62 2.13 61.69 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.77 150.97 19.64 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.455 0.627 . . . . 0.0 111.119 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.47 33.68 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.003 0.521 . . . . 0.0 109.723 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.4 m -135.74 123.14 21.95 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.2 123.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 32.8 t -95.73 127.54 41.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.712 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.48 147.65 26.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -75.71 -17.5 59.92 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 90.5 m-20 -128.27 133.28 24.98 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.048 0.939 . . . . 0.0 110.834 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 30.0 Cg_endo -67.12 -32.65 33.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.669 2.246 . . . . 0.0 114.6 -175.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 95.8 Cg_endo -75.17 -19.35 17.58 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 121.175 1.456 . . . . 0.0 110.753 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.5 m -76.98 -29.32 55.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.74 -47.56 74.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -64.92 -37.39 87.49 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.92 80.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.31 0.244 . . . . 0.0 110.483 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -25.27 65.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 63.7 mt -73.27 -56.07 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -60.93 -21.88 63.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -93.54 -60.78 1.69 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -69.22 -32.1 71.12 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.24 112.17 1.3 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 109.95 -16.06 30.78 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.945 175.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -94.76 -172.3 2.69 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.753 1.276 . . . . 0.0 109.969 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -100.91 174.22 6.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.588 0.355 . . . . 0.0 110.457 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.619 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -129.78 -38.37 1.49 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.3 t -143.9 15.57 1.74 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.698 0.399 . . . . 0.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 120.07 -18.7 9.63 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -104.22 148.77 36.47 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.02 151.11 73.31 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.483 2.789 . . . . 0.0 110.624 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.62 168.76 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.016 0.527 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -134.1 155.39 50.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.139 0.576 . . . . 0.0 111.101 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 55.1 t -144.34 146.27 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 122.899 0.48 . . . . 0.0 110.221 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 20.3 m -154.23 172.91 16.87 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -58.69 160.01 6.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.894 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -130.96 137.54 49.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 12.7 m -140.21 135.6 32.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.399 0.68 . . . . 0.0 109.932 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -47.52 120.47 3.3 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.285 0.366 . . . . 0.0 110.936 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -69.16 -28.74 66.7 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.27 75.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.904 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -67.28 -7.92 28.06 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.509 ' CD2' ' HE3' ' A' ' 264' ' ' LYS . 93.8 m-85 -108.08 -9.2 15.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.93 -40.45 0.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -83.22 -2.8 56.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.802 0.274 . . . . 0.0 111.718 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.2 4.36 88.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.19 1.39 63.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 117.413 0.607 . . . . 0.0 112.263 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -80.72 160.99 43.82 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 117.618 0.709 . . . . 0.0 111.483 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -150.17 169.12 22.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.486 0.715 . . . . 0.0 110.361 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -75.17 167.47 54.88 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -154.52 -177.49 6.51 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.176 0.512 . . . . 0.0 110.604 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.518 ' H ' ' H21' ' B' ' 109' ' ' ' G' . . . -173.8 -161.04 23.23 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 159.78 -1.9 0.09 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 46.9 ttm105 -150.67 148.87 29.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -58.52 148.23 38.35 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -67.55 148.3 51.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.656 0.383 . . . . 0.0 110.236 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 178.56 -179.33 48.72 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 117.334 -1.815 . . . . 0.0 110.978 -179.579 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C5'-C4'-C3' 110.767 -3.156 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.373 -2.517 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 N19-C1'-C2' 109.107 -2.683 . 0.848 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 0 N19-C1'-C2' 109.333 -2.542 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 110.907 2.707 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.51 0 O4'-C1'-N19 110.724 2.524 . 0.831 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.85 0 O4'-C1'-N19 110.83 2.63 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.82 0 C5'-C4'-C3' 111.542 -2.639 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.871 0 C5'-C4'-C3' 111.739 -2.507 . 0.762 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.923 0 C5'-C4'-C3' 110.563 -3.291 . 0.676 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.458 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.051 0 C5'-C4'-C3' 111.575 -2.617 . 0.529 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.458 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.427 -2.175 0 C5'-C4'-C3' 110.707 -3.195 . 0.445 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 C5'-C4'-C3' 109.411 -4.059 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 1 O4'-C1'-N19 112.994 4.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.561 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 C5'-C4'-C3' 109.73 -3.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 1 C3'-C2'-C1' 105.621 4.579 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . 0.486 " H3'" " C5'" ' B' ' 108' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.746 0 C5'-C4'-C3' 109.969 -3.688 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . 0.486 " C5'" " H3'" ' B' ' 107' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.715 0 C4'-C3'-C2' 100.309 -2.391 . 0.132 8d . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . 0.518 ' H21' ' H ' ' A' ' 384' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 C4'-C3'-C2' 100.0 -2.7 . 0.721 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 O4'-C1'-N19 110.777 2.577 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 N19-C1'-C2' 109.154 -2.654 . 0.814 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 0 C4'-C3'-C2' 100.267 -2.433 . 0.733 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 C5'-C4'-C3' 112.202 -2.199 . 0.794 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 O4'-C1'-N19 110.66 2.46 . 0.777 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 110.648 2.448 . 0.758 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 O4'-C1'-N19 110.707 2.507 . 0.799 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 O4'-C1'-N19 110.591 2.391 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.83 0 O4'-C1'-N19 110.764 2.564 . 0.848 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.45 -171.53 54.8 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -72.16 178.56 3.78 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.447 ' CG ' ' H22' ' B' ' 106' ' ' ' G' . 23.8 m-80 -67.0 -176.45 0.52 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.529 0.731 . . . . 0.0 110.656 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.486 ' HD2' ' H ' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -62.36 -19.11 63.04 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.613 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -95.3 -4.45 45.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.702 0.228 . . . . 0.0 110.865 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 85.44 10.24 77.54 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.464 169.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 68.12 -161.37 49.99 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.972 1.386 . . . . 0.0 110.572 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.502 ' HA ' HE21 ' A' ' 271' ' ' GLN . 55.6 Cg_endo -71.11 35.56 0.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.914 3.076 . . . . 0.0 111.873 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -89.42 -39.05 13.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.928 -0.482 . . . . 0.0 110.527 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -112.58 16.26 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.988 0.515 . . . . 0.0 110.343 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.502 HE21 ' HA ' ' A' ' 268' ' ' PRO . 4.6 tp-100 -67.61 -23.81 65.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.842 0.457 . . . . 0.0 111.529 -172.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 114.35 -130.43 9.27 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 9.8 t -78.2 20.71 0.38 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.644 0.777 . . . . 0.0 112.117 -174.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -5.43 3.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.029 0.531 . . . . 0.0 112.307 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . 0.426 ' H ' ' CD2' ' A' ' 275' ' ' HIS . 20.4 p80 -86.93 -19.81 28.26 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.559 0.344 . . . . 0.0 111.09 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -123.38 2.34 9.08 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 57.8 m -151.72 156.83 41.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 109.08 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -104.42 16.81 25.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.42 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -100.09 -108.76 0.21 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 54.84 13.73 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -146.82 151.6 37.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.2 t -156.09 -33.73 0.09 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.556 0.162 . . . . 0.0 110.75 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -79.81 7.38 8.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.648 0.261 . . . . 0.0 111.523 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.62 147.88 52.56 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.934 0.894 . . . . 0.0 109.499 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -154.75 27.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 2.2 m -135.22 149.5 49.9 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -172.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.1 pt -131.95 146.95 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.582 0.353 . . . . 0.0 110.309 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.25 150.19 22.8 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 10.2 t -134.13 147.23 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.866 0.466 . . . . 0.0 111.783 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -136.74 149.85 48.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 96.72 6.15 58.4 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 120.005 -0.33 . . . . 0.0 112.361 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.76 -56.1 24.55 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.467 0.707 . . . . 0.0 110.857 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.469 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.82 -179.89 45.85 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -78.95 -10.35 59.79 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.873 0.869 . . . . 0.0 112.26 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.83 -1.63 43.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.352 0.261 . . . . 0.0 111.348 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.68 156.19 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.3 t -158.7 168.51 26.66 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.2 mm -49.32 -40.27 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.421 1.088 . . . . 0.0 111.728 -174.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -72.71 -29.14 63.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.348 -0.22 . . . . 0.0 111.209 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.1 t -74.68 -50.14 18.7 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.235 0.214 . . . . 0.0 110.594 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.837 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -61.18 -53.57 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.435 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -59.68 -38.15 80.75 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.975 -0.453 . . . . 0.0 110.565 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -75.94 -15.46 60.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 111.028 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -94.39 -27.02 16.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 339' ' ' VAL . 46.8 m-85 -97.66 -20.13 17.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.3 pttt -66.08 -18.9 65.64 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -173.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.9 pt20 -63.77 -21.59 66.49 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 11.9 mm -87.35 -24.06 6.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.968 0.349 . . . . 0.0 110.2 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 161.19 172.72 28.91 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 40.2 mm -66.41 137.39 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 0.0 111.52 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 322' ' ' ILE . 7.1 mm -78.38 133.82 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 342' ' ' ASP . 12.6 tppt? -64.55 133.01 51.47 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 2.8 m -89.96 141.38 28.72 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.7 152.48 45.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -72.16 -23.21 61.25 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -146.35 -13.51 0.46 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.4 p -87.16 -14.56 40.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.746 0.703 . . . . 0.0 112.508 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.15 -19.62 2.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.649 0.642 . . . . 0.0 113.395 171.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -80.78 161.99 61.77 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 117.761 0.78 . . . . 0.0 110.039 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.88 152.04 82.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.04 1.827 . . . . 0.0 109.047 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 71.1 mtp -78.27 80.69 4.67 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.579 0.352 . . . . 0.0 111.196 -175.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.837 HG21 HG21 ' A' ' 301' ' ' VAL . 0.4 OUTLIER -133.78 154.6 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -150.36 121.3 7.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.227 0.611 . . . . 0.0 109.536 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.6 mm? -88.41 121.83 31.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.516 ' CD1' " H1'" ' B' ' 105' ' ' ' U' . 77.6 m-85 -79.26 162.21 25.82 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.108 0.48 . . . . 0.0 112.092 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 51.9 p -137.42 153.57 50.12 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.503 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -63.28 135.53 57.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.607 0.763 . . . . 0.0 112.305 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -78.12 -13.11 59.99 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.286 -0.259 . . . . 0.0 110.405 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -93.44 -5.72 48.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.0 t -150.2 -23.81 0.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.025 0.375 . . . . 0.0 110.588 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.64 17.58 63.57 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.808 173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -119.94 169.67 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.967 0.884 . . . . 0.0 110.299 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 333' ' ' LEU . 0.4 OUTLIER -45.98 122.55 3.9 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.534 0.733 . . . . 0.0 111.469 -174.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.517 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 22.2 ttmm -80.62 -21.43 41.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.596 174.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 97.96 16.88 31.78 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -119.81 154.96 33.49 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 117.398 0.599 . . . . 0.0 110.405 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.81 171.02 20.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.878 0.471 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 42.0 m -134.78 128.18 32.32 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.739 0.416 . . . . 0.0 110.262 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.411 HG21 ' CD1' ' A' ' 305' ' ' PHE . 93.1 t -118.23 128.39 75.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 321' ' ' MET . 43.7 t -98.92 132.91 43.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.73 176.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -90.86 148.28 22.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HA ' ' CE ' ' A' ' 312' ' ' LYS . 47.4 t0 -70.96 -22.78 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.44 ' HB3' ' HD2' ' A' ' 345' ' ' PRO . 98.8 m-20 -124.82 135.82 27.2 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.318 0.647 . . . . 0.0 111.693 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 19.2 Cg_endo -64.05 -36.67 47.13 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.799 2.333 . . . . 0.0 113.925 -175.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 94.5 Cg_endo -76.89 -16.42 16.17 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.579 1.519 . . . . 0.0 111.172 -176.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 50.4 m -77.44 -29.53 52.9 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.87 81.58 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -64.52 -39.47 93.83 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 122.175 0.19 . . . . 0.0 110.742 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.99 -40.37 83.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.565 0.346 . . . . 0.0 110.908 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.14 -24.97 65.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 61.4 mt -72.56 -57.72 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.85 -21.44 63.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -92.8 -59.15 2.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.76 -33.45 70.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -56.43 112.11 1.17 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.37 -16.46 29.45 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.188 -0.785 . . . . 0.0 113.046 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -93.83 -171.92 2.72 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.7 1.25 . . . . 0.0 109.695 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -102.8 172.21 6.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.696 0.284 . . . . 0.0 110.421 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 364' ' ' ILE . 5.6 t80 -126.34 -38.92 2.08 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 26.4 t -142.59 6.29 1.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.834 0.454 . . . . 0.0 110.477 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 133.38 -22.27 3.97 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -101.76 149.37 36.4 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.73 152.29 77.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.474 2.782 . . . . 0.0 110.296 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.607 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -137.66 166.29 24.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 122.747 0.419 . . . . 0.0 110.792 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -131.46 156.1 46.23 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.155 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 45.3 t -144.86 147.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.453 0.471 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -156.53 173.21 17.25 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.809 0.843 . . . . 0.0 108.801 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -60.23 152.89 23.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.623 ' HA ' ' H21' ' B' ' 106' ' ' ' G' . . . -123.95 137.16 54.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 7.4 m -142.71 139.52 31.16 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -44.13 109.57 0.16 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.117 0.567 . . . . 0.0 110.533 -173.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -31.03 67.89 Favored 'General case' 0 C--N 1.337 0.054 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.84 -32.0 73.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.131 0.172 . . . . 0.0 110.803 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.8 -8.81 11.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.78 -7.54 15.03 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.25 -41.84 0.11 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -80.71 -9.13 59.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.178 0.445 . . . . 0.0 111.569 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.69 72.08 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.48 47.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -71.72 163.36 54.33 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.71 169.42 24.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.967 0.507 . . . . 0.0 110.618 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -170.35 164.18 37.46 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -78.14 159.12 28.81 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 122.687 0.395 . . . . 0.0 110.498 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -68.1 139.49 34.37 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -95.81 171.27 28.65 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -64.76 137.94 58.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -81.79 132.06 10.88 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -79.04 151.13 31.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -72.94 -165.64 9.18 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.532 -1.705 . . . . 0.0 110.938 178.319 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 N19-C1'-C2' 109.689 -2.32 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.622 0 C4'-C3'-C2' 100.174 -2.526 . 0.882 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 N19-C1'-C2' 109.177 -2.639 . 0.867 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 N19-C1'-C2' 109.034 -2.729 . 0.838 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.56 0 C5'-C4'-C3' 111.713 -2.524 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.951 0 O4'-C1'-N19 110.911 2.711 . 0.89 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 110.831 2.631 . 0.799 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.903 2.703 . 0.799 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 0 O4'-C1'-N19 110.917 2.717 . 0.662 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 C5'-C4'-C3' 111.426 -2.716 . 0.627 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.527 0 C5'-C4'-C3' 111.014 -2.991 . 0.396 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 C5'-C4'-C3' 110.507 -3.329 . 0.361 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.888 0 C5'-C4'-C3' 109.663 -3.891 . 0.255 4s . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.615 2.211 1 O4'-C1'-N19 113.249 5.049 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.517 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 C5'-C4'-C3' 110.513 -3.325 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.623 ' H21' ' HA ' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.601 1 C3'-C2'-C1' 105.647 4.608 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 C5'-C4'-C3' 109.868 -3.755 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.564 0 C5'-C4'-C3' 110.305 -3.464 . 0.454 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C4'-C3'-C2' 100.071 -2.629 . 0.378 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 N19-C1'-C2' 109.147 -2.658 . 0.749 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 N19-C1'-C2' 109.106 -2.684 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.416 0 N19-C1'-C2' 109.696 -2.315 . 0.752 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 C5'-C4'-C3' 112.428 -2.048 . 0.774 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.029 2.829 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 O4'-C1'-N19 111.181 2.981 . 0.674 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 110.956 2.756 . 0.718 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.962 0 O4'-C1'-N19 110.994 2.794 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 O4'-C1'-N19 110.734 2.534 . 0.841 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.06 172.09 51.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -69.72 108.0 3.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 58.55 -167.21 0.15 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.163 0.585 . . . . 0.0 110.783 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.609 ' H ' ' HD3' ' A' ' 264' ' ' LYS . 0.0 OUTLIER -78.63 -1.62 35.1 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.557 0.743 . . . . 0.0 112.586 -175.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -116.48 -8.79 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.069 0.395 . . . . 0.0 109.967 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.85 87.03 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.962 169.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 269' ' ' ARG . . . 65.36 -149.29 51.63 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.95 1.375 . . . . 0.0 110.56 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.77 16.05 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.999 3.132 . . . . 0.0 112.593 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 267' ' ' GLY . 49.6 tpt85 -82.69 -24.73 33.53 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.217 -0.302 . . . . 0.0 110.58 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -108.96 3.64 22.45 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.16 167.3 19.64 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.745 0.418 . . . . 0.0 110.863 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -79.27 -113.54 0.23 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.759 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 74.5 m -75.54 29.28 0.1 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.808 0.843 . . . . 0.0 113.139 -174.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.56 -6.12 10.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.237 0.471 . . . . 0.0 112.036 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' HIS . . . . . 0.414 ' H ' ' CD2' ' A' ' 275' ' ' HIS . 20.8 p80 -89.54 -17.9 27.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.791 0.436 . . . . 0.0 111.068 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -129.52 -0.03 4.99 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.4 m -144.46 155.05 43.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 122.633 0.373 . . . . 0.0 110.674 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.82 0.73 56.41 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.315 0.646 . . . . 0.0 111.207 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -89.43 -82.65 0.25 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.442 0.297 . . . . 0.0 110.355 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.5 p30 49.62 15.03 0.13 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.142 1.777 . . . . 0.0 114.853 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -152.7 158.43 42.33 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 34.1 t -149.46 2.35 0.54 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.824 0.345 . . . . 0.0 110.632 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -140.46 10.15 2.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.765 0.826 . . . . 0.0 112.425 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -133.2 56.18 1.86 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.296 0.639 . . . . 0.0 110.854 -172.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.4 -12.48 60.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.608 0.363 . . . . 0.0 110.39 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 m -92.57 147.33 22.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.26 147.89 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 122.939 0.496 . . . . 0.0 109.883 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -101.78 148.38 25.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.27 148.7 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.133 0.573 . . . . 0.0 111.125 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.33 149.35 45.54 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.23 5.6 58.06 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.943 -0.365 . . . . 0.0 112.849 172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.39 -53.86 51.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.655 0.727 . . . . 0.0 111.412 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.509 ' H ' ' HA2' ' A' ' 335' ' ' GLY . . . 88.51 -176.61 44.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -170.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -86.87 -7.51 58.14 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.669 0.788 . . . . 0.0 112.519 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -78.01 -5.69 52.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 110.887 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.23 159.62 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.661 0.785 . . . . 0.0 112.303 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.05 168.03 26.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.07 -39.87 12.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.2 1.0 . . . . 0.0 111.712 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -73.47 -28.52 61.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.368 -0.208 . . . . 0.0 110.905 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.2 t -75.09 -49.5 19.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.104 0.161 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.808 HG21 HG21 ' A' ' 322' ' ' ILE . 2.7 m -60.98 -53.86 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.447 ' H ' HG23 ' A' ' 301' ' ' VAL . . . -58.84 -38.07 77.89 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.053 0.388 . . . . 0.0 110.751 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -75.89 -15.67 60.17 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.129 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.58 -27.49 15.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -96.98 -20.42 18.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 309' ' ' GLY . 52.9 pttt -65.39 -19.04 65.77 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -173.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 6.6 pt20 -64.57 -21.19 66.63 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 12.5 mm -88.11 -24.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.312 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 306' ' ' LYS . . . 164.2 169.31 27.56 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.17 137.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 O-C-N 122.645 -0.327 . . . . 0.0 111.093 -172.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.451 HG21 HD11 ' A' ' 322' ' ' ILE . 6.7 mm -78.95 137.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HG2' ' SD ' ' A' ' 321' ' ' MET . 22.3 ttmm -69.42 149.7 48.05 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -125.04 138.46 54.2 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -71.1 141.04 50.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -77.08 -18.43 58.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -112.88 -38.55 4.5 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.151 0.432 . . . . 0.0 111.904 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.8 p -85.1 -20.27 30.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.81 -15.49 4.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.3 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -83.95 158.56 61.68 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 117.837 0.818 . . . . 0.0 109.52 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.34 154.02 70.75 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.368 2.045 . . . . 0.0 109.193 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.453 ' SD ' ' HG2' ' A' ' 312' ' ' LYS . 65.8 mtp -79.35 79.67 5.77 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.696 0.399 . . . . 0.0 110.928 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.808 HG21 HG21 ' A' ' 301' ' ' VAL . 0.3 OUTLIER -135.15 155.53 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.668 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.98 129.53 13.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 324' ' ' LEU . 1.7 mm? -92.08 119.83 32.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.434 ' CD2' " H1'" ' B' ' 105' ' ' ' U' . 97.4 m-85 -83.94 157.33 21.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.429 HG22 HD23 ' A' ' 333' ' ' LEU . 18.9 p -132.33 155.17 48.86 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -170.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -69.64 122.61 19.44 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.19 170.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -74.03 -5.22 40.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.522 0.201 . . . . 0.0 110.728 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.36 -6.78 36.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.475 0.71 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 2.5 t -149.01 -23.72 0.3 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.533 0.606 . . . . 0.0 110.81 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.97 41.33 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.796 -0.446 . . . . 0.0 112.816 172.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -129.29 166.4 19.52 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.756 0.778 . . . . 0.0 109.845 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.429 HD23 HG22 ' A' ' 326' ' ' THR . 4.9 mt -50.23 126.24 14.33 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.522 0.201 . . . . 0.0 110.783 -173.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.714 ' HE3' ' C4 ' ' B' ' 105' ' ' ' U' . 0.1 OUTLIER -85.02 1.81 45.98 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA2' ' H ' ' A' ' 293' ' ' GLY . . . 92.13 -2.31 75.05 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.37 146.62 24.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.786 0.793 . . . . 0.0 111.136 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.77 166.64 32.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 10.3 m -138.56 121.32 16.42 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 122.556 0.342 . . . . 0.0 111.457 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.68 126.07 72.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 38.4 t -97.31 127.69 43.5 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.309 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.439 ' O ' ' HE2' ' A' ' 312' ' ' LYS . 42.2 m-85 -84.29 147.71 27.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.6 -18.66 59.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -126.06 133.79 25.29 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 110.685 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 27.5 Cg_endo -66.31 -33.68 37.96 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 114.405 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 84.8 Cg_endo -75.81 -20.1 15.61 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 121.2 1.464 . . . . 0.0 111.122 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 52.6 m -74.82 -29.61 61.13 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.8 78.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.13 0.172 . . . . 0.0 110.742 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -63.04 -39.75 95.66 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.404 0.282 . . . . 0.0 110.622 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.68 81.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.53 0.332 . . . . 0.0 110.842 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.04 65.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.4 -57.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -59.78 -21.93 61.45 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -93.82 -60.0 1.86 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.44 -31.94 70.58 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -56.43 111.73 1.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.45 -14.97 30.1 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 119.052 -0.86 . . . . 0.0 113.07 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -95.25 -171.99 2.55 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.748 1.274 . . . . 0.0 109.851 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.51 175.5 5.55 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.303 0.241 . . . . 0.0 110.606 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.606 ' HB2' HG21 ' A' ' 364' ' ' ILE . 4.7 t80 -131.08 -38.4 1.23 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 23.2 t -143.23 16.49 1.89 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.157 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.73 -18.89 12.72 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.93 148.51 35.43 Favored Pre-proline 0 C--O 1.233 0.187 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.06 152.1 73.0 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.707 2.938 . . . . 0.0 110.722 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 359' ' ' PHE . 1.3 pt -138.36 168.3 20.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 122.821 0.448 . . . . 0.0 110.953 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.7 156.32 47.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.0 146.11 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.089 0.555 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 m -154.64 171.82 18.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -58.47 159.45 6.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.412 ' HB1' " H1'" ' B' ' 106' ' ' ' G' . . . -130.36 138.24 50.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 4.1 m -141.8 136.69 30.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.76 0.824 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -48.09 109.34 0.22 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 122.895 0.478 . . . . 0.0 110.413 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -31.26 66.53 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.002 0.521 . . . . 0.0 109.923 -173.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.95 -31.47 71.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.447 -0.158 . . . . 0.0 110.807 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -67.21 -11.56 57.72 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.457 ' CG ' ' HE2' ' A' ' 264' ' ' LYS . 96.5 m-85 -97.09 -13.08 22.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.09 -40.48 0.08 Allowed 'General case' 0 C--N 1.341 0.221 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 37.9 mmm-85 -82.9 -2.13 54.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.37 12.09 73.82 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.8 -158.41 35.14 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -73.25 -170.76 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -150.02 169.57 20.9 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.921 0.488 . . . . 0.0 109.707 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -175.25 169.2 42.0 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -135.88 164.23 28.41 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.189 0.596 . . . . 0.0 109.462 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.28 133.81 26.35 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -92.37 175.5 37.73 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -68.89 141.18 55.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' GLY . . . . . . . . . . . . . . . -79.79 172.07 54.76 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -67.79 147.22 52.88 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -72.07 174.34 43.94 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 117.158 -1.912 . . . . 0.0 110.818 -179.78 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.41 0 C5'-C4'-C3' 110.849 -3.101 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.699 0 C4'-C3'-C2' 100.235 -2.465 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 C4'-C3'-C2' 100.102 -2.598 . 0.837 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 O4'-C1'-N19 110.848 2.648 . 0.783 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 110.708 2.508 . 0.846 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 O4'-C1'-N19 110.795 2.595 . 0.867 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O4'-C1'-N19 111.216 3.016 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 0 O4'-C1'-N19 111.2 3.0 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.906 0 O4'-C1'-N19 110.58 2.38 . 0.773 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 C5'-C4'-C3' 111.007 -2.995 . 0.574 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ' C' . . . . . 0.426 " H2'" ' C8 ' ' B' ' 102' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.913 0 C5'-C4'-C3' 111.343 -2.771 . 0.774 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' ' A' . . . . . 0.426 ' C8 ' " H2'" ' B' ' 101' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C5'-C4'-C3' 110.503 -3.331 . 0.404 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.563 0 C5'-C4'-C3' 109.626 -3.916 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.43 -1.886 1 O4'-C1'-N19 112.64 4.44 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ' U' . . . . . 0.714 ' C4 ' ' HE3' ' A' ' 334' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.737 1 C5'-C4'-C3' 109.399 -4.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ' G' . . . . . 0.412 " H1'" ' HB1' ' A' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.8 1 C3'-C2'-C1' 105.795 4.772 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 109.929 -3.714 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 C5'-C4'-C3' 110.928 -3.048 . 0.353 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.393 0 N19-C1'-C2' 109.059 -2.713 . 0.718 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 N19-C1'-C2' 109.29 -2.569 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.584 0 N19-C1'-C2' 109.24 -2.6 . 0.783 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 N19-C1'-C2' 108.999 -2.75 . 0.697 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 C5'-C4'-C3' 112.095 -2.27 . 0.746 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 0 O4'-C1'-N19 110.786 2.586 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.508 0 O4'-C1'-N19 110.715 2.515 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.722 0 O4'-C1'-N19 110.383 2.183 . 0.701 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.787 0 C4'-C3'-C2' 100.445 -2.255 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.678 0 N19-C1'-C2' 109.627 -2.358 . 0.818 1a . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_